drug_name,disease_name,protein_name
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
imatinib,systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
imatinib,systemic mastocytosis,platelet derived growth factor receptor alpha
paracetamol,pain,prostaglandin-endoperoxide synthase 1
paracetamol,pain,prostaglandin-endoperoxide synthase 2
paracetamol,pain,prostaglandin e synthase 3
aspirin,pain,prostaglandin-endoperoxide synthase 1
aspirin,pain,prostaglandin-endoperoxide synthase 2
aspirin,thrombotic disease,prostaglandin-endoperoxide synthase 1
naproxen,pain,prostaglandin-endoperoxide synthase 2
cortisone,keratitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
pinacidil,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
antazoline,vasomotor rhinitis,histamine receptor h1
levofloxacin,pyelonephritis,dna topoisomerase ii alpha
meloxicam,pain,prostaglandin-endoperoxide synthase 2
fluticasone,bronchitis,nuclear receptor subfamily 3 group c member 1
fluphenazine,schizophrenia,dopamine receptor d2
fluphenazine,schizophrenia,dopamine receptor d1
terfenadine,allergic contact dermatitis,histamine receptor h1
norethisterone,menorrhagia,progesterone receptor
ziprasidone,schizophrenia,dopamine receptor d2
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 2a
carbinoxamine,atopic conjunctivitis,histamine receptor h1
fsh,primary ovarian failure,follicle stimulating hormone receptor
warfarin,pulmonary embolism,vitamin k epoxide reductase complex subunit 1
loratadine,allergic rhinitis,histamine receptor h1
oxymetazoline,nasal congestion,adrenoceptor alpha 1a
duloxetine,major depressive disorder,solute carrier family 6 member 4
doxylamine,allergic rhinitis,histamine receptor h1
minoxidil,alopecia,potassium inwardly rectifying channel subfamily j member 1
minoxidil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 1
sildenafil,erectile dysfunction,phosphodiesterase 5a
betamethasone,crohn disease,nuclear receptor subfamily 3 group c member 1
triamcinolone,crohn disease,nuclear receptor subfamily 3 group c member 1
gabapentin,restless legs syndrome,calcium voltage-gated channel auxiliary subunit alpha2delta 1
prednisolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
pimozide,tourette syndrome,dopamine receptor d2
levonorgestrel,menorrhagia,progesterone receptor
dimethyl fumarate,multiple sclerosis,kelch like ech associated protein 1
protriptyline,major depressive disorder,solute carrier family 6 member 2
terguride,pulmonary hypertension,5-hydroxytryptamine receptor 2b
lafutidine,gastroesophageal reflux disease,histamine receptor h2
ospemifene,psychologic dyspareunia,estrogen receptor 1
glipizide,hyperglycemia,atp binding cassette subfamily c member 8
landiolol,tachycardia,adrenoceptor beta 1
levocabastine,atopic conjunctivitis,histamine receptor h1
acenocoumarol,pulmonary embolism,vitamin k epoxide reductase complex subunit 1
dexamethasone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
mosapramine,schizophrenia,dopamine receptor d2
thyrotropin alfa,thyroid tumor,thyroid stimulating hormone receptor
metolazone,hypertensive disorder,solute carrier family 12 member 3
gepirone,major depressive disorder,5-hydroxytryptamine receptor 1a
tramadol,pain,opioid receptor mu 1
trimethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
apalutamide,prostate cancer,androgen receptor
aminoglutethimide,breast neoplasm,cytochrome p450 family 19 subfamily a member 1
anastrozole,breast neoplasm,cytochrome p450 family 19 subfamily a member 1
etizolam,anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha1
sulfasalazine,ulcerative colitis,arachidonate 5-lipoxygenase
vinpocetine,dementia,phosphodiesterase 1a
glutethimide,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
fomepizole,acidosis disorder,"alcohol dehydrogenase 1a (class i), alpha polypeptide"
afamelanotide,erythropoietic protoporphyria,melanocortin 1 receptor
voclosporin,uveitis,"protein phosphatase 3 regulatory subunit b, alpha"
cobicistat,hiv infectious disease,cytochrome p450 family 3 subfamily a member 43
medrysone,uveitis,nuclear receptor subfamily 3 group c member 1
medrysone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
medrysone,iritis,nuclear receptor subfamily 3 group c member 1
medrysone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
diflunisal,osteoarthritis,prostaglandin-endoperoxide synthase 1
diflunisal,osteoarthritis,prostaglandin-endoperoxide synthase 2
diflunisal,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
diflunisal,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
diflunisal,pain,prostaglandin-endoperoxide synthase 1
diflunisal,pain,prostaglandin-endoperoxide synthase 2
diflunisal,chronic pain,prostaglandin-endoperoxide synthase 1
diflunisal,chronic pain,prostaglandin-endoperoxide synthase 2
polythiazide,hypertensive disorder,solute carrier family 12 member 3
mepyramine,atopic conjunctivitis,histamine receptor h1
mepyramine,seasonal allergic rhinitis,histamine receptor h1
mepyramine,sneeze,histamine receptor h1
mepyramine,allergic rhinitis,histamine receptor h1
mepyramine,dysmenorrhea,histamine receptor h1
mepyramine,vasomotor rhinitis,histamine receptor h1
mepyramine,urticaria,histamine receptor h1
mepyramine,pruritus,histamine receptor h1
azilsartan medoxomil,hypertensive disorder,angiotensin ii receptor type 1
teriflunomide,multiple sclerosis,dihydroorotate dehydrogenase (quinone)
hydroxocobalamin,vitamin b12 deficiency,5-methyltetrahydrofolate-homocysteine methyltransferase
hydroxocobalamin,vitamin b12 deficiency,methylmalonyl-coa mutase
hydroxocobalamin,vitamin deficiency disorder,5-methyltetrahydrofolate-homocysteine methyltransferase
hydroxocobalamin,vitamin deficiency disorder,methylmalonyl-coa mutase
hydroxocobalamin,pernicious anemia,5-methyltetrahydrofolate-homocysteine methyltransferase
formoterol,pulmonary emphysema,adrenoceptor beta 2
bromocriptine,acromegaly,dopamine receptor d2
bromocriptine,acromegaly,dopamine receptor d3
bromocriptine,postencephalitic parkinson disease,dopamine receptor d2
bromocriptine,postencephalitic parkinson disease,dopamine receptor d3
bromocriptine,parkinson disease,dopamine receptor d2
bromocriptine,parkinson disease,dopamine receptor d3
bromocriptine,hyperprolactinemia,dopamine receptor d2
bromocriptine,hyperprolactinemia,dopamine receptor d3
pramipexole,parkinson disease,dopamine receptor d2
pramipexole,parkinson disease,dopamine receptor d3
pramipexole,parkinson disease,dopamine receptor d4
pramipexole,restless legs syndrome,dopamine receptor d2
pramipexole,restless legs syndrome,dopamine receptor d3
pramipexole,restless legs syndrome,dopamine receptor d4
spironolactone,hyperaldosteronism,nuclear receptor subfamily 3 group c member 2
spironolactone,edema,nuclear receptor subfamily 3 group c member 2
spironolactone,ascites,nuclear receptor subfamily 3 group c member 2
spironolactone,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
eletriptan,migraine disorder,5-hydroxytryptamine receptor 1d
eletriptan,migraine disorder,5-hydroxytryptamine receptor 1b
eletriptan,migraine disorder,5-hydroxytryptamine receptor 2a
eletriptan,migraine disorder,5-hydroxytryptamine receptor 1a
terbutaline,pulmonary emphysema,adrenoceptor beta 2
terbutaline,pulmonary emphysema,adrenoceptor beta 3
terbutaline,pruritus,adrenoceptor beta 2
terbutaline,pruritus,adrenoceptor beta 3
terbutaline,asthma,adrenoceptor beta 2
terbutaline,asthma,adrenoceptor beta 3
terbutaline,bronchitis,adrenoceptor beta 2
terbutaline,bronchitis,adrenoceptor beta 3
belotecan,non-small cell lung carcinoma,dna topoisomerase i
belotecan,ovarian cancer,dna topoisomerase i
amphetamine,obesity disorder,solute carrier family 18 member a2
amphetamine,obesity disorder,trace amine associated receptor 1
amphetamine,obesity disorder,cart prepropeptide
amphetamine,narcolepsy,solute carrier family 18 member a2
amphetamine,narcolepsy,trace amine associated receptor 1
amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
amphetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
cinnarizine,nausea,histamine receptor h1
cinnarizine,central nervous system origin vertigo,histamine receptor h1
cinnarizine,motion sickness,histamine receptor h1
carmofur,colonic neoplasm,n-acylsphingosine amidohydrolase 1
topiroxostat,hyperuricemia,xanthine dehydrogenase
topiroxostat,hyperuricemia,atp binding cassette subfamily g member 2 (jr blood group)
topiroxostat,gout,xanthine dehydrogenase
topiroxostat,gout,atp binding cassette subfamily g member 2 (jr blood group)
leuprolide,endometriosis,gonadotropin releasing hormone receptor
leuprolide,precocious puberty,gonadotropin releasing hormone receptor
glimepiride,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
glimepiride,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
loxapine,schizophrenia,dopamine receptor d2
loxapine,schizophrenia,5-hydroxytryptamine receptor 2a
loxapine,bipolar disorder,dopamine receptor d2
loxapine,bipolar disorder,5-hydroxytryptamine receptor 2a
oxaprozin,osteoarthritis,prostaglandin-endoperoxide synthase 1
oxaprozin,osteoarthritis,prostaglandin-endoperoxide synthase 2
oxaprozin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
oxaprozin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
oxaprozin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
oxaprozin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
pimozide,tourette syndrome,dopamine receptor d3
dehydroepiandrosterone,psychologic dyspareunia,estrogen receptor 1
dehydroepiandrosterone,psychologic dyspareunia,estrogen receptor 2
dehydroepiandrosterone,psychologic dyspareunia,androgen receptor
dehydroepiandrosterone,systemic lupus erythematosus,androgen receptor
omacetaxine mepesuccinate,"chronic myelogenous leukemia, bcr-abl1 positive",ribosomal protein l3
anagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
clemastine,urticaria,histamine receptor h1
clemastine,pruritus,histamine receptor h1
clemastine,sneeze,histamine receptor h1
clemastine,vasomotor rhinitis,histamine receptor h1
clemastine,allergic rhinitis,histamine receptor h1
clemastine,atopic conjunctivitis,histamine receptor h1
sapropterin,phenylketonuria,phenylalanine hydroxylase
insulin detemir,diabetes mellitus,insulin receptor
benzbromarone,hyperuricemia,solute carrier family 22 member 12
benzbromarone,gout,solute carrier family 22 member 12
phendimetrazine,obesity disorder,adrenoceptor alpha 1a
phendimetrazine,obesity disorder,adrenoceptor alpha 1b
phendimetrazine,obesity disorder,solute carrier family 6 member 2
valproic acid,absence epilepsy,aldehyde dehydrogenase 5 family member a1
valproic acid,absence epilepsy,histone deacetylase 9
valproic acid,bipolar disorder,myristoylated alanine rich protein kinase c substrate
valproic acid,epilepsy,histone deacetylase 9
valproic acid,migraine disorder,solute carrier family 27 member 2
levomethadyl acetate,opiate dependence,opioid receptor mu 1
bunolol,open-angle glaucoma,adrenoceptor beta 1
bunolol,open-angle glaucoma,adrenoceptor beta 2
bunolol,ocular hypertension,adrenoceptor beta 1
bunolol,ocular hypertension,adrenoceptor beta 2
clopidogrel,acute coronary syndrome,purinergic receptor p2y12
clopidogrel,intracranial embolism,purinergic receptor p2y12
carbetocin,post-partum hemorrhage,oxytocin receptor
brompheniramine,seasonal allergic rhinitis,histamine receptor h1
brompheniramine,urticaria,histamine receptor h1
brompheniramine,pruritus,histamine receptor h1
brompheniramine,atopic conjunctivitis,histamine receptor h1
brompheniramine,vasomotor rhinitis,histamine receptor h1
brompheniramine,allergic rhinitis,histamine receptor h1
belotecan,ovarian cancer,thymidylate synthetase
belotecan,ovarian cancer,cytidine/uridine monophosphate kinase 1
belotecan,ovarian cancer,ribonucleotide reductase catalytic subunit m1
belotecan,non-small cell lung carcinoma,thymidylate synthetase
belotecan,non-small cell lung carcinoma,cytidine/uridine monophosphate kinase 1
belotecan,non-small cell lung carcinoma,ribonucleotide reductase catalytic subunit m1
fentanyl,pain,opioid receptor mu 1
fentanyl,pain,opioid receptor delta 1
bitolterol,bronchitis,adrenoceptor beta 2
bitolterol,bronchiectasis,adrenoceptor beta 2
bitolterol,asthma,adrenoceptor beta 2
bitolterol,pulmonary emphysema,adrenoceptor beta 2
diazoxide,pancreatic insulinoma,potassium inwardly rectifying channel subfamily j member 11
diazoxide,hyperinsulinism,potassium inwardly rectifying channel subfamily j member 11
diazoxide,islet cell adenomatosis,potassium inwardly rectifying channel subfamily j member 11
floctafenine,acute pain,prostaglandin-endoperoxide synthase 1
floctafenine,acute pain,prostaglandin-endoperoxide synthase 2
umeclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 2
umeclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
acrivastine,vasomotor rhinitis,histamine receptor h1
acrivastine,atopic conjunctivitis,histamine receptor h1
acrivastine,seasonal allergic rhinitis,histamine receptor h1
acrivastine,sneeze,histamine receptor h1
acrivastine,common cold,histamine receptor h1
acrivastine,allergic rhinitis,histamine receptor h1
oxytocin,post-partum hemorrhage,oxytocin receptor
ribavirin,chronic hepatitis c virus infection,inosine monophosphate dehydrogenase 1
ribavirin,respiratory syncytial virus infectious disease,inosine monophosphate dehydrogenase 1
butenafine,tinea pedis,squalene epoxidase
butenafine,pityriasis versicolor,squalene epoxidase
regorafenib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
regorafenib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
regorafenib,hepatocellular carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
regorafenib,hepatocellular carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
regorafenib,hepatocellular carcinoma,platelet derived growth factor receptor alpha
regorafenib,hepatocellular carcinoma,fibroblast growth factor receptor 1
regorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 1
regorafenib,hepatocellular carcinoma,kinase insert domain receptor
selexipag,pulmonary arterial hypertension,prostaglandin i2 receptor
mizolastine,allergic rhinitis,histamine receptor h1
carbenoxolone,peptic ulcer disease,hydroxysteroid 11-beta dehydrogenase 1
carbenoxolone,peptic ulcer disease,15-hydroxyprostaglandin dehydrogenase
mizolastine,perennial allergic rhinitis,histamine receptor h1
abiraterone acetate,prostate cancer,cytochrome p450 family 17 subfamily a member 1
abiraterone acetate,prostate cancer,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
abiraterone acetate,prostate cancer,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
abiraterone acetate,prostate cancer,cytochrome p450 family 11 subfamily b member 1
abiraterone acetate,prostate cancer,cytochrome p450 family 21 subfamily a member 2
abiraterone acetate,prostate cancer,cytochrome p450 family 1 subfamily a member 2
abiraterone acetate,prostate cancer,cytochrome p450 family 2 subfamily c member 9
abiraterone acetate,prostate cancer,cytochrome p450 family 3 subfamily a member 4
abiraterone acetate,prostate cancer,androgen receptor
venlafaxine,panic disorder,solute carrier family 6 member 4
venlafaxine,panic disorder,solute carrier family 6 member 2
venlafaxine,social phobia,solute carrier family 6 member 4
venlafaxine,social phobia,solute carrier family 6 member 2
venlafaxine,social phobia,solute carrier family 6 member 3
venlafaxine,major depressive disorder,solute carrier family 6 member 4
venlafaxine,major depressive disorder,solute carrier family 6 member 2
venlafaxine,major depressive disorder,solute carrier family 6 member 3
amoxapine,depressive disorder,solute carrier family 6 member 4
venlafaxine,depressive disorder,solute carrier family 6 member 2
amoxapine,depressive disorder,dopamine receptor d1
tulobuterol,asthma,adrenoceptor beta 2
tulobuterol,pulmonary emphysema,adrenoceptor beta 2
rupatadine,allergic rhinitis,histamine receptor h1
rupatadine,allergic rhinitis,platelet activating factor receptor
rupatadine,urticaria,histamine receptor h1
rupatadine,urticaria,platelet activating factor receptor
clobetasone,atopic eczema,nuclear receptor subfamily 3 group c member 1
clobetasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
defibrotide,hepatic veno-occlusive disease,"plasminogen activator, tissue type"
defibrotide,hepatic veno-occlusive disease,serpin family e member 1
celiprolol,hypertensive disorder,adrenoceptor beta 1
celiprolol,hypertensive disorder,adrenoceptor beta 2
celiprolol,angina pectoris,adrenoceptor beta 1
celiprolol,angina pectoris,adrenoceptor beta 2
physostigmine,open-angle glaucoma,acetylcholinesterase (yt blood group)
vigabatrin,west syndrome,4-aminobutyrate aminotransferase
linagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
oxyphencyclimine,peptic ulcer disease,cholinergic receptor muscarinic 3
propylthiouracil,hyperthyroidism,thyroid peroxidase
propylthiouracil,thyroid crisis,thyroid peroxidase
butorphanol,pain,opioid receptor kappa 1
butorphanol,pain,opioid receptor delta 1
butorphanol,pain,opioid receptor mu 1
butorphanol,labor pain,opioid receptor kappa 1
butorphanol,labor pain,opioid receptor delta 1
butorphanol,labor pain,opioid receptor mu 1
dextropropoxyphene,pain,opioid receptor mu 1
dextropropoxyphene,pain,opioid receptor delta 1
cilazapril,hypertensive disorder,angiotensin i converting enzyme
icatibant,hereditary angioedema,bradykinin receptor b2
limaprost,thromboangiitis obliterans,prostaglandin e receptor 2
butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha1
butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha2
butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha3
butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha4
butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha5
riluzole,amyotrophic lateral sclerosis,sodium voltage-gated channel alpha subunit 5
hydrochlorothiazide,edema,solute carrier family 12 member 3
hydrochlorothiazide,hypertensive disorder,solute carrier family 12 member 3
irbesartan,hypertensive disorder,angiotensin ii receptor type 1
irbesartan,diabetic kidney disease,angiotensin ii receptor type 1
estrone sulphate,postmenopausal atrophic vaginitis,estrogen receptor 1
entacapone,parkinson disease,catechol-o-methyltransferase
"1,25-dihydroxyvitamin d3",hypophosphatemia,vitamin d receptor
"1,25-dihydroxyvitamin d3",hypocalcemia,vitamin d receptor
"1,25-dihydroxyvitamin d3",hypoparathyroidism,vitamin d receptor
"1,25-dihydroxyvitamin d3",renal osteodystrophy,vitamin d receptor
carbachol,open-angle glaucoma,cholinergic receptor nicotinic alpha 2 subunit
tazarotene,acne,retinoic acid receptor alpha
tazarotene,acne,retinoid x receptor beta
tazarotene,acne,retinoic acid receptor gamma
tazarotene,acne,retinoic acid receptor beta
tazarotene,psoriasis,retinoic acid receptor alpha
tazarotene,psoriasis,retinoid x receptor beta
tazarotene,psoriasis,retinoic acid receptor gamma
tazarotene,psoriasis,retinoic acid receptor beta
avanafil,erectile dysfunction,phosphodiesterase 5a
dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4a
dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4b
dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4c
dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4d
dyphylline,chronic bronchitis,phosphodiesterase 4a
dyphylline,chronic bronchitis,phosphodiesterase 4b
dyphylline,chronic bronchitis,phosphodiesterase 4c
dyphylline,chronic bronchitis,phosphodiesterase 4d
dyphylline,bronchial disorder,phosphodiesterase 4a
dyphylline,bronchial disorder,phosphodiesterase 4b
dyphylline,bronchial disorder,phosphodiesterase 4c
dyphylline,bronchial disorder,phosphodiesterase 4d
dyphylline,pulmonary emphysema,phosphodiesterase 4a
dyphylline,pulmonary emphysema,phosphodiesterase 4b
dyphylline,pulmonary emphysema,phosphodiesterase 4c
dyphylline,pulmonary emphysema,phosphodiesterase 4d
dyphylline,asthma,phosphodiesterase 4a
dyphylline,asthma,phosphodiesterase 4b
dyphylline,asthma,phosphodiesterase 4c
dyphylline,asthma,phosphodiesterase 4d
lenvatinib,thyroid gland papillary carcinoma,platelet derived growth factor receptor alpha
lenvatinib,thyroid gland papillary carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
lenvatinib,thyroid gland papillary carcinoma,ret proto-oncogene
lenvatinib,thyroid gland follicular carcinoma,platelet derived growth factor receptor alpha
lenvatinib,thyroid gland follicular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
lenvatinib,thyroid gland follicular carcinoma,ret proto-oncogene
lenvatinib,renal cell carcinoma,platelet derived growth factor receptor alpha
lenvatinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
lenvatinib,renal cell carcinoma,ret proto-oncogene
liraglutide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
crizotinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
crizotinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
triflupromazine,psychotic disorder,dopamine receptor d1
triflupromazine,psychotic disorder,dopamine receptor d2
triflupromazine,psychotic disorder,cholinergic receptor muscarinic 1
triflupromazine,psychotic disorder,cholinergic receptor muscarinic 2
triflupromazine,psychotic disorder,5-hydroxytryptamine receptor 2b
triflupromazine,vomiting,dopamine receptor d2
triflupromazine,nausea,dopamine receptor d2
buprenorphine,chronic pain,opioid receptor mu 1
buprenorphine,chronic pain,opioid receptor kappa 1
buprenorphine,opiate dependence,opioid receptor mu 1
buprenorphine,opiate dependence,opioid receptor kappa 1
nebivolol,hypertensive disorder,adrenoceptor beta 1
papaverine,peripheral vascular disease,phosphodiesterase 4b
pioglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
sotalol,atrial fibrillation,adrenoceptor beta 1
sotalol,atrial fibrillation,adrenoceptor beta 2
sotalol,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
sufentanil,post-operative pain,opioid receptor mu 1
tirofiban,acute coronary syndrome,integrin subunit alpha 2b
tirofiban,acute coronary syndrome,integrin subunit beta 3
valrubicin,urinary bladder neoplasm,dna topoisomerase ii alpha
cabergoline,hyperprolactinemia,dopamine receptor d2
atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
estradiol valerate,premenstrual dysphoric disorder,estrogen receptor 1
estradiol valerate,premenstrual dysphoric disorder,estrogen receptor 2
estradiol valerate,hot flashes,estrogen receptor 1
estradiol valerate,hot flashes,estrogen receptor 2
estradiol valerate,postmenopausal osteoporosis,estrogen receptor 1
estradiol valerate,postmenopausal osteoporosis,estrogen receptor 2
estradiol valerate,postmenopausal atrophic vaginitis,estrogen receptor 1
estradiol valerate,postmenopausal atrophic vaginitis,estrogen receptor 2
estradiol valerate,acne,estrogen receptor 1
estradiol valerate,acne,estrogen receptor 2
metformin,type 2 diabetes mellitus,electron transfer flavoprotein dehydrogenase
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase b
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase a
mebendazole,trichuriasis,tubulin alpha 1a
mebendazole,trichuriasis,tubulin beta 4b class ivb
mebendazole,ascariasis,tubulin alpha 1a
mebendazole,ascariasis,tubulin beta 4b class ivb
mebendazole,enterobiasis,tubulin alpha 1a
mebendazole,enterobiasis,tubulin beta 4b class ivb
prednicarbate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
prednicarbate,pruritus ani,nuclear receptor subfamily 3 group c member 1
prednicarbate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
prednicarbate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
prednicarbate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
prednicarbate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
prednicarbate,exanthem,nuclear receptor subfamily 3 group c member 1
prednicarbate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
prednicarbate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
metoclopramide,gastroesophageal reflux disease,dopamine receptor d2
metoclopramide,gastroesophageal reflux disease,cholinergic receptor muscarinic 1
metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 4
fesoterodine,urge incontinence,cholinergic receptor muscarinic 3
chlorthalidone,hypertensive disorder,solute carrier family 12 member 1
chlorthalidone,edema,solute carrier family 12 member 1
nicardipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
nicardipine,angina pectoris,calcium voltage-gated channel auxiliary subunit beta 2
nicardipine,angina pectoris,calcium voltage-gated channel auxiliary subunit alpha2delta 1
nicardipine,angina pectoris,calcium voltage-gated channel subunit alpha1 d
nicardipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
nicardipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
nicardipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
nicardipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
benzphetamine,obesity disorder,adrenoceptor alpha 1a
anakinra,rheumatoid arthritis,interleukin 1 receptor type 1
anakinra,cryopyrin-associated periodic syndrome,interleukin 1 receptor type 1
darifenacin,urge incontinence,cholinergic receptor muscarinic 3
desoximetasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
desoximetasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
desoximetasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
desoximetasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
desoximetasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
desoximetasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
desoximetasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
desoximetasone,exanthem,nuclear receptor subfamily 3 group c member 1
desoximetasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
almotriptan,migraine disorder,5-hydroxytryptamine receptor 1b
almotriptan,migraine disorder,5-hydroxytryptamine receptor 1d
acebutolol,premature ventricular contraction,adrenoceptor beta 1
apraclonidine,open-angle glaucoma,adrenoceptor alpha 2a
eplerenone,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
febuxostat,hyperuricemia,xanthine dehydrogenase
cilastatin,bacterial endocarditis,dipeptidase 1
cilastatin,abdominal abscess,dipeptidase 1
cilastatin,abdominal infection,dipeptidase 1
cilastatin,streptococcal pneumonia,dipeptidase 1
cilastatin,bacterial pneumonia,dipeptidase 1
cilastatin,endometritis,dipeptidase 1
clonidine,hypertensive disorder,adrenoceptor alpha 2a
clonidine,hypertensive disorder,adrenoceptor alpha 2b
clonidine,hypertensive disorder,adrenoceptor alpha 2c
clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
clonidine,open-angle glaucoma,adrenoceptor alpha 2a
clonidine,open-angle glaucoma,adrenoceptor alpha 2b
clonidine,open-angle glaucoma,adrenoceptor alpha 2c
tranexamic acid,endometriosis,plasminogen
tranexamic acid,menorrhagia,plasminogen
trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 g
trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 h
trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 i
(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 2a
(-)-adrenaline,anaphylaxis,adrenoceptor alpha 1a
(-)-adrenaline,anaphylaxis,adrenoceptor alpha 1b
(-)-adrenaline,anaphylaxis,adrenoceptor alpha 1d
(-)-adrenaline,anaphylaxis,adrenoceptor beta 2
(-)-adrenaline,hypotensive disorder,adrenoceptor beta 1
crisaborole,"dermatitis, atopic",phosphodiesterase 4a
crisaborole,"dermatitis, atopic",phosphodiesterase 4b
crisaborole,"dermatitis, atopic",phosphodiesterase 4c
crisaborole,"dermatitis, atopic",phosphodiesterase 4d
ibrutinib,waldenstrom macroglobulinemia,bruton tyrosine kinase
ibrutinib,mantle cell lymphoma,bruton tyrosine kinase
selegiline,parkinson disease,monoamine oxidase b
selegiline,parkinson disease,monoamine oxidase a
selegiline,major depressive disorder,monoamine oxidase b
selegiline,major depressive disorder,monoamine oxidase a
sitagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
beraprost,pulmonary arterial hypertension,prostaglandin i2 receptor
valbenazine,tardive dyskinesia,solute carrier family 18 member a2
radotinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
bepridil,angina pectoris,"troponin c1, slow skeletal and cardiac type"
ethinylestradiol,premenstrual dysphoric disorder,estrogen receptor 1
ethinylestradiol,hot flashes,estrogen receptor 1
ethinylestradiol,acne,estrogen receptor 1
ethinylestradiol,postmenopausal atrophic vaginitis,estrogen receptor 1
ethinylestradiol,postmenopausal osteoporosis,estrogen receptor 1
sildenafil,pulmonary arterial hypertension,phosphodiesterase 5a
miglitol,type 2 diabetes mellitus,maltase-glucoamylase
miglitol,type 2 diabetes mellitus,alpha glucosidase
miglitol,type 2 diabetes mellitus,glucosidase ii alpha subunit
miglitol,type 2 diabetes mellitus,"glucosidase alpha, neutral c"
isoprenaline,cardiac arrest,adrenoceptor beta 1
isoprenaline,cardiac arrest,adrenoceptor beta 2
isoprenaline,cardiac arrest,adrenoceptor beta 3
isoprenaline,atrioventricular block,adrenoceptor beta 1
isoprenaline,atrioventricular block,adrenoceptor beta 2
isoprenaline,atrioventricular block,adrenoceptor beta 3
isoprenaline,decreased cardiac output,adrenoceptor beta 1
isoprenaline,decreased cardiac output,adrenoceptor beta 2
isoprenaline,decreased cardiac output,adrenoceptor beta 3
isoprenaline,common cold,adrenoceptor beta 1
isoprenaline,common cold,adrenoceptor beta 2
isoprenaline,common cold,adrenoceptor beta 3
isoprenaline,shock,adrenoceptor beta 1
isoprenaline,shock,adrenoceptor beta 2
isoprenaline,shock,adrenoceptor beta 3
talinolol,hypertensive disorder,adrenoceptor beta 1
cyproheptadine,atopic conjunctivitis,histamine receptor h1
cyproheptadine,pruritus,histamine receptor h1
cyproheptadine,urticaria,histamine receptor h1
cyproheptadine,sneeze,histamine receptor h1
cyproheptadine,allergic rhinitis,histamine receptor h1
pindolol,hypertensive disorder,adrenoceptor beta 1
pindolol,hypertensive disorder,adrenoceptor beta 2
bortezomib,mantle cell lymphoma,proteasome 20s subunit beta 5
bortezomib,mantle cell lymphoma,proteasome 20s subunit beta 1
bortezomib,plasma cell myeloma,proteasome 20s subunit beta 5
bortezomib,plasma cell myeloma,proteasome 20s subunit beta 1
sufinpyrazone,hyperuricemia,solute carrier family 22 member 12
magnesium salicylate,back pain,prostaglandin-endoperoxide synthase 1
magnesium salicylate,back pain,prostaglandin-endoperoxide synthase 2
magnesium salicylate,bursitis,prostaglandin-endoperoxide synthase 1
magnesium salicylate,bursitis,prostaglandin-endoperoxide synthase 2
magnesium salicylate,arthralgia,prostaglandin-endoperoxide synthase 1
magnesium salicylate,arthralgia,prostaglandin-endoperoxide synthase 2
magnesium salicylate,synovitis,prostaglandin-endoperoxide synthase 1
magnesium salicylate,synovitis,prostaglandin-endoperoxide synthase 2
magnesium salicylate,dysmenorrhea,prostaglandin-endoperoxide synthase 1
magnesium salicylate,dysmenorrhea,prostaglandin-endoperoxide synthase 2
magnesium salicylate,osteoarthritis,prostaglandin-endoperoxide synthase 1
magnesium salicylate,osteoarthritis,prostaglandin-endoperoxide synthase 2
magnesium salicylate,pain,prostaglandin-endoperoxide synthase 1
magnesium salicylate,pain,prostaglandin-endoperoxide synthase 2
magnesium salicylate,fever,prostaglandin-endoperoxide synthase 1
magnesium salicylate,fever,prostaglandin-endoperoxide synthase 2
magnesium salicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
magnesium salicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
magnesium salicylate,headache disorder,prostaglandin-endoperoxide synthase 1
magnesium salicylate,headache disorder,prostaglandin-endoperoxide synthase 2
baricitinib,rheumatoid arthritis,janus kinase 1
baricitinib,rheumatoid arthritis,janus kinase 2
baricitinib,rheumatoid arthritis,janus kinase 3
baricitinib,rheumatoid arthritis,tyrosine kinase 2
budesonide,crohn disease,nuclear receptor subfamily 3 group c member 1
budesonide,asthma,nuclear receptor subfamily 3 group c member 1
budesonide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
citalopram,depressive disorder,solute carrier family 6 member 4
citalopram,major depressive disorder,solute carrier family 6 member 4
nisoldipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
nisoldipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
vilazodone,major depressive disorder,solute carrier family 6 member 4
vilazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
etelcalcetide,secondary hyperparathyroidism,calcium sensing receptor
cilostazol,intermittent vascular claudication,phosphodiesterase 3a
diclofenamide,open-angle glaucoma,carbonic anhydrase 1
diclofenamide,open-angle glaucoma,carbonic anhydrase 2
diclofenamide,open-angle glaucoma,carbonic anhydrase 4
diclofenamide,open-angle glaucoma,carbonic anhydrase 7
diclofenamide,open-angle glaucoma,carbonic anhydrase 12
ethacrynic acid,edema,solute carrier family 12 member 1
oprelvekin,thrombocytopenia,interleukin 11 receptor subunit alpha
tolazoline,vascular disorder,adrenoceptor alpha 1a
tolazoline,vascular disorder,adrenoceptor alpha 2a
tolazoline,vascular disorder,adrenoceptor alpha 2b
tolazoline,vascular disorder,adrenoceptor alpha 2c
tolazoline,vascular disorder,histamine receptor h1
tolazoline,vascular disorder,histamine receptor h2
tolazoline,cerebrovascular disorder,histamine receptor h1
tolazoline,cerebrovascular disorder,histamine receptor h2
tolazoline,cerebrovascular disorder,adrenoceptor alpha 1a
tolazoline,cerebrovascular disorder,adrenoceptor alpha 2a
tolazoline,cerebrovascular disorder,adrenoceptor alpha 2b
tolazoline,cerebrovascular disorder,adrenoceptor alpha 2c
tolazoline,persistent fetal circulation syndrome,histamine receptor h1
tolazoline,persistent fetal circulation syndrome,histamine receptor h2
tolazoline,persistent fetal circulation syndrome,adrenoceptor alpha 1a
tolazoline,persistent fetal circulation syndrome,adrenoceptor alpha 2a
diclofenamide,angle-closure glaucoma,carbonic anhydrase 1
diclofenamide,angle-closure glaucoma,carbonic anhydrase 2
diclofenamide,angle-closure glaucoma,carbonic anhydrase 4
diclofenamide,angle-closure glaucoma,carbonic anhydrase 7
diclofenamide,angle-closure glaucoma,carbonic anhydrase 12
venetoclax,b-cell chronic lymphocytic leukemia,bcl2 apoptosis regulator
ketoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
ketoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
ketoprofen,rheumatoid arthritis,c-x-c motif chemokine receptor 1
ketoprofen,pain,prostaglandin-endoperoxide synthase 1
ketoprofen,pain,prostaglandin-endoperoxide synthase 2
ketoprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
ketoprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
clotrimazole,acne,toll like receptor 2
lusutrombopag,thrombocytopenia,"mpl proto-oncogene, thrombopoietin receptor"
levocabastine,atopic conjunctivitis,neurotensin receptor 2
ethosuximide,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
empagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
cimetidine,duodenal ulcer,histamine receptor h2
cimetidine,gastric ulcer,histamine receptor h2
cimetidine,zollinger-ellison syndrome,histamine receptor h2
cimetidine,multiple endocrine neoplasia,histamine receptor h2
cimetidine,dyspepsia,histamine receptor h2
cimetidine,gastroesophageal reflux disease,histamine receptor h2
cimetidine,systemic mastocytosis,histamine receptor h2
naloxone,opiate dependence,opioid receptor mu 1
naloxone,opiate dependence,opioid receptor delta 1
naloxone,opiate dependence,opioid receptor kappa 1
naloxone,pain,opioid receptor mu 1
naloxone,pain,opioid receptor delta 1
naloxone,pain,opioid receptor kappa 1
benzatropine,postencephalitic parkinson disease,solute carrier family 6 member 3
benzatropine,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
benzatropine,parkinsonian disorder,solute carrier family 6 member 3
benzatropine,parkinsonian disorder,cholinergic receptor muscarinic 1
benzatropine,basal ganglia disorder,solute carrier family 6 member 3
benzatropine,basal ganglia disorder,cholinergic receptor muscarinic 1
benzatropine,parkinson disease,solute carrier family 6 member 3
benzatropine,parkinson disease,cholinergic receptor muscarinic 1
imipramine,depressive disorder,solute carrier family 6 member 2
imipramine,depressive disorder,solute carrier family 6 member 4
nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
nifedipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
dantrolene,spasticity,ryanodine receptor 1
dantrolene,"malignant hyperthermia, susceptibility to, 1",ryanodine receptor 1
alimemazine,urticaria,histamine receptor h1
alimemazine,sneeze,histamine receptor h1
alimemazine,angioedema,histamine receptor h1
alimemazine,atopic conjunctivitis,histamine receptor h1
alimemazine,pruritus,histamine receptor h1
alimemazine,allergic rhinitis,histamine receptor h1
dapoxetine,premature ejaculation,solute carrier family 6 member 4
histrelin,precocious puberty,gonadotropin releasing hormone receptor
befunolol,open-angle glaucoma,adrenoceptor beta 1
befunolol,open-angle glaucoma,adrenoceptor beta 2
befunolol,ocular hypertension,adrenoceptor beta 1
befunolol,ocular hypertension,adrenoceptor beta 2
indapamide,edema,solute carrier family 12 member 3
indapamide,hypertensive disorder,solute carrier family 12 member 3
meclofenamic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
meclofenamic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
meclofenamic acid,menorrhagia,prostaglandin-endoperoxide synthase 1
meclofenamic acid,menorrhagia,prostaglandin-endoperoxide synthase 2
meclofenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 1
meclofenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 2
meclofenamic acid,pain,prostaglandin-endoperoxide synthase 1
meclofenamic acid,pain,prostaglandin-endoperoxide synthase 2
meclofenamic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
meclofenamic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1f
methyltestosterone,eunuchism,androgen receptor
methyltestosterone,delayed puberty,androgen receptor
perphenazine,schizophrenia,dopamine receptor d2
choline magnesium trisalicylate,fever,prostaglandin-endoperoxide synthase 1
choline magnesium trisalicylate,fever,prostaglandin-endoperoxide synthase 2
choline magnesium trisalicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
choline magnesium trisalicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
choline magnesium trisalicylate,osteoarthritis,prostaglandin-endoperoxide synthase 1
choline magnesium trisalicylate,osteoarthritis,prostaglandin-endoperoxide synthase 2
choline magnesium trisalicylate,pain,prostaglandin-endoperoxide synthase 1
choline magnesium trisalicylate,pain,prostaglandin-endoperoxide synthase 2
dexlansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
dexlansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
dexlansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
dexlansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
capsaicin,postherpetic neuralgia,transient receptor potential cation channel subfamily v member 1
capsaicin,neuralgia,transient receptor potential cation channel subfamily v member 1
capsaicin,back pain,transient receptor potential cation channel subfamily v member 1
(-)-adrenaline,bronchiectasis,adrenoceptor alpha 1a
(-)-adrenaline,bronchiectasis,adrenoceptor alpha 1b
(-)-adrenaline,bronchiectasis,adrenoceptor alpha 1d
(-)-adrenaline,bronchiectasis,adrenoceptor alpha 2a
(-)-adrenaline,bronchiectasis,adrenoceptor alpha 2b
(-)-adrenaline,bronchiectasis,adrenoceptor beta 1
(-)-adrenaline,bronchiectasis,adrenoceptor beta 2
(-)-adrenaline,bronchitis,adrenoceptor alpha 1a
(-)-adrenaline,bronchitis,adrenoceptor alpha 1b
(-)-adrenaline,bronchitis,adrenoceptor alpha 1d
(-)-adrenaline,bronchitis,adrenoceptor alpha 2a
(-)-adrenaline,bronchitis,adrenoceptor alpha 2b
(-)-adrenaline,bronchitis,adrenoceptor beta 1
(-)-adrenaline,bronchitis,adrenoceptor beta 2
(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 1a
(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 1b
(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 1d
(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 2a
(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 2b
(-)-adrenaline,pulmonary emphysema,adrenoceptor beta 1
(-)-adrenaline,pulmonary emphysema,adrenoceptor beta 2
(-)-adrenaline,respiratory sounds,adrenoceptor alpha 1a
(-)-adrenaline,respiratory sounds,adrenoceptor alpha 1b
(-)-adrenaline,respiratory sounds,adrenoceptor alpha 1d
(-)-adrenaline,respiratory sounds,adrenoceptor alpha 2a
(-)-adrenaline,respiratory sounds,adrenoceptor alpha 2b
(-)-adrenaline,respiratory sounds,adrenoceptor beta 1
(-)-adrenaline,respiratory sounds,adrenoceptor beta 2
(-)-adrenaline,dyspnea,adrenoceptor alpha 1a
(-)-adrenaline,dyspnea,adrenoceptor alpha 1b
(-)-adrenaline,dyspnea,adrenoceptor alpha 1d
(-)-adrenaline,dyspnea,adrenoceptor alpha 2a
(-)-adrenaline,dyspnea,adrenoceptor alpha 2b
(-)-adrenaline,dyspnea,adrenoceptor beta 1
(-)-adrenaline,dyspnea,adrenoceptor beta 2
ibrutinib,b-cell chronic lymphocytic leukemia,bruton tyrosine kinase
rufinamide,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
vindesine,melanoma,tubulin beta 1 class vi
vindesine,lung neoplasm,tubulin beta 1 class vi
vindesine,"chronic myelogenous leukemia, bcr-abl1 positive",tubulin beta 1 class vi
treprostinil,pulmonary arterial hypertension,prostaglandin i2 receptor
estramustine,prostate cancer,microtubule associated protein 2
estramustine,prostate cancer,microtubule associated protein 1a
testosterone propionate,cryptorchidism,androgen receptor
testosterone propionate,delayed puberty,androgen receptor
testosterone propionate,eunuchism,androgen receptor
testosterone propionate,klinefelter syndrome,androgen receptor
canagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
idelalisib,follicular lymphoma,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"
idelalisib,b-cell chronic lymphocytic leukemia,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"
olaparib,ovarian cancer,poly(adp-ribose) polymerase 1
olaparib,ovarian cancer,poly(adp-ribose) polymerase 2
olaparib,ovarian cancer,poly(adp-ribose) polymerase family member 3
dexbrompheniramine,seasonal allergic rhinitis,histamine receptor h1
dexbrompheniramine,urticaria,histamine receptor h1
dexbrompheniramine,pruritus,histamine receptor h1
dexbrompheniramine,vasomotor rhinitis,histamine receptor h1
dexbrompheniramine,atopic conjunctivitis,histamine receptor h1
epinastine,atopic conjunctivitis,histamine receptor h1
epinastine,atopic conjunctivitis,histamine receptor h2
amantadine,basal ganglia disorder,dopamine receptor d2
amantadine,parkinson disease,dopamine receptor d2
amantadine,parkinsonian disorder,dopamine receptor d2
amantadine,postencephalitic parkinson disease,dopamine receptor d2
emedastine,urticaria,histamine receptor h1
emedastine,pruritus,histamine receptor h1
emedastine,atopic conjunctivitis,histamine receptor h1
tetracosactide,adrenocortical insufficiency,melanocortin 2 receptor
mepenzolic acid,peptic ulcer disease,cholinergic receptor muscarinic 3
mepenzolic acid,peptic ulcer disease,cholinergic receptor muscarinic 1
mepenzolic acid,gastric ulcer,cholinergic receptor muscarinic 3
mepenzolic acid,gastric ulcer,cholinergic receptor muscarinic 1
bepotastine,atopic conjunctivitis,histamine receptor h1
brexpiprazole,major depressive disorder,5-hydroxytryptamine receptor 2a
brexpiprazole,schizophrenia,5-hydroxytryptamine receptor 2a
enalaprilat,hypertensive disorder,angiotensin i converting enzyme
enalaprilat,heart failure,angiotensin i converting enzyme
chlorothiazide,edema,solute carrier family 12 member 3
imiquimod,common wart,toll like receptor 7
imiquimod,anogenital human papillomavirus infection,toll like receptor 7
imiquimod,actinic keratosis,toll like receptor 7
teriparatide,postmenopausal osteoporosis,parathyroid hormone 1 receptor
vorapaxar,stroke disorder,coagulation factor ii thrombin receptor
mirodenafil,erectile dysfunction,phosphodiesterase 5a
luseogliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
luseogliflozin,type 2 diabetes mellitus,solute carrier family 5 member 11
cromoglicic acid,allergic rhinitis,s100 calcium binding protein p
cromoglicic acid,systemic mastocytosis,s100 calcium binding protein p
cromoglicic acid,asthma,s100 calcium binding protein p
gabapentin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
bretylium,ventricular fibrillation,atpase na+/k+ transporting subunit alpha 1
tramadol,pain,solute carrier family 6 member 2
tramadol,pain,solute carrier family 6 member 4
tramadol,osteoarthritis,opioid receptor mu 1
tramadol,osteoarthritis,solute carrier family 6 member 2
tramadol,osteoarthritis,solute carrier family 6 member 4
tramadol,chronic pain,opioid receptor mu 1
tramadol,chronic pain,solute carrier family 6 member 2
tramadol,chronic pain,solute carrier family 6 member 4
isradipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
montelukast,allergic rhinitis,cysteinyl leukotriene receptor 1
chlophedianol,allergic rhinitis,histamine receptor h1
chlophedianol,rhinitis,histamine receptor h1
chlophedianol,vasomotor rhinitis,histamine receptor h1
donepezil,alzheimer disease,acetylcholinesterase (yt blood group)
salmeterol,pulmonary emphysema,adrenoceptor beta 2
azelastine,vasomotor rhinitis,histamine receptor h1
azelastine,vasomotor rhinitis,histamine receptor h2
azelastine,vasomotor rhinitis,phospholipase a2 group ib
azelastine,vasomotor rhinitis,leukotriene c4 synthase
azelastine,seasonal allergic rhinitis,histamine receptor h1
azelastine,seasonal allergic rhinitis,histamine receptor h2
azelastine,seasonal allergic rhinitis,phospholipase a2 group ib
azelastine,seasonal allergic rhinitis,leukotriene c4 synthase
azelastine,allergic rhinitis,histamine receptor h1
azelastine,allergic rhinitis,histamine receptor h2
azelastine,allergic rhinitis,phospholipase a2 group ib
azelastine,allergic rhinitis,leukotriene c4 synthase
azelastine,atopic conjunctivitis,histamine receptor h1
azelastine,atopic conjunctivitis,histamine receptor h2
azelastine,atopic conjunctivitis,phospholipase a2 group ib
azelastine,atopic conjunctivitis,leukotriene c4 synthase
ergometrine,post-partum hemorrhage,adrenoceptor alpha 1a
almitrine,chronic obstructive pulmonary disease,atpase na+/k+ transporting subunit alpha 1
acetylmethadol,opiate dependence,opioid receptor mu 1
pargyline,hypertensive disorder,monoamine oxidase b
teduglutide,short bowel syndrome,glucagon like peptide 2 receptor
chlorcyclizine,atopic conjunctivitis,histamine receptor h1
chlorcyclizine,allergic rhinitis,histamine receptor h1
chlorcyclizine,seasonal allergic rhinitis,histamine receptor h1
chlorcyclizine,sneeze,histamine receptor h1
chlorcyclizine,cough,histamine receptor h1
chlorcyclizine,vasomotor rhinitis,histamine receptor h1
chlorcyclizine,common cold,histamine receptor h1
stanozolol,pheochromocytoma,adrenoceptor alpha 1a
stanozolol,pheochromocytoma,adrenoceptor alpha 2a
stanozolol,pheochromocytoma,adrenoceptor alpha 2c
stanozolol,pheochromocytoma,adrenoceptor alpha 1d
stanozolol,pheochromocytoma,adrenoceptor alpha 1b
stanozolol,pheochromocytoma,adrenoceptor alpha 2b
nedocromil,atopic conjunctivitis,cysteinyl leukotriene receptor 2
nedocromil,atopic conjunctivitis,cysteinyl leukotriene receptor 1
nedocromil,asthma,cysteinyl leukotriene receptor 2
nedocromil,asthma,cysteinyl leukotriene receptor 1
fexofenadine,atopic conjunctivitis,histamine receptor h1
fexofenadine,urticaria,histamine receptor h1
fexofenadine,seasonal allergic rhinitis,histamine receptor h1
fexofenadine,sneeze,histamine receptor h1
fexofenadine,allergic rhinitis,histamine receptor h1
phenacemide,epilepsy,sodium voltage-gated channel alpha subunit 1
carvedilol,hypertensive disorder,adrenoceptor beta 1
carvedilol,hypertensive disorder,adrenoceptor alpha 1a
trabectedin,ovarian cancer,atp binding cassette subfamily b member 1
trabectedin,leiomyosarcoma,atp binding cassette subfamily b member 1
trabectedin,liposarcoma,atp binding cassette subfamily b member 1
trilostane,adrenal gland hyperfunction,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
trilostane,adrenal gland hyperfunction,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 1
axitinib,renal cell carcinoma,kinase insert domain receptor
axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 4
trifluoperazine,schizophrenia,dopamine receptor d2
trifluoperazine,schizophrenia,dopamine receptor d1
trifluoperazine,anxiety,dopamine receptor d2
trifluoperazine,anxiety,dopamine receptor d1
glymidine,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
gonadorelin,amenorrhea,gonadotropin releasing hormone receptor
icosapent,hypertriglyceridemia,diacylglycerol o-acyltransferase 1
icosapent,hypertriglyceridemia,lipoprotein lipase
nicotinic acid,hypertriglyceridemia,diacylglycerol o-acyltransferase 1
nicotinic acid,hypertriglyceridemia,apolipoprotein b
nicotinic acid,hypertriglyceridemia,lipoprotein lipase
nicotinic acid,"hyperlipidemia, familial combined, lpl related",diacylglycerol o-acyltransferase 1
nicotinic acid,"hyperlipidemia, familial combined, lpl related",apolipoprotein b
nicotinic acid,"hyperlipidemia, familial combined, lpl related",apolipoprotein a1
nicotinic acid,hypercholesterolemia,cholesteryl ester transfer protein
nicotinic acid,hypercholesterolemia,apolipoprotein a1
nicotinic acid,hyperlipidemia,diacylglycerol o-acyltransferase 1
nicotinic acid,hyperlipidemia,apolipoprotein b
nicotinic acid,hyperlipidemia,apolipoprotein a1
brimonidine (uk14304),rosacea,adrenoceptor alpha 2a
brimonidine (uk14304),rosacea,adrenoceptor alpha 2b
brimonidine (uk14304),rosacea,adrenoceptor alpha 2c
esomeprazole,peptic esophagitis,atpase h+/k+ transporting subunit alpha
esomeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
esomeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
tolvaptan,hyponatremia,arginine vasopressin receptor 2
tolvaptan,inappropriate adh syndrome,arginine vasopressin receptor 2
tolvaptan,autosomal dominant polycystic kidney disease,arginine vasopressin receptor 2
biperiden,parkinson disease,cholinergic receptor muscarinic 1
biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
biperiden,parkinsonian disorder,cholinergic receptor muscarinic 1
biperiden,basal ganglia disorder,cholinergic receptor muscarinic 1
brimonidine (uk14304),open-angle glaucoma,adrenoceptor alpha 2a
brimonidine (uk14304),open-angle glaucoma,adrenoceptor alpha 2b
brimonidine (uk14304),open-angle glaucoma,adrenoceptor alpha 2c
brimonidine (uk14304),ocular hypertension,adrenoceptor alpha 2a
brimonidine (uk14304),ocular hypertension,adrenoceptor alpha 2b
brimonidine (uk14304),ocular hypertension,adrenoceptor alpha 2c
triiodothyronine,myxedema,thyroid hormone receptor alpha
triiodothyronine,myxedema,thyroid hormone receptor beta
triiodothyronine,hypothyroidism,thyroid hormone receptor alpha
triiodothyronine,hypothyroidism,thyroid hormone receptor beta
triiodothyronine,goiter,thyroid hormone receptor alpha
triiodothyronine,goiter,thyroid hormone receptor beta
triiodothyronine,congenital hypothyroidism,thyroid hormone receptor alpha
triiodothyronine,congenital hypothyroidism,thyroid hormone receptor beta
triiodothyronine,endemic goiter,thyroid hormone receptor alpha
triiodothyronine,endemic goiter,thyroid hormone receptor beta
travoprost,ocular hypertension,prostaglandin f receptor
travoprost,open-angle glaucoma,prostaglandin f receptor
eflornithine,human african trypanosomiasis,ornithine decarboxylase 1
plerixafor,plasma cell myeloma,c-x-c motif chemokine receptor 4
chlorpromazine,psychotic disorder,dopamine receptor d2
chlorpromazine,acute intermittent porphyria,dopamine receptor d2
chlorpromazine,schizophrenia,dopamine receptor d2
chlorpromazine,oppositional defiant disorder,dopamine receptor d2
etoposide,testicular cancer,dna topoisomerase ii alpha
etoposide,small cell lung carcinoma,dna topoisomerase ii alpha
desloratadine,seasonal allergic rhinitis,histamine receptor h1
desloratadine,common cold,histamine receptor h1
desloratadine,vasomotor rhinitis,histamine receptor h1
desloratadine,chronic urticaria,histamine receptor h1
desloratadine,allergic rhinitis,histamine receptor h1
desloratadine,sneeze,histamine receptor h1
desloratadine,atopic conjunctivitis,histamine receptor h1
pasireotide,adrenal gland hyperfunction,somatostatin receptor 1
pasireotide,adrenal gland hyperfunction,somatostatin receptor 2
pasireotide,adrenal gland hyperfunction,somatostatin receptor 3
pasireotide,adrenal gland hyperfunction,somatostatin receptor 5
carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 5
carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 8
carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 1
carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 9
carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 2
carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 10
enzalutamide,prostate cancer,androgen receptor
aspirin,myocardial infarction,prostaglandin-endoperoxide synthase 1
aspirin,myocardial infarction,prostaglandin-endoperoxide synthase 2
aspirin,common cold,prostaglandin-endoperoxide synthase 1
aspirin,common cold,prostaglandin-endoperoxide synthase 2
aspirin,toothache,prostaglandin-endoperoxide synthase 1
aspirin,toothache,prostaglandin-endoperoxide synthase 2
aspirin,headache disorder,prostaglandin-endoperoxide synthase 1
aspirin,headache disorder,prostaglandin-endoperoxide synthase 2
aspirin,migraine disorder,prostaglandin-endoperoxide synthase 1
aspirin,migraine disorder,prostaglandin-endoperoxide synthase 2
aspirin,back pain,prostaglandin-endoperoxide synthase 1
aspirin,back pain,prostaglandin-endoperoxide synthase 2
aspirin,osteoarthritis,prostaglandin-endoperoxide synthase 1
aspirin,osteoarthritis,prostaglandin-endoperoxide synthase 2
aspirin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
aspirin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
aspirin,arthralgia,prostaglandin-endoperoxide synthase 1
aspirin,arthralgia,prostaglandin-endoperoxide synthase 2
metaraminol,hypotensive disorder,adrenoceptor alpha 1a
ibandronic acid,postmenopausal osteoporosis,farnesyl diphosphate synthase
ibandronic acid,postmenopausal osteoporosis,geranylgeranyl diphosphate synthase 1
ibandronic acid,hypercalcemia disease,farnesyl diphosphate synthase
ibandronic acid,hypercalcemia disease,geranylgeranyl diphosphate synthase 1
lixisenatide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
perospirone,schizophrenia,5-hydroxytryptamine receptor 1a
perospirone,schizophrenia,dopamine receptor d2
perospirone,schizophrenia,5-hydroxytryptamine receptor 2a
flunisolide,asthma,nuclear receptor subfamily 3 group c member 1
flunisolide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
ropinirole,parkinson disease,dopamine receptor d2
ropinirole,parkinson disease,dopamine receptor d3
latanoprost (isopropyl ester),ocular hypertension,prostaglandin f receptor
latanoprost (isopropyl ester),open-angle glaucoma,prostaglandin f receptor
apomorphine,parkinson disease,dopamine receptor d2
apomorphine,parkinson disease,dopamine receptor d3
apomorphine,parkinson disease,dopamine receptor d4
modafinil,narcolepsy,solute carrier family 6 member 3
salicylamide,arthralgia,prostaglandin-endoperoxide synthase 1
salicylamide,arthralgia,prostaglandin-endoperoxide synthase 2
salicylamide,headache disorder,prostaglandin-endoperoxide synthase 1
salicylamide,headache disorder,prostaglandin-endoperoxide synthase 2
salicylamide,pain,prostaglandin-endoperoxide synthase 1
salicylamide,pain,prostaglandin-endoperoxide synthase 2
salicylamide,back pain,prostaglandin-endoperoxide synthase 1
salicylamide,back pain,prostaglandin-endoperoxide synthase 2
salicylamide,fever,prostaglandin-endoperoxide synthase 1
salicylamide,fever,prostaglandin-endoperoxide synthase 2
mesalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 1
mesalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 2
mesalazine,ulcerative colitis,arachidonate 5-lipoxygenase
mesalazine,ulcerative colitis,peroxisome proliferator activated receptor gamma
pimecrolimus,"dermatitis, atopic",protein phosphatase 3 catalytic subunit alpha
phytomenadione,hypocalcemia,bone gamma-carboxyglutamate protein
phytomenadione,postmenopausal osteoporosis,bone gamma-carboxyglutamate protein
phytomenadione,osteoporosis,bone gamma-carboxyglutamate protein
orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 2d
orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 1
orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 3b
orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 3a
asenapine,schizophrenia,5-hydroxytryptamine receptor 2a
asenapine,schizophrenia,dopamine receptor d2
ubidecarenone,heart failure,nadh:ubiquinone oxidoreductase subunit v3
ubidecarenone,heart failure,succinate dehydrogenase complex flavoprotein subunit a
quetiapine,schizophrenia,dopamine receptor d2
quetiapine,schizophrenia,5-hydroxytryptamine receptor 2a
imatinib,chronic eosinophilic leukemia,platelet derived growth factor receptor alpha
imatinib,hypereosinophilic syndrome,platelet derived growth factor receptor alpha
imatinib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
imatinib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
imatinib,dermatofibrosarcoma protuberans,platelet derived growth factor receptor alpha
dosulepin,major depressive disorder,solute carrier family 6 member 4
dosulepin,major depressive disorder,solute carrier family 6 member 2
quetiapine,bipolar disorder,solute carrier family 6 member 2
losartan,diabetic kidney disease,angiotensin ii receptor type 1
losartan,hypertensive disorder,angiotensin ii receptor type 1
bethanechol,urinary retention,cholinergic receptor muscarinic 2
mercaptopurine,acute promyelocytic leukemia,hypoxanthine phosphoribosyltransferase 1
mercaptopurine,acute promyelocytic leukemia,phosphoribosyl pyrophosphate amidotransferase
mercaptopurine,acute promyelocytic leukemia,inosine monophosphate dehydrogenase 1
mercaptopurine,acute promyelocytic leukemia,inosine monophosphate dehydrogenase 2
diamicron,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
pilsicainide,tachycardia,sodium voltage-gated channel alpha subunit 5
tropicamide,mydriasis,cholinergic receptor muscarinic 3
tenoxicam,arthritic joint disease,prostaglandin-endoperoxide synthase 1
tenoxicam,arthritic joint disease,prostaglandin-endoperoxide synthase 2
rotigotine,parkinson disease,dopamine receptor d3
rotigotine,parkinson disease,dopamine receptor d4
rotigotine,parkinson disease,dopamine receptor d2
rotigotine,parkinson disease,dopamine receptor d5
rotigotine,parkinson disease,dopamine receptor d1
rotigotine,restless legs syndrome,dopamine receptor d3
rotigotine,restless legs syndrome,dopamine receptor d4
rotigotine,restless legs syndrome,dopamine receptor d2
rotigotine,restless legs syndrome,dopamine receptor d5
rotigotine,restless legs syndrome,dopamine receptor d1
prasugrel,acute coronary syndrome,purinergic receptor p2y12
dutasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 2
dutasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 1
calcium citrate,hypocalcemia,calcium sensing receptor
theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,histone deacetylase 2
theophylline,asthma,histone deacetylase 2
theophylline,bronchitis,histone deacetylase 2
theophylline,pulmonary emphysema,histone deacetylase 2
theophylline,bronchial disorder,histone deacetylase 2
dofetilide,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
dofetilide,atrial fibrillation,potassium two pore domain channel subfamily k member 2
dofetilide,atrial fibrillation,potassium inwardly rectifying channel subfamily j member 12
clidinium,enterocolitis,cholinergic receptor muscarinic 1
clidinium,irritable bowel syndrome,cholinergic receptor muscarinic 1
cycrimine,parkinson disease,cholinergic receptor muscarinic 1
insulin lispro,type 1 diabetes mellitus,insulin receptor
insulin lispro,type 2 diabetes mellitus,insulin receptor
calcium citrate,postmenopausal osteoporosis,calcium sensing receptor
lasofoxifene,postmenopausal osteoporosis,estrogen receptor 1
lasofoxifene,postmenopausal osteoporosis,estrogen receptor 2
brigatinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
brigatinib,non-small cell lung carcinoma,epidermal growth factor receptor
benzquinamide,postoperative nausea and vomiting,dopamine receptor d2
insulin glulisine,diabetes mellitus,insulin receptor
olodaterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
ripasudil,ocular hypertension,rho associated coiled-coil containing protein kinase 1
ripasudil,ocular hypertension,rho associated coiled-coil containing protein kinase 2
ripasudil,glaucoma,rho associated coiled-coil containing protein kinase 1
ripasudil,glaucoma,rho associated coiled-coil containing protein kinase 2
amcinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
amcinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
amcinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
amcinonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
amcinonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
amcinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
amcinonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
naltrexone,chronic pain,toll like receptor 4
naltrexone,alcohol abuse,opioid receptor kappa 1
naltrexone,alcohol abuse,opioid receptor delta 1
naltrexone,alcohol abuse,opioid receptor mu 1
piribedil,parkinsonian disorder,dopamine receptor d2
piribedil,parkinsonian disorder,dopamine receptor d3
dexibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
dexibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
dexibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
dexibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
dexibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
dexibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
dexibuprofen,fever,prostaglandin-endoperoxide synthase 1
dexibuprofen,fever,prostaglandin-endoperoxide synthase 2
dexibuprofen,pain,prostaglandin-endoperoxide synthase 1
dexibuprofen,pain,prostaglandin-endoperoxide synthase 2
dexibuprofen,headache,prostaglandin-endoperoxide synthase 1
dexibuprofen,headache,prostaglandin-endoperoxide synthase 2
dexibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
dexibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
linaclotide,irritable bowel syndrome,guanylate cyclase 2c
prucalopride,constipation disorder,5-hydroxytryptamine receptor 4
bazedoxifene,postmenopausal osteoporosis,estrogen receptor 1
bazedoxifene,postmenopausal osteoporosis,estrogen receptor 2
echothiophate,esotropia,acetylcholinesterase (yt blood group)
echothiophate,esotropia,butyrylcholinesterase
echothiophate,open-angle glaucoma,acetylcholinesterase (yt blood group)
echothiophate,open-angle glaucoma,butyrylcholinesterase
echothiophate,glaucoma,acetylcholinesterase (yt blood group)
echothiophate,glaucoma,butyrylcholinesterase
echothiophate,stargardt disease,acetylcholinesterase (yt blood group)
echothiophate,stargardt disease,butyrylcholinesterase
colecalciferol,osteoporosis,vitamin d receptor
colecalciferol,postmenopausal osteoporosis,vitamin d receptor
colecalciferol,hypoparathyroidism,vitamin d receptor
colecalciferol,vitamin d deficiency,vitamin d receptor
colecalciferol,rickets,vitamin d receptor
colecalciferol,hypocalcemia,vitamin d receptor
pge1,pulmonary valve atresia,prostaglandin e receptor 2
pge1,pulmonary artery stenosis,prostaglandin e receptor 2
pge1,tricuspid atresia,prostaglandin e receptor 2
pge1,aorta coarctation,prostaglandin e receptor 2
pge1,erectile dysfunction,prostaglandin e receptor 2
pge1,tetralogy of fallot,prostaglandin e receptor 2
guanfacine,hypertensive disorder,adrenoceptor alpha 2a
oxybutynin,urge incontinence,cholinergic receptor muscarinic 3
oxybutynin,urge incontinence,cholinergic receptor muscarinic 2
oxybutynin,urge incontinence,cholinergic receptor muscarinic 1
oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 3
oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 2
oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 1
(r)-cetirizine,seasonal allergic rhinitis,histamine receptor h1
(r)-cetirizine,allergic rhinitis,histamine receptor h1
(r)-cetirizine,chronic urticaria,histamine receptor h1
diphenylpyraline,sneeze,histamine receptor h1
diphenylpyraline,pruritus,histamine receptor h1
diphenylpyraline,allergic rhinitis,histamine receptor h1
diphenylpyraline,atopic conjunctivitis,histamine receptor h1
diphenylpyraline,vasomotor rhinitis,histamine receptor h1
diphenylpyraline,urticaria,histamine receptor h1
alcaftadine,atopic conjunctivitis,histamine receptor h1
omarigliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
azelnidipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 1
naratriptan,migraine disorder,5-hydroxytryptamine receptor 1d
naratriptan,migraine disorder,5-hydroxytryptamine receptor 1b
naratriptan,migraine disorder,5-hydroxytryptamine receptor 1f
bisoprolol,hypertensive disorder,adrenoceptor beta 1
dextrothyroxine,hyperlipidemia,thyroid hormone receptor alpha
dextrothyroxine,hyperlipidemia,thyroid hormone receptor beta
betaxolol,ocular hypertension,adrenoceptor beta 1
betaxolol,open-angle glaucoma,adrenoceptor beta 1
betaxolol,hypertensive disorder,adrenoceptor beta 1
ketotifen,atopic conjunctivitis,histamine receptor h1
ephedrine,vasomotor rhinitis,adrenoceptor alpha 1a
ephedrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
ephedrine,allergic rhinitis,adrenoceptor alpha 1a
ephedrine,atopic conjunctivitis,adrenoceptor alpha 1a
ephedrine,sneeze,adrenoceptor alpha 1a
ephedrine,headache disorder,adrenoceptor alpha 1a
ephedrine,bronchitis,adrenoceptor beta 2
ephedrine,common cold,adrenoceptor alpha 1a
ephedrine,bronchial disorder,adrenoceptor beta 2
viloxazine,narcolepsy,solute carrier family 6 member 2
hydroxyzine,atopic conjunctivitis,histamine receptor h1
hydroxyzine,allergic rhinitis,histamine receptor h1
hydroxyzine,"dermatitis, atopic",histamine receptor h1
hydroxyzine,urticaria,histamine receptor h1
hydroxyzine,pruritus,histamine receptor h1
levorphanol,pain,opioid receptor mu 1
gemfibrozil,hypertriglyceridemia,peroxisome proliferator activated receptor alpha
pitavastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
pitavastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 i
amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
amlodipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
amlodipine,angina pectoris,calcium voltage-gated channel subunit alpha1 i
amlodipine,stroke disorder,calcium voltage-gated channel subunit alpha1 c
amlodipine,stroke disorder,calcium voltage-gated channel subunit alpha1 i
cyclopentolate,mydriasis,cholinergic receptor muscarinic 1
flecainide,atrial fibrillation,sodium voltage-gated channel alpha subunit 4
flecainide,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
insulin glargine,type 1 diabetes mellitus,insulin receptor
insulin glargine,type 2 diabetes mellitus,insulin receptor
olanzapine,schizophrenia,dopamine receptor d2
olanzapine,major depressive disorder,dopamine receptor d2
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2a
olanzapine,bipolar disorder,dopamine receptor d2
olanzapine,bipolar disorder,5-hydroxytryptamine receptor 2a
propranolol,hypertrophic cardiomyopathy,adrenoceptor beta 1
propranolol,hypertrophic cardiomyopathy,adrenoceptor beta 2
propranolol,angina pectoris,adrenoceptor beta 1
propranolol,angina pectoris,adrenoceptor beta 2
propranolol,hypertensive disorder,adrenoceptor beta 1
propranolol,hypertensive disorder,adrenoceptor beta 2
propranolol,hemangioma,vascular endothelial growth factor a
propranolol,atrial fibrillation,adrenoceptor beta 1
propranolol,atrial fibrillation,adrenoceptor beta 2
propranolol,supraventricular tachycardia,adrenoceptor beta 1
propranolol,supraventricular tachycardia,adrenoceptor beta 2
bosentan,localized scleroderma,endothelin receptor type a
bosentan,localized scleroderma,endothelin receptor type b
bosentan,pulmonary hypertension,endothelin receptor type a
bosentan,pulmonary hypertension,endothelin receptor type b
bosentan,pulmonary arterial hypertension,endothelin receptor type a
bosentan,pulmonary arterial hypertension,endothelin receptor type b
testosterone propionate,hot flashes,androgen receptor
diethylcarbamazine,pulmonary eosinophilia,arachidonate 5-lipoxygenase
diethylcarbamazine,pulmonary eosinophilia,prostaglandin-endoperoxide synthase 1
drospirenone,postmenopausal atrophic vaginitis,progesterone receptor
etidronic acid,humoral hypercalcemia of malignancy,atpase h+ transporting v1 subunit a
etidronic acid,bone paget disease,atpase h+ transporting v1 subunit a
reboxetine,major depressive disorder,solute carrier family 6 member 2
flibanserin,psychosexual disorder,5-hydroxytryptamine receptor 1a
flibanserin,psychosexual disorder,5-hydroxytryptamine receptor 2a
erlotinib,non-small cell lung carcinoma,epidermal growth factor receptor
doxapram,respiratory failure,potassium two pore domain channel subfamily k member 3
doxapram,respiratory failure,potassium two pore domain channel subfamily k member 9
etodolac,pain,prostaglandin-endoperoxide synthase 2
etodolac,pain,prostaglandin-endoperoxide synthase 1
etodolac,osteoarthritis,prostaglandin-endoperoxide synthase 2
etodolac,osteoarthritis,prostaglandin-endoperoxide synthase 1
etodolac,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
etodolac,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
etodolac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
etodolac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
levosalbutamol,bronchial disorder,adrenoceptor beta 2
tripelennamine,sneeze,histamine receptor h1
tripelennamine,pruritus,histamine receptor h1
tripelennamine,atopic conjunctivitis,histamine receptor h1
tripelennamine,allergic rhinitis,histamine receptor h1
tripelennamine,urticaria,histamine receptor h1
tripelennamine,vasomotor rhinitis,histamine receptor h1
nortriptyline,depressive disorder,solute carrier family 6 member 2
nortriptyline,depressive disorder,solute carrier family 6 member 4
triprolidine,pruritus,histamine receptor h1
triprolidine,urticaria,histamine receptor h1
triprolidine,allergic rhinitis,histamine receptor h1
triprolidine,atopic conjunctivitis,histamine receptor h1
triprolidine,common cold,histamine receptor h1
triprolidine,vasomotor rhinitis,histamine receptor h1
triprolidine,seasonal allergic rhinitis,histamine receptor h1
(-)-noradrenaline,bronchiectasis,adrenoceptor beta 2
(-)-noradrenaline,bronchitis,adrenoceptor beta 2
(-)-noradrenaline,asthma,adrenoceptor beta 2
(-)-noradrenaline,hypotensive disorder,adrenoceptor alpha 1a
(-)-noradrenaline,hypotensive disorder,adrenoceptor alpha 1b
(-)-noradrenaline,hypotensive disorder,adrenoceptor alpha 1d
(-)-noradrenaline,pulmonary emphysema,adrenoceptor beta 2
pregabalin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
pregabalin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
glycopyrrolate,peptic ulcer disease,cholinergic receptor muscarinic 3
glycopyrrolate,peptic ulcer disease,cholinergic receptor muscarinic 1
glycopyrrolate,drooling,cholinergic receptor muscarinic 3
glycopyrrolate,drooling,cholinergic receptor muscarinic 1
glycopyrrolate,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
vonoprazan,gastric ulcer,atpase h+/k+ transporting subunit alpha
vonoprazan,duodenal ulcer,atpase h+/k+ transporting subunit alpha
diflorasone diacetate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
diflorasone diacetate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
diflorasone diacetate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
diflorasone diacetate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
diflorasone diacetate,exanthem,nuclear receptor subfamily 3 group c member 1
diflorasone diacetate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
diflorasone diacetate,pruritus ani,nuclear receptor subfamily 3 group c member 1
diflorasone diacetate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
carmustine,diffuse large b-cell lymphoma,glutathione-disulfide reductase
carmustine,plasma cell myeloma,glutathione-disulfide reductase
carmustine,glioma,glutathione-disulfide reductase
carmustine,classic hodgkin lymphoma,glutathione-disulfide reductase
carmustine,brain cancer,glutathione-disulfide reductase
carmustine,non-hodgkin lymphoma,glutathione-disulfide reductase
dibucaine,pruritus,sodium voltage-gated channel alpha subunit 10
dibucaine,pruritus,sodium voltage-gated channel alpha subunit 5
doxazosin,hypertensive disorder,adrenoceptor alpha 1a
doxazosin,hypertensive disorder,adrenoceptor alpha 1d
doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
loteprednol etabonate,iritis,nuclear receptor subfamily 3 group c member 1
loteprednol etabonate,uveitis,nuclear receptor subfamily 3 group c member 1
loteprednol etabonate,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
loteprednol etabonate,iridocyclitis,nuclear receptor subfamily 3 group c member 1
loteprednol etabonate,anterior uveitis,nuclear receptor subfamily 3 group c member 1
apremilast,psoriatic arthritis,phosphodiesterase 4a
apremilast,psoriatic arthritis,phosphodiesterase 4b
apremilast,psoriatic arthritis,phosphodiesterase 4c
apremilast,psoriatic arthritis,phosphodiesterase 4d
levobetaxolol,open-angle glaucoma,adrenoceptor beta 1
levobetaxolol,ocular hypertension,adrenoceptor beta 1
nafarelin,endometriosis,gonadotropin releasing hormone receptor
nafarelin,precocious puberty,gonadotropin releasing hormone receptor
pethidine,labor pain,opioid receptor kappa 1
pethidine,labor pain,opioid receptor mu 1
pethidine,pain,opioid receptor kappa 1
pethidine,pain,opioid receptor mu 1
brinzolamide,ocular hypertension,carbonic anhydrase 2
brinzolamide,open-angle glaucoma,carbonic anhydrase 2
ezetimibe,sitosterolemia,npc1 like intracellular cholesterol transporter 1
ezetimibe,hyperlipidemia,npc1 like intracellular cholesterol transporter 1
ezetimibe,"hyperlipidemia, familial combined, lpl related",npc1 like intracellular cholesterol transporter 1
ezetimibe,hypercholesterolemia,npc1 like intracellular cholesterol transporter 1
lisinopril,myocardial infarction,angiotensin i converting enzyme
lisinopril,hypertensive disorder,angiotensin i converting enzyme
eptifibatide,acute coronary syndrome,integrin subunit beta 3
eptifibatide,acute coronary syndrome,integrin subunit alpha 2b
pantoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
pantoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
pantoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
pantoprazole,multiple endocrine neoplasia,atpase h+/k+ transporting subunit alpha
gefitinib,non-small cell lung carcinoma,epidermal growth factor receptor
lisuride,amenorrhea,dopamine receptor d2
lisuride,acromegaly,dopamine receptor d2
eprosartan,hypertensive disorder,angiotensin ii receptor type 1
pemetrexed,non-small cell lung carcinoma,thymidylate synthetase
pemetrexed,non-small cell lung carcinoma,dihydrofolate reductase
pemetrexed,non-small cell lung carcinoma,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
pemetrexed,non-small cell lung carcinoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
tocilizumab,castleman disease,interleukin 6 receptor
tocilizumab,temporal arteritis,interleukin 6 receptor
tocilizumab,rheumatoid arthritis,interleukin 6 receptor
tocilizumab,juvenile idiopathic arthritis,interleukin 6 receptor
safinamide,parkinson disease,monoamine oxidase b
opipramol,depressive disorder,sigma non-opioid intracellular receptor 1
acetophenazine,psychotic disorder,dopamine receptor d2
goserelin,endometriosis,gonadotropin releasing hormone receptor
dromostanolone propionate,breast neoplasm,androgen receptor
tetrabenazine,huntington disease,solute carrier family 18 member a2
tranilast,asthma,histamine receptor h1
tranilast,allergic rhinitis,histamine receptor h1
tranilast,allergic rhinitis,prostaglandin-endoperoxide synthase 2
tranilast,"dermatitis, atopic",histamine receptor h1
tranilast,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
tranilast,keloid,histamine receptor h1
tranilast,"cicatrix, hypertrophic",histamine receptor h1
loperamide,diarrheal disease,opioid receptor mu 1
levodopa,parkinsonian disorder,dopamine receptor d1
levodopa,parkinsonian disorder,dopamine receptor d5
levodopa,parkinsonian disorder,dopamine receptor d2
levodopa,parkinsonian disorder,dopamine receptor d3
levodopa,parkinsonian disorder,dopamine receptor d4
formoterol,chronic bronchitis,adrenoceptor beta 2
formoterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
mesuximide,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
mesuximide,epilepsy,calcium voltage-gated channel subunit alpha1 g
tofacitinib,rheumatoid arthritis,janus kinase 1
tofacitinib,rheumatoid arthritis,janus kinase 3
isoxsuprine,vascular disorder,adrenoceptor beta 2
isoxsuprine,raynaud disease,adrenoceptor beta 2
tenofovir alafenamide,depressive disorder,monoamine oxidase a
pamidronic acid,bone paget disease,farnesyl diphosphate synthase
pamidronic acid,bone paget disease,geranylgeranyl diphosphate synthase 1
pamidronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
pamidronic acid,humoral hypercalcemia of malignancy,geranylgeranyl diphosphate synthase 1
rofecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
rofecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
rofecoxib,migraine disorder,prostaglandin-endoperoxide synthase 2
rofecoxib,dysmenorrhea,prostaglandin-endoperoxide synthase 2
rofecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
rofecoxib,pain,prostaglandin-endoperoxide synthase 2
flumethasone pivalate,exanthem,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,pruritus ani,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 3
sulpiride,schizophrenia,dopamine receptor d2
sulpiride,schizophrenia,dopamine receptor d3
lercanidipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit gamma 1
cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 4
cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3a
cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 2a
pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 1
promethazine,atopic conjunctivitis,histamine receptor h1
promethazine,seasonal allergic rhinitis,histamine receptor h1
promethazine,vasomotor rhinitis,histamine receptor h1
promethazine,urticaria,histamine receptor h1
sertraline,depressive disorder,solute carrier family 6 member 4
sertraline,social phobia,solute carrier family 6 member 4
sertraline,premenstrual dysphoric disorder,solute carrier family 6 member 4
sertraline,obsessive-compulsive disorder,solute carrier family 6 member 4
sertraline,post-traumatic stress disorder,solute carrier family 6 member 4
sertraline,panic disorder,solute carrier family 6 member 4
penbutolol,hypertensive disorder,adrenoceptor beta 1
vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 3
vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 6
nilotinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
lobeglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
phentermine,hypotensive disorder,solute carrier family 6 member 2
phentermine,obesity disorder,solute carrier family 6 member 2
phentermine,obesity disorder,neuropeptide y
methoxamine,hypotensive disorder,adrenoceptor alpha 1a
methoxamine,hypotensive disorder,adrenoceptor alpha 1b
pomalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
pomalidomide,plasma cell myeloma,tumor necrosis factor
aliskiren,hypertensive disorder,renin
flurbiprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
flurbiprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
flurbiprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
flurbiprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
eldecalcitol,osteoporosis,vitamin d receptor
camphor,back pain,transient receptor potential cation channel subfamily a member 1
desvenlafaxine,major depressive disorder,solute carrier family 6 member 4
desvenlafaxine,major depressive disorder,solute carrier family 6 member 2
desvenlafaxine,major depressive disorder,solute carrier family 6 member 3
nalbuphine,pain,opioid receptor kappa 1
nalbuphine,labor pain,opioid receptor kappa 1
diphenhydramine,vasomotor rhinitis,histamine receptor h1
diphenhydramine,seasonal allergic rhinitis,histamine receptor h1
diphenhydramine,atopic conjunctivitis,histamine receptor h1
paclitaxel,ovarian cancer,tubulin beta 1 class vi
paclitaxel,ovarian cancer,bcl2 apoptosis regulator
paclitaxel,non-small cell lung carcinoma,tubulin beta 1 class vi
paclitaxel,non-small cell lung carcinoma,bcl2 apoptosis regulator
paclitaxel,breast neoplasm,tubulin beta 1 class vi
paclitaxel,breast neoplasm,bcl2 apoptosis regulator
paclitaxel,kaposi's sarcoma,tubulin beta 1 class vi
paclitaxel,kaposi's sarcoma,bcl2 apoptosis regulator
felbinac,pain,prostaglandin-endoperoxide synthase 2
felbinac,pain,prostaglandin-endoperoxide synthase 1
felbinac,osteoarthritis,prostaglandin-endoperoxide synthase 2
felbinac,osteoarthritis,prostaglandin-endoperoxide synthase 1
vilanterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
vilanterol,pulmonary emphysema,adrenoceptor beta 2
vilanterol,chronic bronchitis,adrenoceptor beta 2
vilanterol,asthma,adrenoceptor beta 2
tranylcypromine,major depressive disorder,monoamine oxidase b
tranylcypromine,major depressive disorder,monoamine oxidase a
propantheline,peptic ulcer disease,cholinergic receptor muscarinic 3
tacrolimus,"dermatitis, atopic",fkbp prolyl isomerase 1a
(+)-chlorpheniramine,pruritus,histamine receptor h1
(+)-chlorpheniramine,atopic conjunctivitis,histamine receptor h1
(+)-chlorpheniramine,allergic rhinitis,histamine receptor h1
(+)-chlorpheniramine,vasomotor rhinitis,histamine receptor h1
(+)-chlorpheniramine,urticaria,histamine receptor h1
(+)-chlorpheniramine,seasonal allergic rhinitis,histamine receptor h1
methyclothiazide,edema,solute carrier family 12 member 3
tolmetin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
tolmetin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
tolmetin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
tolmetin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
tolmetin,osteoarthritis,prostaglandin-endoperoxide synthase 2
tolmetin,osteoarthritis,prostaglandin-endoperoxide synthase 1
candesartan,hypertensive disorder,angiotensin ii receptor type 1
milnacipran,fibromyalgia,solute carrier family 6 member 4
milnacipran,fibromyalgia,solute carrier family 6 member 2
armodafinil,narcolepsy,solute carrier family 6 member 3
alclometasone dipropionate,pruritus ani,nuclear receptor subfamily 3 group c member 1
alclometasone dipropionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
alclometasone dipropionate,exanthem,nuclear receptor subfamily 3 group c member 1
alclometasone dipropionate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
alclometasone dipropionate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
alclometasone dipropionate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
alclometasone dipropionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
alclometasone dipropionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
alclometasone dipropionate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
calcitonin (salmon),bone paget disease,calcitonin receptor
calcitonin (salmon),postmenopausal osteoporosis,calcitonin receptor
(-)-menthol,pruritus,transient receptor potential cation channel subfamily m member 8
(-)-menthol,pruritus,transient receptor potential cation channel subfamily a member 1
(-)-menthol,pruritus,transient receptor potential cation channel subfamily v member 3
(-)-menthol,back pain,transient receptor potential cation channel subfamily m member 8
(-)-menthol,back pain,transient receptor potential cation channel subfamily a member 1
(-)-menthol,back pain,transient receptor potential cation channel subfamily v member 3
vardenafil,erectile dysfunction,phosphodiesterase 5a
trifluridine,colonic neoplasm,thymidylate synthetase
paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 h
paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 i
paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 g
paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 h
paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 i
meloxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
meloxicam,osteoarthritis,prostaglandin-endoperoxide synthase 2
meloxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
dimethyl fumarate,psoriasis,hydroxycarboxylic acid receptor 2
moxonidine,essential hypertension,adrenoceptor alpha 2a
moxonidine,essential hypertension,nischarin
istradefylline,parkinson disease,adenosine a2a receptor
alclofenac,pain,prostaglandin-endoperoxide synthase 2
reserpine,psychotic disorder,solute carrier family 18 member a2
reserpine,hypertensive disorder,solute carrier family 18 member a2
clomipramine,obsessive-compulsive disorder,solute carrier family 6 member 4
midostaurin,systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
midostaurin,acute myeloid leukemia,fms related receptor tyrosine kinase 3
midostaurin,acute myeloid leukemia,"kit proto-oncogene, receptor tyrosine kinase"
midostaurin,acute myeloid leukemia,protein kinase c alpha
midostaurin,acute myeloid leukemia,platelet derived growth factor receptor beta
midostaurin,acute myeloid leukemia,platelet derived growth factor receptor alpha
midostaurin,acute myeloid leukemia,kinase insert domain receptor
midostaurin,mast cell leukemia,fms related receptor tyrosine kinase 3
midostaurin,mast cell leukemia,"kit proto-oncogene, receptor tyrosine kinase"
midostaurin,mast cell leukemia,protein kinase c alpha
midostaurin,mast cell leukemia,platelet derived growth factor receptor beta
midostaurin,mast cell leukemia,platelet derived growth factor receptor alpha
midostaurin,mast cell leukemia,kinase insert domain receptor
phentolamine,peripheral vascular disease,adrenoceptor alpha 1b
phentolamine,peripheral vascular disease,adrenoceptor alpha 1a
phentolamine,peripheral vascular disease,adrenoceptor alpha 1d
phentolamine,pheochromocytoma,adrenoceptor alpha 1b
phentolamine,pheochromocytoma,adrenoceptor alpha 1a
phentolamine,pheochromocytoma,adrenoceptor alpha 1d
bunazosin,essential hypertension,adrenoceptor alpha 1a
bunazosin,essential hypertension,adrenoceptor alpha 1d
loratadine,sneeze,histamine receptor h1
loratadine,vasomotor rhinitis,histamine receptor h1
loratadine,seasonal allergic rhinitis,histamine receptor h1
loratadine,common cold,histamine receptor h1
loratadine,atopic conjunctivitis,histamine receptor h1
fludarabine,b-cell chronic lymphocytic leukemia,"dna polymerase alpha 1, catalytic subunit"
fludarabine,b-cell chronic lymphocytic leukemia,ribonucleotide reductase catalytic subunit m1
fludarabine,b-cell chronic lymphocytic leukemia,dna primase subunit 2
tiagabine,focal epilepsy,solute carrier family 6 member 1
raloxifene,postmenopausal osteoporosis,estrogen receptor 1
raloxifene,postmenopausal osteoporosis,estrogen receptor 2
lornoxicam,pain,prostaglandin-endoperoxide synthase 1
lornoxicam,pain,prostaglandin-endoperoxide synthase 2
solifenacin,urge incontinence,cholinergic receptor muscarinic 3
solifenacin,urge incontinence,cholinergic receptor muscarinic 2
pyridostigmine,myasthenia gravis,acetylcholinesterase (yt blood group)
tolcapone,parkinson disease,catechol-o-methyltransferase
diclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 2
diclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 1
diclofenac,actinic keratosis,prostaglandin-endoperoxide synthase 2
diclofenac,actinic keratosis,prostaglandin-endoperoxide synthase 1
diclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
diclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
diclofenac,pain,prostaglandin-endoperoxide synthase 2
diclofenac,pain,prostaglandin-endoperoxide synthase 1
diclofenac,dysmenorrhea,prostaglandin-endoperoxide synthase 1
diclofenac,dysmenorrhea,prostaglandin-endoperoxide synthase 2
diclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
diclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
(-)-pentazocine,pain,opioid receptor kappa 1
tolterodine,urge incontinence,cholinergic receptor muscarinic 3
dihydrotachysterol,hypophosphatemia,vitamin d receptor
dihydrotachysterol,hypoparathyroidism,vitamin d receptor
dihydrotachysterol,hypocalcemia,vitamin d receptor
dihydrotachysterol,rickets,vitamin d receptor
dihydrotachysterol,tetany,vitamin d receptor
molindone,schizophrenia,dopamine receptor d2
somatrem,pituitary dwarfism,growth hormone receptor
lesinurad,hyperuricemia,solute carrier family 22 member 12
lesinurad,hyperuricemia,solute carrier family 22 member 11
imrecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
desmopressin,polyuria,arginine vasopressin receptor 2
desmopressin,von willebrand disease (hereditary or acquired),arginine vasopressin receptor 2
desmopressin,hemophilia a,arginine vasopressin receptor 2
desmopressin,nocturnal enuresis,arginine vasopressin receptor 2
ulobetasol propionate,pruritus ani,nuclear receptor subfamily 3 group c member 1
ulobetasol propionate,exanthem,nuclear receptor subfamily 3 group c member 1
ulobetasol propionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
ulobetasol propionate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
ulobetasol propionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
ulobetasol propionate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
ulobetasol propionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
ulobetasol propionate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
sulindac,tendinopathy,prostaglandin-endoperoxide synthase 1
sulindac,tendinopathy,prostaglandin-endoperoxide synthase 2
sulindac,osteoarthritis,prostaglandin-endoperoxide synthase 1
sulindac,osteoarthritis,prostaglandin-endoperoxide synthase 2
sulindac,gout,prostaglandin-endoperoxide synthase 1
sulindac,gout,prostaglandin-endoperoxide synthase 2
sulindac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
sulindac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
sulindac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
sulindac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
sulindac,bursitis,prostaglandin-endoperoxide synthase 2
sulindac,bursitis,prostaglandin-endoperoxide synthase 1
silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
toloxatone,depressive disorder,monoamine oxidase a
vinblastine,kaposi's sarcoma,tubulin alpha 1a
vinblastine,kaposi's sarcoma,tubulin beta class i
vinblastine,kaposi's sarcoma,tubulin delta 1
vinblastine,kaposi's sarcoma,tubulin gamma 1
vinblastine,kaposi's sarcoma,tubulin epsilon 1
vinblastine,mycosis fungoides,tubulin alpha 1a
vinblastine,mycosis fungoides,tubulin beta class i
vinblastine,mycosis fungoides,tubulin delta 1
vinblastine,mycosis fungoides,tubulin gamma 1
vinblastine,mycosis fungoides,tubulin epsilon 1
vinblastine,non-hodgkin lymphoma,tubulin alpha 1a
vinblastine,non-hodgkin lymphoma,tubulin beta class i
vinblastine,non-hodgkin lymphoma,tubulin delta 1
vinblastine,non-hodgkin lymphoma,tubulin gamma 1
vinblastine,non-hodgkin lymphoma,tubulin epsilon 1
vinblastine,testicular cancer,tubulin alpha 1a
vinblastine,testicular cancer,tubulin beta class i
vinblastine,testicular cancer,tubulin delta 1
vinblastine,testicular cancer,tubulin gamma 1
vinblastine,testicular cancer,tubulin epsilon 1
vinblastine,langerhans cell histiocytosis,tubulin alpha 1a
vinblastine,langerhans cell histiocytosis,tubulin beta class i
vinblastine,langerhans cell histiocytosis,tubulin delta 1
vinblastine,langerhans cell histiocytosis,tubulin gamma 1
vinblastine,langerhans cell histiocytosis,tubulin epsilon 1
vinblastine,classic hodgkin lymphoma,tubulin alpha 1a
vinblastine,classic hodgkin lymphoma,tubulin beta class i
vinblastine,classic hodgkin lymphoma,tubulin delta 1
vinblastine,classic hodgkin lymphoma,tubulin gamma 1
vinblastine,classic hodgkin lymphoma,tubulin epsilon 1
vinblastine,"hydatidiform mole, recurrent, 1",tubulin alpha 1a
vinblastine,"hydatidiform mole, recurrent, 1",tubulin beta class i
vinblastine,"hydatidiform mole, recurrent, 1",tubulin delta 1
vinblastine,"hydatidiform mole, recurrent, 1",tubulin gamma 1
vinblastine,"hydatidiform mole, recurrent, 1",tubulin epsilon 1
sunitinib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 1
sunitinib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
sunitinib,gastrointestinal stromal tumor,kinase insert domain receptor
sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 4
sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 3
sunitinib,gastrointestinal stromal tumor,colony stimulating factor 1 receptor
sunitinib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
sunitinib,renal cell carcinoma,platelet derived growth factor receptor beta
sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 1
sunitinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
sunitinib,renal cell carcinoma,kinase insert domain receptor
sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 4
sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 3
sunitinib,renal cell carcinoma,colony stimulating factor 1 receptor
sunitinib,renal cell carcinoma,platelet derived growth factor receptor alpha
warfarin,thromboembolism,vitamin k epoxide reductase complex subunit 1
warfarin,intracranial embolism,vitamin k epoxide reductase complex subunit 1
warfarin,thrombophilia due to thrombin defect,vitamin k epoxide reductase complex subunit 1
warfarin,thrombotic disease,vitamin k epoxide reductase complex subunit 1
tipiracil,colonic neoplasm,thymidine phosphorylase
sermorelin,pituitary dwarfism,growth hormone releasing hormone receptor
nadolol,hypertensive disorder,adrenoceptor beta 1
nadolol,angina pectoris,adrenoceptor beta 1
mephentermine,hypotensive disorder,adrenoceptor alpha 1a
mephentermine,hypotensive disorder,adrenoceptor alpha 1b
mephentermine,hypotensive disorder,adrenoceptor alpha 1d
mephentermine,hypotensive disorder,adrenoceptor beta 1
albiglutide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
thiothixene,schizophrenia,dopamine receptor d2
thiothixene,schizophrenia,5-hydroxytryptamine receptor 2a
phenindamine,urticaria,histamine receptor h1
phenindamine,pruritus,histamine receptor h1
phenindamine,sneeze,histamine receptor h1
phenindamine,allergic rhinitis,histamine receptor h1
phenindamine,vasomotor rhinitis,histamine receptor h1
phenindamine,atopic conjunctivitis,histamine receptor h1
fluoxymesterone,delayed puberty,androgen receptor
fluoxymesterone,klinefelter syndrome,androgen receptor
fluoxymesterone,cryptorchidism,androgen receptor
trichlormethiazide,hypertensive disorder,solute carrier family 12 member 3
gemtuzumab ozogamicin,acute myeloid leukemia,cd33 molecule
nitisinone,tyrosinemia,4-hydroxyphenylpyruvate dioxygenase
colestipol,hypercholesterolemia,low density lipoprotein receptor
colestipol,hyperlipidemia,low density lipoprotein receptor
guanabenz,hypertensive disorder,adrenoceptor alpha 2a
tamoxifen,breast ductal adenocarcinoma,estrogen receptor 1
tamoxifen,breast ductal adenocarcinoma,estrogen receptor 2
norethisterone,endometriosis,progesterone receptor
norethisterone,metrorrhagia,progesterone receptor
danazol,endometriosis,gonadotropin releasing hormone receptor
danazol,endometriosis,androgen receptor
fluorometholone,uveitis,nuclear receptor subfamily 3 group c member 1
fluorometholone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
fluorometholone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
chlorpropamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
pentoxifylline,peripheral vascular disease,phosphodiesterase 3a
pentoxifylline,peripheral vascular disease,phosphodiesterase 3b
pentoxifylline,peripheral vascular disease,adenosine a2a receptor
famotidine,gastric ulcer,histamine receptor h2
famotidine,gastroesophageal reflux disease,histamine receptor h2
famotidine,dyspepsia,histamine receptor h2
famotidine,zollinger-ellison syndrome,histamine receptor h2
famotidine,duodenal ulcer,histamine receptor h2
famotidine,peptic esophagitis,histamine receptor h2
carteolol,open-angle glaucoma,adrenoceptor beta 2
carteolol,open-angle glaucoma,adrenoceptor beta 1
carteolol,hypertensive disorder,adrenoceptor beta 2
carteolol,hypertensive disorder,adrenoceptor beta 1
carteolol,ocular hypertension,adrenoceptor beta 2
carteolol,ocular hypertension,adrenoceptor beta 1
acth,stevens-johnson syndrome,melanocortin 2 receptor
acth,west syndrome,melanocortin 2 receptor
bromfenac,pain,prostaglandin-endoperoxide synthase 1
bromfenac,pain,prostaglandin-endoperoxide synthase 2
aceclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
aceclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
aceclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
aceclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
aceclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 1
aceclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 2
aceclofenac,back pain,prostaglandin-endoperoxide synthase 1
aceclofenac,back pain,prostaglandin-endoperoxide synthase 2
rabeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
rabeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
rabeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
rabeprazole,systemic mastocytosis,atpase h+/k+ transporting subunit alpha
rabeprazole,multiple endocrine neoplasia,atpase h+/k+ transporting subunit alpha
rabeprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
celecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
celecoxib,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
celecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
celecoxib,dysmenorrhea,prostaglandin-endoperoxide synthase 2
celecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
rasagiline,parkinson disease,bcl2 apoptosis regulator
rasagiline,parkinson disease,monoamine oxidase b
trihexyphenidyl,parkinson disease,cholinergic receptor muscarinic 1
trihexyphenidyl,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
trihexyphenidyl,basal ganglia disorder,cholinergic receptor muscarinic 1
trihexyphenidyl,parkinsonian disorder,cholinergic receptor muscarinic 1
methotrexate,head and neck neoplasm,thymidylate synthetase
methotrexate,head and neck neoplasm,dihydrofolate reductase
methotrexate,head and neck neoplasm,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
methotrexate,burkitt lymphoma,thymidylate synthetase
methotrexate,burkitt lymphoma,dihydrofolate reductase
methotrexate,burkitt lymphoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
methotrexate,lung neoplasm,thymidylate synthetase
methotrexate,lung neoplasm,dihydrofolate reductase
methotrexate,lung neoplasm,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
methotrexate,non-hodgkin lymphoma,thymidylate synthetase
methotrexate,non-hodgkin lymphoma,dihydrofolate reductase
methotrexate,non-hodgkin lymphoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
methotrexate,mycosis fungoides,thymidylate synthetase
methotrexate,mycosis fungoides,dihydrofolate reductase
methotrexate,mycosis fungoides,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
methotrexate,"hydatidiform mole, recurrent, 1",thymidylate synthetase
methotrexate,"hydatidiform mole, recurrent, 1",dihydrofolate reductase
methotrexate,"hydatidiform mole, recurrent, 1",5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
maprotiline,depressive disorder,solute carrier family 6 member 2
macitentan,pulmonary arterial hypertension,endothelin receptor type a
macitentan,pulmonary arterial hypertension,endothelin receptor type b
progesterone,metrorrhagia,progesterone receptor
progesterone,endometriosis,progesterone receptor
progesterone,endometrium neoplasm,progesterone receptor
tapentadol,pain,opioid receptor mu 1
tapentadol,pain,solute carrier family 6 member 2
udenafil,erectile dysfunction,phosphodiesterase 5a
tafluprost,ocular hypertension,prostaglandin f receptor
tafluprost,open-angle glaucoma,prostaglandin f receptor
acarbose,type 2 diabetes mellitus,amylase alpha 2a
acarbose,type 2 diabetes mellitus,maltase-glucoamylase
probucol,hypercholesterolemia,atp binding cassette subfamily a member 1
probucol,hyperlipidemia,atp binding cassette subfamily a member 1
migalastat,fabry disease,galactosidase alpha
orciprenaline,asthma,adrenoceptor beta 2
orciprenaline,bronchitis,adrenoceptor beta 2
orciprenaline,pulmonary emphysema,adrenoceptor beta 2
ibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
ibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
ibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
ibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
ibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
ibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
ibuprofen,headache disorder,prostaglandin-endoperoxide synthase 1
ibuprofen,headache disorder,prostaglandin-endoperoxide synthase 2
ibuprofen,fever,prostaglandin-endoperoxide synthase 1
ibuprofen,fever,prostaglandin-endoperoxide synthase 2
ibuprofen,patent ductus arteriosus,prostaglandin-endoperoxide synthase 1
ibuprofen,patent ductus arteriosus,prostaglandin-endoperoxide synthase 2
ibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
ibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
ibuprofen,pain,prostaglandin-endoperoxide synthase 2
ibuprofen,pain,prostaglandin-endoperoxide synthase 1
docetaxel,prostate cancer,tubulin beta 1 class vi
docetaxel,prostate cancer,bcl2 apoptosis regulator
docetaxel,non-small cell lung carcinoma,tubulin beta 1 class vi
docetaxel,non-small cell lung carcinoma,bcl2 apoptosis regulator
docetaxel,breast neoplasm,tubulin beta 1 class vi
docetaxel,breast neoplasm,bcl2 apoptosis regulator
docetaxel,head and neck neoplasm,tubulin beta 1 class vi
docetaxel,head and neck neoplasm,bcl2 apoptosis regulator
docetaxel,gastric neoplasm,tubulin beta 1 class vi
docetaxel,gastric neoplasm,bcl2 apoptosis regulator
dexamfetamine,narcolepsy,solute carrier family 6 member 2
dexamfetamine,narcolepsy,solute carrier family 6 member 3
dexamfetamine,narcolepsy,solute carrier family 18 member a2
dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
edoxaban,pulmonary embolism,coagulation factor x
edoxaban,embolism,coagulation factor x
ergotamine,vascular headaches,adrenoceptor alpha 1a
ergotamine,vascular headaches,adrenoceptor alpha 2a
ergotamine,vascular headaches,adrenoceptor alpha 2c
ergotamine,vascular headaches,adrenoceptor alpha 1d
ergotamine,vascular headaches,adrenoceptor alpha 1b
ergotamine,vascular headaches,adrenoceptor alpha 2b
ergotamine,vascular headaches,5-hydroxytryptamine receptor 1d
ergotamine,migraine disorder,adrenoceptor alpha 1a
ergotamine,migraine disorder,adrenoceptor alpha 2a
ergotamine,migraine disorder,adrenoceptor alpha 2c
ergotamine,migraine disorder,adrenoceptor alpha 1d
ergotamine,migraine disorder,adrenoceptor alpha 1b
ergotamine,migraine disorder,adrenoceptor alpha 2b
ergotamine,migraine disorder,5-hydroxytryptamine receptor 1d
ergotamine,cluster headache syndrome,adrenoceptor alpha 1a
ergotamine,cluster headache syndrome,adrenoceptor alpha 2a
ergotamine,cluster headache syndrome,adrenoceptor alpha 2c
ergotamine,cluster headache syndrome,adrenoceptor alpha 1d
ergotamine,cluster headache syndrome,adrenoceptor alpha 1b
ergotamine,cluster headache syndrome,adrenoceptor alpha 2b
ergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1d
meclizine,motion sickness,histamine receptor h1
meclizine,central nervous system origin vertigo,histamine receptor h1
dimenhydrinate,motion sickness,histamine receptor h1
dimenhydrinate,nausea,histamine receptor h1
dimenhydrinate,central nervous system origin vertigo,histamine receptor h1
dimenhydrinate,vomiting,histamine receptor h1
hydroflumethiazide,edema,solute carrier family 12 member 3
atenolol,myocardial infarction,adrenoceptor beta 1
atenolol,angina pectoris,adrenoceptor beta 1
atenolol,hypertensive disorder,adrenoceptor beta 1
metipranolol,ocular hypertension,adrenoceptor beta 1
metipranolol,ocular hypertension,adrenoceptor beta 2
metipranolol,open-angle glaucoma,adrenoceptor beta 1
metipranolol,open-angle glaucoma,adrenoceptor beta 2
pirbuterol,bronchitis,adrenoceptor beta 2
pirbuterol,asthma,adrenoceptor beta 2
pirbuterol,pulmonary emphysema,adrenoceptor beta 2
pirbuterol,bronchiectasis,adrenoceptor beta 2
pirbuterol,lung disorder,adrenoceptor beta 2
oxprenolol,angina pectoris,adrenoceptor beta 1
oxprenolol,angina pectoris,adrenoceptor beta 2
oxprenolol,hypertensive disorder,adrenoceptor beta 1
oxprenolol,hypertensive disorder,adrenoceptor beta 2
oxprenolol,anxiety,adrenoceptor beta 1
oxprenolol,anxiety,adrenoceptor beta 2
tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
captopril,hypertensive disorder,angiotensin i converting enzyme
captopril,diabetic kidney disease,angiotensin i converting enzyme
sofalcone,gastric ulcer,15-hydroxyprostaglandin dehydrogenase
pralidoxime,poisoning of animals with phosphate salts,acetylcholinesterase (yt blood group)
ecallantide,hereditary angioedema,kallikrein b1
ticagrelor,acute coronary syndrome,purinergic receptor p2y12
ticagrelor,peripheral vascular disease,purinergic receptor p2y12
tramazoline,seasonal allergic rhinitis,adrenoceptor alpha 2a
tramazoline,allergic rhinitis,adrenoceptor alpha 2a
tramazoline,atopic conjunctivitis,adrenoceptor alpha 2a
tramazoline,sneeze,adrenoceptor alpha 2a
tramazoline,vasomotor rhinitis,adrenoceptor alpha 2a
tramazoline,common cold,adrenoceptor alpha 2a
prazosin,hypertensive disorder,adrenoceptor alpha 1a
prazosin,hypertensive disorder,adrenoceptor alpha 1b
prazosin,hypertensive disorder,adrenoceptor alpha 1d
methdilazine,sneeze,histamine receptor h1
methdilazine,atopic conjunctivitis,histamine receptor h1
methdilazine,angioedema,histamine receptor h1
methdilazine,allergic rhinitis,histamine receptor h1
methdilazine,pruritus,histamine receptor h1
methdilazine,urticaria,histamine receptor h1
mitiglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
parathyroid hormone,hypoparathyroidism,parathyroid hormone 1 receptor
calcium acetate,hypocalcemia,calcium sensing receptor
lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 10
lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 9
lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 5
lidocaine,urethritis,sodium voltage-gated channel alpha subunit 10
lidocaine,urethritis,sodium voltage-gated channel alpha subunit 9
lidocaine,urethritis,sodium voltage-gated channel alpha subunit 5
lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 10
lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 9
lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 5
lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 10
lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 9
lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 5
lidocaine,pruritus,sodium voltage-gated channel alpha subunit 10
lidocaine,pruritus,sodium voltage-gated channel alpha subunit 9
lidocaine,pruritus,sodium voltage-gated channel alpha subunit 5
lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 10
lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 9
lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 5
lidocaine,scabies,sodium voltage-gated channel alpha subunit 10
lidocaine,scabies,sodium voltage-gated channel alpha subunit 9
lidocaine,scabies,sodium voltage-gated channel alpha subunit 5
lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 10
lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 9
lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 5
nateglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
pseudoephedrine,common cold,adrenoceptor alpha 1a
pseudoephedrine,common cold,adrenoceptor beta 2
pseudoephedrine,allergic rhinitis,adrenoceptor alpha 1a
pseudoephedrine,vasomotor rhinitis,adrenoceptor alpha 1a
pseudoephedrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
pseudoephedrine,atopic conjunctivitis,adrenoceptor alpha 1a
pseudoephedrine,rhinitis,adrenoceptor alpha 1a
pseudoephedrine,headache disorder,adrenoceptor alpha 1a
misoprostol (methyl ester),post-partum hemorrhage,prostaglandin e receptor 4
ipragliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
lansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
lansoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
lansoprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
lansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
lansoprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
ketorolac,atopic conjunctivitis,prostaglandin-endoperoxide synthase 1
ketorolac,atopic conjunctivitis,prostaglandin-endoperoxide synthase 2
nizatidine,duodenal ulcer,histamine receptor h2
nizatidine,gastric ulcer,histamine receptor h2
nizatidine,gastroesophageal reflux disease,histamine receptor h2
nizatidine,peptic esophagitis,histamine receptor h2
nizatidine,peptic ulcer disease,histamine receptor h2
tretinoin,acne,retinoic acid receptor alpha
tretinoin,acne,retinoic acid receptor gamma
tretinoin,acne,retinoic acid receptor beta
tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor alpha
tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor gamma
tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor beta
tretinoin,acute promyelocytic leukemia,retinoic acid receptor alpha
tretinoin,acute promyelocytic leukemia,retinoic acid receptor gamma
tretinoin,acute promyelocytic leukemia,retinoic acid receptor beta
secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
sirolimus,renal cell carcinoma,mechanistic target of rapamycin kinase
aminobenzoic acid,pemphigus,monoamine oxidase a
aminobenzoic acid,peyronie disease,monoamine oxidase a
aminobenzoic acid,localized scleroderma,monoamine oxidase a
aminobenzoic acid,dermatomyositis,monoamine oxidase a
lorcaserin,obesity disorder,5-hydroxytryptamine receptor 2c
ofatumumab,b-cell chronic lymphocytic leukemia,membrane spanning 4-domains a1
dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
probenecid,hyperuricemia,solute carrier family 22 member 6
probenecid,hyperuricemia,solute carrier family 22 member 11
probenecid,hyperuricemia,solute carrier family 22 member 8
probenecid,gout,solute carrier family 22 member 6
probenecid,gout,solute carrier family 22 member 11
probenecid,gout,solute carrier family 22 member 8
rosuvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
rosuvastatin,hypercholesterolemia,low density lipoprotein receptor
rosuvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
rosuvastatin,"hyperlipidemia, familial combined, lpl related",low density lipoprotein receptor
rosuvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
rosuvastatin,hyperlipoproteinemia type 3,low density lipoprotein receptor
rosuvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
rosuvastatin,stroke disorder,low density lipoprotein receptor
rosuvastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
rosuvastatin,hypertriglyceridemia,low density lipoprotein receptor
rosuvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
rosuvastatin,arteriosclerosis disorder,low density lipoprotein receptor
glisoxepide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 8
vildagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
bumetanide,edema,solute carrier family 12 member 1
orlistat,obesity disorder,"lipase f, gastric type"
orlistat,obesity disorder,pancreatic lipase
levetiracetam,focal epilepsy,synaptic vesicle glycoprotein 2a
levetiracetam,focal epilepsy,calcium voltage-gated channel subunit alpha1 b
aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
insulin degludec,diabetes mellitus,insulin receptor
buclizine,motion sickness,histamine receptor h1
buclizine,motion sickness,cholinergic receptor muscarinic 1
tolbutamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
isopropamide,peptic ulcer disease,cholinergic receptor muscarinic 3
romidepsin,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
romidepsin,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
romidepsin,mature t-cell and nk-cell non-hodgkin lymphoma,histone deacetylase 1
romidepsin,mature t-cell and nk-cell non-hodgkin lymphoma,histone deacetylase 2
ziconotide,chronic pain,calcium voltage-gated channel subunit alpha1 b
sivelestat,acute lung injury,"elastase, neutrophil expressed"
ceritinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
dorzolamide,ocular hypertension,carbonic anhydrase 2
dorzolamide,open-angle glaucoma,carbonic anhydrase 2
dobutamine,cardiogenic shock,adrenoceptor beta 1
indomethacin,tenosynovitis,prostaglandin-endoperoxide synthase 1
indomethacin,tenosynovitis,prostaglandin-endoperoxide synthase 2
indomethacin,bursitis,prostaglandin-endoperoxide synthase 1
indomethacin,bursitis,prostaglandin-endoperoxide synthase 2
indomethacin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
indomethacin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
indomethacin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
indomethacin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
indomethacin,gout,prostaglandin-endoperoxide synthase 1
indomethacin,gout,prostaglandin-endoperoxide synthase 2
indomethacin,tendinopathy,prostaglandin-endoperoxide synthase 1
indomethacin,tendinopathy,prostaglandin-endoperoxide synthase 2
indomethacin,synovitis,prostaglandin-endoperoxide synthase 1
indomethacin,synovitis,prostaglandin-endoperoxide synthase 2
indomethacin,osteoarthritis,prostaglandin-endoperoxide synthase 1
indomethacin,osteoarthritis,prostaglandin-endoperoxide synthase 2
indomethacin,patent ductus arteriosus,prostaglandin-endoperoxide synthase 1
indomethacin,patent ductus arteriosus,prostaglandin-endoperoxide synthase 2
alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
astemizole,sneeze,histamine receptor h1
astemizole,atopic conjunctivitis,histamine receptor h1
astemizole,chronic urticaria,histamine receptor h1
astemizole,allergic rhinitis,histamine receptor h1
fluocinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
fluocinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
fluocinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
fluocinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
fluocinonide,exanthem,nuclear receptor subfamily 3 group c member 1
fluocinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
lithium ion,bipolar disorder,inositol monophosphatase 1
lithium ion,headache disorder,inositol monophosphatase 1
lithium ion,pain,inositol monophosphatase 1
lithium ion,osteoarthritis,inositol monophosphatase 1
lithium ion,juvenile idiopathic arthritis,inositol monophosphatase 1
lithium ion,rheumatoid arthritis,inositol monophosphatase 1
lithium ion,dysmenorrhea,inositol monophosphatase 1
lifitegrast,dry eye syndrome,integrin subunit alpha l
menatetrenone,hemorrhagic disease of newborn,gamma-glutamyl carboxylase
methapyrilene,urticaria,histamine receptor h1
methapyrilene,vasomotor rhinitis,histamine receptor h1
methapyrilene,allergic rhinitis,histamine receptor h1
methapyrilene,sneeze,histamine receptor h1
methapyrilene,atopic conjunctivitis,histamine receptor h1
methapyrilene,pruritus,histamine receptor h1
homatropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 1
homatropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 5
homatropine methylbromide,cough,cholinergic receptor muscarinic 2
homatropine methylbromide,cough,cholinergic receptor muscarinic 3
homatropine methylbromide,irritable bowel syndrome,cholinergic receptor muscarinic 2
homatropine methylbromide,irritable bowel syndrome,cholinergic receptor muscarinic 3
zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1d
zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1b
zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1f
pentostatin,hairy cell leukemia,adenosine deaminase
lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
n-methyl-n-(1-naphthalenylmethyl)-3-phenyl-2-propen-1-amine,tinea pedis,squalene epoxidase
roxatidine acetate,gastroesophageal reflux disease,histamine receptor h2
roxatidine acetate,zollinger-ellison syndrome,histamine receptor h2
roxatidine acetate,gastric ulcer,histamine receptor h2
levomilnacipran,major depressive disorder,solute carrier family 6 member 2
levomilnacipran,major depressive disorder,solute carrier family 6 member 4
pravastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
pravastatin,arteriosclerosis disorder,low density lipoprotein receptor
pravastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
pravastatin,stroke disorder,low density lipoprotein receptor
pravastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
pravastatin,hyperlipoproteinemia type 3,low density lipoprotein receptor
pravastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
pravastatin,"hyperlipidemia, familial combined, lpl related",low density lipoprotein receptor
pravastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
pravastatin,hypertriglyceridemia,low density lipoprotein receptor
pravastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
pravastatin,hypercholesterolemia,low density lipoprotein receptor
bupivacaine,pruritus,sodium voltage-gated channel alpha subunit 10
dihydroergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1d
dihydroergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1b
dihydroergotamine,vascular headaches,5-hydroxytryptamine receptor 1d
dihydroergotamine,vascular headaches,5-hydroxytryptamine receptor 1b
dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1d
dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1b
pemirolast,allergic rhinitis,histamine receptor h1
pemirolast,atopic conjunctivitis,histamine receptor h1
pemirolast,asthma,histamine receptor h1
salbutamol,bronchial disorder,adrenoceptor beta 2
heparin,disseminated intravascular coagulation,coagulation factor x
heparin,disseminated intravascular coagulation,serpin family c member 1
heparin,thrombophilia due to thrombin defect,coagulation factor x
heparin,thrombophilia due to thrombin defect,serpin family c member 1
heparin,pulmonary embolism,coagulation factor x
heparin,pulmonary embolism,serpin family c member 1
ruxolitinib,myeloproliferative neoplasm,janus kinase 2
ruxolitinib,myeloproliferative neoplasm,janus kinase 1
ruxolitinib,acquired polycythemia vera,janus kinase 2
ruxolitinib,acquired polycythemia vera,janus kinase 1
somatropin,turner syndrome,growth hormone receptor
somatropin,pituitary dwarfism,growth hormone receptor
somatropin,prader-willi syndrome,growth hormone receptor
pranlukast,asthma,cysteinyl leukotriene receptor 1
pranlukast,allergic rhinitis,cysteinyl leukotriene receptor 1
alteplase,pulmonary embolism,plasminogen
methylergonovine,post-partum hemorrhage,5-hydroxytryptamine receptor 2b
vincristine,rhabdomyosarcoma,tubulin beta class i
vincristine,non-hodgkin lymphoma,tubulin beta class i
vincristine,neuroblastoma,tubulin beta class i
vincristine,burkitt lymphoma,tubulin beta class i
vincristine,classic hodgkin lymphoma,tubulin beta class i
vincristine,follicular lymphoma,tubulin beta class i
vincristine,wilms tumor,tubulin beta class i
vincristine,diffuse large b-cell lymphoma,tubulin beta class i
fludroxycortide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
fludroxycortide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
fludroxycortide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
fludroxycortide,exanthem,nuclear receptor subfamily 3 group c member 1
fludroxycortide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
fludroxycortide,pruritus ani,nuclear receptor subfamily 3 group c member 1
fludroxycortide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
fludroxycortide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
fludroxycortide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
iloperidone,schizophrenia,5-hydroxytryptamine receptor 2a
iloperidone,schizophrenia,dopamine receptor d1
ramatroban,allergic rhinitis,prostaglandin d2 receptor 2
ramatroban,allergic rhinitis,thromboxane a2 receptor
duloxetine,major depressive disorder,solute carrier family 6 member 2
duloxetine,fibromyalgia,solute carrier family 6 member 4
duloxetine,fibromyalgia,solute carrier family 6 member 2
dipyridamole,atrial fibrillation,phosphodiesterase 10a
dipyridamole,atrial fibrillation,phosphodiesterase 5a
dipyridamole,atrial fibrillation,phosphodiesterase 4a
dipyridamole,atrial fibrillation,adenosine deaminase
melatonin,insomnia,melatonin receptor 1a
melatonin,insomnia,melatonin receptor 1b
bupropion,seasonal affective disorder,solute carrier family 6 member 2
bupropion,seasonal affective disorder,solute carrier family 6 member 3
bupropion,major depressive disorder,solute carrier family 6 member 2
bupropion,major depressive disorder,solute carrier family 6 member 3
bupropion,nicotine dependence,solute carrier family 6 member 3
bupropion,nicotine dependence,cholinergic receptor nicotinic alpha 3 subunit
bupropion,depressive disorder,solute carrier family 6 member 2
bupropion,depressive disorder,solute carrier family 6 member 3
tiaprofenic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
tiaprofenic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
tiaprofenic acid,pain,prostaglandin-endoperoxide synthase 2
tiaprofenic acid,pain,prostaglandin-endoperoxide synthase 1
tiaprofenic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
tiaprofenic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
crotamiton,pruritus,transient receptor potential cation channel subfamily v member 4
crotamiton,scabies,transient receptor potential cation channel subfamily v member 4
esomeprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
esomeprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
esomeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
trimethobenzamide,vomiting,dopamine receptor d2
trimethobenzamide,nausea,dopamine receptor d2
rimexolone,uveitis,nuclear receptor subfamily 3 group c member 1
dasatinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
dasatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
calcium gluconate,hypocalcemia,calcium sensing receptor
dimethyl fumarate,relapsing-remitting multiple sclerosis,kelch like ech associated protein 1
thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha1
thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha2
thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha3
thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha4
thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha5
thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha6
glucagon,hypoglycemia,glucagon receptor
phenelzine,depressive disorder,monoamine oxidase b
phenelzine,depressive disorder,monoamine oxidase a
terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
terazosin,hypertensive disorder,adrenoceptor alpha 1a
terazosin,hypertensive disorder,adrenoceptor alpha 1b
terazosin,hypertensive disorder,adrenoceptor alpha 1d
isocarboxazid,major depressive disorder,monoamine oxidase b
isocarboxazid,major depressive disorder,monoamine oxidase a
zuclopenthixol,schizophrenia,dopamine receptor d2
zuclopenthixol,schizophrenia,dopamine receptor d5
zuclopenthixol,schizophrenia,dopamine receptor d1
pazopanib,sarcoma,platelet derived growth factor receptor beta
pazopanib,sarcoma,fms related receptor tyrosine kinase 1
pazopanib,sarcoma,"kit proto-oncogene, receptor tyrosine kinase"
pazopanib,sarcoma,kinase insert domain receptor
pazopanib,sarcoma,fms related receptor tyrosine kinase 4
pazopanib,sarcoma,fms related receptor tyrosine kinase 3
pazopanib,sarcoma,colony stimulating factor 1 receptor
pazopanib,sarcoma,platelet derived growth factor receptor alpha
pazopanib,renal cell carcinoma,platelet derived growth factor receptor beta
pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 1
pazopanib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
pazopanib,renal cell carcinoma,kinase insert domain receptor
pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 4
pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 3
pazopanib,renal cell carcinoma,colony stimulating factor 1 receptor
pazopanib,renal cell carcinoma,platelet derived growth factor receptor alpha
agomelatine,major depressive disorder,5-hydroxytryptamine receptor 2c
agomelatine,major depressive disorder,melatonin receptor 1a
agomelatine,major depressive disorder,melatonin receptor 1b
antazoline,sneeze,histamine receptor h1
antazoline,urticaria,histamine receptor h1
antazoline,pruritus,histamine receptor h1
antazoline,allergic rhinitis,histamine receptor h1
antazoline,atopic conjunctivitis,histamine receptor h1
cetuximab,colonic neoplasm,epidermal growth factor receptor
risedronate,bone paget disease,atpase h+ transporting v1 subunit a
risedronate,osteoporosis,atpase h+ transporting v1 subunit a
risedronate,postmenopausal osteoporosis,atpase h+ transporting v1 subunit a
hydromorphone,pain,opioid receptor mu 1
lenalidomide,plasma cell myeloma,tumor necrosis factor
lenalidomide,mantle cell lymphoma,tumor necrosis factor
clocortolone pivalate,exanthem,nuclear receptor subfamily 3 group c member 1
clocortolone pivalate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
clocortolone pivalate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
clocortolone pivalate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
clocortolone pivalate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
clocortolone pivalate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
clocortolone pivalate,pruritus ani,nuclear receptor subfamily 3 group c member 1
clocortolone pivalate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
pirfenidone,acute interstitial pneumonia,tumor necrosis factor
obinutuzumab,b-cell chronic lymphocytic leukemia,membrane spanning 4-domains a1
5-fluorouracil,actinic keratosis,thymidylate synthetase
5-fluorouracil,gastric neoplasm,thymidylate synthetase
5-fluorouracil,colonic neoplasm,thymidylate synthetase
medroxyprogesterone,endometrium neoplasm,progesterone receptor
medroxyprogesterone,endometriosis,progesterone receptor
medroxyprogesterone,metrorrhagia,progesterone receptor
telmisartan,hypertensive disorder,angiotensin ii receptor type 1
telmisartan,hypertensive disorder,peroxisome proliferator activated receptor gamma
telmisartan,stroke disorder,angiotensin ii receptor type 1
telmisartan,stroke disorder,peroxisome proliferator activated receptor gamma
vernakalant,atrial fibrillation,potassium voltage-gated channel subfamily a member 5
vernakalant,atrial fibrillation,potassium voltage-gated channel subfamily d member 3
metoprolol,hypertensive disorder,adrenoceptor beta 1
metoprolol,myocardial infarction,adrenoceptor beta 1
metoprolol,acute coronary syndrome,adrenoceptor beta 1
metoprolol,angina pectoris,adrenoceptor beta 1
chlorpheniramine,atopic conjunctivitis,histamine receptor h1
chlorpheniramine,seasonal allergic rhinitis,histamine receptor h1
chlorpheniramine,sneeze,histamine receptor h1
chlorpheniramine,vasomotor rhinitis,histamine receptor h1
chlorpheniramine,pruritus,histamine receptor h1
chlorpheniramine,allergic rhinitis,histamine receptor h1
chlorpheniramine,urticaria,histamine receptor h1
neostigmine,myasthenia gravis,acetylcholinesterase (yt blood group)
neostigmine,urinary retention,acetylcholinesterase (yt blood group)
cabozantinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
cabozantinib,renal cell carcinoma,kinase insert domain receptor
cabozantinib,renal cell carcinoma,ret proto-oncogene
cabozantinib,medullary thyroid gland carcinoma,"met proto-oncogene, receptor tyrosine kinase"
cabozantinib,medullary thyroid gland carcinoma,kinase insert domain receptor
cabozantinib,medullary thyroid gland carcinoma,ret proto-oncogene
perazine,anxiety,dopamine receptor d2
perazine,schizophrenia,dopamine receptor d2
halcinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
halcinonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
halcinonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
halcinonide,exanthem,nuclear receptor subfamily 3 group c member 1
halcinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
halcinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
halcinonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
halcinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
halcinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
colchicine,gout,tubulin beta class i
colchicine,familial mediterranean fever,tubulin beta class i
masoprocol,actinic keratosis,mechanistic target of rapamycin kinase
cetirizine,allergic rhinitis,histamine receptor h1
cetirizine,sneeze,histamine receptor h1
cetirizine,vasomotor rhinitis,histamine receptor h1
cetirizine,chronic urticaria,histamine receptor h1
cetirizine,common cold,histamine receptor h1
cetirizine,seasonal allergic rhinitis,histamine receptor h1
cetirizine,atopic conjunctivitis,histamine receptor h1
benzocaine,pharyngitis,sodium voltage-gated channel alpha subunit 10
benzocaine,cough,sodium voltage-gated channel alpha subunit 10
benzocaine,pruritus,sodium voltage-gated channel alpha subunit 10
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 10
piroxicam,osteoarthritis,prostaglandin-endoperoxide synthase 1
piroxicam,osteoarthritis,prostaglandin-endoperoxide synthase 2
piroxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
piroxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 1
acetyldigitoxin,heart failure,atpase na+/k+ transporting subunit alpha 1
zoledronic acid,postmenopausal osteoporosis,farnesyl diphosphate synthase
zoledronic acid,postmenopausal osteoporosis,geranylgeranyl diphosphate synthase 1
zoledronic acid,bone paget disease,farnesyl diphosphate synthase
zoledronic acid,bone paget disease,geranylgeranyl diphosphate synthase 1
zoledronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
zoledronic acid,humoral hypercalcemia of malignancy,geranylgeranyl diphosphate synthase 1
zoledronic acid,osteoporosis,farnesyl diphosphate synthase
zoledronic acid,osteoporosis,geranylgeranyl diphosphate synthase 1
escitalopram,major depressive disorder,solute carrier family 6 member 4
sertindole,schizophrenia,dopamine receptor d2
sertindole,schizophrenia,5-hydroxytryptamine receptor 2c
sertindole,schizophrenia,5-hydroxytryptamine receptor 2a
sertindole,schizophrenia,adrenoceptor alpha 1b
sertindole,schizophrenia,adrenoceptor alpha 1a
sertindole,schizophrenia,adrenoceptor alpha 1d
zaleplon,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
salicylic acid,synovitis,prostaglandin-endoperoxide synthase 1
salicylic acid,synovitis,prostaglandin-endoperoxide synthase 2
salicylic acid,pain,prostaglandin-endoperoxide synthase 1
salicylic acid,pain,prostaglandin-endoperoxide synthase 2
salicylic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
salicylic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
salicylic acid,tinea pedis,prostaglandin-endoperoxide synthase 1
salicylic acid,tinea pedis,prostaglandin-endoperoxide synthase 2
salicylic acid,acne,prostaglandin-endoperoxide synthase 1
salicylic acid,acne,prostaglandin-endoperoxide synthase 2
salicylic acid,common cold,prostaglandin-endoperoxide synthase 1
salicylic acid,common cold,prostaglandin-endoperoxide synthase 2
salicylic acid,fever,prostaglandin-endoperoxide synthase 1
salicylic acid,fever,prostaglandin-endoperoxide synthase 2
salicylic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
salicylic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
salicylic acid,allergic rhinitis,prostaglandin-endoperoxide synthase 1
salicylic acid,allergic rhinitis,prostaglandin-endoperoxide synthase 2
salicylic acid,seborrheic dermatitis,prostaglandin-endoperoxide synthase 1
salicylic acid,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
glipizide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
glipizide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
clofazimine,pyoderma gangrenosum,potassium voltage-gated channel subfamily a member 3
torsemide,hypertensive disorder,solute carrier family 12 member 1
torsemide,edema,solute carrier family 12 member 1
conjugated estrogens,hot flashes,estrogen receptor 1
conjugated estrogens,hot flashes,estrogen receptor 2
conjugated estrogens,psychologic dyspareunia,estrogen receptor 1
conjugated estrogens,psychologic dyspareunia,estrogen receptor 2
dicumarol,intracranial embolism,vitamin k epoxide reductase complex subunit 1
dicumarol,thromboembolism,vitamin k epoxide reductase complex subunit 1
dicumarol,myocardial infarction,vitamin k epoxide reductase complex subunit 1
dicumarol,thrombotic disease,vitamin k epoxide reductase complex subunit 1
conivaptan,hyponatremia,arginine vasopressin receptor 1a
conivaptan,hyponatremia,arginine vasopressin receptor 2
doxylamine,sneeze,histamine receptor h1
doxylamine,atopic conjunctivitis,histamine receptor h1
doxylamine,urticaria,histamine receptor h1
doxylamine,vasomotor rhinitis,histamine receptor h1
doxylamine,common cold,histamine receptor h1
doxylamine,seasonal allergic rhinitis,histamine receptor h1
doxylamine,pruritus,histamine receptor h1
fluvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
fluvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
fluvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
lurasidone,bipolar disorder,dopamine receptor d2
lurasidone,bipolar disorder,5-hydroxytryptamine receptor 2a
lurasidone,schizophrenia,dopamine receptor d2
lurasidone,schizophrenia,5-hydroxytryptamine receptor 2a
diltiazem,angina pectoris,calcium voltage-gated channel subunit alpha1 c
diltiazem,angina pectoris,calcium voltage-gated channel auxiliary subunit gamma 1
diltiazem,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
diltiazem,prinzmetal angina,calcium voltage-gated channel auxiliary subunit gamma 1
diltiazem,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
diltiazem,hypertensive disorder,calcium voltage-gated channel auxiliary subunit gamma 1
diltiazem,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
diltiazem,atrial fibrillation,calcium voltage-gated channel auxiliary subunit gamma 1
polmacoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
repaglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor gamma
bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor alpha
bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor delta
bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor gamma
bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor delta
mefenamic acid,pain,prostaglandin-endoperoxide synthase 1
mefenamic acid,pain,prostaglandin-endoperoxide synthase 2
mefenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 1
mefenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 2
clofibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
frovatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
frovatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
desipramine,depressive disorder,solute carrier family 6 member 2
fluspirilene,schizophrenia,dopamine receptor d2
naftopidil,benign prostatic hyperplasia,adrenoceptor alpha 1d
fenoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
fenoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
fenoprofen,pain,prostaglandin-endoperoxide synthase 1
fenoprofen,pain,prostaglandin-endoperoxide synthase 2
fenoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
fenoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
tadalafil,erectile dysfunction,phosphodiesterase 5a
tadalafil,pulmonary hypertension,phosphodiesterase 5a
loxoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
loxoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
haloperidol,tourette syndrome,dopamine receptor d2
haloperidol,psychotic disorder,dopamine receptor d2
sumatriptan,cluster headache syndrome,5-hydroxytryptamine receptor 1d
sumatriptan,cluster headache syndrome,5-hydroxytryptamine receptor 1b
gliquidone,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 8
quinestrol,hot flashes,estrogen receptor 1
quinestrol,postmenopausal atrophic vaginitis,estrogen receptor 1
cyclosporin a,dry eye syndrome,peptidylprolyl isomerase a
cyclosporin a,xerophthalmia,peptidylprolyl isomerase a
cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase a
protriptyline,depressive disorder,solute carrier family 6 member 4
protriptyline,depressive disorder,solute carrier family 6 member 2
phenprocoumon,thrombotic disease,vitamin k epoxide reductase complex subunit 1
phenprocoumon,myocardial infarction,vitamin k epoxide reductase complex subunit 1
phenprocoumon,thromboembolism,vitamin k epoxide reductase complex subunit 1
riociguat,pulmonary arterial hypertension,guanylate cyclase 1 soluble subunit alpha 2
megestrol,endometrium neoplasm,progesterone receptor
azatadine,sneeze,histamine receptor h1
azatadine,seasonal allergic rhinitis,histamine receptor h1
azatadine,pruritus,histamine receptor h1
azatadine,common cold,histamine receptor h1
azatadine,urticaria,histamine receptor h1
azatadine,vasomotor rhinitis,histamine receptor h1
azatadine,allergic rhinitis,histamine receptor h1
azatadine,atopic conjunctivitis,histamine receptor h1
bilastine,allergic rhinitis,histamine receptor h1
bilastine,urticaria,histamine receptor h1
rilmenidine,hypertensive disorder,nischarin
olmutinib,non-small cell lung carcinoma,epidermal growth factor receptor
flutamide,prostate cancer,androgen receptor
fluphenazine,psychotic disorder,dopamine receptor d2
furosemide,edema,solute carrier family 12 member 1
furosemide,hypertensive disorder,solute carrier family 12 member 1
voglibose,type 2 diabetes mellitus,maltase-glucoamylase
voglibose,type 2 diabetes mellitus,alpha glucosidase
voglibose,type 2 diabetes mellitus,sucrase-isomaltase
voglibose,type 2 diabetes mellitus,maltase-glucoamylase 2 (putative)
oxymetholone,aplastic anemia,androgen receptor
oxymetholone,diamond-blackfan anemia,androgen receptor
insulin aspart,diabetes mellitus,insulin receptor
mianserin,major depressive disorder,5-hydroxytryptamine receptor 2a
mianserin,major depressive disorder,5-hydroxytryptamine receptor 2c
mianserin,major depressive disorder,solute carrier family 6 member 2
mianserin,major depressive disorder,adrenoceptor alpha 2a
mianserin,major depressive disorder,adrenoceptor alpha 2c
mianserin,major depressive disorder,histamine receptor h1
blonanserin,schizophrenia,dopamine receptor d2
blonanserin,schizophrenia,dopamine receptor d3
blonanserin,schizophrenia,5-hydroxytryptamine receptor 2a
paroxetine,post-traumatic stress disorder,solute carrier family 6 member 4
paroxetine,premenstrual dysphoric disorder,solute carrier family 6 member 4
paroxetine,hot flashes,solute carrier family 6 member 4
paroxetine,panic disorder,solute carrier family 6 member 4
paroxetine,obsessive-compulsive disorder,solute carrier family 6 member 4
paroxetine,major depressive disorder,solute carrier family 6 member 4
paroxetine,social phobia,solute carrier family 6 member 4
paroxetine,depressive disorder,solute carrier family 6 member 4
phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha1
phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha2
phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha3
phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha4
phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha5
phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha6
phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha1
phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha2
phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha3
phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha4
phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha5
phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha6
phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
amiloride,hypertensive disorder,sodium channel epithelial 1 subunit gamma
amiloride,hypertensive disorder,sodium channel epithelial 1 subunit alpha
amiloride,hypertensive disorder,sodium channel epithelial 1 subunit beta
amiloride,edema,sodium channel epithelial 1 subunit gamma
amiloride,edema,sodium channel epithelial 1 subunit alpha
amiloride,edema,sodium channel epithelial 1 subunit beta
nefazodone,major depressive disorder,solute carrier family 6 member 4
nefazodone,major depressive disorder,solute carrier family 6 member 2
nefazodone,major depressive disorder,5-hydroxytryptamine receptor 2a
nefazodone,major depressive disorder,5-hydroxytryptamine receptor 2c
dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 4
dronedarone,atrial fibrillation,potassium inwardly rectifying channel subfamily j member 2
alogliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
nicorandil,angina pectoris,atp binding cassette subfamily c member 9
reproterol,asthma,adrenoceptor beta 2
allopurinol,gout,xanthine dehydrogenase
allopurinol,hyperuricemia,xanthine dehydrogenase
ebastine,allergic rhinitis,histamine receptor h1
ebastine,chronic urticaria,histamine receptor h1
efonidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
efonidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
dopamine,decreased cardiac output,adrenoceptor beta 1
mitoxantrone,relapsing-remitting multiple sclerosis,dna topoisomerase ii alpha
mitoxantrone,acute myeloid leukemia,dna topoisomerase ii alpha
dezocine,pain,opioid receptor mu 1
dezocine,pain,opioid receptor kappa 1
piretanide,hypertensive disorder,solute carrier family 12 member 1
piretanide,edema,solute carrier family 12 member 1
fluticasone,asthma,nuclear receptor subfamily 3 group c member 1
fluticasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
icotinib,non-small cell lung carcinoma,epidermal growth factor receptor
fluvoxamine,social phobia,solute carrier family 6 member 4
fluvoxamine,obsessive-compulsive disorder,solute carrier family 6 member 4
paracetamol,tension-type headache,prostaglandin-endoperoxide synthase 1
paracetamol,tension-type headache,prostaglandin-endoperoxide synthase 2
paracetamol,tension-type headache,prostaglandin e synthase 3
paracetamol,migraine disorder,prostaglandin-endoperoxide synthase 1
paracetamol,migraine disorder,prostaglandin-endoperoxide synthase 2
paracetamol,migraine disorder,prostaglandin e synthase 3
paracetamol,toothache,prostaglandin-endoperoxide synthase 1
paracetamol,toothache,prostaglandin-endoperoxide synthase 2
paracetamol,toothache,prostaglandin e synthase 3
paracetamol,headache disorder,prostaglandin-endoperoxide synthase 1
paracetamol,headache disorder,prostaglandin-endoperoxide synthase 2
paracetamol,headache disorder,prostaglandin e synthase 3
paracetamol,arthralgia,prostaglandin-endoperoxide synthase 1
paracetamol,arthralgia,prostaglandin-endoperoxide synthase 2
paracetamol,arthralgia,prostaglandin e synthase 3
paracetamol,common cold,prostaglandin-endoperoxide synthase 1
paracetamol,common cold,prostaglandin-endoperoxide synthase 2
paracetamol,common cold,prostaglandin e synthase 3
paracetamol,allergic rhinitis,prostaglandin-endoperoxide synthase 1
paracetamol,allergic rhinitis,prostaglandin-endoperoxide synthase 2
paracetamol,allergic rhinitis,prostaglandin e synthase 3
alpha-methyltyrosine,pheochromocytoma,tyrosine hydroxylase
captodiame,anxiety disorder,5-hydroxytryptamine receptor 2c
captodiame,anxiety disorder,sigma non-opioid intracellular receptor 1
fluoxetine,bipolar disorder,solute carrier family 6 member 4
fluoxetine,panic disorder,solute carrier family 6 member 4
fluoxetine,premenstrual dysphoric disorder,solute carrier family 6 member 4
fluoxetine,depressive disorder,solute carrier family 6 member 4
fluoxetine,bulimia nervosa,solute carrier family 6 member 4
fluoxetine,major depressive disorder,solute carrier family 6 member 4
fluoxetine,obsessive-compulsive disorder,solute carrier family 6 member 4
topotecan,ovarian cancer,dna topoisomerase i
topotecan,small cell lung carcinoma,dna topoisomerase i
cyclizine,motion sickness,histamine receptor h1
cyclizine,sneeze,histamine receptor h1
cyclizine,seasonal allergic rhinitis,histamine receptor h1
cyclizine,allergic rhinitis,histamine receptor h1
cyclizine,common cold,histamine receptor h1
cyclizine,atopic conjunctivitis,histamine receptor h1
cyclizine,vasomotor rhinitis,histamine receptor h1
cyclizine,cough,histamine receptor h1
methyl salicylate,back pain,prostaglandin-endoperoxide synthase 1
methyl salicylate,back pain,prostaglandin-endoperoxide synthase 2
carbinoxamine,allergic rhinitis,histamine receptor h1
carbinoxamine,common cold,histamine receptor h1
carbinoxamine,pruritus,histamine receptor h1
carbinoxamine,seasonal allergic rhinitis,histamine receptor h1
carbinoxamine,urticaria,histamine receptor h1
carbinoxamine,vasomotor rhinitis,histamine receptor h1
gemigliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
oxymorphone,chronic pain,opioid receptor mu 1
oxymorphone,labor pain,opioid receptor mu 1
oxymorphone,pain,opioid receptor mu 1
ranitidine,duodenal ulcer,histamine receptor h2
ranitidine,gastric ulcer,histamine receptor h2
ranitidine,gastroesophageal reflux disease,histamine receptor h2
ranitidine,dyspepsia,histamine receptor h2
ranitidine,zollinger-ellison syndrome,histamine receptor h2
rivastigmine,alzheimer disease,acetylcholinesterase (yt blood group)
trazodone,major depressive disorder,solute carrier family 6 member 4
diethylpropion,obesity disorder,solute carrier family 6 member 2
diethylpropion,obesity disorder,solute carrier family 6 member 3
risperidone,autism spectrum disorder,dopamine receptor d2
risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 2a
risperidone,schizophrenia,dopamine receptor d2
risperidone,schizophrenia,5-hydroxytryptamine receptor 2a
salsalate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
salsalate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
salsalate,osteoarthritis,prostaglandin-endoperoxide synthase 1
salsalate,osteoarthritis,prostaglandin-endoperoxide synthase 2
tolazamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
tolazamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
trimetazidine,angina pectoris,acetyl-coa acyltransferase 2
ambenonium,myasthenia gravis,acetylcholinesterase (yt blood group)
benoxaprofen,rheumatoid arthritis,arachidonate 5-lipoxygenase
flufenamic acid,pain,prostaglandin-endoperoxide synthase 1
flufenamic acid,pain,prostaglandin-endoperoxide synthase 2
ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 2a
methimazole,hyperthyroidism,thyroid peroxidase
anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 1
anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 2
anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 3
anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 1
anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 2
anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 3
perampanel,focal epilepsy,glutamate ionotropic receptor ampa type subunit 1
atorvastatin,angina pectoris,3-hydroxy-3-methylglutaryl-coa reductase
atorvastatin,prinzmetal angina,3-hydroxy-3-methylglutaryl-coa reductase
atorvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
atorvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
atorvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
atorvastatin,"hyperlipidemia, familial combined, lpl related",lipoprotein lipase
atorvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
atorvastatin,hyperlipoproteinemia type 3,lipoprotein lipase
atorvastatin,hypertriglyceridemia,lipoprotein lipase
atorvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
hydroquinone,dyschromatosis universalis hereditaria,tyrosinase
fluticasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
fluticasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
fluticasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
fluticasone,exanthem,nuclear receptor subfamily 3 group c member 1
fluticasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
fluticasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
fluticasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
fluticasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
fluticasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
fluticasone,pulmonary emphysema,nuclear receptor subfamily 3 group c member 1
phenylephrine,common cold,adrenoceptor alpha 1a
phenylephrine,common cold,adrenoceptor alpha 1b
phenylephrine,common cold,adrenoceptor alpha 1d
phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1a
phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1b
phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1d
phenylephrine,cough,adrenoceptor alpha 1a
phenylephrine,cough,adrenoceptor alpha 1b
phenylephrine,cough,adrenoceptor alpha 1d
phenylephrine,fever,adrenoceptor alpha 1a
phenylephrine,fever,adrenoceptor alpha 1b
phenylephrine,fever,adrenoceptor alpha 1d
phenylephrine,headache disorder,adrenoceptor alpha 1a
phenylephrine,headache disorder,adrenoceptor alpha 1b
phenylephrine,headache disorder,adrenoceptor alpha 1d
phenylephrine,hemorrhoid,adrenoceptor alpha 1a
phenylephrine,hemorrhoid,adrenoceptor alpha 1b
phenylephrine,hemorrhoid,adrenoceptor alpha 1d
phenylephrine,proctitis,adrenoceptor alpha 1a
phenylephrine,proctitis,adrenoceptor alpha 1b
phenylephrine,proctitis,adrenoceptor alpha 1d
phenylephrine,pruritus ani,adrenoceptor alpha 1a
phenylephrine,pruritus ani,adrenoceptor alpha 1b
phenylephrine,pruritus ani,adrenoceptor alpha 1d
phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1b
phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1d
phenylephrine,allergic rhinitis,adrenoceptor alpha 1a
phenylephrine,allergic rhinitis,adrenoceptor alpha 1b
phenylephrine,allergic rhinitis,adrenoceptor alpha 1d
phenylephrine,rhinitis,adrenoceptor alpha 1a
phenylephrine,rhinitis,adrenoceptor alpha 1b
phenylephrine,rhinitis,adrenoceptor alpha 1d
phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1a
phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1b
phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1d
phenylephrine,sneeze,adrenoceptor alpha 1a
phenylephrine,sneeze,adrenoceptor alpha 1b
phenylephrine,sneeze,adrenoceptor alpha 1d
incadronic acid,osteoporosis,farnesyl diphosphate synthase
incadronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,dihydrofolate reductase
pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,thymidylate synthetase
ixazomib,plasma cell myeloma,proteasome 20s subunit beta 5
ixazomib,plasma cell myeloma,proteasome 20s subunit beta 1
caffeine,back pain,adenosine a2a receptor
caffeine,back pain,adenosine a2b receptor
caffeine,cluster headache syndrome,adenosine a2a receptor
caffeine,cluster headache syndrome,adenosine a2b receptor
caffeine,headache disorder,adenosine a2a receptor
caffeine,headache disorder,adenosine a2b receptor
caffeine,migraine disorder,adenosine a2a receptor
caffeine,migraine disorder,adenosine a2b receptor
caffeine,pain,adenosine a2a receptor
caffeine,pain,adenosine a2b receptor
caffeine,tension-type headache,adenosine a2a receptor
caffeine,tension-type headache,adenosine a2b receptor
caffeine,vascular headaches,adenosine a2a receptor
caffeine,vascular headaches,adenosine a2b receptor
desonide,asthma,nuclear receptor subfamily 3 group c member 1
desonide,crohn disease,nuclear receptor subfamily 3 group c member 1
desonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
desonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
desonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
desonide,exanthem,nuclear receptor subfamily 3 group c member 1
desonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
desonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
desonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
desonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
desonide,otitis externa,nuclear receptor subfamily 3 group c member 1
desonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
desonide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
doxorubicin,kaposi's sarcoma,dna topoisomerase ii alpha
doxorubicin,breast neoplasm,dna topoisomerase ii alpha
doxorubicin,burkitt lymphoma,dna topoisomerase ii alpha
doxorubicin,classic hodgkin lymphoma,dna topoisomerase ii alpha
doxorubicin,acute myeloid leukemia,dna topoisomerase ii alpha
doxorubicin,lung neoplasm,dna topoisomerase ii alpha
doxorubicin,follicular lymphoma,dna topoisomerase ii alpha
doxorubicin,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
doxorubicin,non-hodgkin lymphoma,dna topoisomerase ii alpha
doxorubicin,plasma cell myeloma,dna topoisomerase ii alpha
doxorubicin,neuroblastoma,dna topoisomerase ii alpha
doxorubicin,ovarian cancer,dna topoisomerase ii alpha
doxorubicin,small cell lung carcinoma,dna topoisomerase ii alpha
doxorubicin,wilms tumor,dna topoisomerase ii alpha
cortisol,acne,nuclear receptor subfamily 3 group c member 1
cortisol,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
cortisol,angioedema,nuclear receptor subfamily 3 group c member 1
cortisol,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
cortisol,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
cortisol,corneal ulcer,nuclear receptor subfamily 3 group c member 1
cortisol,crohn disease,nuclear receptor subfamily 3 group c member 1
cortisol,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
cortisol,granuloma annulare,nuclear receptor subfamily 3 group c member 1
cortisol,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
cortisol,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
cortisol,iridocyclitis,nuclear receptor subfamily 3 group c member 1
cortisol,iritis,nuclear receptor subfamily 3 group c member 1
cortisol,keratitis,nuclear receptor subfamily 3 group c member 1
cortisol,laryngeal edema,nuclear receptor subfamily 3 group c member 1
cortisol,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
cortisol,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
cortisol,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
cortisol,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
cortisol,neurodermatitis,nuclear receptor subfamily 3 group c member 1
cortisol,otitis externa,nuclear receptor subfamily 3 group c member 1
cortisol,proctitis,nuclear receptor subfamily 3 group c member 1
cortisol,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
cortisol,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
cortisol,rosacea,nuclear receptor subfamily 3 group c member 1
cortisol,canker sore,nuclear receptor subfamily 3 group c member 1
cortisol,tenosynovitis,nuclear receptor subfamily 3 group c member 1
cortisol,tinea pedis,nuclear receptor subfamily 3 group c member 1
cortisol,trichinellosis,nuclear receptor subfamily 3 group c member 1
cortisol,uveitis,nuclear receptor subfamily 3 group c member 1
naproxen,arthralgia,prostaglandin-endoperoxide synthase 1
naproxen,arthralgia,prostaglandin-endoperoxide synthase 2
naproxen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
naproxen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
naproxen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
naproxen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
naproxen,bursitis,prostaglandin-endoperoxide synthase 1
naproxen,bursitis,prostaglandin-endoperoxide synthase 2
naproxen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
naproxen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
naproxen,fever,prostaglandin-endoperoxide synthase 1
naproxen,fever,prostaglandin-endoperoxide synthase 2
naproxen,gout,prostaglandin-endoperoxide synthase 1
naproxen,gout,prostaglandin-endoperoxide synthase 2
naproxen,headache disorder,prostaglandin-endoperoxide synthase 1
naproxen,headache disorder,prostaglandin-endoperoxide synthase 2
naproxen,migraine disorder,prostaglandin-endoperoxide synthase 1
naproxen,migraine disorder,prostaglandin-endoperoxide synthase 2
naproxen,myalgia,prostaglandin-endoperoxide synthase 1
naproxen,myalgia,prostaglandin-endoperoxide synthase 2
naproxen,osteoarthritis,prostaglandin-endoperoxide synthase 1
naproxen,osteoarthritis,prostaglandin-endoperoxide synthase 2
naproxen,pain,prostaglandin-endoperoxide synthase 1
naproxen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
naproxen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
naproxen,tendinopathy,prostaglandin-endoperoxide synthase 1
naproxen,tendinopathy,prostaglandin-endoperoxide synthase 2
naproxen,toothache,prostaglandin-endoperoxide synthase 1
naproxen,toothache,prostaglandin-endoperoxide synthase 2
pheniramine,common cold,histamine receptor h1
pheniramine,atopic conjunctivitis,histamine receptor h1
pheniramine,cough,histamine receptor h1
pheniramine,fever,histamine receptor h1
pheniramine,headache disorder,histamine receptor h1
pheniramine,pharyngitis,histamine receptor h1
pheniramine,pruritus,histamine receptor h1
pheniramine,allergic rhinitis,histamine receptor h1
pheniramine,seasonal allergic rhinitis,histamine receptor h1
pheniramine,sneeze,histamine receptor h1
pheniramine,urticaria,histamine receptor h1
pheniramine,vasomotor rhinitis,histamine receptor h1
levoketoconazole,adrenal gland hyperfunction,cytochrome p450 family 17 subfamily a member 1
methylprednisolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
methylprednisolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
methylprednisolone,angioedema,nuclear receptor subfamily 3 group c member 1
methylprednisolone,gout,nuclear receptor subfamily 3 group c member 1
methylprednisolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,asthma,nuclear receptor subfamily 3 group c member 1
methylprednisolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
methylprednisolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
methylprednisolone,brain edema,nuclear receptor subfamily 3 group c member 1
methylprednisolone,bursitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,crohn disease,nuclear receptor subfamily 3 group c member 1
methylprednisolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
methylprednisolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
methylprednisolone,exanthem,nuclear receptor subfamily 3 group c member 1
methylprednisolone,eye disorder,nuclear receptor subfamily 3 group c member 1
methylprednisolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
methylprednisolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
methylprednisolone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
methylprednisolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
methylprednisolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
methylprednisolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
methylprednisolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
methylprednisolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
methylprednisolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
methylprednisolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
methylprednisolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
methylprednisolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
methylprednisolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
methylprednisolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,pemphigus,nuclear receptor subfamily 3 group c member 1
methylprednisolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
methylprednisolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
methylprednisolone,psoriasis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
methylprednisolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
methylprednisolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,serum sickness,nuclear receptor subfamily 3 group c member 1
methylprednisolone,skin disorder,nuclear receptor subfamily 3 group c member 1
methylprednisolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,synovitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
methylprednisolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,trichinellosis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
triamcinolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
triamcinolone,angioedema,nuclear receptor subfamily 3 group c member 1
triamcinolone,gout,nuclear receptor subfamily 3 group c member 1
triamcinolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
triamcinolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
triamcinolone,asthma,nuclear receptor subfamily 3 group c member 1
triamcinolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
triamcinolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
triamcinolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
triamcinolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
triamcinolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
triamcinolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
triamcinolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
triamcinolone,sympathetic ophthalmia,nuclear receptor subfamily 3 group c member 1
triamcinolone,psoriasis,nuclear receptor subfamily 3 group c member 1
triamcinolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
triamcinolone,serum sickness,nuclear receptor subfamily 3 group c member 1
triamcinolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,synovitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
triamcinolone,bursitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,cutaneous candidiasis,nuclear receptor subfamily 3 group c member 1
triamcinolone,exanthem,nuclear receptor subfamily 3 group c member 1
triamcinolone,eye disorder,nuclear receptor subfamily 3 group c member 1
triamcinolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
triamcinolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
triamcinolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
triamcinolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
triamcinolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
triamcinolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
triamcinolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
triamcinolone,seasonal allergic rhinitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
triamcinolone,canker sore,nuclear receptor subfamily 3 group c member 1
triamcinolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
triamcinolone,uveitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
triamcinolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
triamcinolone,brain edema,nuclear receptor subfamily 3 group c member 1
triamcinolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
triamcinolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
triamcinolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
triamcinolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
triamcinolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
triamcinolone,pemphigus,nuclear receptor subfamily 3 group c member 1
triamcinolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
triamcinolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
triamcinolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,skin disorder,nuclear receptor subfamily 3 group c member 1
triamcinolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
triamcinolone,trichinellosis,nuclear receptor subfamily 3 group c member 1
triamcinolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
triamcinolone,diffuse alopecia areata,nuclear receptor subfamily 3 group c member 1
triamcinolone,keloid,nuclear receptor subfamily 3 group c member 1
triamcinolone,lichen planus,nuclear receptor subfamily 3 group c member 1
triamcinolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
triamcinolone,necrobiosis lipoidica,nuclear receptor subfamily 3 group c member 1
triamcinolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
cortisone,acne,nuclear receptor subfamily 3 group c member 1
cortisone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
cortisone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
cortisone,angioedema,nuclear receptor subfamily 3 group c member 1
cortisone,gout,nuclear receptor subfamily 3 group c member 1
cortisone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
cortisone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
cortisone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
cortisone,asthma,nuclear receptor subfamily 3 group c member 1
cortisone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
cortisone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
cortisone,brain edema,nuclear receptor subfamily 3 group c member 1
cortisone,bursitis,nuclear receptor subfamily 3 group c member 1
cortisone,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
cortisone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
cortisone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
cortisone,crohn disease,nuclear receptor subfamily 3 group c member 1
cortisone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
cortisone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
cortisone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
cortisone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
cortisone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
cortisone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
cortisone,exanthem,nuclear receptor subfamily 3 group c member 1
cortisone,eye disorder,nuclear receptor subfamily 3 group c member 1
cortisone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
cortisone,hemorrhoid,nuclear receptor subfamily 3 group c member 1
cortisone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
cortisone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
cortisone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
cortisone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
cortisone,iritis,nuclear receptor subfamily 3 group c member 1
cortisone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
cortisone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
cortisone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
cortisone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
cortisone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
cortisone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
cortisone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
cortisone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
cortisone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
cortisone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
cortisone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
cortisone,otitis externa,nuclear receptor subfamily 3 group c member 1
cortisone,pemphigus,nuclear receptor subfamily 3 group c member 1
cortisone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
cortisone,proctitis,nuclear receptor subfamily 3 group c member 1
cortisone,pruritus ani,nuclear receptor subfamily 3 group c member 1
cortisone,psoriasis,nuclear receptor subfamily 3 group c member 1
cortisone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
cortisone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
cortisone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
cortisone,rosacea,nuclear receptor subfamily 3 group c member 1
cortisone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
cortisone,serum sickness,nuclear receptor subfamily 3 group c member 1
cortisone,skin disorder,nuclear receptor subfamily 3 group c member 1
cortisone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
cortisone,canker sore,nuclear receptor subfamily 3 group c member 1
cortisone,synovitis,nuclear receptor subfamily 3 group c member 1
cortisone,tendinopathy,nuclear receptor subfamily 3 group c member 1
cortisone,epicondylitis,nuclear receptor subfamily 3 group c member 1
cortisone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
cortisone,thyroiditis,nuclear receptor subfamily 3 group c member 1
cortisone,tinea pedis,nuclear receptor subfamily 3 group c member 1
cortisone,trichinellosis,nuclear receptor subfamily 3 group c member 1
cortisone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
cortisone,uveitis,nuclear receptor subfamily 3 group c member 1
prednisolone,hypersensitivity pneumonitis,nuclear receptor subfamily 3 group c member 1
prednisolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
prednisolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
prednisolone,angioedema,nuclear receptor subfamily 3 group c member 1
prednisolone,gout,nuclear receptor subfamily 3 group c member 1
prednisolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
prednisolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
prednisolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
prednisolone,allergic bronchopulmonary aspergillosis,nuclear receptor subfamily 3 group c member 1
prednisolone,asthma,nuclear receptor subfamily 3 group c member 1
prednisolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
prednisolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
prednisolone,brain edema,nuclear receptor subfamily 3 group c member 1
prednisolone,bursitis,nuclear receptor subfamily 3 group c member 1
prednisolone,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
prednisolone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
prednisolone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
prednisolone,crohn disease,nuclear receptor subfamily 3 group c member 1
prednisolone,dacryocystitis,nuclear receptor subfamily 3 group c member 1
prednisolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
prednisolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
prednisolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
prednisolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
prednisolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
prednisolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
prednisolone,exanthem,nuclear receptor subfamily 3 group c member 1
prednisolone,eye disorder,nuclear receptor subfamily 3 group c member 1
prednisolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
prednisolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
prednisolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
prednisolone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
prednisolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
prednisolone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
prednisolone,iritis,nuclear receptor subfamily 3 group c member 1
prednisolone,keratitis,nuclear receptor subfamily 3 group c member 1
prednisolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
prednisolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
prednisolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
prednisolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
prednisolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
prednisolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
prednisolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
prednisolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
prednisolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
prednisolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
prednisolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
prednisolone,sympathetic ophthalmia,nuclear receptor subfamily 3 group c member 1
prednisolone,pemphigus,nuclear receptor subfamily 3 group c member 1
prednisolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
prednisolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
prednisolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
prednisolone,psoriasis,nuclear receptor subfamily 3 group c member 1
prednisolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
prednisolone,pulmonary fibrosis,nuclear receptor subfamily 3 group c member 1
prednisolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
prednisolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
prednisolone,rosacea,nuclear receptor subfamily 3 group c member 1
prednisolone,serum sickness,nuclear receptor subfamily 3 group c member 1
prednisolone,sjogren syndrome,nuclear receptor subfamily 3 group c member 1
prednisolone,skin disorder,nuclear receptor subfamily 3 group c member 1
prednisolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
prednisolone,stevens-johnson syndrome,nuclear receptor subfamily 3 group c member 1
prednisolone,synovitis,nuclear receptor subfamily 3 group c member 1
prednisolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
prednisolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
prednisolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
prednisolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
prednisolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
prednisolone,uveitis,nuclear receptor subfamily 3 group c member 1
betamethasone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
betamethasone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
betamethasone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
betamethasone,asthma,nuclear receptor subfamily 3 group c member 1
betamethasone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
betamethasone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
betamethasone,brain edema,nuclear receptor subfamily 3 group c member 1
betamethasone,bursitis,nuclear receptor subfamily 3 group c member 1
betamethasone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
betamethasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
betamethasone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
betamethasone,eye disorder,nuclear receptor subfamily 3 group c member 1
betamethasone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
betamethasone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
betamethasone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
betamethasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
betamethasone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
betamethasone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
betamethasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
betamethasone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
betamethasone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
betamethasone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
betamethasone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
betamethasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
betamethasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
betamethasone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
betamethasone,scalp dermatosis,nuclear receptor subfamily 3 group c member 1
betamethasone,serum sickness,nuclear receptor subfamily 3 group c member 1
betamethasone,skin disorder,nuclear receptor subfamily 3 group c member 1
betamethasone,tendinopathy,nuclear receptor subfamily 3 group c member 1
betamethasone,epicondylitis,nuclear receptor subfamily 3 group c member 1
betamethasone,thyroiditis,nuclear receptor subfamily 3 group c member 1
betamethasone,tinea pedis,nuclear receptor subfamily 3 group c member 1
betamethasone,trichinellosis,nuclear receptor subfamily 3 group c member 1
betamethasone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
betamethasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
betamethasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,exanthem,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
fluocinolone acetonide,choroiditis,nuclear receptor subfamily 3 group c member 1
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
eliglustat,gaucher disease,udp-glucose ceramide glucosyltransferase
hydroxyurea,ovarian cancer,ribonucleotide reductase catalytic subunit m1
hydroxyurea,head and neck neoplasm,ribonucleotide reductase catalytic subunit m1
hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",ribonucleotide reductase catalytic subunit m1
hydroxyurea,melanoma,ribonucleotide reductase catalytic subunit m1
hydroxyurea,sickle cell anemia,ribonucleotide reductase catalytic subunit m1
everolimus,renal cell carcinoma,mechanistic target of rapamycin kinase
everolimus,breast neoplasm,mechanistic target of rapamycin kinase
everolimus,sebaceous adenoma,mechanistic target of rapamycin kinase
acetazolamide,absence epilepsy,carbonic anhydrase 2
acetazolamide,open-angle glaucoma,carbonic anhydrase 1
acetazolamide,open-angle glaucoma,carbonic anhydrase 14
acetazolamide,open-angle glaucoma,carbonic anhydrase 3
acetazolamide,open-angle glaucoma,carbonic anhydrase 2
acetazolamide,open-angle glaucoma,carbonic anhydrase 4
acetazolamide,open-angle glaucoma,carbonic anhydrase 7
acetazolamide,open-angle glaucoma,carbonic anhydrase 12
acetazolamide,edema,carbonic anhydrase 1
acetazolamide,edema,carbonic anhydrase 14
acetazolamide,edema,carbonic anhydrase 3
acetazolamide,edema,carbonic anhydrase 2
acetazolamide,edema,carbonic anhydrase 4
acetazolamide,edema,carbonic anhydrase 7
acetazolamide,edema,carbonic anhydrase 12
acetazolamide,angle-closure glaucoma,carbonic anhydrase 1
acetazolamide,angle-closure glaucoma,carbonic anhydrase 14
acetazolamide,angle-closure glaucoma,carbonic anhydrase 3
acetazolamide,angle-closure glaucoma,carbonic anhydrase 2
acetazolamide,angle-closure glaucoma,carbonic anhydrase 4
acetazolamide,angle-closure glaucoma,carbonic anhydrase 7
acetazolamide,angle-closure glaucoma,carbonic anhydrase 12
acetazolamide,altitude sickness,carbonic anhydrase 1
acetazolamide,altitude sickness,carbonic anhydrase 14
acetazolamide,altitude sickness,carbonic anhydrase 3
acetazolamide,altitude sickness,carbonic anhydrase 2
acetazolamide,altitude sickness,carbonic anhydrase 4
acetazolamide,altitude sickness,carbonic anhydrase 7
acetazolamide,altitude sickness,carbonic anhydrase 12
diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 1
diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 2
diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 3
acebutolol,hypertensive disorder,adrenoceptor beta 1
dexamethasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
dexamethasone,psoriasis,nuclear receptor subfamily 3 group c member 1
dexamethasone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
dexamethasone,crohn disease,nuclear receptor subfamily 3 group c member 1
dexamethasone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
dexamethasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,keloid,nuclear receptor subfamily 3 group c member 1
dexamethasone,keratitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,uveitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,bursitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,iritis,nuclear receptor subfamily 3 group c member 1
dexamethasone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
dexamethasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,asthma,nuclear receptor subfamily 3 group c member 1
dexamethasone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
dexamethasone,epicondylitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
dexamethasone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
dexamethasone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
dexamethasone,thyroiditis,nuclear receptor subfamily 3 group c member 1
dexamethasone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
dexamethasone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
dexamethasone,pemphigus,nuclear receptor subfamily 3 group c member 1
dexamethasone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
dexamethasone,trichinellosis,nuclear receptor subfamily 3 group c member 1
dexamethasone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
dexamethasone,otitis externa,nuclear receptor subfamily 3 group c member 1
dexamethasone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
dexamethasone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
dexamethasone,rosacea,nuclear receptor subfamily 3 group c member 1
dexamethasone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
dexamethasone,exanthem,nuclear receptor subfamily 3 group c member 1
dexamethasone,anterior uveitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,gout,nuclear receptor subfamily 3 group c member 1
dexamethasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
dexamethasone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
dexamethasone,burkitt lymphoma,nuclear receptor subfamily 3 group c member 1
dexamethasone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
dexamethasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
dexamethasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
dexamethasone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
dexamethasone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
dexamethasone,diffuse large b-cell lymphoma,nuclear receptor subfamily 3 group c member 1
dexamethasone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
dexamethasone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
dexamethasone,serum sickness,nuclear receptor subfamily 3 group c member 1
dexamethasone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
dexamethasone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
dexamethasone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
dexamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
dexamethasone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
selumetinib,neurofibromatosis 1,structural maintenance of chromosomes 1a
selumetinib,neurofibromatosis 1,structural maintenance of chromosomes 2
selumetinib,neurofibromatosis 1,mitogen-activated protein kinase kinase 1
selumetinib,neurofibromatosis 1,mitogen-activated protein kinase kinase 2
ethinylestradiol,atrophic vulva,estrogen receptor 1
ethinylestradiol,atrophic vulva,sex hormone binding globulin
drospirenone,atrophic vulva,nuclear receptor subfamily 3 group c member 2
drospirenone,atrophic vulva,progesterone receptor
norethisterone,atrophic vulva,sex hormone binding globulin
norethisterone,atrophic vulva,progesterone receptor
norgestimate,atrophic vulva,estrogen receptor 1
norgestimate,atrophic vulva,progesterone receptor
estradiol valerate,atrophic vulva,estrogen related receptor beta
estradiol valerate,atrophic vulva,estrogen receptor 1
estradiol valerate,atrophic vulva,sex hormone binding globulin
estradiol valerate,atrophic vulva,estrogen related receptor alpha
ospemifene,atrophic vulva,estrogen receptor 1
nizatidine,multiple endocrine neoplasia,histamine receptor h2
duloxetine,generalized anxiety disorder,solute carrier family 6 member 4
duloxetine,generalized anxiety disorder,solute carrier family 6 member 2
duloxetine,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
paroxetine,generalized anxiety disorder,solute carrier family 6 member 4
paroxetine,generalized anxiety disorder,solute carrier family 6 member 2
paroxetine,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
pregabalin,generalized anxiety disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
pregabalin,generalized anxiety disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 2
escitalopram,generalized anxiety disorder,solute carrier family 6 member 4
escitalopram,generalized anxiety disorder,solute carrier family 6 member 2
buspirone,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha5
alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha3
alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha2
alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha1
alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit gamma2
alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit beta2
alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit beta3
venlafaxine,generalized anxiety disorder,solute carrier family 6 member 2
venlafaxine,generalized anxiety disorder,solute carrier family 6 member 4
desvenlafaxine,generalized anxiety disorder,solute carrier family 6 member 2
desvenlafaxine,generalized anxiety disorder,solute carrier family 6 member 4
citalopram,generalized anxiety disorder,solute carrier family 6 member 2
citalopram,generalized anxiety disorder,solute carrier family 6 member 4
hydroxychloroquine,plasmodium malariae malaria,toll like receptor 7
hydroxychloroquine,plasmodium malariae malaria,toll like receptor 9
hydroxychloroquine,plasmodium malariae malaria,transmembrane protein 97
chloroquine,plasmodium malariae malaria,toll like receptor 9
chloroquine,plasmodium malariae malaria,transmembrane protein 97
biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 4
benzatropine,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 4
procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
carbidopa,postencephalitic parkinson disease,dopa decarboxylase
bromocriptine,postencephalitic parkinson disease,5-hydroxytryptamine receptor 6
bromocriptine,postencephalitic parkinson disease,dopamine receptor d1
levodopa,postencephalitic parkinson disease,dopa decarboxylase
levodopa,postencephalitic parkinson disease,dopamine receptor d2
levodopa,postencephalitic parkinson disease,dopamine receptor d1
levodopa,postencephalitic parkinson disease,dopamine receptor d3
amantadine,postencephalitic parkinson disease,dopa decarboxylase
amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2b
amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 3b
amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2c
amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2a
amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 1
amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2d
amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 3a
dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
dextromethorphan,major depressive disorder,solute carrier family 6 member 4
dextromethorphan,major depressive disorder,atp binding cassette subfamily b member 1
dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
dextromethorphan,major depressive disorder,solute carrier family 6 member 2
dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
vilazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
vilazodone,major depressive disorder,dopamine receptor d2
vilazodone,major depressive disorder,5-hydroxytryptamine receptor 7
mianserin,major depressive disorder,5-hydroxytryptamine receptor 6
mianserin,major depressive disorder,solute carrier family 6 member 3
mianserin,major depressive disorder,dopamine receptor d3
mianserin,major depressive disorder,5-hydroxytryptamine receptor 2b
mianserin,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
mianserin,major depressive disorder,5-hydroxytryptamine receptor 1a
mianserin,major depressive disorder,5-hydroxytryptamine receptor 7
mianserin,major depressive disorder,solute carrier family 6 member 4
mianserin,major depressive disorder,5-hydroxytryptamine receptor 1d
mianserin,major depressive disorder,dopamine receptor d2
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 3a
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 6
olanzapine,major depressive disorder,dopamine receptor d3
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 7
olanzapine,major depressive disorder,dopamine receptor d4
olanzapine,major depressive disorder,atp binding cassette subfamily b member 1
olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1b
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1a
olanzapine,major depressive disorder,albumin
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2b
olanzapine,major depressive disorder,histamine receptor h1
olanzapine,major depressive disorder,h1.0 linker histone
olanzapine,major depressive disorder,adrenoceptor alpha 2c
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2c
olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
olanzapine,major depressive disorder,dopamine receptor d5
olanzapine,major depressive disorder,adrenoceptor alpha 1a
olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1d
olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
olanzapine,major depressive disorder,cholinergic receptor muscarinic 2
olanzapine,major depressive disorder,adrenoceptor alpha 2a
olanzapine,major depressive disorder,cholinergic receptor muscarinic 3
paroxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
paroxetine,major depressive disorder,atp binding cassette subfamily b member 1
paroxetine,major depressive disorder,cholinergic receptor muscarinic 3
paroxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
paroxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
paroxetine,major depressive disorder,solute carrier family 6 member 3
paroxetine,major depressive disorder,cholinergic receptor muscarinic 2
paroxetine,major depressive disorder,solute carrier family 6 member 2
paroxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
paroxetine,major depressive disorder,adrenoceptor alpha 2a
paroxetine,major depressive disorder,adrenoceptor alpha 1a
ketamine,major depressive disorder,dopamine receptor d2
ketamine,major depressive disorder,atp binding cassette subfamily b member 1
ketamine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
ketamine,major depressive disorder,solute carrier family 6 member 2
fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
fluoxetine,major depressive disorder,albumin
fluoxetine,major depressive disorder,solute carrier family 6 member 2
fluoxetine,major depressive disorder,atp binding cassette subfamily b member 1
fluoxetine,major depressive disorder,adrenoceptor alpha 2a
fluoxetine,major depressive disorder,solute carrier family 6 member 3
fluoxetine,major depressive disorder,histamine receptor h1
fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2b
fluoxetine,major depressive disorder,adrenoceptor alpha 1a
fluoxetine,major depressive disorder,cholinergic receptor muscarinic 2
fluoxetine,major depressive disorder,cholinergic receptor muscarinic 3
bupropion,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
bupropion,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
bupropion,major depressive disorder,adrenoceptor alpha 1a
bupropion,major depressive disorder,solute carrier family 6 member 4
duloxetine,major depressive disorder,solute carrier family 6 member 3
duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
duloxetine,major depressive disorder,5-hydroxytryptamine receptor 6
duloxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
duloxetine,major depressive disorder,neuropeptide y receptor y1
duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
duloxetine,major depressive disorder,adrenoceptor alpha 1a
duloxetine,major depressive disorder,5-hydroxytryptamine receptor 7
duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2b
duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1d
duloxetine,major depressive disorder,cholinergic receptor muscarinic 2
duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1b
duloxetine,major depressive disorder,histamine receptor h1
duloxetine,major depressive disorder,adrenoceptor alpha 2a
selegiline,major depressive disorder,atp binding cassette subfamily b member 1
selegiline,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
selegiline,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
selegiline,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
escitalopram,major depressive disorder,histamine receptor h1
escitalopram,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
escitalopram,major depressive disorder,5-hydroxytryptamine receptor 2c
escitalopram,major depressive disorder,solute carrier family 6 member 3
escitalopram,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
escitalopram,major depressive disorder,adrenoceptor alpha 1a
escitalopram,major depressive disorder,solute carrier family 6 member 2
citalopram,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
citalopram,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
citalopram,major depressive disorder,solute carrier family 6 member 2
citalopram,major depressive disorder,solute carrier family 6 member 3
citalopram,major depressive disorder,atp binding cassette subfamily b member 1
citalopram,major depressive disorder,adrenoceptor alpha 1a
citalopram,major depressive disorder,histamine receptor h1
citalopram,major depressive disorder,5-hydroxytryptamine receptor 2c
vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 6
vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 1b
vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 3a
vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
vortioxetine,major depressive disorder,histamine receptor h1
vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 7
vortioxetine,major depressive disorder,solute carrier family 6 member 4
vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
nefazodone,major depressive disorder,atp binding cassette subfamily b member 1
nefazodone,major depressive disorder,solute carrier family 6 member 3
nefazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
nefazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
nefazodone,major depressive disorder,adrenoceptor alpha 2a
nefazodone,major depressive disorder,adrenoceptor alpha 1a
nefazodone,major depressive disorder,dopamine receptor d2
venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
venlafaxine,major depressive disorder,neuropeptide y receptor y1
venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
venlafaxine,major depressive disorder,atp binding cassette subfamily b member 1
venlafaxine,major depressive disorder,adrenoceptor alpha 2a
venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 6
venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 2c
venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 2a
venlafaxine,major depressive disorder,cholinergic receptor muscarinic 2
trazodone,major depressive disorder,histamine receptor h1
trazodone,major depressive disorder,adrenoceptor alpha 2a
trazodone,major depressive disorder,atp binding cassette subfamily b member 1
trazodone,major depressive disorder,5-hydroxytryptamine receptor 2c
trazodone,major depressive disorder,adrenoceptor alpha 1a
trazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
trazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
trazodone,major depressive disorder,5-hydroxytryptamine receptor 2b
trazodone,major depressive disorder,5-hydroxytryptamine receptor 2a
trazodone,major depressive disorder,solute carrier family 6 member 3
trazodone,major depressive disorder,dopamine receptor d2
trazodone,major depressive disorder,solute carrier family 6 member 2
tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
tranylcypromine,major depressive disorder,solute carrier family 6 member 3
tranylcypromine,major depressive disorder,solute carrier family 6 member 2
tranylcypromine,major depressive disorder,5-hydroxytryptamine receptor 1a
mirtazapine,major depressive disorder,solute carrier family 6 member 4
mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2c
mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 1a
mirtazapine,major depressive disorder,dopamine receptor d2
mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2a
mirtazapine,major depressive disorder,dopamine receptor d3
mirtazapine,major depressive disorder,dopamine receptor d4
mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2b
mirtazapine,major depressive disorder,adrenoceptor alpha 2c
mirtazapine,major depressive disorder,adrenoceptor alpha 1a
mirtazapine,major depressive disorder,histamine receptor h1
mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 3a
mirtazapine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
mirtazapine,major depressive disorder,solute carrier family 6 member 2
mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 7
mirtazapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
mirtazapine,major depressive disorder,adrenoceptor alpha 2a
mirtazapine,major depressive disorder,solute carrier family 6 member 3
gepirone,major depressive disorder,5-hydroxytryptamine receptor 2a
gepirone,major depressive disorder,dopamine receptor d2
hydroxocobalamin,methylmalonic acidemia,5-methyltetrahydrofolate-homocysteine methyltransferase
hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated b
hydroxocobalamin,methylmalonic acidemia,methylmalonyl-coa mutase
hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated a
hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated c
hydroxocobalamin,methylmalonic acidemia,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
sirolimus,lymphangioma,fkbp prolyl isomerase 1a
sirolimus,lymphangioma,eukaryotic translation initiation factor 4e
sirolimus,lymphangioma,fkbp prolyl isomerase 1b
sirolimus,lymphangioma,fkbp prolyl isomerase 5
nortriptyline,depressive disorder,histamine receptor h1
nortriptyline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
nortriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
nortriptyline,depressive disorder,5-hydroxytryptamine receptor 1a
nortriptyline,depressive disorder,5-hydroxytryptamine receptor 2c
nortriptyline,depressive disorder,albumin
nortriptyline,depressive disorder,5-hydroxytryptamine receptor 2a
nortriptyline,depressive disorder,dopamine receptor d2
nortriptyline,depressive disorder,cholinergic receptor muscarinic 2
nortriptyline,depressive disorder,solute carrier family 6 member 3
nortriptyline,depressive disorder,adrenoceptor alpha 2a
trimipramine,depressive disorder,5-hydroxytryptamine receptor 2a
trimipramine,depressive disorder,solute carrier family 6 member 3
trimipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
trimipramine,depressive disorder,solute carrier family 6 member 4
trimipramine,depressive disorder,5-hydroxytryptamine receptor 2c
trimipramine,depressive disorder,5-hydroxytryptamine receptor 3a
trimipramine,depressive disorder,5-hydroxytryptamine receptor 1a
trimipramine,depressive disorder,adrenoceptor alpha 2b
trimipramine,depressive disorder,atp binding cassette subfamily b member 1
trimipramine,depressive disorder,solute carrier family 6 member 2
trimipramine,depressive disorder,5-hydroxytryptamine receptor 1d
trimipramine,depressive disorder,histamine receptor h1
trimipramine,depressive disorder,adrenoceptor alpha 2a
trimipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
trimipramine,depressive disorder,dopamine receptor d2
amoxapine,depressive disorder,5-hydroxytryptamine receptor 2a
amoxapine,depressive disorder,dopamine receptor d3
amoxapine,depressive disorder,5-hydroxytryptamine receptor 2c
amoxapine,depressive disorder,5-hydroxytryptamine receptor 3a
amoxapine,depressive disorder,gamma-aminobutyric acid type a receptor subunit alpha1
amoxapine,depressive disorder,solute carrier family 6 member 3
amoxapine,depressive disorder,5-hydroxytryptamine receptor 1a
amoxapine,depressive disorder,dopamine receptor d2
amoxapine,depressive disorder,5-hydroxytryptamine receptor 1b
amoxapine,depressive disorder,solute carrier family 6 member 2
amoxapine,depressive disorder,histamine receptor h1
amoxapine,depressive disorder,adrenoceptor alpha 2a
amoxapine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
amoxapine,depressive disorder,5-hydroxytryptamine receptor 7
amoxapine,depressive disorder,dopamine receptor d4
fluvoxamine,depressive disorder,sigma non-opioid intracellular receptor 1
fluvoxamine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
fluvoxamine,depressive disorder,solute carrier family 6 member 4
fluvoxamine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
fluvoxamine,depressive disorder,solute carrier family 6 member 3
fluvoxamine,depressive disorder,atp binding cassette subfamily b member 1
fluvoxamine,depressive disorder,solute carrier family 6 member 2
imipramine,depressive disorder,cholinergic receptor muscarinic 2
imipramine,depressive disorder,histamine receptor h1
imipramine,depressive disorder,dopamine receptor d2
imipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
imipramine,depressive disorder,5-hydroxytryptamine receptor 2a
imipramine,depressive disorder,solute carrier family 6 member 3
imipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
imipramine,depressive disorder,5-hydroxytryptamine receptor 2c
imipramine,depressive disorder,atp binding cassette subfamily b member 1
imipramine,depressive disorder,5-hydroxytryptamine receptor 1a
imipramine,depressive disorder,5-hydroxytryptamine receptor 7
imipramine,depressive disorder,dopamine receptor d3
imipramine,depressive disorder,adrenoceptor alpha 2a
protriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
protriptyline,depressive disorder,atp binding cassette subfamily b member 1
protriptyline,depressive disorder,solute carrier family 6 member 3
fluoxetine,depressive disorder,5-hydroxytryptamine receptor 2a
fluoxetine,depressive disorder,sigma non-opioid intracellular receptor 1
fluoxetine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
fluoxetine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
fluoxetine,depressive disorder,5-hydroxytryptamine receptor 2c
fluoxetine,depressive disorder,albumin
fluoxetine,depressive disorder,solute carrier family 6 member 2
fluoxetine,depressive disorder,atp binding cassette subfamily b member 1
fluoxetine,depressive disorder,adrenoceptor alpha 2a
fluoxetine,depressive disorder,solute carrier family 6 member 3
fluoxetine,depressive disorder,histamine receptor h1
fluoxetine,depressive disorder,cholinergic receptor muscarinic 2
citalopram,depressive disorder,cytochrome p450 family 2 subfamily c member 19
citalopram,depressive disorder,cytochrome p450 family 2 subfamily d member 6
citalopram,depressive disorder,solute carrier family 6 member 2
citalopram,depressive disorder,solute carrier family 6 member 3
citalopram,depressive disorder,atp binding cassette subfamily b member 1
citalopram,depressive disorder,histamine receptor h1
citalopram,depressive disorder,5-hydroxytryptamine receptor 2c
sertraline,depressive disorder,atp binding cassette subfamily b member 1
sertraline,depressive disorder,sigma non-opioid intracellular receptor 1
sertraline,depressive disorder,monoamine oxidase b
sertraline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
sertraline,depressive disorder,solute carrier family 6 member 2
sertraline,depressive disorder,solute carrier family 6 member 3
sertraline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
sertraline,depressive disorder,monoamine oxidase a
lofepramine,depressive disorder,dopamine receptor d2
lofepramine,depressive disorder,cholinergic receptor muscarinic 2
lofepramine,depressive disorder,solute carrier family 6 member 2
lofepramine,depressive disorder,5-hydroxytryptamine receptor 2c
lofepramine,depressive disorder,5-hydroxytryptamine receptor 1a
lofepramine,depressive disorder,adrenoceptor alpha 2a
lofepramine,depressive disorder,histamine receptor h1
lofepramine,depressive disorder,solute carrier family 6 member 4
moclobemide,depressive disorder,cytochrome p450 family 2 subfamily d member 6
moclobemide,depressive disorder,monoamine oxidase a
moclobemide,depressive disorder,monoamine oxidase b
moclobemide,depressive disorder,cytochrome p450 family 2 subfamily c member 19
moclobemide,depressive disorder,5-hydroxytryptamine receptor 1a
clomipramine,depressive disorder,adrenoceptor alpha 2a
clomipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
clomipramine,depressive disorder,5-hydroxytryptamine receptor 2c
clomipramine,depressive disorder,5-hydroxytryptamine receptor 2a
clomipramine,depressive disorder,solute carrier family 6 member 2
clomipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
clomipramine,depressive disorder,atp binding cassette subfamily b member 1
clomipramine,depressive disorder,solute carrier family 6 member 4
clomipramine,depressive disorder,albumin
clomipramine,depressive disorder,dopamine receptor d3
clomipramine,depressive disorder,dopamine receptor d2
clomipramine,depressive disorder,solute carrier family 6 member 3
clomipramine,depressive disorder,dopamine receptor d1
doxepin,depressive disorder,cytochrome p450 family 2 subfamily c member 19
doxepin,depressive disorder,adrenoceptor alpha 2a
doxepin,depressive disorder,5-hydroxytryptamine receptor 2a
doxepin,depressive disorder,5-hydroxytryptamine receptor 2c
doxepin,depressive disorder,atp binding cassette subfamily b member 1
doxepin,depressive disorder,solute carrier family 6 member 2
doxepin,depressive disorder,adrenoceptor alpha 2c
doxepin,depressive disorder,histamine receptor h1
doxepin,depressive disorder,dopamine receptor d2
doxepin,depressive disorder,adrenoceptor alpha 2b
doxepin,depressive disorder,solute carrier family 6 member 4
doxepin,depressive disorder,5-hydroxytryptamine receptor 1a
doxepin,depressive disorder,cholinergic receptor muscarinic 2
doxepin,depressive disorder,cytochrome p450 family 2 subfamily d member 6
desipramine,depressive disorder,5-hydroxytryptamine receptor 2c
desipramine,depressive disorder,cholinergic receptor muscarinic 2
desipramine,depressive disorder,atp binding cassette subfamily b member 1
desipramine,depressive disorder,5-hydroxytryptamine receptor 1a
desipramine,depressive disorder,adrenoceptor beta 1
desipramine,depressive disorder,5-hydroxytryptamine receptor 2a
desipramine,depressive disorder,dopamine receptor d2
desipramine,depressive disorder,solute carrier family 6 member 3
desipramine,depressive disorder,solute carrier family 6 member 4
desipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
desipramine,depressive disorder,histamine receptor h1
desipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
desipramine,depressive disorder,sphingomyelin phosphodiesterase 1
desipramine,depressive disorder,dopamine receptor d1
desipramine,depressive disorder,albumin
desipramine,depressive disorder,adrenoceptor alpha 2a
toloxatone,depressive disorder,monoamine oxidase b
methylphenidate,depressive disorder,solute carrier family 6 member 4
methylphenidate,depressive disorder,solute carrier family 6 member 3
methylphenidate,depressive disorder,cytochrome p450 family 2 subfamily d member 6
methylphenidate,depressive disorder,solute carrier family 6 member 2
paroxetine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
paroxetine,depressive disorder,tachykinin receptor 1
paroxetine,depressive disorder,atp binding cassette subfamily b member 1
paroxetine,depressive disorder,5-hydroxytryptamine receptor 2a
paroxetine,depressive disorder,solute carrier family 6 member 3
paroxetine,depressive disorder,cholinergic receptor muscarinic 2
paroxetine,depressive disorder,solute carrier family 6 member 2
paroxetine,depressive disorder,5-hydroxytryptamine receptor 1a
paroxetine,depressive disorder,adrenoceptor alpha 2a
paroxetine,depressive disorder,g protein-coupled receptor kinase 2
amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1a
amitriptyline,depressive disorder,solute carrier family 6 member 4
amitriptyline,depressive disorder,neurotrophic receptor tyrosine kinase 2
amitriptyline,depressive disorder,albumin
amitriptyline,depressive disorder,dopamine receptor d2
amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1d
amitriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
amitriptyline,depressive disorder,5-hydroxytryptamine receptor 2c
amitriptyline,depressive disorder,5-hydroxytryptamine receptor 2a
amitriptyline,depressive disorder,opioid receptor mu 1
amitriptyline,depressive disorder,opioid receptor kappa 1
amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1b
amitriptyline,depressive disorder,atp binding cassette subfamily b member 1
amitriptyline,depressive disorder,cholinergic receptor muscarinic 2
amitriptyline,depressive disorder,histamine receptor h1
amitriptyline,depressive disorder,dopamine receptor d3
amitriptyline,depressive disorder,solute carrier family 6 member 2
amitriptyline,depressive disorder,5-hydroxytryptamine receptor 7
amitriptyline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
amitriptyline,depressive disorder,sigma non-opioid intracellular receptor 1
amitriptyline,depressive disorder,adrenoceptor alpha 2a
amitriptyline,depressive disorder,solute carrier family 6 member 3
amitriptyline,depressive disorder,dopamine receptor d1
amitriptyline,depressive disorder,dopamine receptor d5
bupropion,depressive disorder,cytochrome p450 family 2 subfamily d member 6
bupropion,depressive disorder,solute carrier family 6 member 4
prednisolone,musculoskeletal system disorder,serpin family a member 6
triamcinolone,musculoskeletal system disorder,serpin family a member 6
cortisol,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
cortisol,musculoskeletal system disorder,sex hormone binding globulin
cortisol,musculoskeletal system disorder,serpin family a member 6
prednisone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
phenytoin,status epilepticus,atp binding cassette subfamily c member 2
phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 3
phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 1
phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 5
phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 2
phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 8
phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 4
phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 9
levetiracetam,status epilepticus,calcium voltage-gated channel subunit alpha1 b
levetiracetam,status epilepticus,atp binding cassette subfamily c member 2
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma3
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit delta
secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
secobarbital,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
phenobarbital,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
phenobarbital,status epilepticus,atp binding cassette subfamily c member 2
phenobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
pentobarbitone,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit delta
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma3
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
cortisol,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
cortisol,adrenocortical insufficiency,sex hormone binding globulin
cortisol,adrenocortical insufficiency,serpin family a member 6
triamcinolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
triamcinolone,adrenocortical insufficiency,serpin family a member 6
prednisone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
betamethasone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
prednisolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
prednisolone,adrenocortical insufficiency,serpin family a member 6
methylprednisolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
vasopressin,nocturnal enuresis,arginine vasopressin receptor 2
medroxyprogesterone,precocious puberty,nuclear receptor subfamily 3 group c member 1
progesterone,precocious puberty,nuclear receptor subfamily 3 group c member 1
danazol,precocious puberty,gonadotropin releasing hormone receptor
amiodarone,ventricular fibrillation,potassium voltage-gated channel subfamily h member 2
"1,25-dihydroxyvitamin d3",hypophosphatemia,gc vitamin d binding protein
"1,25-dihydroxyvitamin d3",hypophosphatemia,cytochrome p450 family 3 subfamily a member 4
calcifediol,hypophosphatemia,vitamin d receptor
calcifediol,hypophosphatemia,cytochrome p450 family 27 subfamily b member 1
pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,solute carrier family 19 member 1
biotin,nutritional biotin deficiency,solute carrier family 5 member 6
biotin,nutritional biotin deficiency,holocarboxylase synthetase
isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
mometasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
prednisone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 6
panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 3
bupropion,seasonal affective disorder,solute carrier family 6 member 4
fluoxetine,seasonal affective disorder,5-hydroxytryptamine receptor 2a
fluoxetine,seasonal affective disorder,solute carrier family 6 member 4
fluoxetine,seasonal affective disorder,5-hydroxytryptamine receptor 2c
fluoxetine,seasonal affective disorder,solute carrier family 6 member 2
fluoxetine,seasonal affective disorder,solute carrier family 6 member 3
sertraline,seasonal affective disorder,solute carrier family 6 member 4
sertraline,seasonal affective disorder,solute carrier family 6 member 2
sertraline,seasonal affective disorder,solute carrier family 6 member 3
(-)-adrenaline,cardiac arrest,adrenoceptor beta 1
(-)-adrenaline,cardiac arrest,adrenoceptor beta 2
(-)-adrenaline,cardiac arrest,adrenoceptor beta 3
(-)-adrenaline,cardiac arrest,tumor necrosis factor
phenprocoumon,thrombotic disease,albumin
warfarin,thrombotic disease,cytochrome p450 family 2 subfamily c member 19
warfarin,thrombotic disease,albumin
dicumarol,thrombotic disease,g protein-coupled receptor 35
ceftriaxone,endometritis,synuclein alpha
5-fluorouracil,small intestine cancer,thymidylate synthetase
oxaliplatin,gastric cancer,glutathione s-transferase pi 1
oxaliplatin,gastric cancer,metallothionein 2a
oxaliplatin,gastric cancer,glutathione s-transferase theta 1
oxaliplatin,gastric cancer,glutathione s-transferase mu 1
tipiracil,gastric cancer,thymidine phosphorylase
capecitabine,gastric cancer,thymidine phosphorylase
capecitabine,gastric cancer,dihydropyrimidine dehydrogenase
capecitabine,gastric cancer,thymidylate synthetase
docetaxel,gastric cancer,epidermal growth factor receptor
docetaxel,gastric cancer,tubulin beta 6 class v
docetaxel,gastric cancer,tubulin beta 2b class iib
docetaxel,gastric cancer,tubulin beta 2a class iia
docetaxel,gastric cancer,tubulin beta class i
docetaxel,gastric cancer,tubulin beta 3 class iii
docetaxel,gastric cancer,tubulin beta 1 class vi
docetaxel,gastric cancer,tubulin beta 4a class iva
docetaxel,gastric cancer,tubulin beta 4b class ivb
docetaxel,gastric cancer,tubulin beta 8 class viii
5-fluorouracil,gastric cancer,cytochrome p450 family 2 subfamily a member 6
5-fluorouracil,gastric cancer,thymidine phosphorylase
5-fluorouracil,gastric cancer,albumin
5-fluorouracil,gastric cancer,thymidylate synthetase
5-fluorouracil,gastric cancer,methylenetetrahydrofolate reductase
5-fluorouracil,gastric cancer,dihydropyrimidine dehydrogenase
5-fluorouracil,gastric cancer,uridine monophosphate synthetase
trifluridine,gastric cancer,thymidylate synthetase
trifluridine,gastric cancer,thymidine phosphorylase
ergocalciferol,osteomalacia,cytochrome p450 family 2 subfamily r member 1
ergocalciferol,osteomalacia,vitamin d receptor
ergocalciferol,osteomalacia,cytochrome p450 family 27 subfamily b member 1
ceftriaxone,acute gonococcal cervicitis,synuclein alpha
esomeprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
pantoprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
pantoprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
cimetidine,gastric ulcer,solute carrier family 47 member 1
lansoprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
famotidine,gastric ulcer,solute carrier family 47 member 1
fenoldopam,malignant essential hypertension,dopamine receptor d1
5-fluorouracil,urinary bladder cancer,thymidine phosphorylase
5-fluorouracil,urinary bladder cancer,thymidylate synthetase
5-fluorouracil,urinary bladder cancer,methylenetetrahydrofolate reductase
mitomycin c,urinary bladder cancer,cytochrome p450 oxidoreductase
carboplatin,urinary bladder cancer,glutathione s-transferase theta 1
carboplatin,urinary bladder cancer,metallothionein 1a
carboplatin,urinary bladder cancer,nad(p)h quinone dehydrogenase 1
carboplatin,urinary bladder cancer,metallothionein 2a
carboplatin,urinary bladder cancer,myeloperoxidase
carboplatin,urinary bladder cancer,glutathione s-transferase pi 1
carboplatin,urinary bladder cancer,glutathione s-transferase mu 1
gemcitabine,urinary bladder cancer,ribonucleotide reductase regulatory subunit m2
gemcitabine,urinary bladder cancer,thymidylate synthetase
prednisolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
prednisolone,acquired thrombocytopenia,serpin family a member 6
prednisone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
methylprednisolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
betamethasone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
cortisol,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
cortisol,acquired thrombocytopenia,sex hormone binding globulin
cortisol,acquired thrombocytopenia,serpin family a member 6
triamcinolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
triamcinolone,acquired thrombocytopenia,serpin family a member 6
"1,25-dihydroxyvitamin d3",hypoparathyroidism,gc vitamin d binding protein
alfacalcidol,hypoparathyroidism,cytochrome p450 family 27 subfamily b member 1
alfacalcidol,hypoparathyroidism,gc vitamin d binding protein
alfacalcidol,hypoparathyroidism,vitamin d receptor
ergocalciferol,hypoparathyroidism,vitamin d receptor
ergocalciferol,hypoparathyroidism,cytochrome p450 family 27 subfamily b member 1
sertraline,social phobia,solute carrier family 6 member 2
sertraline,social phobia,solute carrier family 6 member 3
desvenlafaxine,social phobia,solute carrier family 6 member 2
desvenlafaxine,social phobia,solute carrier family 6 member 4
desvenlafaxine,social phobia,solute carrier family 6 member 3
fluvoxamine,social phobia,solute carrier family 6 member 3
fluvoxamine,social phobia,solute carrier family 6 member 2
paroxetine,social phobia,solute carrier family 6 member 3
paroxetine,social phobia,solute carrier family 6 member 2
ceftriaxone,streptococcal meningitis,synuclein alpha
bimatoprost,hypertrichosis of eyelid,prostaglandin f receptor
theophylline,bronchial disorder,phosphodiesterase 4c
theophylline,bronchial disorder,phosphodiesterase 4a
theophylline,bronchial disorder,phosphodiesterase 4d
theophylline,bronchial disorder,phosphodiesterase 4b
triamcinolone,thyroiditis,serpin family a member 6
prednisone,thyroiditis,nuclear receptor subfamily 3 group c member 1
cortisol,thyroiditis,nuclear receptor subfamily 3 group c member 1
cortisol,thyroiditis,sex hormone binding globulin
cortisol,thyroiditis,serpin family a member 6
prednisolone,thyroiditis,serpin family a member 6
duloxetine,female stress incontinence,solute carrier family 6 member 4
duloxetine,female stress incontinence,solute carrier family 6 member 2
chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha3
chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit gamma2
chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha2
chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit beta3
chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha1
chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit beta2
chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha5
lansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 5
pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 4
pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 2
pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 3
pantoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
rabeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
esomeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
atropine,peptic ulcer disease,cholinergic receptor muscarinic 5
atropine,peptic ulcer disease,cholinergic receptor muscarinic 4
atropine,peptic ulcer disease,cholinergic receptor muscarinic 3
atropine,peptic ulcer disease,cholinergic receptor muscarinic 2
atropine,peptic ulcer disease,cholinergic receptor muscarinic 1
ceftriaxone,acute gonococcal endometritis,synuclein alpha
ceftriaxone,gonorrhea,synuclein alpha
diazoxide,hyperinsulinism,atp binding cassette subfamily c member 8
magnesium sulfate,constipation disorder,calcium voltage-gated channel subunit alpha1 s
magnesium sulfate,constipation disorder,calcium voltage-gated channel subunit alpha1 c
olaparib,ovarian epithelial tumor,poly(adp-ribose) polymerase 2
olaparib,ovarian epithelial tumor,poly(adp-ribose) polymerase 1
olaparib,ovarian epithelial tumor,poly(adp-ribose) polymerase family member 4
olaparib,ovarian epithelial tumor,poly(adp-ribose) polymerase family member 3
nizatidine,dyspepsia,histamine receptor h2
lovastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
simvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
cortisol,blepharoconjunctivitis,nuclear receptor subfamily 3 group c member 1
cortisol,blepharoconjunctivitis,sex hormone binding globulin
cortisol,blepharoconjunctivitis,serpin family a member 6
prednisolone,blepharoconjunctivitis,nuclear receptor subfamily 3 group c member 1
prednisolone,blepharoconjunctivitis,serpin family a member 6
cromoglicic acid,vernal conjunctivitis,g protein-coupled receptor 35
cinnarizine,central nervous system origin vertigo,calcium voltage-gated channel subunit alpha1 c
cinnarizine,central nervous system origin vertigo,calcium voltage-gated channel subunit alpha1 g
everolimus,sebaceous adenoma,fkbp prolyl isomerase 1a
sirolimus,sebaceous adenoma,fkbp prolyl isomerase 1a
sirolimus,sebaceous adenoma,eukaryotic translation initiation factor 4e
sirolimus,sebaceous adenoma,mechanistic target of rapamycin kinase
sirolimus,sebaceous adenoma,fkbp prolyl isomerase 1b
sirolimus,sebaceous adenoma,fkbp prolyl isomerase 5
indomethacin,synovitis,c-x-c motif chemokine ligand 8
indomethacin,synovitis,aldo-keto reductase family 1 member c3
betamethasone,synovitis,prostaglandin-endoperoxide synthase 2
betamethasone,synovitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,synovitis,prostaglandin-endoperoxide synthase 2
triamcinolone,synovitis,serpin family a member 6
cortisol,synovitis,nuclear receptor subfamily 3 group c member 1
cortisol,synovitis,sex hormone binding globulin
cortisol,synovitis,serpin family a member 6
prednisolone,synovitis,serpin family a member 6
lidocaine,dermatitis,epidermal growth factor receptor
clobetasol propionate,dermatitis,nuclear receptor subfamily 3 group c member 1
cortisol,dermatitis,nuclear receptor subfamily 3 group c member 1
tandospirone,bruxism,5-hydroxytryptamine receptor 1a
tandospirone,bruxism,dopamine receptor d4
progesterone,endometrial carcinoma,progesterone receptor
progesterone,endometrial carcinoma,sex hormone binding globulin
progesterone,endometrial carcinoma,estrogen receptor 1
progesterone,endometrial carcinoma,serpin family a member 6
paclitaxel,endometrial carcinoma,cytochrome p450 family 19 subfamily a member 1
tamoxifen,endometrial carcinoma,estrogen receptor 2
tamoxifen,endometrial carcinoma,cytochrome p450 family 19 subfamily a member 1
tamoxifen,endometrial carcinoma,estrogen receptor 1
megestrol,endometrial carcinoma,progesterone receptor
lenvatinib,endometrial carcinoma,kinase insert domain receptor
lenvatinib,endometrial carcinoma,receptor interacting serine/threonine kinase 2
lenvatinib,endometrial carcinoma,ret proto-oncogene
medroxyprogesterone,endometrial carcinoma,aldo-keto reductase family 1 member c3
medroxyprogesterone,endometrial carcinoma,sex hormone binding globulin
medroxyprogesterone,endometrial carcinoma,progesterone receptor
medroxyprogesterone,endometrial carcinoma,estrogen receptor 1
triamcinolone,bursitis,prostaglandin-endoperoxide synthase 2
triamcinolone,bursitis,serpin family a member 6
etodolac,bursitis,prostaglandin-endoperoxide synthase 1
etodolac,bursitis,prostaglandin-endoperoxide synthase 2
prednisolone,bursitis,serpin family a member 6
naproxen,bursitis,aldo-keto reductase family 1 member c3
indomethacin,bursitis,c-x-c motif chemokine ligand 8
indomethacin,bursitis,aldo-keto reductase family 1 member c3
diclofenac,bursitis,prostaglandin-endoperoxide synthase 2
diclofenac,bursitis,prostaglandin-endoperoxide synthase 1
diclofenac,bursitis,c-x-c motif chemokine ligand 8
cortisol,bursitis,nuclear receptor subfamily 3 group c member 1
cortisol,bursitis,sex hormone binding globulin
cortisol,bursitis,serpin family a member 6
betamethasone,bursitis,prostaglandin-endoperoxide synthase 2
carmustine,brain glioblastoma,glutathione-disulfide reductase
chlorhexidine,gingivitis,solute carrier family 47 member 1
chlorhexidine,gingivitis,solute carrier family 22 member 1
chlorhexidine,gingivitis,solute carrier family 47 member 2
chlorhexidine,gingivitis,solute carrier family 22 member 3
chlorhexidine,gingivitis,solute carrier family 22 member 2
pexidartinib,tenosynovial giant cell tumor,protein kinase c theta
betamethasone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
cortisol,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
cortisol,aspiration pneumonitis,sex hormone binding globulin
cortisol,aspiration pneumonitis,serpin family a member 6
triamcinolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,aspiration pneumonitis,serpin family a member 6
methylprednisolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
prednisolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
prednisolone,aspiration pneumonitis,serpin family a member 6
ifosfamide,bone osteosarcoma,cytochrome p450 family 3 subfamily a member 4
epirubicin,bone osteosarcoma,dna topoisomerase ii alpha
etoposide,bone osteosarcoma,glutathione s-transferase pi 1
etoposide,bone osteosarcoma,dna topoisomerase ii alpha
etoposide,bone osteosarcoma,cytochrome p450 family 3 subfamily a member 4
floxuridine,liver cancer,thymidylate synthetase
prednisolone,pulmonary fibrosis,serpin family a member 6
butenafine,dermatophytosis of groin and perianal area,squalene epoxidase
betamethasone,dermatophytosis of groin and perianal area,nuclear receptor subfamily 3 group c member 1
clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 17 subfamily a member 1
clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 51 subfamily a member 1
clotrimazole,dermatophytosis of groin and perianal area,potassium calcium-activated channel subfamily n member 4
cortisol,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 2
cortisol,dermatophytosis of groin and perianal area,nuclear receptor subfamily 3 group c member 1
cortisol,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
cortisol,dermatophytosis of groin and perianal area,sex hormone binding globulin
cortisol,dermatophytosis of groin and perianal area,serpin family a member 6
miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 51 subfamily a member 1
miconazole,dermatophytosis of groin and perianal area,potassium calcium-activated channel subfamily n member 4
miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 17 subfamily a member 1
miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
ethinylestradiol,postmenopausal atrophic vaginitis,estrogen receptor 2
medroxyprogesterone,postmenopausal atrophic vaginitis,progesterone receptor
medroxyprogesterone,postmenopausal atrophic vaginitis,estrogen receptor 1
norgestimate,postmenopausal atrophic vaginitis,estrogen receptor 1
norgestimate,postmenopausal atrophic vaginitis,progesterone receptor
norethisterone,postmenopausal atrophic vaginitis,progesterone receptor
progesterone,postmenopausal atrophic vaginitis,progesterone receptor
progesterone,postmenopausal atrophic vaginitis,estrogen receptor 1
butenafine,tinea corporis,squalene epoxidase
cortisol,tinea corporis,cytochrome p450 family 11 subfamily b member 2
cortisol,tinea corporis,nuclear receptor subfamily 3 group c member 1
cortisol,tinea corporis,cytochrome p450 family 11 subfamily b member 1
cortisol,tinea corporis,sex hormone binding globulin
cortisol,tinea corporis,serpin family a member 6
betamethasone,tinea corporis,nuclear receptor subfamily 3 group c member 1
clotrimazole,tinea corporis,cytochrome p450 family 11 subfamily b member 1
clotrimazole,tinea corporis,cytochrome p450 family 17 subfamily a member 1
clotrimazole,tinea corporis,cytochrome p450 family 51 subfamily a member 1
clotrimazole,tinea corporis,potassium calcium-activated channel subfamily n member 4
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 11
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 5
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 10
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 9
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 3
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 7
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 2
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 8
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 1
benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 4
miconazole,tinea corporis,cytochrome p450 family 51 subfamily a member 1
miconazole,tinea corporis,potassium calcium-activated channel subfamily n member 4
miconazole,tinea corporis,cytochrome p450 family 17 subfamily a member 1
miconazole,tinea corporis,cytochrome p450 family 11 subfamily b member 1
loteprednol etabonate,punctate epithelial keratoconjunctivitis,nuclear receptor subfamily 3 group c member 1
ethacrynic acid,hypercalcemia disease,solute carrier family 12 member 1
bumetanide,hypercalcemia disease,solute carrier family 12 member 1
furosemide,hypercalcemia disease,solute carrier family 12 member 1
danazol,gynecomastia disorder,androgen receptor
danazol,gynecomastia disorder,cytochrome p450 family 19 subfamily a member 1
danazol,gynecomastia disorder,gonadotropin releasing hormone receptor
chloroquine,plasmodium ovale malaria,toll like receptor 9
chloroquine,plasmodium ovale malaria,transmembrane protein 97
hydroxychloroquine,plasmodium ovale malaria,toll like receptor 7
hydroxychloroquine,plasmodium ovale malaria,toll like receptor 9
hydroxychloroquine,plasmodium ovale malaria,transmembrane protein 97
morphine,diarrheal disease,opioid receptor mu 1
morphine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
clonidine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
clonidine,diarrheal disease,solute carrier family 22 member 5
diphenoxylate,diarrheal disease,opioid receptor mu 1
difenoxin,diarrheal disease,opioid receptor mu 1
loperamide,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
loperamide,diarrheal disease,calcium voltage-gated channel subunit alpha1 a
codeine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
codeine,diarrheal disease,opioid receptor mu 1
alfacalcidol,hyperparathyroidism,cytochrome p450 family 27 subfamily b member 1
alfacalcidol,hyperparathyroidism,vitamin d receptor
diclofenamide,angle-closure glaucoma,carbonic anhydrase 14
diclofenamide,angle-closure glaucoma,carbonic anhydrase 3
acetazolamide,angle-closure glaucoma,carbonic anhydrase 11
prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 2
prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 3
prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 5
prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 1
lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 2
lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 3
lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 4
lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 2
lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 9
lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 3
lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 5
lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 10
lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 4
ceftriaxone,chancroid,synuclein alpha
flibanserin,hypoactive sexual desire disorder,5-hydroxytryptamine receptor 1a
lisuride,amenorrhea,5-hydroxytryptamine receptor 2b
lisuride,amenorrhea,dopamine receptor d4
lisuride,amenorrhea,dopamine receptor d5
norethisterone,amenorrhea,sex hormone binding globulin
ethinylestradiol,amenorrhea,sex hormone binding globulin
desogestrel,amenorrhea,sex hormone binding globulin
estradiol valerate,amenorrhea,sex hormone binding globulin
estrone,amenorrhea,sex hormone binding globulin
triamcinolone,epicondylitis,serpin family a member 6
prednisolone,epicondylitis,serpin family a member 6
prednisone,epicondylitis,nuclear receptor subfamily 3 group c member 1
(-)-adrenaline,toxic shock syndrome,tumor necrosis factor
clomiphene,oligospermia,estrogen receptor 1
ceftriaxone,rhinoscleroma,synuclein alpha
ivermectin,strongyloidiasis,glycine receptor alpha 3
betamethasone,tinea pedis,prostaglandin-endoperoxide synthase 2
sertaconazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 11
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 5
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 9
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 3
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 7
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 2
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 8
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 1
benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 4
cortisol,tinea pedis,cytochrome p450 family 11 subfamily b member 2
cortisol,tinea pedis,cytochrome p450 family 11 subfamily b member 1
cortisol,tinea pedis,sex hormone binding globulin
cortisol,tinea pedis,serpin family a member 6
miconazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
miconazole,tinea pedis,potassium calcium-activated channel subfamily n member 4
miconazole,tinea pedis,cytochrome p450 family 17 subfamily a member 1
miconazole,tinea pedis,cytochrome p450 family 11 subfamily b member 1
clotrimazole,tinea pedis,cytochrome p450 family 11 subfamily b member 1
clotrimazole,tinea pedis,cytochrome p450 family 17 subfamily a member 1
clotrimazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
clotrimazole,tinea pedis,potassium calcium-activated channel subfamily n member 4
azelastine,vasomotor rhinitis,adrenoceptor alpha 1b
azelastine,vasomotor rhinitis,adrenoceptor alpha 1a
dextromethorphan,vasomotor rhinitis,solute carrier family 6 member 2
promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 4
promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 5
promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 2
promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 3
promethazine,vasomotor rhinitis,adrenoceptor alpha 1a
promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 1
chlorpheniramine,vasomotor rhinitis,solute carrier family 6 member 2
pseudoephedrine,vasomotor rhinitis,adrenoceptor alpha 2a
pseudoephedrine,vasomotor rhinitis,solute carrier family 6 member 2
pseudoephedrine,vasomotor rhinitis,adrenoceptor beta 2
ephedrine,vasomotor rhinitis,solute carrier family 6 member 2
ephedrine,vasomotor rhinitis,adrenoceptor beta 2
n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 1
n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 5
n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 2
n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 3
n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 4
diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 2
diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 4
diphenhydramine,vasomotor rhinitis,solute carrier family 6 member 2
diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 1
diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 5
diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 3
beclometasone,vasomotor rhinitis,nuclear receptor subfamily 3 group c member 1
brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 4
brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 2
brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 5
brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 3
brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 1
clemastine,vasomotor rhinitis,adrenoceptor alpha 2a
clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 4
clemastine,vasomotor rhinitis,transmembrane protein 97
clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 3
clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 5
clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 1
clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 2
phenylephrine,vasomotor rhinitis,adrenoceptor alpha 2a
doxylamine,vasomotor rhinitis,cholinergic receptor muscarinic 1
imiquimod,superficial multifocal basal cell carcinoma,toll like receptor 7
5-fluorouracil,superficial multifocal basal cell carcinoma,thymidylate synthetase
paclitaxel,cervical cancer,tubulin beta class i
5-fluorouracil,cervical cancer,methylenetetrahydrofolate reductase
topotecan,cervical cancer,dna topoisomerase i mitochondrial
spironolactone,hyperaldosteronism,nuclear receptor subfamily 3 group c member 1
spironolactone,hyperaldosteronism,cytochrome p450 family 11 subfamily b member 2
spironolactone,hyperaldosteronism,cytochrome p450 family 11 subfamily b member 1
dextromethorphan,rhinitis,opioid receptor mu 1
dextromethorphan,rhinitis,solute carrier family 6 member 2
beclometasone,rhinitis,nuclear receptor subfamily 3 group c member 1
hydrocodone,rhinitis,opioid receptor mu 1
ephedrine,rhinitis,adrenoceptor alpha 1a
ephedrine,rhinitis,solute carrier family 6 member 2
ephedrine,rhinitis,adrenoceptor beta 2
pseudoephedrine,rhinitis,solute carrier family 6 member 2
pseudoephedrine,rhinitis,adrenoceptor beta 2
codeine,rhinitis,opioid receptor mu 1
triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit beta
triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit gamma
triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit alpha
cortisol,keratitis,annexin a1
cortisol,keratitis,sex hormone binding globulin
cortisol,keratitis,serpin family a member 6
prednisolone,keratitis,serpin family a member 6
propylthiouracil,hyperthyroidism,iodothyronine deiodinase 1
carbimazole,hyperthyroidism,thyroid peroxidase
lidocaine,scabies,sodium voltage-gated channel alpha subunit 2
lidocaine,scabies,sodium voltage-gated channel alpha subunit 3
lidocaine,scabies,sodium voltage-gated channel alpha subunit 4
everolimus,kidney angiomyolipoma,fkbp prolyl isomerase 1a
fluorometholone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
fluorometholone,corneal ulcer,serpin family a member 6
prednisolone,corneal ulcer,serpin family a member 6
cortisol,corneal ulcer,sex hormone binding globulin
cortisol,corneal ulcer,serpin family a member 6
mupirocin,impetigo,isoleucyl-trna synthetase 1
ceftriaxone,bacterial pneumonia,synuclein alpha
hydroxocobalamin,homocystinuria,5-methyltetrahydrofolate-homocysteine methyltransferase
hydroxocobalamin,homocystinuria,metabolism of cobalamin associated a
hydroxocobalamin,homocystinuria,metabolism of cobalamin associated c
hydroxocobalamin,homocystinuria,methylenetetrahydrofolate reductase
hydroxocobalamin,homocystinuria,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
montelukast,intrinsic asthma,cysteinyl leukotriene receptor 1
montelukast,intrinsic asthma,arachidonate 5-lipoxygenase
mometasone,intrinsic asthma,nuclear receptor subfamily 3 group c member 1
salmeterol,intrinsic asthma,adrenoceptor beta 2
fluticasone,intrinsic asthma,nuclear receptor subfamily 3 group c member 1
zileuton,intrinsic asthma,arachidonate 5-lipoxygenase
zileuton,intrinsic asthma,epoxide hydrolase 2
formoterol,intrinsic asthma,adrenoceptor beta 2
fluorometholone,iridocyclitis,serpin family a member 6
cortisol,iridocyclitis,sex hormone binding globulin
cortisol,iridocyclitis,serpin family a member 6
prednisolone,iridocyclitis,serpin family a member 6
fluticasone,allergic asthma,nuclear receptor subfamily 3 group c member 1
montelukast,allergic asthma,cysteinyl leukotriene receptor 1
montelukast,allergic asthma,arachidonate 5-lipoxygenase
formoterol,allergic asthma,adrenoceptor beta 2
zileuton,allergic asthma,arachidonate 5-lipoxygenase
zileuton,allergic asthma,epoxide hydrolase 2
mometasone,allergic asthma,nuclear receptor subfamily 3 group c member 1
salmeterol,allergic asthma,adrenoceptor beta 2
fluorometholone,otitis externa,nuclear receptor subfamily 3 group c member 1
fluorometholone,otitis externa,serpin family a member 6
prednisolone,otitis externa,nuclear receptor subfamily 3 group c member 1
prednisolone,otitis externa,serpin family a member 6
cortisol,otitis externa,sex hormone binding globulin
cortisol,otitis externa,serpin family a member 6
(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 2a
(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 2b
(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 1b
(-)-noradrenaline,bronchiectasis,adrenoceptor beta 1
(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 1a
(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 2c
(-)-noradrenaline,bronchiectasis,adrenoceptor alpha 1d
terbutaline,bronchiectasis,adrenoceptor beta 2
terbutaline,bronchiectasis,adrenoceptor beta 1
(-)-adrenaline,bronchiectasis,tumor necrosis factor
(-)-adrenaline,bronchiectasis,adrenoceptor alpha 2c
5-fluorouracil,oral mucosa leukoplakia,thymidylate synthetase
formoterol,pulmonary emphysema,cytochrome p450 family 2 subfamily a member 6
formoterol,pulmonary emphysema,adrenoceptor beta 1
formoterol,pulmonary emphysema,adrenoceptor beta 3
(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 2a
(-)-noradrenaline,pulmonary emphysema,adrenoceptor beta 3
(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 2b
(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 1b
(-)-noradrenaline,pulmonary emphysema,adrenoceptor beta 1
(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 1a
(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 2c
(-)-noradrenaline,pulmonary emphysema,adrenoceptor alpha 1d
(-)-adrenaline,pulmonary emphysema,adrenoceptor beta 3
(-)-adrenaline,pulmonary emphysema,tumor necrosis factor
(-)-adrenaline,pulmonary emphysema,adrenoceptor alpha 2c
salmeterol,pulmonary emphysema,adrenoceptor beta 3
salmeterol,pulmonary emphysema,adrenoceptor beta 1
dyphylline,pulmonary emphysema,adenosine a1 receptor
dyphylline,pulmonary emphysema,adenosine a2a receptor
dyphylline,pulmonary emphysema,phosphodiesterase 3a
terbutaline,pulmonary emphysema,adrenoceptor beta 1
theophylline,pulmonary emphysema,adenosine a2a receptor
theophylline,pulmonary emphysema,adenosine a2b receptor
theophylline,pulmonary emphysema,phosphodiesterase 4c
theophylline,pulmonary emphysema,phosphodiesterase 4a
theophylline,pulmonary emphysema,phosphodiesterase 3a
theophylline,pulmonary emphysema,phosphodiesterase 4d
theophylline,pulmonary emphysema,phosphodiesterase 4b
theophylline,pulmonary emphysema,adenosine a1 receptor
theophylline,pulmonary emphysema,adenosine a3 receptor
cortisol,tenosynovitis,sex hormone binding globulin
cortisol,tenosynovitis,serpin family a member 6
indomethacin,tenosynovitis,c-x-c motif chemokine ligand 8
indomethacin,tenosynovitis,aldo-keto reductase family 1 member c3
diclofenac,tenosynovitis,prostaglandin-endoperoxide synthase 2
diclofenac,tenosynovitis,prostaglandin-endoperoxide synthase 1
diclofenac,tenosynovitis,c-x-c motif chemokine ligand 8
betamethasone,tenosynovitis,prostaglandin-endoperoxide synthase 2
betamethasone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,tenosynovitis,prostaglandin-endoperoxide synthase 2
triamcinolone,tenosynovitis,serpin family a member 6
salicylic acid,tenosynovitis,prostaglandin-endoperoxide synthase 1
salicylic acid,tenosynovitis,prostaglandin-endoperoxide synthase 2
prednisolone,tenosynovitis,serpin family a member 6
betamethasone,tendinitis,prostaglandin-endoperoxide synthase 2
betamethasone,tendinitis,nuclear receptor subfamily 3 group c member 1
sulindac,tendinitis,prostaglandin-endoperoxide synthase 1
sulindac,tendinitis,prostaglandin-endoperoxide synthase 2
triamcinolone,tendinitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,tendinitis,prostaglandin-endoperoxide synthase 2
triamcinolone,tendinitis,serpin family a member 6
salicylic acid,tendinitis,prostaglandin-endoperoxide synthase 1
salicylic acid,tendinitis,prostaglandin-endoperoxide synthase 2
diclofenac,tendinitis,prostaglandin-endoperoxide synthase 2
diclofenac,tendinitis,prostaglandin-endoperoxide synthase 1
diclofenac,tendinitis,c-x-c motif chemokine ligand 8
cortisol,tendinitis,nuclear receptor subfamily 3 group c member 1
cortisol,tendinitis,sex hormone binding globulin
cortisol,tendinitis,serpin family a member 6
methylprednisolone,tendinitis,nuclear receptor subfamily 3 group c member 1
naproxen,tendinitis,prostaglandin-endoperoxide synthase 1
naproxen,tendinitis,aldo-keto reductase family 1 member c3
naproxen,tendinitis,prostaglandin-endoperoxide synthase 2
indomethacin,tendinitis,c-x-c motif chemokine ligand 8
indomethacin,tendinitis,prostaglandin-endoperoxide synthase 1
indomethacin,tendinitis,prostaglandin-endoperoxide synthase 2
indomethacin,tendinitis,aldo-keto reductase family 1 member c3
prednisolone,tendinitis,nuclear receptor subfamily 3 group c member 1
prednisolone,tendinitis,serpin family a member 6
etodolac,tendinitis,prostaglandin-endoperoxide synthase 1
etodolac,tendinitis,prostaglandin-endoperoxide synthase 2
lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 2
lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 3
lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 4
cortisol,hemorrhoid,nuclear receptor subfamily 3 group c member 1
cortisol,hemorrhoid,sex hormone binding globulin
cortisol,hemorrhoid,serpin family a member 6
lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 2
lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 9
lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 3
lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 5
lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 10
lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 4
terbutaline,bronchitis,adrenoceptor beta 1
theophylline,bronchitis,adenosine a2a receptor
theophylline,bronchitis,adenosine a2b receptor
theophylline,bronchitis,phosphodiesterase 4a
theophylline,bronchitis,phosphodiesterase 3a
theophylline,bronchitis,phosphodiesterase 4b
theophylline,bronchitis,adenosine a1 receptor
theophylline,bronchitis,adenosine a3 receptor
ephedrine,bronchitis,adrenoceptor alpha 1a
minocycline,bronchitis,vascular endothelial growth factor a
methylprednisolone,bronchitis,nuclear receptor subfamily 3 group c member 1
betamethasone,bronchitis,nuclear receptor subfamily 3 group c member 1
prednisolone,bronchitis,nuclear receptor subfamily 3 group c member 1
(-)-noradrenaline,bronchitis,adrenoceptor alpha 2a
(-)-noradrenaline,bronchitis,adrenoceptor beta 3
(-)-noradrenaline,bronchitis,adrenoceptor alpha 2b
(-)-noradrenaline,bronchitis,adrenoceptor alpha 1b
(-)-noradrenaline,bronchitis,adrenoceptor beta 1
(-)-noradrenaline,bronchitis,adrenoceptor alpha 1a
(-)-noradrenaline,bronchitis,adrenoceptor alpha 2c
(-)-noradrenaline,bronchitis,adrenoceptor alpha 1d
(-)-adrenaline,bronchitis,adrenoceptor beta 3
(-)-adrenaline,bronchitis,adrenoceptor alpha 2c
triamcinolone,bronchitis,nuclear receptor subfamily 3 group c member 1
betahistine,meniere disease,histamine receptor h3
betahistine,meniere disease,histamine receptor h1
cinnarizine,motion sickness,calcium voltage-gated channel subunit alpha1 c
clotrimazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
clotrimazole,vulvovaginal candidiasis,potassium calcium-activated channel subfamily n member 4
tioconazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
miconazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
miconazole,vulvovaginal candidiasis,potassium calcium-activated channel subfamily n member 4
amlodipine,prinzmetal angina,atp binding cassette subfamily b member 1
amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
diltiazem,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
diltiazem,prinzmetal angina,atp binding cassette subfamily b member 1
nifedipine,prinzmetal angina,atp binding cassette subfamily b member 1
nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 f
verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
verapamil,prinzmetal angina,atp binding cassette subfamily b member 1
verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 i
verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
felodipine,prinzmetal angina,atp binding cassette subfamily b member 1
nicardipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
nicardipine,prinzmetal angina,atp binding cassette subfamily b member 1
nicardipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
irinotecan,pancreatic adenocarcinoma,dna topoisomerase i
gemcitabine,pancreatic adenocarcinoma,ribonucleotide reductase regulatory subunit m2
gemcitabine,pancreatic adenocarcinoma,ribonucleotide reductase catalytic subunit m1
gemcitabine,pancreatic adenocarcinoma,"dna polymerase epsilon, catalytic subunit"
gemcitabine,pancreatic adenocarcinoma,"dna polymerase delta 1, catalytic subunit"
gemcitabine,pancreatic adenocarcinoma,"dna polymerase alpha 1, catalytic subunit"
gemcitabine,pancreatic adenocarcinoma,thymidylate synthetase
5-fluorouracil,pancreatic adenocarcinoma,thymidylate synthetase
capecitabine,pancreatic adenocarcinoma,thymidylate synthetase
erlotinib,pancreatic adenocarcinoma,mitogen-activated protein kinase kinase kinase 19
erlotinib,pancreatic adenocarcinoma,serine/threonine kinase 10
erlotinib,pancreatic adenocarcinoma,ste20 like kinase
erlotinib,pancreatic adenocarcinoma,solute carrier organic anion transporter family member 2b1
erlotinib,pancreatic adenocarcinoma,epidermal growth factor receptor
erlotinib,pancreatic adenocarcinoma,cyclin g associated kinase
aminosalicylic acid,pulmonary tuberculosis,prostaglandin-endoperoxide synthase 1
aminosalicylic acid,pulmonary tuberculosis,prostaglandin-endoperoxide synthase 2
daunorubicin,wilms tumor,nuclear receptor subfamily 5 group a member 1
daunorubicin,wilms tumor,dna topoisomerase ii alpha
vincristine,wilms tumor,nuclear receptor subfamily 0 group b member 1
bosutinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
bosutinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
imatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
imatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
dasatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 1a
sirolimus,lung lymphangioleiomyomatosis,eukaryotic translation initiation factor 4e
sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 1b
sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 5
propranolol,hemangioma,adrenoceptor beta 2
propranolol,hemangioma,adrenoceptor beta 1
desloratadine,allergic urticaria,histamine receptor h1
prednisolone,erythema multiforme,serpin family a member 6
triamcinolone,erythema multiforme,serpin family a member 6
prednisone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
cortisol,erythema multiforme,nuclear receptor subfamily 3 group c member 1
cortisol,erythema multiforme,sex hormone binding globulin
cortisol,erythema multiforme,serpin family a member 6
cortisol,exanthem,nuclear receptor subfamily 3 group c member 1
cortisol,exanthem,sex hormone binding globulin
cortisol,exanthem,serpin family a member 6
prednisolone,exanthem,serpin family a member 6
fluocinolone acetonide,exanthem,serpin family a member 6
betamethasone,exanthem,nuclear receptor subfamily 3 group c member 1
mometasone,exanthem,nuclear receptor subfamily 3 group c member 1
triamcinolone,exanthem,serpin family a member 6
amcinonide,exanthem,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,exanthem,serpin family a member 6
fluticasone,exanthem,serpin family a member 6
alclometasone dipropionate,exanthem,serpin family a member 6
fluocinolone acetonide,granuloma annulare,serpin family a member 6
prednisolone,granuloma annulare,serpin family a member 6
triamcinolone,granuloma annulare,serpin family a member 6
alclometasone dipropionate,granuloma annulare,serpin family a member 6
mometasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
fluticasone,granuloma annulare,serpin family a member 6
cortisol,granuloma annulare,sex hormone binding globulin
cortisol,granuloma annulare,serpin family a member 6
clocortolone pivalate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,granuloma annulare,serpin family a member 6
amcinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
prednisolone,pemphigus,serpin family a member 6
betamethasone,pemphigus,nuclear receptor subfamily 3 group c member 1
triamcinolone,pemphigus,serpin family a member 6
prednisone,pemphigus,nuclear receptor subfamily 3 group c member 1
cortisol,pemphigus,nuclear receptor subfamily 3 group c member 1
cortisol,pemphigus,sex hormone binding globulin
cortisol,pemphigus,serpin family a member 6
cortisol,rosacea,sex hormone binding globulin
cortisol,rosacea,serpin family a member 6
prednisolone,rosacea,serpin family a member 6
loteprednol etabonate,rosacea,nuclear receptor subfamily 3 group c member 1
fluorometholone,rosacea,nuclear receptor subfamily 3 group c member 1
fluorometholone,rosacea,serpin family a member 6
clobetasol propionate,scalp dermatosis,nuclear receptor subfamily 3 group c member 1
fluticasone,seborrheic dermatitis,serpin family a member 6
betamethasone,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
prednisolone,seborrheic dermatitis,serpin family a member 6
cortisol,seborrheic dermatitis,cytochrome p450 family 11 subfamily b member 2
cortisol,seborrheic dermatitis,cytochrome p450 family 11 subfamily b member 1
cortisol,seborrheic dermatitis,sex hormone binding globulin
cortisol,seborrheic dermatitis,serpin family a member 6
(-)-menthol,seborrheic dermatitis,transient receptor potential cation channel subfamily m member 8
alclometasone dipropionate,seborrheic dermatitis,serpin family a member 6
triamcinolone,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
triamcinolone,seborrheic dermatitis,serpin family a member 6
clobetasol propionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
flumethasone pivalate,seborrheic dermatitis,serpin family a member 6
fluocinolone acetonide,seborrheic dermatitis,serpin family a member 6
mometasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
metyrapone,adrenal gland hyperfunction,cytochrome p450 family 11 subfamily b member 1
metyrapone,adrenal gland hyperfunction,cytochrome p450 family 11 subfamily b member 2
prednisolone,bacterial conjunctivitis,nuclear receptor subfamily 3 group c member 1
prednisolone,bacterial conjunctivitis,serpin family a member 6
ceftriaxone,bacterial meningitis,synuclein alpha
minoxidil,alopecia,potassium inwardly rectifying channel subfamily j member 11
minoxidil,alopecia,atp binding cassette subfamily c member 9
prednisolone,dacryocystitis,serpin family a member 6
prednisone,b-cell chronic lymphocytic leukemia,nuclear receptor subfamily 3 group c member 1
acalabrutinib,b-cell chronic lymphocytic leukemia,bruton tyrosine kinase
acalabrutinib,b-cell chronic lymphocytic leukemia,txk tyrosine kinase
acalabrutinib,b-cell chronic lymphocytic leukemia,bmx non-receptor tyrosine kinase
acalabrutinib,b-cell chronic lymphocytic leukemia,"blk proto-oncogene, src family tyrosine kinase"
acalabrutinib,b-cell chronic lymphocytic leukemia,tec protein tyrosine kinase
venetoclax,b-cell chronic lymphocytic leukemia,bcl2 like 2
venetoclax,b-cell chronic lymphocytic leukemia,bcl2 like 1
ibrutinib,b-cell chronic lymphocytic leukemia,bmx non-receptor tyrosine kinase
ibrutinib,b-cell chronic lymphocytic leukemia,tec protein tyrosine kinase
ibrutinib,b-cell chronic lymphocytic leukemia,"blk proto-oncogene, src family tyrosine kinase"
ibrutinib,b-cell chronic lymphocytic leukemia,txk tyrosine kinase
carmustine,hodgkins lymphoma,glutathione-disulfide reductase
vincristine,hodgkins lymphoma,atp binding cassette subfamily b member 1
vincristine,hodgkins lymphoma,tubulin beta 8 class viii
vincristine,hodgkins lymphoma,tubulin beta 3 class iii
vincristine,hodgkins lymphoma,tubulin beta class i
vincristine,hodgkins lymphoma,tubulin beta 1 class vi
vincristine,hodgkins lymphoma,tubulin beta 4a class iva
vincristine,hodgkins lymphoma,tubulin beta 2a class iia
vincristine,hodgkins lymphoma,tubulin beta 2b class iib
vincristine,hodgkins lymphoma,tubulin beta 4b class ivb
vincristine,hodgkins lymphoma,tubulin beta 6 class v
prednisolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
prednisolone,hodgkins lymphoma,atp binding cassette subfamily b member 1
prednisolone,hodgkins lymphoma,serpin family a member 6
cortisol,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
cortisol,hodgkins lymphoma,atp binding cassette subfamily b member 1
cortisol,hodgkins lymphoma,sex hormone binding globulin
cortisol,hodgkins lymphoma,serpin family a member 6
etoposide,hodgkins lymphoma,glutathione s-transferase pi 1
etoposide,hodgkins lymphoma,dna topoisomerase ii alpha
etoposide,hodgkins lymphoma,udp glucuronosyltransferase family 1 member a1
etoposide,hodgkins lymphoma,atp binding cassette subfamily b member 1
betamethasone,hodgkins lymphoma,atp binding cassette subfamily b member 1
betamethasone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
triamcinolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
triamcinolone,hodgkins lymphoma,serpin family a member 6
chlorambucil,hodgkins lymphoma,glutathione s-transferase pi 1
epirubicin,hodgkins lymphoma,dna topoisomerase ii alpha
vinblastine,hodgkins lymphoma,tubulin beta 4a class iva
vinblastine,hodgkins lymphoma,tubulin gamma 1
vinblastine,hodgkins lymphoma,tubulin beta 1 class vi
vinblastine,hodgkins lymphoma,tubulin beta 8 class viii
vinblastine,hodgkins lymphoma,atp binding cassette subfamily b member 1
vinblastine,hodgkins lymphoma,tubulin alpha 1a
vinblastine,hodgkins lymphoma,tubulin beta 2b class iib
vinblastine,hodgkins lymphoma,tubulin beta 4b class ivb
vinblastine,hodgkins lymphoma,tubulin beta class i
vinblastine,hodgkins lymphoma,tubulin beta 2a class iia
vinblastine,hodgkins lymphoma,tubulin beta 3 class iii
vinblastine,hodgkins lymphoma,tubulin delta 1
vinblastine,hodgkins lymphoma,tubulin beta 6 class v
vinblastine,hodgkins lymphoma,tubulin epsilon 1
prednisone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
prednisone,hodgkins lymphoma,atp binding cassette subfamily b member 1
cyclophosphamide,hodgkins lymphoma,atp binding cassette subfamily b member 1
methylprednisolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
methylprednisolone,hodgkins lymphoma,atp binding cassette subfamily b member 1
tamoxifen,invasive ductal breast carcinoma,ebp cholestenol delta-isomerase
tamoxifen,invasive ductal breast carcinoma,7-dehydrocholesterol reductase
tamoxifen,invasive ductal breast carcinoma,ebp like
tamoxifen,invasive ductal breast carcinoma,estrogen receptor 1
prednisolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
prednisolone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
prednisolone,acute lymphoblastic leukemia,serpin family a member 6
cytarabine,acute lymphoblastic leukemia,"dna polymerase alpha 1, catalytic subunit"
cytarabine,acute lymphoblastic leukemia,"dna polymerase delta 1, catalytic subunit"
cytarabine,acute lymphoblastic leukemia,"dna polymerase epsilon, catalytic subunit"
daunorubicin,acute lymphoblastic leukemia,cytochrome p450 family 1 subfamily b member 1
daunorubicin,acute lymphoblastic leukemia,dna topoisomerase ii alpha
daunorubicin,acute lymphoblastic leukemia,cytochrome p450 family 1 subfamily a member 2
daunorubicin,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
mercaptopurine,acute lymphoblastic leukemia,phosphoribosyl pyrophosphate amidotransferase
cyclophosphamide,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
cyclophosphamide,acute lymphoblastic leukemia,cytochrome p450 family 2 subfamily c member 8
cortisol,acute lymphoblastic leukemia,cytochrome p450 family 2 subfamily c member 8
cortisol,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
cortisol,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
cortisol,acute lymphoblastic leukemia,sex hormone binding globulin
cortisol,acute lymphoblastic leukemia,serpin family a member 6
prednisone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
prednisone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
vincristine,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
vincristine,acute lymphoblastic leukemia,tubulin beta 8 class viii
vincristine,acute lymphoblastic leukemia,tubulin beta 3 class iii
vincristine,acute lymphoblastic leukemia,tubulin beta class i
vincristine,acute lymphoblastic leukemia,tubulin beta 1 class vi
vincristine,acute lymphoblastic leukemia,tubulin beta 4a class iva
vincristine,acute lymphoblastic leukemia,tubulin beta 2a class iia
vincristine,acute lymphoblastic leukemia,tubulin beta 2b class iib
vincristine,acute lymphoblastic leukemia,tubulin beta 4b class ivb
vincristine,acute lymphoblastic leukemia,tubulin beta 6 class v
teniposide,acute lymphoblastic leukemia,dna topoisomerase ii alpha
clofarabine,acute lymphoblastic leukemia,ribonucleotide reductase catalytic subunit m1
clofarabine,acute lymphoblastic leukemia,"dna polymerase alpha 1, catalytic subunit"
clofarabine,acute lymphoblastic leukemia,ribonucleotide reductase regulatory subunit m2
triamcinolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
triamcinolone,acute lymphoblastic leukemia,serpin family a member 6
betamethasone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
betamethasone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
methylprednisolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
methylprednisolone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
galantamine,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
galantamine,alzheimer disease,cholinergic receptor nicotinic alpha 4 subunit
galantamine,alzheimer disease,cholinergic receptor nicotinic beta 2 subunit
galantamine,alzheimer disease,butyrylcholinesterase
galantamine,alzheimer disease,cholinergic receptor nicotinic alpha 7 subunit
galantamine,alzheimer disease,acetylcholinesterase (yt blood group)
rivastigmine,alzheimer disease,butyrylcholinesterase
rivastigmine,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
donepezil,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
donepezil,alzheimer disease,5-hydroxytryptamine receptor 2a
donepezil,alzheimer disease,butyrylcholinesterase
terbutaline,asthma,adrenoceptor beta 1
betamethasone,asthma,prostaglandin-endoperoxide synthase 2
theophylline,asthma,adenosine a2a receptor
theophylline,asthma,adenosine a2b receptor
theophylline,asthma,phosphodiesterase 4c
theophylline,asthma,phosphodiesterase 4a
theophylline,asthma,phosphodiesterase 3a
theophylline,asthma,phosphodiesterase 4d
theophylline,asthma,phosphodiesterase 4b
theophylline,asthma,adenosine deaminase
theophylline,asthma,adenosine a1 receptor
theophylline,asthma,adenosine a3 receptor
prednisone,asthma,nuclear receptor subfamily 3 group c member 1
prednisone,asthma,albumin
beclometasone,asthma,serpin family a member 6
beclometasone,asthma,nuclear receptor subfamily 3 group c member 1
(-)-noradrenaline,asthma,adrenoceptor alpha 2a
(-)-noradrenaline,asthma,adrenoceptor beta 3
(-)-noradrenaline,asthma,adrenoceptor alpha 1b
(-)-noradrenaline,asthma,adrenoceptor beta 1
(-)-noradrenaline,asthma,adrenoceptor alpha 1a
(-)-noradrenaline,asthma,adrenoceptor alpha 2c
(-)-noradrenaline,asthma,solute carrier family 22 member 5
(-)-noradrenaline,asthma,adrenoceptor alpha 1d
mometasone,asthma,nuclear receptor subfamily 3 group c member 1
triamcinolone,asthma,prostaglandin-endoperoxide synthase 2
triamcinolone,asthma,serpin family a member 6
indacaterol,asthma,adrenoceptor beta 2
indacaterol,asthma,adrenoceptor beta 1
indacaterol,asthma,cholinergic receptor muscarinic 3
nedocromil,asthma,prostaglandin d2 receptor
(-)-adrenaline,asthma,adrenoceptor beta 1
(-)-adrenaline,asthma,adrenoceptor beta 2
(-)-adrenaline,asthma,adrenoceptor alpha 1a
(-)-adrenaline,asthma,solute carrier family 22 member 5
(-)-adrenaline,asthma,adrenoceptor alpha 1b
(-)-adrenaline,asthma,adrenoceptor alpha 2a
(-)-adrenaline,asthma,adrenoceptor alpha 1d
(-)-adrenaline,asthma,adrenoceptor beta 3
(-)-adrenaline,asthma,tumor necrosis factor
(-)-adrenaline,asthma,adrenoceptor alpha 2c
flunisolide,asthma,serpin family a member 6
zafirlukast,asthma,cysteinyl leukotriene receptor 1
zafirlukast,asthma,cysteinyl leukotriene receptor 2
zafirlukast,asthma,prostaglandin-endoperoxide synthase 1
zafirlukast,asthma,leukotriene b4 receptor
prednisolone,asthma,serpin family a member 6
fluticasone,asthma,serpin family a member 6
fluticasone,asthma,phospholipase a2 group iva
cortisol,asthma,nuclear receptor subfamily 3 group c member 1
cortisol,asthma,sex hormone binding globulin
cortisol,asthma,serpin family a member 6
dyphylline,asthma,adenosine a1 receptor
dyphylline,asthma,adenosine a2a receptor
dyphylline,asthma,phosphodiesterase 3a
prednisolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
prednisolone,atopic eczema,serpin family a member 6
triamcinolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
triamcinolone,atopic eczema,serpin family a member 6
methylprednisolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
betamethasone,atopic eczema,nuclear receptor subfamily 3 group c member 1
dronedarone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
dronedarone,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
dronedarone,atrial fibrillation,potassium two pore domain channel subfamily k member 2
dronedarone,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
dronedarone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
dronedarone,atrial fibrillation,sodium voltage-gated channel alpha subunit 1
dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 1
dronedarone,atrial fibrillation,adrenoceptor beta 1
dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 3
dronedarone,atrial fibrillation,calcium voltage-gated channel auxiliary subunit beta 2
dronedarone,atrial fibrillation,atp binding cassette subfamily b member 1
flecainide,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
propranolol,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
propranolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
propranolol,atrial fibrillation,atp binding cassette subfamily b member 1
digoxin,atrial fibrillation,fxyd domain containing ion transport regulator 2
digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 1
digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 3
digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 3
digoxin,atrial fibrillation,atp binding cassette subfamily b member 1
digoxin,atrial fibrillation,solute carrier organic anion transporter family member 4a1
digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 1
digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 2
digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 2
digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 4
rivaroxaban,atrial fibrillation,atp binding cassette subfamily b member 1
rivaroxaban,atrial fibrillation,coagulation factor x
metoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
metoprolol,atrial fibrillation,atp binding cassette subfamily b member 1
metoprolol,atrial fibrillation,adrenoceptor beta 2
metoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
metoprolol,atrial fibrillation,adrenoceptor beta 1
benazepril,atrial fibrillation,methylenetetrahydrofolate reductase
benazepril,atrial fibrillation,angiotensin i converting enzyme
clopidogrel,atrial fibrillation,atp binding cassette subfamily b member 1
clopidogrel,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
clopidogrel,atrial fibrillation,purinergic receptor p2y12
quinapril,atrial fibrillation,angiotensin i converting enzyme
losartan,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
losartan,atrial fibrillation,angiotensin i converting enzyme
losartan,atrial fibrillation,atp binding cassette subfamily b member 1
losartan,atrial fibrillation,solute carrier family 2 member 9
perindopril,atrial fibrillation,angiotensin i converting enzyme
perindopril,atrial fibrillation,atp binding cassette subfamily b member 1
ramipril,atrial fibrillation,angiotensin i converting enzyme
carvedilol,atrial fibrillation,selectin e
carvedilol,atrial fibrillation,adrenoceptor beta 2
carvedilol,atrial fibrillation,natriuretic peptide b
carvedilol,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
carvedilol,atrial fibrillation,atp binding cassette subfamily b member 1
carvedilol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
carvedilol,atrial fibrillation,adrenoceptor beta 1
telmisartan,atrial fibrillation,atp binding cassette subfamily b member 1
telmisartan,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
telmisartan,atrial fibrillation,angiotensin i converting enzyme
bisoprolol,atrial fibrillation,adrenoceptor beta 2
bisoprolol,atrial fibrillation,adrenoceptor beta 1
bisoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
trandolapril,atrial fibrillation,angiotensin i converting enzyme
diltiazem,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
diltiazem,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
diltiazem,atrial fibrillation,atp binding cassette subfamily b member 1
diltiazem,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
diltiazem,atrial fibrillation,potassium voltage-gated channel subfamily a member 5
amiodarone,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
amiodarone,atrial fibrillation,adrenoceptor beta 1
amiodarone,atrial fibrillation,atp binding cassette subfamily b member 1
amiodarone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
amiodarone,atrial fibrillation,thyroid hormone receptor beta
amiodarone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
nebivolol,atrial fibrillation,adrenoceptor beta 2
nebivolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
nebivolol,atrial fibrillation,adrenoceptor beta 1
dipyridamole,atrial fibrillation,phosphodiesterase 3b
dipyridamole,atrial fibrillation,solute carrier family 29 member 1 (augustine blood group)
dipyridamole,atrial fibrillation,phosphodiesterase 2a
dipyridamole,atrial fibrillation,phosphodiesterase 1b
dipyridamole,atrial fibrillation,phosphodiesterase 7a
dipyridamole,atrial fibrillation,phosphodiesterase 1c
dipyridamole,atrial fibrillation,phosphodiesterase 3a
dipyridamole,atrial fibrillation,phosphodiesterase 7b
dipyridamole,atrial fibrillation,atp binding cassette subfamily b member 1
dipyridamole,atrial fibrillation,phosphodiesterase 8a
dipyridamole,atrial fibrillation,prune exopolyphosphatase 1
dipyridamole,atrial fibrillation,phosphodiesterase 6d
dipyridamole,atrial fibrillation,phosphodiesterase 6b
dipyridamole,atrial fibrillation,phosphodiesterase 11a
dipyridamole,atrial fibrillation,phosphodiesterase 6c
dipyridamole,atrial fibrillation,phosphodiesterase 6a
dipyridamole,atrial fibrillation,phosphodiesterase 1a
dipyridamole,atrial fibrillation,phosphodiesterase 6g
dipyridamole,atrial fibrillation,phosphodiesterase 6h
dipyridamole,atrial fibrillation,phosphodiesterase 8b
captopril,atrial fibrillation,atp binding cassette subfamily b member 1
captopril,atrial fibrillation,angiotensin i converting enzyme
captopril,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
verapamil,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
verapamil,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
verapamil,atrial fibrillation,atp binding cassette subfamily b member 1
verapamil,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
verapamil,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
verapamil,atrial fibrillation,calcium voltage-gated channel auxiliary subunit beta 2
verapamil,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
verapamil,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
candesartan,atrial fibrillation,atp binding cassette subfamily b member 1
propafenone,atrial fibrillation,adrenoceptor beta 1
propafenone,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
propafenone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
propafenone,atrial fibrillation,atp binding cassette subfamily b member 1
propafenone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
irbesartan,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
esmolol,atrial fibrillation,adrenoceptor beta 1
esmolol,atrial fibrillation,adrenoceptor beta 2
quinine,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
quinine,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 3
quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 1
quinine,atrial fibrillation,atp binding cassette subfamily b member 1
quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 2
quinine,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 4
acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 2
acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 2
acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 1
acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 3
acetyldigitoxin,atrial fibrillation,fxyd domain containing ion transport regulator 2
acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 3
atenolol,atrial fibrillation,adrenoceptor beta 1
atenolol,atrial fibrillation,adrenoceptor beta 2
atenolol,atrial fibrillation,atp binding cassette subfamily b member 1
lisinopril,atrial fibrillation,atp binding cassette subfamily b member 1
lisinopril,atrial fibrillation,angiotensin i converting enzyme
ziprasidone,bipolar disorder,h1.0 linker histone
ziprasidone,bipolar disorder,dopamine receptor d1
ziprasidone,bipolar disorder,adrenoceptor alpha 1a
ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 2c
ziprasidone,bipolar disorder,adrenoceptor alpha 2c
ziprasidone,bipolar disorder,dopamine receptor d2
ziprasidone,bipolar disorder,dopamine receptor d4
ziprasidone,bipolar disorder,dopamine receptor d5
ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 6
ziprasidone,bipolar disorder,solute carrier family 6 member 4
ziprasidone,bipolar disorder,cholinergic receptor muscarinic 2
ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 2a
ziprasidone,bipolar disorder,histamine receptor h1
ziprasidone,bipolar disorder,dopamine receptor d3
ziprasidone,bipolar disorder,cholinergic receptor muscarinic 3
ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1e
ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1b
ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 3a
ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1a
ziprasidone,bipolar disorder,tachykinin precursor 1
ziprasidone,bipolar disorder,adrenoceptor beta 2
risperidone,bipolar disorder,dopamine receptor d2
risperidone,bipolar disorder,5-hydroxytryptamine receptor 1b
risperidone,bipolar disorder,h1.0 linker histone
risperidone,bipolar disorder,dopamine receptor d4
risperidone,bipolar disorder,5-hydroxytryptamine receptor 2a
risperidone,bipolar disorder,adrenoceptor alpha 2c
risperidone,bipolar disorder,adrenoceptor alpha 1a
risperidone,bipolar disorder,5-hydroxytryptamine receptor 2c
risperidone,bipolar disorder,dopamine receptor d1
risperidone,bipolar disorder,dopamine receptor d3
risperidone,bipolar disorder,5-hydroxytryptamine receptor 1a
risperidone,bipolar disorder,histamine receptor h1
risperidone,bipolar disorder,atp binding cassette subfamily b member 1
risperidone,bipolar disorder,5-hydroxytryptamine receptor 1e
risperidone,bipolar disorder,cholinergic receptor muscarinic 2
risperidone,bipolar disorder,tachykinin precursor 1
risperidone,bipolar disorder,dopamine receptor d5
risperidone,bipolar disorder,solute carrier family 6 member 4
risperidone,bipolar disorder,5-hydroxytryptamine receptor 6
risperidone,bipolar disorder,adrenoceptor beta 2
cariprazine,bipolar disorder,histamine receptor h1
cariprazine,bipolar disorder,vitamin d receptor
cariprazine,bipolar disorder,dopamine receptor d3
cariprazine,bipolar disorder,5-hydroxytryptamine receptor 2a
cariprazine,bipolar disorder,dopamine receptor d5
cariprazine,bipolar disorder,dopamine receptor d4
cariprazine,bipolar disorder,5-hydroxytryptamine receptor 1a
cariprazine,bipolar disorder,5-hydroxytryptamine receptor 2c
cariprazine,bipolar disorder,dopamine receptor d1
cariprazine,bipolar disorder,dopamine receptor d2
loxapine,bipolar disorder,5-hydroxytryptamine receptor 1e
loxapine,bipolar disorder,5-hydroxytryptamine receptor 5a
loxapine,bipolar disorder,5-hydroxytryptamine receptor 1a
loxapine,bipolar disorder,cholinergic receptor muscarinic 3
loxapine,bipolar disorder,dopamine receptor d4
loxapine,bipolar disorder,dopamine receptor d5
loxapine,bipolar disorder,dopamine receptor d1
loxapine,bipolar disorder,5-hydroxytryptamine receptor 2c
loxapine,bipolar disorder,adrenoceptor alpha 1a
loxapine,bipolar disorder,cholinergic receptor muscarinic 2
loxapine,bipolar disorder,histamine receptor h1
loxapine,bipolar disorder,5-hydroxytryptamine receptor 3a
loxapine,bipolar disorder,5-hydroxytryptamine receptor 6
loxapine,bipolar disorder,5-hydroxytryptamine receptor 1b
loxapine,bipolar disorder,solute carrier family 6 member 2
loxapine,bipolar disorder,adrenoceptor alpha 2c
loxapine,bipolar disorder,dopamine receptor d3
loxapine,bipolar disorder,solute carrier family 6 member 4
loxapine,bipolar disorder,solute carrier family 6 member 3
paliperidone,bipolar disorder,dopamine receptor d2
paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1a
paliperidone,bipolar disorder,5-hydroxytryptamine receptor 2c
paliperidone,bipolar disorder,dopamine receptor d3
paliperidone,bipolar disorder,adrenoceptor alpha 1a
paliperidone,bipolar disorder,dopamine receptor d1
paliperidone,bipolar disorder,5-hydroxytryptamine receptor 2a
paliperidone,bipolar disorder,histamine receptor h1
paliperidone,bipolar disorder,adrenoceptor alpha 2c
paliperidone,bipolar disorder,dopamine receptor d4
paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1b
paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1e
paliperidone,bipolar disorder,adrenoceptor beta 2
paliperidone,bipolar disorder,cholinergic receptor muscarinic 2
paliperidone,bipolar disorder,tachykinin precursor 1
quetiapine,bipolar disorder,adrenoceptor alpha 1a
quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1e
quetiapine,bipolar disorder,5-hydroxytryptamine receptor 3a
quetiapine,bipolar disorder,dopamine receptor d5
quetiapine,bipolar disorder,histamine receptor h1
quetiapine,bipolar disorder,adrenoceptor alpha 2c
quetiapine,bipolar disorder,dopamine receptor d3
quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1b
quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1a
quetiapine,bipolar disorder,atp binding cassette subfamily b member 1
quetiapine,bipolar disorder,dopamine receptor d4
quetiapine,bipolar disorder,cholinergic receptor muscarinic 3
quetiapine,bipolar disorder,5-hydroxytryptamine receptor 2a
quetiapine,bipolar disorder,cholinergic receptor muscarinic 2
quetiapine,bipolar disorder,h1.0 linker histone
quetiapine,bipolar disorder,5-hydroxytryptamine receptor 2c
quetiapine,bipolar disorder,5-hydroxytryptamine receptor 6
quetiapine,bipolar disorder,dopamine receptor d1
quetiapine,bipolar disorder,dopamine receptor d2
quetiapine,bipolar disorder,tachykinin precursor 1
quetiapine,bipolar disorder,solute carrier family 6 member 4
quetiapine,bipolar disorder,adrenoceptor beta 2
carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 4
carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 5
carbamazepine,bipolar disorder,atp binding cassette subfamily b member 1
carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 9
carbamazepine,bipolar disorder,solute carrier family 6 member 4
olanzapine,bipolar disorder,5-hydroxytryptamine receptor 3a
olanzapine,bipolar disorder,5-hydroxytryptamine receptor 6
olanzapine,bipolar disorder,dopamine receptor d3
olanzapine,bipolar disorder,dopamine receptor d4
olanzapine,bipolar disorder,atp binding cassette subfamily b member 1
olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1b
olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1a
olanzapine,bipolar disorder,dopamine receptor d1
olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1e
olanzapine,bipolar disorder,histamine receptor h1
olanzapine,bipolar disorder,h1.0 linker histone
olanzapine,bipolar disorder,adrenoceptor alpha 2c
olanzapine,bipolar disorder,5-hydroxytryptamine receptor 5a
olanzapine,bipolar disorder,5-hydroxytryptamine receptor 2c
olanzapine,bipolar disorder,dopamine receptor d5
olanzapine,bipolar disorder,adrenoceptor alpha 1a
olanzapine,bipolar disorder,cholinergic receptor muscarinic 2
olanzapine,bipolar disorder,cholinergic receptor muscarinic 3
asenapine,bipolar disorder,dopamine receptor d4
asenapine,bipolar disorder,5-hydroxytryptamine receptor 2a
asenapine,bipolar disorder,dopamine receptor d1
asenapine,bipolar disorder,solute carrier family 6 member 4
asenapine,bipolar disorder,adrenoceptor alpha 1a
asenapine,bipolar disorder,5-hydroxytryptamine receptor 1b
asenapine,bipolar disorder,5-hydroxytryptamine receptor 1a
asenapine,bipolar disorder,adrenoceptor alpha 2c
asenapine,bipolar disorder,dopamine receptor d3
asenapine,bipolar disorder,5-hydroxytryptamine receptor 1e
asenapine,bipolar disorder,histamine receptor h1
asenapine,bipolar disorder,dopamine receptor d2
asenapine,bipolar disorder,5-hydroxytryptamine receptor 5a
asenapine,bipolar disorder,5-hydroxytryptamine receptor 2c
asenapine,bipolar disorder,adrenoceptor beta 2
asenapine,bipolar disorder,5-hydroxytryptamine receptor 6
asenapine,bipolar disorder,cholinergic receptor muscarinic 2
asenapine,bipolar disorder,tachykinin precursor 1
aripiprazole,bipolar disorder,adrenoceptor alpha 2c
aripiprazole,bipolar disorder,cholinergic receptor muscarinic 3
aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1e
aripiprazole,bipolar disorder,h1.0 linker histone
aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 2c
aripiprazole,bipolar disorder,cholinergic receptor muscarinic 2
aripiprazole,bipolar disorder,dopamine receptor d5
aripiprazole,bipolar disorder,histamine receptor h1
aripiprazole,bipolar disorder,atp binding cassette subfamily b member 1
aripiprazole,bipolar disorder,dopamine receptor d3
aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1a
aripiprazole,bipolar disorder,dopamine receptor d4
aripiprazole,bipolar disorder,dopamine receptor d1
aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 6
aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 3a
aripiprazole,bipolar disorder,solute carrier family 6 member 4
aripiprazole,bipolar disorder,adrenoceptor alpha 1a
aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1b
aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 2a
aripiprazole,bipolar disorder,dopamine receptor d2
aripiprazole,bipolar disorder,solute carrier family 6 member 2
aripiprazole,bipolar disorder,adrenoceptor beta 2
aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 5a
aripiprazole,bipolar disorder,solute carrier family 6 member 3
docetaxel,breast carcinoma,epidermal growth factor receptor
docetaxel,breast carcinoma,tubulin beta 6 class v
docetaxel,breast carcinoma,tubulin beta 2b class iib
docetaxel,breast carcinoma,tubulin beta 2a class iia
docetaxel,breast carcinoma,tubulin beta class i
docetaxel,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
docetaxel,breast carcinoma,tubulin beta 3 class iii
docetaxel,breast carcinoma,bcl2 apoptosis regulator
docetaxel,breast carcinoma,atp binding cassette subfamily g member 2 (jr blood group)
docetaxel,breast carcinoma,tubulin beta 1 class vi
docetaxel,breast carcinoma,atp binding cassette subfamily b member 1
docetaxel,breast carcinoma,tubulin beta 4a class iva
docetaxel,breast carcinoma,tubulin beta 4b class ivb
docetaxel,breast carcinoma,tubulin beta 8 class viii
docetaxel,breast carcinoma,cytochrome p450 family 1 subfamily b member 1
docetaxel,breast carcinoma,atp binding cassette subfamily c member 1 (abcc1 blood group)
epirubicin,breast carcinoma,atp binding cassette subfamily c member 1 (abcc1 blood group)
epirubicin,breast carcinoma,aurora kinase a
epirubicin,breast carcinoma,phospholipase a2 group iva
epirubicin,breast carcinoma,dna topoisomerase ii alpha
paclitaxel,breast carcinoma,atp binding cassette subfamily c member 1 (abcc1 blood group)
paclitaxel,breast carcinoma,tubulin beta 2b class iib
paclitaxel,breast carcinoma,bcl2 apoptosis regulator
paclitaxel,breast carcinoma,cytochrome p450 family 19 subfamily a member 1
paclitaxel,breast carcinoma,atp binding cassette subfamily b member 1
paclitaxel,breast carcinoma,tubulin beta 1 class vi
paclitaxel,breast carcinoma,tubulin beta 6 class v
paclitaxel,breast carcinoma,atp binding cassette subfamily g member 2 (jr blood group)
paclitaxel,breast carcinoma,tubulin beta class i
paclitaxel,breast carcinoma,tubulin beta 3 class iii
paclitaxel,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
paclitaxel,breast carcinoma,tubulin beta 8 class viii
paclitaxel,breast carcinoma,cytochrome p450 family 1 subfamily b member 1
paclitaxel,breast carcinoma,tubulin beta 4a class iva
paclitaxel,breast carcinoma,tubulin beta 2a class iia
paclitaxel,breast carcinoma,tubulin beta 4b class ivb
paclitaxel,breast carcinoma,solute carrier organic anion transporter family member 1b1
5-fluorouracil,breast carcinoma,atp binding cassette subfamily g member 2 (jr blood group)
5-fluorouracil,breast carcinoma,thymidylate synthetase
5-fluorouracil,breast carcinoma,methylenetetrahydrofolate reductase
5-fluorouracil,breast carcinoma,dihydropyrimidine dehydrogenase
5-fluorouracil,breast carcinoma,uridine monophosphate synthetase
cyclophosphamide,breast carcinoma,atp binding cassette subfamily b member 1
cyclophosphamide,breast carcinoma,cytochrome p450 family 2 subfamily d member 6
cyclophosphamide,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
everolimus,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
everolimus,breast carcinoma,fkbp prolyl isomerase 1a
ixabepilone,breast carcinoma,tubulin beta class i
ixabepilone,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
ixabepilone,breast carcinoma,tubulin beta 1 class vi
ixabepilone,breast carcinoma,tubulin beta 2a class iia
ixabepilone,breast carcinoma,tubulin beta 4a class iva
ixabepilone,breast carcinoma,tubulin beta 8 class viii
ixabepilone,breast carcinoma,tubulin beta 2b class iib
ixabepilone,breast carcinoma,tubulin beta 4b class ivb
ixabepilone,breast carcinoma,tubulin beta 3 class iii
ixabepilone,breast carcinoma,tubulin beta 6 class v
ixabepilone,breast carcinoma,bcl2 apoptosis regulator
methylprednisolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
methylprednisolone,chronic obstructive pulmonary disease,glucose-6-phosphate dehydrogenase
formoterol,chronic obstructive pulmonary disease,cytochrome p450 family 2 subfamily a member 6
fluticasone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 5
aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 1
aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 4
aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 2
triamcinolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
triamcinolone,chronic obstructive pulmonary disease,prostaglandin-endoperoxide synthase 2
salbutamol,chronic obstructive pulmonary disease,adrenoceptor beta 2
prednisolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
prednisolone,chronic obstructive pulmonary disease,cytochrome p450 family 2 subfamily a member 6
prednisolone,chronic obstructive pulmonary disease,solute carrier organic anion transporter family member 1a2
prednisone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
prednisone,chronic obstructive pulmonary disease,solute carrier organic anion transporter family member 1a2
prednisone,chronic obstructive pulmonary disease,albumin
betamethasone,chronic obstructive pulmonary disease,prostaglandin-endoperoxide synthase 2
betamethasone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
losartan,congestive heart failure,angiotensin i converting enzyme
losartan,congestive heart failure,albumin
losartan,congestive heart failure,angiotensin ii receptor type 1
metoprolol,congestive heart failure,adrenoceptor beta 1
metoprolol,congestive heart failure,adrenoceptor beta 3
ramipril,congestive heart failure,butyrylcholinesterase
ramipril,congestive heart failure,angiotensin i converting enzyme
nebivolol,congestive heart failure,adrenoceptor beta 1
valsartan,congestive heart failure,albumin
valsartan,congestive heart failure,angiotensin ii receptor type 1
isosorbide mononitrate,congestive heart failure,guanylate cyclase 1 soluble subunit beta 1
isosorbide dinitrate,congestive heart failure,guanylate cyclase 1 soluble subunit beta 1
isosorbide dinitrate,congestive heart failure,natriuretic peptide receptor 1
irbesartan,congestive heart failure,endothelin receptor type a
irbesartan,congestive heart failure,prostaglandin-endoperoxide synthase 1
irbesartan,congestive heart failure,angiotensin ii receptor type 1
benazepril,congestive heart failure,angiotensin i converting enzyme
olmesartan,congestive heart failure,angiotensin ii receptor type 1
dipyridamole,congestive heart failure,phosphodiesterase 11a
digoxin,congestive heart failure,fxyd domain containing ion transport regulator 2
digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 1
digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 3
digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 3
digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 1
digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 2
digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 2
digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 4
lisinopril,congestive heart failure,angiotensin i converting enzyme
bisoprolol,congestive heart failure,adrenoceptor beta 1
bisoprolol,congestive heart failure,adrenoceptor beta 3
quinapril,congestive heart failure,angiotensin i converting enzyme
enalapril,congestive heart failure,angiotensin i converting enzyme
trandolapril,congestive heart failure,angiotensin i converting enzyme
atenolol,congestive heart failure,adrenoceptor beta 1
atenolol,congestive heart failure,adrenoceptor beta 3
candesartan,congestive heart failure,angiotensin ii receptor type 1
candesartan,congestive heart failure,prostaglandin-endoperoxide synthase 1
eprosartan,congestive heart failure,angiotensin ii receptor type 1
levosimendan,congestive heart failure,"troponin c1, slow skeletal and cardiac type"
carvedilol,congestive heart failure,vascular endothelial growth factor a
carvedilol,congestive heart failure,natriuretic peptide b
carvedilol,congestive heart failure,xanthine dehydrogenase
carvedilol,congestive heart failure,adrenoceptor alpha 2c
carvedilol,congestive heart failure,hypoxia inducible factor 1 subunit alpha
carvedilol,congestive heart failure,adrenoceptor beta 3
carvedilol,congestive heart failure,prostaglandin-endoperoxide synthase 1
carvedilol,congestive heart failure,adrenoceptor beta 1
telmisartan,congestive heart failure,peroxisome proliferator activated receptor gamma
telmisartan,congestive heart failure,angiotensin ii receptor type 1
telmisartan,congestive heart failure,angiotensin i converting enzyme
spironolactone,congestive heart failure,nuclear receptor subfamily 3 group c member 2
acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 1
acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 4
acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 2
acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 2
acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 1
acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 3
acetyldigitoxin,congestive heart failure,fxyd domain containing ion transport regulator 2
acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 3
captopril,congestive heart failure,renin
captopril,congestive heart failure,albumin
captopril,congestive heart failure,angiotensin i converting enzyme
captopril,congestive heart failure,prostaglandin-endoperoxide synthase 2
captopril,congestive heart failure,prostaglandin-endoperoxide synthase 1
hydrochlorothiazide,congestive heart failure,albumin
perindopril,congestive heart failure,butyrylcholinesterase
perindopril,congestive heart failure,angiotensin i converting enzyme
prednisone,crohn disease,nuclear receptor subfamily 3 group c member 1
prednisone,crohn disease,albumin
prednisone,crohn disease,atp binding cassette subfamily b member 1
sulfasalazine,crohn disease,prostaglandin-endoperoxide synthase 2
sulfasalazine,crohn disease,solute carrier family 7 member 11
sulfasalazine,crohn disease,acetyl-coa acetyltransferase 1
sulfasalazine,crohn disease,peroxisome proliferator activated receptor gamma
betamethasone,crohn disease,prostaglandin-endoperoxide synthase 2
betamethasone,crohn disease,atp binding cassette subfamily b member 1
aminosalicylic acid,crohn disease,phospholipase a2 group iie
aminosalicylic acid,crohn disease,myeloperoxidase
aminosalicylic acid,crohn disease,prostaglandin-endoperoxide synthase 2
mesalazine,crohn disease,prostaglandin-endoperoxide synthase 2
mesalazine,crohn disease,peroxisome proliferator activated receptor gamma
mesalazine,crohn disease,myeloperoxidase
prednisolone,crohn disease,atp binding cassette subfamily b member 1
prednisolone,crohn disease,serpin family a member 6
methylprednisolone,crohn disease,atp binding cassette subfamily b member 1
triamcinolone,crohn disease,prostaglandin-endoperoxide synthase 2
triamcinolone,crohn disease,serpin family a member 6
cortisol,crohn disease,atp binding cassette subfamily b member 1
cortisol,crohn disease,sex hormone binding globulin
cortisol,crohn disease,serpin family a member 6
salicylic acid,crohn disease,albumin
salicylic acid,crohn disease,prostaglandin-endoperoxide synthase 2
salicylic acid,crohn disease,atp binding cassette subfamily b member 1
ramipril,diabetic kidney disease,angiotensin i converting enzyme
perindopril,diabetic kidney disease,angiotensin i converting enzyme
telmisartan,diabetic kidney disease,peroxisome proliferator activated receptor gamma
telmisartan,diabetic kidney disease,angiotensin ii receptor type 1
telmisartan,diabetic kidney disease,angiotensin i converting enzyme
captopril,diabetic kidney disease,albumin
quinapril,diabetic kidney disease,angiotensin i converting enzyme
valsartan,diabetic kidney disease,albumin
valsartan,diabetic kidney disease,angiotensin ii receptor type 1
benazepril,diabetic kidney disease,angiotensin i converting enzyme
losartan,diabetic kidney disease,angiotensin i converting enzyme
losartan,diabetic kidney disease,albumin
candesartan,diabetic kidney disease,angiotensin ii receptor type 1
lisinopril,diabetic kidney disease,angiotensin i converting enzyme
lisinopril,diabetic kidney disease,angiotensin converting enzyme 2
trandolapril,diabetic kidney disease,angiotensin i converting enzyme
eprosartan,diabetic kidney disease,angiotensin ii receptor type 1
phenytoin,epilepsy,atp binding cassette subfamily c member 2
phenytoin,epilepsy,albumin
phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 3
phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 1
phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 5
phenytoin,epilepsy,cytochrome p450 family 2 subfamily c member 19
phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 2
phenytoin,epilepsy,atp binding cassette subfamily b member 1
phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 8
phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 4
phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 9
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta3
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit pi
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma3
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit epsilon
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit theta
diazepam,epilepsy,cytochrome p450 family 2 subfamily c member 19
diazepam,epilepsy,albumin
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma1
diazepam,epilepsy,atp binding cassette subfamily b member 1
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta1
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit delta
thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
thiopental,epilepsy,glutamate ionotropic receptor kainate type subunit 2
thiopental,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
thiopental,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
thiopental,epilepsy,glutamate ionotropic receptor ampa type subunit 2
thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
thiopental,epilepsy,fatty acid amide hydrolase
lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 1
lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 9
lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 8
lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 4
lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 3
lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 5
lamotrigine,epilepsy,atp binding cassette subfamily b member 1
lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 10
lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 2
trimethadione,epilepsy,cytochrome p450 family 2 subfamily c member 19
methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
methylphenobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
methylphenobarbital,epilepsy,cytochrome p450 family 2 subfamily c member 19
methylphenobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
methylphenobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
methylphenobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
acetazolamide,epilepsy,carbonic anhydrase 4
acetazolamide,epilepsy,aquaporin 1 (colton blood group)
acetazolamide,epilepsy,carbonic anhydrase 13
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
pentobarbitone,epilepsy,glutamate ionotropic receptor ampa type subunit 2
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta3
pentobarbitone,epilepsy,cytochrome p450 family 2 subfamily c member 19
pentobarbitone,epilepsy,glutamate ionotropic receptor kainate type subunit 2
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
pentobarbitone,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
pentobarbitone,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
phenobarbital,epilepsy,atp binding cassette subfamily b member 1
phenobarbital,epilepsy,cytochrome p450 family 2 subfamily c member 19
phenobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
phenobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
phenobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
phenobarbital,epilepsy,atp binding cassette subfamily c member 2
phenobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
valproic acid,epilepsy,aldehyde dehydrogenase 5 family member a1
valproic acid,epilepsy,4-aminobutyrate aminotransferase
valproic acid,epilepsy,acyl-coa dehydrogenase short/branched chain
valproic acid,epilepsy,cytochrome p450 family 2 subfamily c member 19
secobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
secobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
secobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
secobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
felbamate,epilepsy,glutamate ionotropic receptor nmda type subunit 2a
felbamate,epilepsy,glutamate ionotropic receptor nmda type subunit 2b
felbamate,epilepsy,cytochrome p450 family 2 subfamily c member 19
carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 4
carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 5
carbamazepine,epilepsy,cytochrome p450 family 2 subfamily c member 19
carbamazepine,epilepsy,atp binding cassette subfamily b member 1
carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 9
carbamazepine,epilepsy,atp binding cassette subfamily c member 2
carbamazepine,epilepsy,solute carrier family 6 member 4
primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
primidone,epilepsy,cytochrome p450 family 2 subfamily c member 19
primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
primidone,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
primidone,epilepsy,glutamate ionotropic receptor kainate type subunit 2
primidone,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
primidone,epilepsy,glutamate ionotropic receptor ampa type subunit 2
primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
anagrelide,essential thrombocythemia,phosphodiesterase 3a
lenvatinib,thyroid gland follicular carcinoma,kinase insert domain receptor
lenvatinib,thyroid gland follicular carcinoma,receptor interacting serine/threonine kinase 2
acetylcholine,glaucoma,cholinergic receptor muscarinic 3
bisoprolol,hypertensive disorder,adrenoceptor beta 2
bisoprolol,hypertensive disorder,adrenoceptor beta 3
ketanserin,hypertensive disorder,adrenoceptor alpha 2b
ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 1b
ketanserin,hypertensive disorder,adrenoceptor alpha 2a
ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 2b
ketanserin,hypertensive disorder,solute carrier family 18 member a2
ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 7
ketanserin,hypertensive disorder,dopamine receptor d4
ketanserin,hypertensive disorder,dopamine receptor d2
ketanserin,hypertensive disorder,adrenoceptor alpha 1a
trandolapril,hypertensive disorder,angiotensin i converting enzyme
bumetanide,hypertensive disorder,solute carrier family 12 member 2
bumetanide,hypertensive disorder,prostaglandin-endoperoxide synthase 2
bumetanide,hypertensive disorder,solute carrier family 12 member 1
bumetanide,hypertensive disorder,carbonic anhydrase 9
bumetanide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
bumetanide,hypertensive disorder,carbonic anhydrase 2
paclitaxel,hypertensive disorder,atp binding cassette subfamily c member 1 (abcc1 blood group)
paclitaxel,hypertensive disorder,tubulin beta 2b class iib
paclitaxel,hypertensive disorder,bcl2 apoptosis regulator
paclitaxel,hypertensive disorder,cytochrome p450 family 19 subfamily a member 1
paclitaxel,hypertensive disorder,atp binding cassette subfamily b member 1
paclitaxel,hypertensive disorder,tubulin beta 1 class vi
paclitaxel,hypertensive disorder,tubulin beta 6 class v
paclitaxel,hypertensive disorder,tubulin beta class i
paclitaxel,hypertensive disorder,tubulin beta 3 class iii
paclitaxel,hypertensive disorder,tubulin beta 8 class viii
paclitaxel,hypertensive disorder,tubulin beta 4a class iva
paclitaxel,hypertensive disorder,tubulin beta 2a class iia
paclitaxel,hypertensive disorder,tubulin beta 4b class ivb
paclitaxel,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
paclitaxel,hypertensive disorder,paraoxonase 1
prazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
prazosin,hypertensive disorder,atp binding cassette subfamily b member 1
prazosin,hypertensive disorder,adrenoceptor alpha 2b
prazosin,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
prazosin,hypertensive disorder,adrenoceptor alpha 2a
prazosin,hypertensive disorder,adrenoceptor alpha 2c
prazosin,hypertensive disorder,dopamine receptor d4
indapamide,hypertensive disorder,carbonic anhydrase 2
indapamide,hypertensive disorder,potassium voltage-gated channel subfamily q member 1
indapamide,hypertensive disorder,carbonic anhydrase 9
nicardipine,hypertensive disorder,adrenoceptor alpha 1b
nicardipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
nicardipine,hypertensive disorder,adrenoceptor alpha 1d
nicardipine,hypertensive disorder,adrenoceptor alpha 1a
nicardipine,hypertensive disorder,calmodulin 2
nicardipine,hypertensive disorder,atp binding cassette subfamily b member 1
nicardipine,hypertensive disorder,calmodulin 1
captopril,hypertensive disorder,leukotriene a4 hydrolase
captopril,hypertensive disorder,matrix metallopeptidase 9
captopril,hypertensive disorder,"coagulation factor ii, thrombin"
captopril,hypertensive disorder,renin
captopril,hypertensive disorder,atp binding cassette subfamily b member 1
captopril,hypertensive disorder,albumin
captopril,hypertensive disorder,matrix metallopeptidase 2
captopril,hypertensive disorder,prostaglandin-endoperoxide synthase 2
captopril,hypertensive disorder,prostaglandin-endoperoxide synthase 1
perindopril,hypertensive disorder,angiotensin i converting enzyme
perindopril,hypertensive disorder,atp binding cassette subfamily b member 1
acebutolol,hypertensive disorder,adrenoceptor beta 2
acebutolol,hypertensive disorder,atp binding cassette subfamily b member 1
acebutolol,hypertensive disorder,adrenoceptor beta 3
hydralazine,hypertensive disorder,ryanodine receptor 2
hydralazine,hypertensive disorder,amine oxidase copper containing 3
hydralazine,hypertensive disorder,glutamic-oxaloacetic transaminase 1
amlodipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
amlodipine,hypertensive disorder,atp binding cassette subfamily b member 1
amlodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
amlodipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
amlodipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
amlodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
diltiazem,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
diltiazem,hypertensive disorder,atp binding cassette subfamily b member 1
diltiazem,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
diltiazem,hypertensive disorder,potassium voltage-gated channel subfamily a member 5
isotretinoin,hypertensive disorder,retinoic acid receptor beta
hydrochlorothiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
hydrochlorothiazide,hypertensive disorder,carbonic anhydrase 9
hydrochlorothiazide,hypertensive disorder,carbonic anhydrase 2
hydrochlorothiazide,hypertensive disorder,albumin
amiloride,hypertensive disorder,amine oxidase copper containing 1
amiloride,hypertensive disorder,solute carrier family 9 member a1
amiloride,hypertensive disorder,solute carrier family 22 member 4
amiloride,hypertensive disorder,acid sensing ion channel subunit 1
telmisartan,hypertensive disorder,atp binding cassette subfamily b member 1
telmisartan,hypertensive disorder,cytochrome p450 family 2 subfamily j member 2
telmisartan,hypertensive disorder,angiotensin i converting enzyme
metoprolol,hypertensive disorder,atp binding cassette subfamily b member 1
metoprolol,hypertensive disorder,adrenoceptor beta 2
metoprolol,hypertensive disorder,adrenoceptor beta 3
clonidine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
clonidine,hypertensive disorder,solute carrier family 22 member 4
clonidine,hypertensive disorder,adrenoceptor alpha 1d
clonidine,hypertensive disorder,adrenoceptor alpha 1b
clonidine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
clonidine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
clonidine,hypertensive disorder,atp binding cassette subfamily b member 1
clonidine,hypertensive disorder,nischarin
clonidine,hypertensive disorder,solute carrier family 6 member 2
clonidine,hypertensive disorder,adrenoceptor alpha 1a
olmesartan,hypertensive disorder,angiotensin ii receptor type 1
verapamil,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
verapamil,hypertensive disorder,cytochrome p450 family 2 subfamily c member 18
verapamil,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 g
verapamil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 11
verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
verapamil,hypertensive disorder,atp binding cassette subfamily b member 1
verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
verapamil,hypertensive disorder,solute carrier family 6 member 4
verapamil,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 1
verapamil,hypertensive disorder,solute carrier family 22 member 4
verapamil,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
verapamil,hypertensive disorder,atp binding cassette subfamily c member 1 (abcc1 blood group)
verapamil,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
lisinopril,hypertensive disorder,atp binding cassette subfamily b member 1
lisinopril,hypertensive disorder,angiotensin converting enzyme 2
hydroflumethiazide,hypertensive disorder,solute carrier family 12 member 3
hydroflumethiazide,hypertensive disorder,solute carrier family 12 member 1
hydroflumethiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
hydroflumethiazide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
hydroflumethiazide,hypertensive disorder,carbonic anhydrase 2
hydroflumethiazide,hypertensive disorder,carbonic anhydrase 9
cilazapril,hypertensive disorder,atp binding cassette subfamily b member 1
benazepril,hypertensive disorder,methylenetetrahydrofolate reductase
benazepril,hypertensive disorder,angiotensin i converting enzyme
felodipine,hypertensive disorder,atp binding cassette subfamily b member 1
felodipine,hypertensive disorder,calmodulin 2
felodipine,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
felodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
felodipine,hypertensive disorder,calmodulin 1
felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
felodipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
felodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
reserpine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
reserpine,hypertensive disorder,atp binding cassette subfamily b member 1
reserpine,hypertensive disorder,solute carrier family 18 member a1
reserpine,hypertensive disorder,dopamine receptor d3
reserpine,hypertensive disorder,dopamine receptor d2
reserpine,hypertensive disorder,solute carrier family 6 member 4
guanfacine,hypertensive disorder,nischarin
guanfacine,hypertensive disorder,adrenoceptor alpha 2b
guanfacine,hypertensive disorder,adrenoceptor alpha 2c
irbesartan,hypertensive disorder,endothelin receptor type a
irbesartan,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
irbesartan,hypertensive disorder,prostaglandin-endoperoxide synthase 1
irbesartan,hypertensive disorder,"jun proto-oncogene, ap-1 transcription factor subunit"
atenolol,hypertensive disorder,adrenoceptor beta 2
atenolol,hypertensive disorder,atp binding cassette subfamily b member 1
atenolol,hypertensive disorder,adrenoceptor beta 3
candesartan,hypertensive disorder,prostaglandin-endoperoxide synthase 1
candesartan,hypertensive disorder,atp binding cassette subfamily b member 1
labetalol,hypertensive disorder,adrenoceptor beta 1
labetalol,hypertensive disorder,adrenoceptor beta 3
labetalol,hypertensive disorder,adrenoceptor beta 2
chlorothiazide,hypertensive disorder,solute carrier family 12 member 3
chlorothiazide,hypertensive disorder,carbonic anhydrase 2
losartan,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
losartan,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
losartan,hypertensive disorder,angiotensin i converting enzyme
losartan,hypertensive disorder,atp binding cassette subfamily b member 1
losartan,hypertensive disorder,albumin
losartan,hypertensive disorder,angiotensin ii receptor type 2
nisoldipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
nisoldipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
nisoldipine,hypertensive disorder,atp binding cassette subfamily b member 1
furosemide,hypertensive disorder,albumin
furosemide,hypertensive disorder,carbonic anhydrase 9
furosemide,hypertensive disorder,carbonic anhydrase 2
furosemide,hypertensive disorder,paraoxonase 1
terazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
terazosin,hypertensive disorder,atp binding cassette subfamily b member 1
terazosin,hypertensive disorder,adrenoceptor alpha 2c
terazosin,hypertensive disorder,adrenoceptor alpha 2b
terazosin,hypertensive disorder,adrenoceptor alpha 2a
bendroflumethiazide,hypertensive disorder,carbonic anhydrase 2
bendroflumethiazide,hypertensive disorder,solute carrier family 12 member 3
bendroflumethiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
propranolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
propranolol,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
propranolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
propranolol,hypertensive disorder,atp binding cassette subfamily b member 1
propranolol,hypertensive disorder,5-hydroxytryptamine receptor 1b
propranolol,hypertensive disorder,adrenoceptor beta 3
propranolol,hypertensive disorder,albumin
l--methyldopa,hypertensive disorder,adrenoceptor alpha 2a
l--methyldopa,hypertensive disorder,catechol-o-methyltransferase
guanadrel,hypertensive disorder,solute carrier family 6 member 2
ethacrynic acid,hypertensive disorder,solute carrier family 12 member 1
ethacrynic acid,hypertensive disorder,albumin
ethacrynic acid,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
ethacrynic acid,hypertensive disorder,glutathione s-transferase alpha 2
betaxolol,hypertensive disorder,adrenoceptor beta 2
betaxolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
timolol,hypertensive disorder,atp binding cassette subfamily b member 1
timolol,hypertensive disorder,adrenoceptor beta 3
timolol,hypertensive disorder,adrenoceptor beta 1
timolol,hypertensive disorder,adrenoceptor beta 2
doxazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
doxazosin,hypertensive disorder,adrenoceptor alpha 1b
doxazosin,hypertensive disorder,atp binding cassette subfamily b member 1
doxazosin,hypertensive disorder,adrenoceptor alpha 2a
doxazosin,hypertensive disorder,adrenoceptor alpha 2c
valsartan,hypertensive disorder,albumin
valsartan,hypertensive disorder,angiotensin ii receptor type 1
valsartan,hypertensive disorder,angiotensin ii receptor type 2
spironolactone,hypertensive disorder,nuclear receptor subfamily 3 group c member 1
spironolactone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 2
spironolactone,hypertensive disorder,androgen receptor
spironolactone,hypertensive disorder,atp binding cassette subfamily b member 1
spironolactone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 1
minoxidil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 11
minoxidil,hypertensive disorder,prostaglandin-endoperoxide synthase 1
minoxidil,hypertensive disorder,atp binding cassette subfamily c member 9
triamterene,hypertensive disorder,sodium channel epithelial 1 subunit beta
triamterene,hypertensive disorder,sodium channel epithelial 1 subunit gamma
triamterene,hypertensive disorder,sodium channel epithelial 1 subunit alpha
triamterene,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
torsemide,hypertensive disorder,prostaglandin-endoperoxide synthase 1
trichlormethiazide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
trichlormethiazide,hypertensive disorder,solute carrier family 12 member 1
trichlormethiazide,hypertensive disorder,carbonic anhydrase 9
trichlormethiazide,hypertensive disorder,carbonic anhydrase 2
metolazone,hypertensive disorder,carbonic anhydrase 9
metolazone,hypertensive disorder,solute carrier family 12 member 1
metolazone,hypertensive disorder,carbonic anhydrase 2
pindolol,hypertensive disorder,adrenoceptor beta 3
pindolol,hypertensive disorder,5-hydroxytryptamine receptor 1b
pindolol,hypertensive disorder,5-hydroxytryptamine receptor 2a
pindolol,hypertensive disorder,5-hydroxytryptamine receptor 2b
guanethidine,hypertensive disorder,solute carrier family 6 member 2
nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
nifedipine,hypertensive disorder,atp binding cassette subfamily b member 1
nifedipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
nifedipine,hypertensive disorder,calmodulin 1
nifedipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
nifedipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
nifedipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
nifedipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
nifedipine,hypertensive disorder,calmodulin 2
enalapril,hypertensive disorder,atp binding cassette subfamily b member 1
enalapril,hypertensive disorder,angiotensin i converting enzyme
eplerenone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 2
eplerenone,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
eplerenone,hypertensive disorder,nuclear receptor subfamily 3 group c member 1
guanabenz,hypertensive disorder,nischarin
guanabenz,hypertensive disorder,adrenoceptor alpha 2b
guanabenz,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
guanabenz,hypertensive disorder,adrenoceptor alpha 2c
nebivolol,hypertensive disorder,adrenoceptor beta 2
nebivolol,hypertensive disorder,macrophage migration inhibitory factor
quinapril,hypertensive disorder,angiotensin i converting enzyme
spirapril,hypertensive disorder,angiotensin i converting enzyme
carvedilol,hypertensive disorder,adrenoceptor alpha 2b
carvedilol,hypertensive disorder,adrenoceptor alpha 1b
carvedilol,hypertensive disorder,vascular endothelial growth factor a
carvedilol,hypertensive disorder,selectin e
carvedilol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
carvedilol,hypertensive disorder,adrenoceptor beta 2
carvedilol,hypertensive disorder,natriuretic peptide b
carvedilol,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
carvedilol,hypertensive disorder,atp binding cassette subfamily b member 1
carvedilol,hypertensive disorder,xanthine dehydrogenase
carvedilol,hypertensive disorder,adrenoceptor alpha 2c
carvedilol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
carvedilol,hypertensive disorder,adrenoceptor alpha 2a
carvedilol,hypertensive disorder,hypoxia inducible factor 1 subunit alpha
carvedilol,hypertensive disorder,adrenoceptor beta 3
carvedilol,hypertensive disorder,gap junction protein alpha 1
carvedilol,hypertensive disorder,adrenoceptor alpha 1d
carvedilol,hypertensive disorder,vascular cell adhesion molecule 1
carvedilol,hypertensive disorder,prostaglandin-endoperoxide synthase 1
ramipril,hypertensive disorder,angiotensin i converting enzyme
n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 1
n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 2
n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 3
chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit beta3
chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit beta2
chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 2
dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 1
atropine,irritable bowel syndrome,cholinergic receptor muscarinic 3
atropine,irritable bowel syndrome,cholinergic receptor muscarinic 2
atropine,irritable bowel syndrome,cholinergic receptor muscarinic 1
etoposide,kaposi's sarcoma,dna topoisomerase ii alpha
etoposide,kaposi's sarcoma,atp binding cassette subfamily b member 1
vinblastine,kaposi's sarcoma,tubulin beta 4a class iva
vinblastine,kaposi's sarcoma,tubulin beta 1 class vi
vinblastine,kaposi's sarcoma,tubulin beta 8 class viii
vinblastine,kaposi's sarcoma,atp binding cassette subfamily b member 1
vinblastine,kaposi's sarcoma,tubulin beta 2b class iib
vinblastine,kaposi's sarcoma,tubulin beta 4b class ivb
vinblastine,kaposi's sarcoma,tubulin beta 2a class iia
vinblastine,kaposi's sarcoma,tubulin beta 3 class iii
vinblastine,kaposi's sarcoma,tubulin beta 6 class v
paclitaxel,kaposi's sarcoma,tubulin beta 2b class iib
paclitaxel,kaposi's sarcoma,atp binding cassette subfamily b member 1
paclitaxel,kaposi's sarcoma,tubulin beta 6 class v
paclitaxel,kaposi's sarcoma,tubulin beta class i
paclitaxel,kaposi's sarcoma,tubulin beta 3 class iii
paclitaxel,kaposi's sarcoma,tubulin beta 8 class viii
paclitaxel,kaposi's sarcoma,tubulin beta 4a class iva
paclitaxel,kaposi's sarcoma,tubulin beta 2a class iia
paclitaxel,kaposi's sarcoma,tubulin beta 4b class ivb
daunorubicin,kaposi's sarcoma,dna topoisomerase ii alpha
daunorubicin,kaposi's sarcoma,atp binding cassette subfamily b member 1
vinorelbine,kaposi's sarcoma,tubulin beta 2b class iib
vinorelbine,kaposi's sarcoma,tubulin beta 6 class v
vinorelbine,kaposi's sarcoma,tubulin beta 1 class vi
vinorelbine,kaposi's sarcoma,tubulin beta 2a class iia
vinorelbine,kaposi's sarcoma,tubulin beta 4a class iva
vinorelbine,kaposi's sarcoma,atp binding cassette subfamily b member 1
vinorelbine,kaposi's sarcoma,tubulin beta class i
vinorelbine,kaposi's sarcoma,tubulin beta 4b class ivb
vinorelbine,kaposi's sarcoma,tubulin beta 8 class viii
vinorelbine,kaposi's sarcoma,tubulin beta 3 class iii
eribulin,liposarcoma,tubulin beta 1 class vi
eribulin,liposarcoma,tubulin beta 2b class iib
eribulin,liposarcoma,tubulin beta 8 class viii
eribulin,liposarcoma,tubulin beta 4b class ivb
eribulin,liposarcoma,tubulin beta 2a class iia
eribulin,liposarcoma,tubulin beta 6 class v
eribulin,liposarcoma,tubulin beta 3 class iii
eribulin,liposarcoma,tubulin beta class i
eribulin,liposarcoma,tubulin beta 4a class iva
dicumarol,myocardial infarction,g protein-coupled receptor 35
nitroglycerin,myocardial infarction,guanylate cyclase 1 soluble subunit alpha 1
nitroglycerin,myocardial infarction,guanylate cyclase 1 soluble subunit beta 1
nitroglycerin,myocardial infarction,aldehyde dehydrogenase 2 family member
aspirin,myocardial infarction,heat shock protein family a (hsp70) member 5
aspirin,myocardial infarction,endothelin receptor type a
aspirin,myocardial infarction,tumor protein p53
cyclophosphamide,neuroblastoma,atp binding cassette subfamily b member 1
etoposide,neuroblastoma,dna topoisomerase ii alpha
etoposide,neuroblastoma,atp binding cassette subfamily b member 1
vincristine,neuroblastoma,atp binding cassette subfamily b member 1
vincristine,neuroblastoma,tubulin beta 8 class viii
vincristine,neuroblastoma,tubulin beta 3 class iii
vincristine,neuroblastoma,tubulin beta 1 class vi
vincristine,neuroblastoma,tubulin beta 4a class iva
vincristine,neuroblastoma,tubulin beta 2a class iia
vincristine,neuroblastoma,tubulin beta 2b class iib
vincristine,neuroblastoma,tubulin beta 4b class ivb
vincristine,neuroblastoma,tubulin beta 6 class v
daunorubicin,neuroblastoma,dna topoisomerase ii alpha
daunorubicin,neuroblastoma,atp binding cassette subfamily b member 1
teniposide,neuroblastoma,dna topoisomerase ii alpha
vinblastine,neuroblastoma,tubulin beta 4a class iva
vinblastine,neuroblastoma,tubulin beta 1 class vi
vinblastine,neuroblastoma,tubulin beta 8 class viii
vinblastine,neuroblastoma,atp binding cassette subfamily b member 1
vinblastine,neuroblastoma,tubulin beta 2b class iib
vinblastine,neuroblastoma,tubulin beta 4b class ivb
vinblastine,neuroblastoma,tubulin beta class i
vinblastine,neuroblastoma,tubulin beta 2a class iia
vinblastine,neuroblastoma,tubulin beta 3 class iii
vinblastine,neuroblastoma,tubulin beta 6 class v
lenvatinib,thyroid gland papillary carcinoma,kinase insert domain receptor
lenvatinib,thyroid gland papillary carcinoma,receptor interacting serine/threonine kinase 2
minocycline,periodontitis,interleukin 1 beta
minocycline,periodontitis,matrix metallopeptidase 9
prednisolone,psoriasis,serpin family a member 6
triamcinolone,psoriasis,serpin family a member 6
cortisol,psoriasis,nuclear receptor subfamily 3 group c member 1
cortisol,psoriasis,sex hormone binding globulin
cortisol,psoriasis,serpin family a member 6
calcipotriol,psoriasis,vitamin d receptor
betamethasone,psoriasis,nuclear receptor subfamily 3 group c member 1
prednisone,psoriasis,nuclear receptor subfamily 3 group c member 1
lenvatinib,renal cell carcinoma,traf2 and nck interacting kinase
lenvatinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
lenvatinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
lenvatinib,renal cell carcinoma,ste20 like kinase
lenvatinib,renal cell carcinoma,kinase insert domain receptor
lenvatinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
lenvatinib,renal cell carcinoma,serine/threonine kinase 10
lenvatinib,renal cell carcinoma,aurora kinase b
cabozantinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
cabozantinib,renal cell carcinoma,aurora kinase a
cabozantinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
cabozantinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
cabozantinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
sunitinib,renal cell carcinoma,serine/threonine kinase 33
sunitinib,renal cell carcinoma,myosin light chain kinase family member 4
sunitinib,renal cell carcinoma,leucine rich repeat kinase 2
sunitinib,renal cell carcinoma,fibroblast growth factor receptor 1
sunitinib,renal cell carcinoma,homeodomain interacting protein kinase 4
sunitinib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
sunitinib,renal cell carcinoma,death associated protein kinase 3
sunitinib,renal cell carcinoma,serine/threonine kinase 17a
sunitinib,renal cell carcinoma,cdc like kinase 4
sunitinib,renal cell carcinoma,p21 (rac1) activated kinase 3
sunitinib,renal cell carcinoma,cdc like kinase 2
sunitinib,renal cell carcinoma,ribosomal protein s6 kinase a2
sunitinib,renal cell carcinoma,cdc like kinase 1
sunitinib,renal cell carcinoma,death associated protein kinase 1
sunitinib,renal cell carcinoma,alk receptor tyrosine kinase
sunitinib,renal cell carcinoma,homeodomain interacting protein kinase 2
sunitinib,renal cell carcinoma,ribosomal protein s6 kinase a5
sunitinib,renal cell carcinoma,il2 inducible t cell kinase
sunitinib,renal cell carcinoma,ste20 like kinase
sunitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
sunitinib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
sunitinib,renal cell carcinoma,bmp2 inducible kinase
sunitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
sunitinib,renal cell carcinoma,checkpoint kinase 2
sunitinib,renal cell carcinoma,myosin light chain kinase
sunitinib,renal cell carcinoma,ret proto-oncogene
sunitinib,renal cell carcinoma,phosphorylase kinase catalytic subunit gamma 2
sunitinib,renal cell carcinoma,phosphorylase kinase catalytic subunit gamma 1
sunitinib,renal cell carcinoma,serine/threonine kinase 4
sunitinib,renal cell carcinoma,serine/threonine kinase 11
sunitinib,renal cell carcinoma,serine/threonine kinase 10
sunitinib,renal cell carcinoma,polo like kinase 4
sunitinib,renal cell carcinoma,axl receptor tyrosine kinase
sunitinib,renal cell carcinoma,aurora kinase c
sunitinib,renal cell carcinoma,traf2 and nck interacting kinase
sunitinib,renal cell carcinoma,myosin light chain kinase 3
sunitinib,renal cell carcinoma,cyclin g associated kinase
sunitinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
sunitinib,renal cell carcinoma,"src proto-oncogene, non-receptor tyrosine kinase"
sunitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 1
sunitinib,renal cell carcinoma,casein kinase 1 delta
sunitinib,renal cell carcinoma,bub1 mitotic checkpoint serine/threonine kinase
sunitinib,renal cell carcinoma,delta like non-canonical notch ligand 1
sunitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
sunitinib,renal cell carcinoma,ap2 associated kinase 1
sunitinib,renal cell carcinoma,misshapen like kinase 1
sunitinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
sunitinib,renal cell carcinoma,fibroblast growth factor receptor 3
sunitinib,renal cell carcinoma,aurora kinase b
sunitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 2
sunitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
sunitinib,renal cell carcinoma,aurora kinase a
sirolimus,renal cell carcinoma,fkbp prolyl isomerase 1a
sirolimus,renal cell carcinoma,eukaryotic translation initiation factor 4e
sirolimus,renal cell carcinoma,fkbp prolyl isomerase 1b
sirolimus,renal cell carcinoma,fkbp prolyl isomerase 5
everolimus,renal cell carcinoma,fkbp prolyl isomerase 1a
sorafenib,renal cell carcinoma,fibroblast growth factor receptor 1
sorafenib,renal cell carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
sorafenib,renal cell carcinoma,epoxide hydrolase 2
sorafenib,renal cell carcinoma,serine/threonine kinase 10
sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 3
sorafenib,renal cell carcinoma,ret proto-oncogene
sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 1
sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 4
sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
sorafenib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 20
sorafenib,renal cell carcinoma,aurora kinase c
sorafenib,renal cell carcinoma,kinase insert domain receptor
sorafenib,renal cell carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
sorafenib,renal cell carcinoma,homeodomain interacting protein kinase 4
sorafenib,renal cell carcinoma,platelet derived growth factor receptor alpha
sorafenib,renal cell carcinoma,platelet derived growth factor receptor beta
sorafenib,renal cell carcinoma,colony stimulating factor 1 receptor
sorafenib,renal cell carcinoma,homeodomain interacting protein kinase 2
sorafenib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
sorafenib,renal cell carcinoma,polo like kinase 4
sorafenib,renal cell carcinoma,aurora kinase b
sorafenib,renal cell carcinoma,axl receptor tyrosine kinase
sorafenib,renal cell carcinoma,traf2 and nck interacting kinase
sorafenib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
sorafenib,renal cell carcinoma,ste20 like kinase
sorafenib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
sorafenib,renal cell carcinoma,serine/threonine kinase 33
sorafenib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
sorafenib,renal cell carcinoma,cdc like kinase 1
sorafenib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
sorafenib,renal cell carcinoma,eph receptor b2
sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
sorafenib,renal cell carcinoma,myosin light chain kinase 3
sorafenib,renal cell carcinoma,tek receptor tyrosine kinase
sorafenib,renal cell carcinoma,fibroblast growth factor receptor 3
pazopanib,renal cell carcinoma,aurora kinase c
pazopanib,renal cell carcinoma,il2 inducible t cell kinase
pazopanib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
pazopanib,renal cell carcinoma,fibroblast growth factor receptor 1
pazopanib,renal cell carcinoma,serine/threonine kinase 10
pazopanib,renal cell carcinoma,polo like kinase 4
pazopanib,renal cell carcinoma,fibroblast growth factor receptor 3
pazopanib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
pazopanib,renal cell carcinoma,bmp2 inducible kinase
pazopanib,renal cell carcinoma,tek receptor tyrosine kinase
pazopanib,renal cell carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
pazopanib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
pazopanib,renal cell carcinoma,"src proto-oncogene, non-receptor tyrosine kinase"
pazopanib,renal cell carcinoma,ste20 like kinase
pazopanib,renal cell carcinoma,ret proto-oncogene
pazopanib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
pazopanib,renal cell carcinoma,aurora kinase a
pazopanib,renal cell carcinoma,cyclin g associated kinase
pazopanib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
pazopanib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
pazopanib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
pazopanib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
pazopanib,renal cell carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
pazopanib,renal cell carcinoma,traf2 and nck interacting kinase
pazopanib,renal cell carcinoma,ap2 associated kinase 1
pazopanib,renal cell carcinoma,alk receptor tyrosine kinase
pazopanib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
axitinib,renal cell carcinoma,leucine rich repeat kinase 2
axitinib,renal cell carcinoma,aurora kinase b
axitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
axitinib,renal cell carcinoma,traf2 and nck interacting kinase
axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
axitinib,renal cell carcinoma,colony stimulating factor 1 receptor
axitinib,renal cell carcinoma,ap2 associated kinase 1
axitinib,renal cell carcinoma,misshapen like kinase 1
axitinib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
axitinib,renal cell carcinoma,platelet derived growth factor receptor alpha
axitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 2
axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 20
axitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
axitinib,renal cell carcinoma,tek receptor tyrosine kinase
axitinib,renal cell carcinoma,polo like kinase 4
axitinib,renal cell carcinoma,serine/threonine kinase 4
axitinib,renal cell carcinoma,cyclin g associated kinase
axitinib,renal cell carcinoma,aurora kinase c
axitinib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
axitinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
axitinib,renal cell carcinoma,bmp2 inducible kinase
axitinib,renal cell carcinoma,aurora kinase a
axitinib,renal cell carcinoma,myosin light chain kinase 3
axitinib,renal cell carcinoma,serine/threonine kinase 10
axitinib,renal cell carcinoma,fibroblast growth factor receptor 1
axitinib,renal cell carcinoma,il2 inducible t cell kinase
axitinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
axitinib,renal cell carcinoma,ste20 like kinase
axitinib,renal cell carcinoma,platelet derived growth factor receptor beta
axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 3
axitinib,renal cell carcinoma,ret proto-oncogene
axitinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
axitinib,renal cell carcinoma,axl receptor tyrosine kinase
axitinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
axitinib,renal cell carcinoma,fibroblast growth factor receptor 3
pazopanib,sarcoma,bone morphogenetic protein receptor type 1b
pazopanib,sarcoma,tek receptor tyrosine kinase
pazopanib,sarcoma,"raf-1 proto-oncogene, serine/threonine kinase"
pazopanib,sarcoma,"src proto-oncogene, non-receptor tyrosine kinase"
pazopanib,sarcoma,"b-raf proto-oncogene, serine/threonine kinase"
paliperidone,schizophrenia,dopamine receptor d2
paliperidone,schizophrenia,5-hydroxytryptamine receptor 1d
paliperidone,schizophrenia,5-hydroxytryptamine receptor 1a
paliperidone,schizophrenia,adrenoceptor alpha 2a
paliperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
paliperidone,schizophrenia,5-hydroxytryptamine receptor 2c
paliperidone,schizophrenia,dopamine receptor d3
paliperidone,schizophrenia,adrenoceptor alpha 1a
paliperidone,schizophrenia,dopamine receptor d1
paliperidone,schizophrenia,5-hydroxytryptamine receptor 2a
paliperidone,schizophrenia,adrenoceptor alpha 1b
paliperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
paliperidone,schizophrenia,histamine receptor h1
paliperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
paliperidone,schizophrenia,dopamine receptor d4
paliperidone,schizophrenia,5-hydroxytryptamine receptor 1b
paliperidone,schizophrenia,5-hydroxytryptamine receptor 1e
paliperidone,schizophrenia,cholinergic receptor muscarinic 2
paliperidone,schizophrenia,tachykinin precursor 1
prochlorperazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
prochlorperazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
prochlorperazine,schizophrenia,histamine receptor h1
prochlorperazine,schizophrenia,dopamine receptor d2
prochlorperazine,schizophrenia,cholinergic receptor muscarinic 2
prochlorperazine,schizophrenia,dopamine receptor d3
prochlorperazine,schizophrenia,5-hydroxytryptamine receptor 2c
prochlorperazine,schizophrenia,adrenoceptor alpha 1a
prochlorperazine,schizophrenia,5-hydroxytryptamine receptor 1a
prochlorperazine,schizophrenia,adrenoceptor alpha 2a
prochlorperazine,schizophrenia,dopamine receptor d4
fluphenazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
fluphenazine,schizophrenia,cytochrome p450 family 2 subfamily e member 1
fluphenazine,schizophrenia,adrenoceptor alpha 2a
fluphenazine,schizophrenia,5-hydroxytryptamine receptor 2c
fluphenazine,schizophrenia,atp binding cassette subfamily b member 1
fluphenazine,schizophrenia,5-hydroxytryptamine receptor 6
fluphenazine,schizophrenia,5-hydroxytryptamine receptor 1a
fluphenazine,schizophrenia,dopamine receptor d3
fluphenazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
fluphenazine,schizophrenia,histamine receptor h1
fluphenazine,schizophrenia,5-hydroxytryptamine receptor 2a
fluphenazine,schizophrenia,calmodulin 1
fluphenazine,schizophrenia,adrenoceptor alpha 1a
fluphenazine,schizophrenia,5-hydroxytryptamine receptor 7
fluphenazine,schizophrenia,cholinergic receptor muscarinic 2
fluphenazine,schizophrenia,dopamine receptor d4
fluphenazine,schizophrenia,dopamine receptor d5
cariprazine,schizophrenia,histamine receptor h1
cariprazine,schizophrenia,vitamin d receptor
cariprazine,schizophrenia,dopamine receptor d3
cariprazine,schizophrenia,5-hydroxytryptamine receptor 7
cariprazine,schizophrenia,5-hydroxytryptamine receptor 2a
cariprazine,schizophrenia,dopamine receptor d5
cariprazine,schizophrenia,dopamine receptor d4
cariprazine,schizophrenia,5-hydroxytryptamine receptor 1a
cariprazine,schizophrenia,5-hydroxytryptamine receptor 2c
cariprazine,schizophrenia,dopamine receptor d1
cariprazine,schizophrenia,dopamine receptor d2
ziprasidone,schizophrenia,h1.0 linker histone
ziprasidone,schizophrenia,dopamine receptor d1
ziprasidone,schizophrenia,cholinergic receptor muscarinic 5
ziprasidone,schizophrenia,adrenoceptor alpha 2a
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 7
ziprasidone,schizophrenia,adrenoceptor alpha 1a
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 2c
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1d
ziprasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
ziprasidone,schizophrenia,cholinergic receptor muscarinic 1
ziprasidone,schizophrenia,potassium voltage-gated channel subfamily h member 2
ziprasidone,schizophrenia,dopamine receptor d4
ziprasidone,schizophrenia,dopamine receptor d5
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 6
ziprasidone,schizophrenia,adrenoceptor alpha 1b
ziprasidone,schizophrenia,solute carrier family 6 member 4
ziprasidone,schizophrenia,cytochrome p450 family 1 subfamily a member 2
ziprasidone,schizophrenia,cholinergic receptor muscarinic 2
ziprasidone,schizophrenia,histamine receptor h1
ziprasidone,schizophrenia,dopamine receptor d3
ziprasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
ziprasidone,schizophrenia,cholinergic receptor muscarinic 4
ziprasidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1e
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1b
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 3a
ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1a
ziprasidone,schizophrenia,tachykinin precursor 1
haloperidol,schizophrenia,atp binding cassette subfamily b member 1
haloperidol,schizophrenia,5-hydroxytryptamine receptor 2a
haloperidol,schizophrenia,5-hydroxytryptamine receptor 1b
haloperidol,schizophrenia,5-hydroxytryptamine receptor 1d
haloperidol,schizophrenia,ebp cholestenol delta-isomerase
haloperidol,schizophrenia,histamine receptor h1
haloperidol,schizophrenia,dopamine receptor d4
haloperidol,schizophrenia,dopamine receptor d2
haloperidol,schizophrenia,dopamine receptor d1
haloperidol,schizophrenia,dopamine receptor d3
haloperidol,schizophrenia,cytochrome p450 family 3 subfamily a member 5
haloperidol,schizophrenia,cytochrome p450 family 1 subfamily a member 2
haloperidol,schizophrenia,glutamate ionotropic receptor nmda type subunit 2b
haloperidol,schizophrenia,cytochrome p450 family 2 subfamily d member 6
haloperidol,schizophrenia,cytochrome p450 family 3 subfamily a member 4
haloperidol,schizophrenia,potassium voltage-gated channel subfamily h member 2
haloperidol,schizophrenia,h1.0 linker histone
haloperidol,schizophrenia,sigma non-opioid intracellular receptor 1
haloperidol,schizophrenia,5-hydroxytryptamine receptor 6
haloperidol,schizophrenia,cholinergic receptor muscarinic 1
haloperidol,schizophrenia,solute carrier family 6 member 2
haloperidol,schizophrenia,"major histocompatibility complex, class i, a"
haloperidol,schizophrenia,adrenoceptor alpha 2a
haloperidol,schizophrenia,opioid receptor mu 1
haloperidol,schizophrenia,5-hydroxytryptamine receptor 2c
haloperidol,schizophrenia,5-hydroxytryptamine receptor 1a
haloperidol,schizophrenia,adrenoceptor alpha 1a
haloperidol,schizophrenia,transmembrane protein 97
haloperidol,schizophrenia,solute carrier family 6 member 4
haloperidol,schizophrenia,dopamine receptor d5
haloperidol,schizophrenia,5-hydroxytryptamine receptor 1f
haloperidol,schizophrenia,5-hydroxytryptamine receptor 7
haloperidol,schizophrenia,tachykinin precursor 1
haloperidol,schizophrenia,5-hydroxytryptamine receptor 1e
chlorpromazine,schizophrenia,adrenoceptor alpha 1b
chlorpromazine,schizophrenia,dopamine receptor d5
chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 1a
chlorpromazine,schizophrenia,calmodulin 1
chlorpromazine,schizophrenia,adrenoceptor alpha 1a
chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 7
chlorpromazine,schizophrenia,adrenoceptor alpha 2a
chlorpromazine,schizophrenia,cytochrome p450 family 2 subfamily e member 1
chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 2a
chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 6
chlorpromazine,schizophrenia,histamine receptor h1
chlorpromazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
chlorpromazine,schizophrenia,cholinergic receptor muscarinic 1
chlorpromazine,schizophrenia,dopamine receptor d3
chlorpromazine,schizophrenia,dopamine receptor d4
chlorpromazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
chlorpromazine,schizophrenia,dopamine receptor d1
chlorpromazine,schizophrenia,atp binding cassette subfamily b member 1
chlorpromazine,schizophrenia,cholinergic receptor muscarinic 2
chlorpromazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 2c
chlorpromazine,schizophrenia,potassium voltage-gated channel subfamily h member 2
chlorpromazine,schizophrenia,solute carrier family 6 member 4
chlorpromazine,schizophrenia,cholinergic receptor muscarinic 4
chlorpromazine,schizophrenia,cholinergic receptor muscarinic 5
mesoridazine,schizophrenia,histamine receptor h1
mesoridazine,schizophrenia,5-hydroxytryptamine receptor 6
mesoridazine,schizophrenia,5-hydroxytryptamine receptor 2c
mesoridazine,schizophrenia,5-hydroxytryptamine receptor 2a
mesoridazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
mesoridazine,schizophrenia,5-hydroxytryptamine receptor 1a
mesoridazine,schizophrenia,dopamine receptor d2
mesoridazine,schizophrenia,cholinergic receptor muscarinic 2
mesoridazine,schizophrenia,potassium voltage-gated channel subfamily h member 2
mesoridazine,schizophrenia,dopamine receptor d3
mesoridazine,schizophrenia,cholinergic receptor muscarinic 5
mesoridazine,schizophrenia,adrenoceptor alpha 1a
mesoridazine,schizophrenia,adrenoceptor alpha 2a
mesoridazine,schizophrenia,dopamine receptor d4
mesoridazine,schizophrenia,cholinergic receptor muscarinic 4
mesoridazine,schizophrenia,cholinergic receptor muscarinic 1
risperidone,schizophrenia,5-hydroxytryptamine receptor 1b
risperidone,schizophrenia,adrenoceptor alpha 1b
risperidone,schizophrenia,h1.0 linker histone
risperidone,schizophrenia,dopamine receptor d4
risperidone,schizophrenia,5-hydroxytryptamine receptor 1d
risperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
risperidone,schizophrenia,adrenoceptor alpha 1a
risperidone,schizophrenia,5-hydroxytryptamine receptor 2c
risperidone,schizophrenia,potassium voltage-gated channel subfamily h member 2
risperidone,schizophrenia,dopamine receptor d1
risperidone,schizophrenia,dopamine receptor d3
risperidone,schizophrenia,5-hydroxytryptamine receptor 7
risperidone,schizophrenia,5-hydroxytryptamine receptor 1a
risperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
risperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
risperidone,schizophrenia,adrenoceptor alpha 2a
risperidone,schizophrenia,histamine receptor h1
risperidone,schizophrenia,atp binding cassette subfamily b member 1
risperidone,schizophrenia,cholinergic receptor muscarinic 1
risperidone,schizophrenia,5-hydroxytryptamine receptor 1e
risperidone,schizophrenia,cholinergic receptor muscarinic 2
risperidone,schizophrenia,5-hydroxytryptamine receptor 1f
risperidone,schizophrenia,tachykinin precursor 1
risperidone,schizophrenia,dopamine receptor d5
risperidone,schizophrenia,sigma non-opioid intracellular receptor 1
risperidone,schizophrenia,solute carrier family 6 member 4
risperidone,schizophrenia,cholinergic receptor muscarinic 4
risperidone,schizophrenia,5-hydroxytryptamine receptor 6
aripiprazole,schizophrenia,adrenoceptor alpha 2a
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1e
aripiprazole,schizophrenia,h1.0 linker histone
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 2c
aripiprazole,schizophrenia,cholinergic receptor muscarinic 2
aripiprazole,schizophrenia,cholinergic receptor muscarinic 1
aripiprazole,schizophrenia,dopamine receptor d5
aripiprazole,schizophrenia,histamine receptor h1
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 7
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1d
aripiprazole,schizophrenia,atp binding cassette subfamily b member 1
aripiprazole,schizophrenia,dopamine receptor d3
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1a
aripiprazole,schizophrenia,cytochrome p450 family 3 subfamily a member 4
aripiprazole,schizophrenia,dopamine receptor d4
aripiprazole,schizophrenia,dopamine receptor d1
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 6
aripiprazole,schizophrenia,adrenoceptor alpha 1b
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 3a
aripiprazole,schizophrenia,potassium voltage-gated channel subfamily h member 2
aripiprazole,schizophrenia,cholinergic receptor muscarinic 4
aripiprazole,schizophrenia,solute carrier family 6 member 4
aripiprazole,schizophrenia,cytochrome p450 family 3 subfamily a member 5
aripiprazole,schizophrenia,adrenoceptor alpha 1a
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1b
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 2a
aripiprazole,schizophrenia,cytochrome p450 family 2 subfamily d member 6
aripiprazole,schizophrenia,dopamine receptor d2
aripiprazole,schizophrenia,cholinergic receptor muscarinic 5
aripiprazole,schizophrenia,solute carrier family 6 member 2
aripiprazole,schizophrenia,5-hydroxytryptamine receptor 5a
aripiprazole,schizophrenia,solute carrier family 6 member 3
mosapramine,schizophrenia,dopamine receptor d4
trifluoperazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 6
trifluoperazine,schizophrenia,sigma non-opioid intracellular receptor 1
trifluoperazine,schizophrenia,adrenoceptor alpha 1a
trifluoperazine,schizophrenia,atp binding cassette subfamily b member 1
trifluoperazine,schizophrenia,cholinergic receptor muscarinic 2
trifluoperazine,schizophrenia,histamine receptor h1
trifluoperazine,schizophrenia,calmodulin 1
trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 1a
trifluoperazine,schizophrenia,ebp like
trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 2a
trifluoperazine,schizophrenia,ebp cholestenol delta-isomerase
trifluoperazine,schizophrenia,calcyon neuron specific vesicular protein
trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 2c
trifluoperazine,schizophrenia,adrenoceptor alpha 2a
trifluoperazine,schizophrenia,dopamine receptor d3
trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 7
trifluoperazine,schizophrenia,dopamine receptor d4
iloperidone,schizophrenia,adrenoceptor alpha 2a
iloperidone,schizophrenia,cytochrome p450 family 2 subfamily e member 1
iloperidone,schizophrenia,cytochrome p450 family 1 subfamily a member 2
iloperidone,schizophrenia,histamine receptor h1
iloperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
iloperidone,schizophrenia,5-hydroxytryptamine receptor 1a
iloperidone,schizophrenia,dopamine receptor d2
iloperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
iloperidone,schizophrenia,sigma non-opioid intracellular receptor 1
iloperidone,schizophrenia,adrenoceptor alpha 1a
iloperidone,schizophrenia,5-hydroxytryptamine receptor 7
iloperidone,schizophrenia,5-hydroxytryptamine receptor 2c
iloperidone,schizophrenia,5-hydroxytryptamine receptor 1d
iloperidone,schizophrenia,5-hydroxytryptamine receptor 6
iloperidone,schizophrenia,dopamine receptor d3
iloperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
iloperidone,schizophrenia,dopamine receptor d4
iloperidone,schizophrenia,cholinergic receptor muscarinic 1
iloperidone,schizophrenia,solute carrier family 6 member 3
iloperidone,schizophrenia,solute carrier family 6 member 2
iloperidone,schizophrenia,cholinergic receptor muscarinic 2
iloperidone,schizophrenia,cholinergic receptor muscarinic 4
iloperidone,schizophrenia,dopamine receptor d5
asenapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
asenapine,schizophrenia,histamine receptor h2
asenapine,schizophrenia,dopamine receptor d4
asenapine,schizophrenia,dopamine receptor d1
asenapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
asenapine,schizophrenia,solute carrier family 6 member 4
asenapine,schizophrenia,adrenoceptor alpha 1a
asenapine,schizophrenia,5-hydroxytryptamine receptor 1b
asenapine,schizophrenia,5-hydroxytryptamine receptor 1a
asenapine,schizophrenia,5-hydroxytryptamine receptor 1d
asenapine,schizophrenia,adrenoceptor alpha 2a
asenapine,schizophrenia,dopamine receptor d3
asenapine,schizophrenia,5-hydroxytryptamine receptor 1e
asenapine,schizophrenia,histamine receptor h1
asenapine,schizophrenia,5-hydroxytryptamine receptor 5a
asenapine,schizophrenia,5-hydroxytryptamine receptor 2c
asenapine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
asenapine,schizophrenia,5-hydroxytryptamine receptor 7
asenapine,schizophrenia,5-hydroxytryptamine receptor 6
asenapine,schizophrenia,cholinergic receptor muscarinic 2
asenapine,schizophrenia,tachykinin precursor 1
zuclopenthixol,schizophrenia,histamine receptor h1
zuclopenthixol,schizophrenia,5-hydroxytryptamine receptor 6
zuclopenthixol,schizophrenia,cytochrome p450 family 2 subfamily d member 6
zuclopenthixol,schizophrenia,5-hydroxytryptamine receptor 2a
zuclopenthixol,schizophrenia,adrenoceptor alpha 1a
zuclopenthixol,schizophrenia,adrenoceptor alpha 2a
sertindole,schizophrenia,5-hydroxytryptamine receptor 1d
sertindole,schizophrenia,solute carrier family 6 member 4
sertindole,schizophrenia,dopamine receptor d3
sertindole,schizophrenia,adrenoceptor alpha 2a
sertindole,schizophrenia,cytochrome p450 family 2 subfamily d member 6
sertindole,schizophrenia,5-hydroxytryptamine receptor 1e
sertindole,schizophrenia,potassium voltage-gated channel subfamily h member 2
sertindole,schizophrenia,cytochrome p450 family 3 subfamily a member 4
sertindole,schizophrenia,5-hydroxytryptamine receptor 1b
sertindole,schizophrenia,histamine receptor h1
sertindole,schizophrenia,5-hydroxytryptamine receptor 1f
sertindole,schizophrenia,dopamine receptor d4
sertindole,schizophrenia,5-hydroxytryptamine receptor 1a
sertindole,schizophrenia,5-hydroxytryptamine receptor 6
sertindole,schizophrenia,dopamine receptor d1
sertindole,schizophrenia,tachykinin precursor 1
sertindole,schizophrenia,cholinergic receptor muscarinic 2
sertindole,schizophrenia,5-hydroxytryptamine receptor 7
quetiapine,schizophrenia,adrenoceptor alpha 1a
quetiapine,schizophrenia,cytochrome p450 family 3 subfamily a member 5
quetiapine,schizophrenia,5-hydroxytryptamine receptor 1e
quetiapine,schizophrenia,5-hydroxytryptamine receptor 7
quetiapine,schizophrenia,5-hydroxytryptamine receptor 3a
quetiapine,schizophrenia,adrenoceptor alpha 1d
quetiapine,schizophrenia,dopamine receptor d5
quetiapine,schizophrenia,cholinergic receptor muscarinic 4
quetiapine,schizophrenia,histamine receptor h1
quetiapine,schizophrenia,adrenoceptor alpha 2a
quetiapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
quetiapine,schizophrenia,cholinergic receptor muscarinic 5
quetiapine,schizophrenia,cholinergic receptor muscarinic 1
quetiapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
quetiapine,schizophrenia,dopamine receptor d3
quetiapine,schizophrenia,5-hydroxytryptamine receptor 1b
quetiapine,schizophrenia,adrenoceptor alpha 1b
quetiapine,schizophrenia,5-hydroxytryptamine receptor 1a
quetiapine,schizophrenia,atp binding cassette subfamily b member 1
quetiapine,schizophrenia,dopamine receptor d4
quetiapine,schizophrenia,5-hydroxytryptamine receptor 1d
quetiapine,schizophrenia,cholinergic receptor muscarinic 2
quetiapine,schizophrenia,h1.0 linker histone
quetiapine,schizophrenia,5-hydroxytryptamine receptor 2c
quetiapine,schizophrenia,5-hydroxytryptamine receptor 6
quetiapine,schizophrenia,dopamine receptor d1
quetiapine,schizophrenia,5-hydroxytryptamine receptor 1f
quetiapine,schizophrenia,tachykinin precursor 1
quetiapine,schizophrenia,solute carrier family 6 member 4
quetiapine,schizophrenia,potassium voltage-gated channel subfamily h member 2
lurasidone,schizophrenia,5-hydroxytryptamine receptor 1a
lurasidone,schizophrenia,adrenoceptor alpha 2a
lurasidone,schizophrenia,5-hydroxytryptamine receptor 7
lurasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
lurasidone,schizophrenia,dopamine receptor d4
spiperone,schizophrenia,"major histocompatibility complex, class i, a"
spiperone,schizophrenia,cholinergic receptor muscarinic 2
spiperone,schizophrenia,adrenoceptor alpha 1b
spiperone,schizophrenia,dopamine receptor d5
spiperone,schizophrenia,dopamine receptor d1
spiperone,schizophrenia,5-hydroxytryptamine receptor 6
spiperone,schizophrenia,dopamine receptor d2
spiperone,schizophrenia,5-hydroxytryptamine receptor 5a
spiperone,schizophrenia,5-hydroxytryptamine receptor 1a
spiperone,schizophrenia,5-hydroxytryptamine receptor 1b
spiperone,schizophrenia,adrenoceptor alpha 1a
spiperone,schizophrenia,5-hydroxytryptamine receptor 7
spiperone,schizophrenia,dopamine receptor d4
spiperone,schizophrenia,histamine receptor h1
spiperone,schizophrenia,5-hydroxytryptamine receptor 2c
spiperone,schizophrenia,5-hydroxytryptamine receptor 1f
spiperone,schizophrenia,dopamine receptor d3
spiperone,schizophrenia,adrenoceptor alpha 2a
spiperone,schizophrenia,sigma non-opioid intracellular receptor 1
spiperone,schizophrenia,5-hydroxytryptamine receptor 1d
spiperone,schizophrenia,5-hydroxytryptamine receptor 2a
spiperone,schizophrenia,5-hydroxytryptamine receptor 1e
spiperone,schizophrenia,adrenoceptor alpha 1d
sulpiride,schizophrenia,carbonic anhydrase 2
sulpiride,schizophrenia,dopamine receptor d4
loxapine,schizophrenia,5-hydroxytryptamine receptor 1e
loxapine,schizophrenia,5-hydroxytryptamine receptor 5a
loxapine,schizophrenia,5-hydroxytryptamine receptor 1a
loxapine,schizophrenia,cholinergic receptor muscarinic 5
loxapine,schizophrenia,dopamine receptor d4
loxapine,schizophrenia,histamine receptor h2
loxapine,schizophrenia,dopamine receptor d5
loxapine,schizophrenia,dopamine receptor d1
loxapine,schizophrenia,adrenoceptor alpha 2a
loxapine,schizophrenia,5-hydroxytryptamine receptor 2c
loxapine,schizophrenia,cholinergic receptor muscarinic 1
loxapine,schizophrenia,adrenoceptor alpha 1a
loxapine,schizophrenia,cholinergic receptor muscarinic 2
loxapine,schizophrenia,5-hydroxytryptamine receptor 7
loxapine,schizophrenia,5-hydroxytryptamine receptor 1d
loxapine,schizophrenia,histamine receptor h1
loxapine,schizophrenia,adrenoceptor alpha 1b
loxapine,schizophrenia,5-hydroxytryptamine receptor 3a
loxapine,schizophrenia,5-hydroxytryptamine receptor 6
loxapine,schizophrenia,5-hydroxytryptamine receptor 1b
loxapine,schizophrenia,cholinergic receptor muscarinic 4
loxapine,schizophrenia,solute carrier family 6 member 2
loxapine,schizophrenia,dopamine receptor d3
loxapine,schizophrenia,solute carrier family 6 member 4
loxapine,schizophrenia,solute carrier family 6 member 3
olanzapine,schizophrenia,5-hydroxytryptamine receptor 3a
olanzapine,schizophrenia,adrenoceptor alpha 1b
olanzapine,schizophrenia,5-hydroxytryptamine receptor 6
olanzapine,schizophrenia,cholinergic receptor muscarinic 5
olanzapine,schizophrenia,dopamine receptor d3
olanzapine,schizophrenia,cholinergic receptor muscarinic 1
olanzapine,schizophrenia,5-hydroxytryptamine receptor 7
olanzapine,schizophrenia,dopamine receptor d4
olanzapine,schizophrenia,atp binding cassette subfamily b member 1
olanzapine,schizophrenia,5-hydroxytryptamine receptor 1b
olanzapine,schizophrenia,5-hydroxytryptamine receptor 1a
olanzapine,schizophrenia,dopamine receptor d1
olanzapine,schizophrenia,cholinergic receptor muscarinic 4
olanzapine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
olanzapine,schizophrenia,5-hydroxytryptamine receptor 1e
olanzapine,schizophrenia,histamine receptor h1
olanzapine,schizophrenia,h1.0 linker histone
olanzapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
olanzapine,schizophrenia,5-hydroxytryptamine receptor 2a
olanzapine,schizophrenia,5-hydroxytryptamine receptor 5a
olanzapine,schizophrenia,5-hydroxytryptamine receptor 2c
olanzapine,schizophrenia,histamine receptor h2
olanzapine,schizophrenia,dopamine receptor d5
olanzapine,schizophrenia,adrenoceptor alpha 1a
olanzapine,schizophrenia,5-hydroxytryptamine receptor 1d
olanzapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
olanzapine,schizophrenia,cholinergic receptor muscarinic 2
olanzapine,schizophrenia,adrenoceptor alpha 2a
perphenazine,schizophrenia,5-hydroxytryptamine receptor 1a
perphenazine,schizophrenia,dopamine receptor d1
perphenazine,schizophrenia,5-hydroxytryptamine receptor 2c
perphenazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
perphenazine,schizophrenia,histamine receptor h1
perphenazine,schizophrenia,calmodulin 1
perphenazine,schizophrenia,5-hydroxytryptamine receptor 2a
perphenazine,schizophrenia,5-hydroxytryptamine receptor 6
perphenazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
perphenazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
perphenazine,schizophrenia,5-hydroxytryptamine receptor 7
perphenazine,schizophrenia,adrenoceptor alpha 2a
perphenazine,schizophrenia,adrenoceptor alpha 1a
perphenazine,schizophrenia,cholinergic receptor muscarinic 2
perphenazine,schizophrenia,dopamine receptor d3
perphenazine,schizophrenia,dopamine receptor d4
promazine,schizophrenia,dopamine receptor d4
promazine,schizophrenia,adrenoceptor alpha 1a
promazine,schizophrenia,adrenoceptor alpha 1b
promazine,schizophrenia,5-hydroxytryptamine receptor 2c
promazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
promazine,schizophrenia,cholinergic receptor muscarinic 5
promazine,schizophrenia,adrenoceptor alpha 2a
promazine,schizophrenia,5-hydroxytryptamine receptor 2a
promazine,schizophrenia,dopamine receptor d2
promazine,schizophrenia,cholinergic receptor muscarinic 1
promazine,schizophrenia,adrenoceptor alpha 1d
promazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
promazine,schizophrenia,cholinergic receptor muscarinic 4
promazine,schizophrenia,dopamine receptor d1
promazine,schizophrenia,histamine receptor h1
promazine,schizophrenia,cholinergic receptor muscarinic 2
promazine,schizophrenia,dopamine receptor d3
betamethasone,skin disorder,prostaglandin-endoperoxide synthase 2
prednisolone,skin disorder,serpin family a member 6
prednisone,skin disorder,nuclear receptor subfamily 3 group c member 1
prednisone,skin disorder,albumin
triamcinolone,skin disorder,prostaglandin-endoperoxide synthase 2
triamcinolone,skin disorder,serpin family a member 6
lovastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
simvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
rosuvastatin,stroke disorder,albumin
ramipril,stroke disorder,angiotensin i converting enzyme
fluvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
telmisartan,stroke disorder,angiotensin i converting enzyme
nimodipine,subarachnoid hemorrhage,calcium voltage-gated channel subunit alpha1 c
mesalazine,ulcerative colitis,myeloperoxidase
sulfasalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 1
sulfasalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 2
sulfasalazine,ulcerative colitis,peroxisome proliferator activated receptor gamma
prednisolone,ulcerative colitis,atp binding cassette subfamily b member 1
prednisolone,ulcerative colitis,serpin family a member 6
cortisol,ulcerative colitis,atp binding cassette subfamily b member 1
cortisol,ulcerative colitis,sex hormone binding globulin
cortisol,ulcerative colitis,serpin family a member 6
aminosalicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 1
aminosalicylic acid,ulcerative colitis,phospholipase a2 group iie
aminosalicylic acid,ulcerative colitis,myeloperoxidase
aminosalicylic acid,ulcerative colitis,arachidonate 5-lipoxygenase
aminosalicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 2
balsalazide,ulcerative colitis,peroxisome proliferator activated receptor gamma
balsalazide,ulcerative colitis,arachidonate 5-lipoxygenase
balsalazide,ulcerative colitis,prostaglandin-endoperoxide synthase 1
balsalazide,ulcerative colitis,prostaglandin-endoperoxide synthase 2
tofacitinib,ulcerative colitis,doublecortin like kinase 3
tofacitinib,ulcerative colitis,ribosomal protein s6 kinase a2
tofacitinib,ulcerative colitis,janus kinase 3
tofacitinib,ulcerative colitis,calcium/calmodulin dependent protein kinase ii alpha
tofacitinib,ulcerative colitis,janus kinase 1
tofacitinib,ulcerative colitis,ribosomal protein s6 kinase a6
tofacitinib,ulcerative colitis,tyrosine kinase 2
tofacitinib,ulcerative colitis,bmp2 inducible kinase
tofacitinib,ulcerative colitis,janus kinase 2
salicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 1
salicylic acid,ulcerative colitis,albumin
salicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 2
salicylic acid,ulcerative colitis,atp binding cassette subfamily b member 1
hydroxyurea,melanoma,ribonucleotide reductase regulatory subunit m2
darunavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 43
zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
zalcitabine,hiv infectious disease,cyp3a7-cyp3a51p readthrough
zalcitabine,hiv infectious disease,albumin
efavirenz,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
efavirenz,hiv infectious disease,cytochrome p450 family 46 subfamily a member 1
lopinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
delavirdine,hiv infectious disease,cyp3a7-cyp3a51p readthrough
delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
nevirapine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
nevirapine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
fosamprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
atazanavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
saquinavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
saquinavir,hiv infectious disease,albumin
saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
abacavir,hiv infectious disease,albumin
zidovudine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
zidovudine,hiv infectious disease,albumin
amprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
amprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
nelfinavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
tipranavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
lamivudine,hiv infectious disease,albumin
emtricitabine,hiv infectious disease,albumin
raltegravir,hiv infectious disease,c-c motif chemokine receptor 1
ritonavir,hiv infectious disease,solute carrier family 47 member 1
ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
ritonavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
pemetrexed,malignant pleural mesothelioma,dihydrofolate reductase
pemetrexed,malignant pleural mesothelioma,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
pemetrexed,malignant pleural mesothelioma,solute carrier family 46 member 1
pemetrexed,malignant pleural mesothelioma,thymidylate synthetase
dapsone,leprosy,myeloperoxidase
danazol,endometriosis,estrogen receptor 1
danazol,endometriosis,progesterone receptor
danazol,endometriosis,cytochrome p450 family 19 subfamily a member 1
danazol,endometriosis,sex hormone binding globulin
progesterone,endometriosis,androgen receptor
progesterone,endometriosis,nuclear receptor subfamily 3 group c member 2
progesterone,endometriosis,sex hormone binding globulin
progesterone,endometriosis,nuclear receptor subfamily 3 group c member 1
progesterone,endometriosis,estrogen receptor 1
progesterone,endometriosis,serpin family a member 6
medroxyprogesterone,endometriosis,aldo-keto reductase family 1 member c3
medroxyprogesterone,endometriosis,nuclear receptor subfamily 3 group c member 1
medroxyprogesterone,endometriosis,sex hormone binding globulin
medroxyprogesterone,endometriosis,estrogen receptor 1
medroxyprogesterone,endometriosis,androgen receptor
norethisterone,endometriosis,sex hormone binding globulin
levonorgestrel,endometriosis,steroid 5 alpha-reductase 1
levonorgestrel,endometriosis,cytochrome p450 family 19 subfamily a member 1
levonorgestrel,endometriosis,androgen receptor
levonorgestrel,endometriosis,progesterone receptor
levonorgestrel,endometriosis,sex hormone binding globulin
levonorgestrel,endometriosis,estrogen receptor 1
mestranol,endometriosis,estrogen receptor 1
quinine,malaria,cytochrome p450 family 2 subfamily d member 6
quinine,malaria,sodium voltage-gated channel alpha subunit 3
quinine,malaria,sodium voltage-gated channel alpha subunit 1
quinine,malaria,sodium voltage-gated channel alpha subunit 5
quinine,malaria,sodium voltage-gated channel alpha subunit 2
pyrimethamine,malaria,dihydrofolate reductase
pyrimethamine,malaria,cytochrome p450 family 2 subfamily d member 6
citalopram,post-traumatic stress disorder,solute carrier family 6 member 4
fluoxetine,post-traumatic stress disorder,solute carrier family 6 member 4
escitalopram,post-traumatic stress disorder,solute carrier family 6 member 4
venlafaxine,post-traumatic stress disorder,solute carrier family 6 member 4
fluvoxamine,post-traumatic stress disorder,solute carrier family 6 member 4
mirtazapine,post-traumatic stress disorder,solute carrier family 6 member 4
amitriptyline,post-traumatic stress disorder,solute carrier family 6 member 4
dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 4
dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 1
dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 11
dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 2
glimepiride,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
nateglinide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
nateglinide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
nateglinide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
nateglinide,type 2 diabetes mellitus,albumin
sitagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
troglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
alogliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
acarbose,type 2 diabetes mellitus,amylase alpha 1c
acarbose,type 2 diabetes mellitus,alpha glucosidase
acarbose,type 2 diabetes mellitus,amylase alpha 1b
acarbose,type 2 diabetes mellitus,sucrase-isomaltase
acarbose,type 2 diabetes mellitus,amylase alpha 1a
pioglitazone,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
pioglitazone,type 2 diabetes mellitus,cdgsh iron sulfur domain 1
canagliflozin,type 2 diabetes mellitus,albumin
canagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
canagliflozin,type 2 diabetes mellitus,atp binding cassette subfamily c member 2
canagliflozin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
glibenclamide,type 2 diabetes mellitus,albumin
glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 2
glibenclamide,type 2 diabetes mellitus,carnitine palmitoyltransferase 1a
glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily b member 11
glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
glibenclamide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
glibenclamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
glibenclamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
glibenclamide,type 2 diabetes mellitus,cdgsh iron sulfur domain 1
glibenclamide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
linagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase complex assembly factor 3
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a10
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s3
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase complex assembly factor 2
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit v1
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a12
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b9
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit s5
metformin,type 2 diabetes mellitus,solute carrier family 22 member 3
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit s4
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit ab1
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit c2
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b10
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a6
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a7
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a13
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s7
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase complex assembly factor 4
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit v2
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase complex assembly factor 1
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b2
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit v3
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a9
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s1
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b4
metformin,type 2 diabetes mellitus,ndufa4 mitochondrial complex associated like 2
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a11
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b3
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a8
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b8
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit s6
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s8
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a1
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a2
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b1
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit c1
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a5
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b6
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b7
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit a3
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b5
metformin,type 2 diabetes mellitus,ndufa4 mitochondrial complex associated
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase core subunit s2
metformin,type 2 diabetes mellitus,nadh:ubiquinone oxidoreductase subunit b11
tolazamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
glipizide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
glipizide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 4
dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 11
dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
dapagliflozin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
dapagliflozin,type 2 diabetes mellitus,cytochrome p450 family 1 subfamily a member 2
saxagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 8
saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 9
chlorpropamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
chlorpropamide,type 2 diabetes mellitus,albumin
tolbutamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
tolbutamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
tolbutamide,type 2 diabetes mellitus,albumin
glymidine,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
diclofenac,actinic keratosis,c-x-c motif chemokine receptor 1
diclofenac,actinic keratosis,c-x-c motif chemokine ligand 8
masoprocol,actinic keratosis,leukotriene b4 receptor
meclofenamic acid,osteoarthritis,arachidonate 5-lipoxygenase
meclofenamic acid,osteoarthritis,aldo-keto reductase family 1 member c3
tolmetin,osteoarthritis,c-x-c motif chemokine ligand 8
lumiracoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
lumiracoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
celecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
diclofenac,osteoarthritis,c-x-c motif chemokine receptor 1
diclofenac,osteoarthritis,arachidonate 5-lipoxygenase
diclofenac,osteoarthritis,c-x-c motif chemokine ligand 8
duloxetine,osteoarthritis,solute carrier family 6 member 4
duloxetine,osteoarthritis,solute carrier family 6 member 2
duloxetine,osteoarthritis,histamine receptor h1
nabumetone,osteoarthritis,prostaglandin-endoperoxide synthase 1
nabumetone,osteoarthritis,prostaglandin-endoperoxide synthase 2
ketoprofen,osteoarthritis,c-x-c motif chemokine ligand 8
ketoprofen,osteoarthritis,c-x-c motif chemokine receptor 1
ketoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
ketoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
histamine,osteoarthritis,histamine receptor h4
histamine,osteoarthritis,histamine receptor h1
indomethacin,osteoarthritis,c-x-c motif chemokine ligand 8
indomethacin,osteoarthritis,peroxisome proliferator activated receptor gamma
indomethacin,osteoarthritis,aldo-keto reductase family 1 member c3
salicylic acid,osteoarthritis,aldo-keto reductase family 1 member c1
rofecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
ibuprofen,osteoarthritis,c-x-c motif chemokine ligand 8
ibuprofen,osteoarthritis,peroxisome proliferator activated receptor gamma
aspirin,osteoarthritis,heat shock protein family a (hsp70) member 5
aspirin,osteoarthritis,aldo-keto reductase family 1 member c1
naproxen,osteoarthritis,aldo-keto reductase family 1 member c3
meloxicam,osteoarthritis,prostaglandin-endoperoxide synthase 1
valdecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
valdecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
pimavanserin,parkinson disease,5-hydroxytryptamine receptor 2a
levodopa,parkinson disease,dopa decarboxylase
levodopa,parkinson disease,dopamine receptor d2
levodopa,parkinson disease,dopamine receptor d5
levodopa,parkinson disease,dopamine receptor d1
levodopa,parkinson disease,cytochrome p450 family 2 subfamily d member 6
levodopa,parkinson disease,dopamine receptor d4
levodopa,parkinson disease,dopamine receptor d3
amantadine,parkinson disease,dopa decarboxylase
amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2b
amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 3b
amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2c
amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2a
amantadine,parkinson disease,monoamine oxidase b
amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 1
amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2d
amantadine,parkinson disease,atp binding cassette subfamily b member 1
amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 3a
pramipexole,parkinson disease,adrenoceptor alpha 2b
pramipexole,parkinson disease,dopamine receptor d5
pramipexole,parkinson disease,5-hydroxytryptamine receptor 1a
pramipexole,parkinson disease,dopamine receptor d1
pramipexole,parkinson disease,adrenoceptor alpha 2a
pramipexole,parkinson disease,5-hydroxytryptamine receptor 2a
pramipexole,parkinson disease,adrenoceptor alpha 2c
pramipexole,parkinson disease,5-hydroxytryptamine receptor 7
benzatropine,parkinson disease,cytochrome p450 family 2 subfamily d member 6
benzatropine,parkinson disease,cholinergic receptor muscarinic 2
rasagiline,parkinson disease,5-hydroxytryptamine receptor 6
rasagiline,parkinson disease,monoamine oxidase a
bromocriptine,parkinson disease,5-hydroxytryptamine receptor 6
bromocriptine,parkinson disease,5-hydroxytryptamine receptor 1a
bromocriptine,parkinson disease,dopamine receptor d1
bromocriptine,parkinson disease,adrenoceptor alpha 2a
bromocriptine,parkinson disease,dopamine receptor d4
bromocriptine,parkinson disease,adrenoceptor alpha 1b
bromocriptine,parkinson disease,atp binding cassette subfamily b member 1
bromocriptine,parkinson disease,adrenoceptor alpha 1d
bromocriptine,parkinson disease,adrenoceptor alpha 1a
bromocriptine,parkinson disease,dopamine receptor d5
bromocriptine,parkinson disease,adrenoceptor alpha 2b
bromocriptine,parkinson disease,5-hydroxytryptamine receptor 7
bromocriptine,parkinson disease,5-hydroxytryptamine receptor 2a
bromocriptine,parkinson disease,adrenoceptor beta 1
bromocriptine,parkinson disease,adrenoceptor alpha 2c
bromocriptine,parkinson disease,adrenoceptor beta 2
apomorphine,parkinson disease,adrenoceptor alpha 2c
apomorphine,parkinson disease,adrenoceptor alpha 2a
apomorphine,parkinson disease,adrenoceptor alpha 2b
apomorphine,parkinson disease,adrenoceptor alpha 1d
apomorphine,parkinson disease,dopamine receptor d5
apomorphine,parkinson disease,5-hydroxytryptamine receptor 2a
apomorphine,parkinson disease,dopamine receptor d1
apomorphine,parkinson disease,5-hydroxytryptamine receptor 1a
apomorphine,parkinson disease,adrenoceptor alpha 1b
apomorphine,parkinson disease,adrenoceptor alpha 1a
droxidopa,parkinson disease,adrenoceptor alpha 2b
droxidopa,parkinson disease,adrenoceptor beta 3
droxidopa,parkinson disease,adrenoceptor beta 2
droxidopa,parkinson disease,adrenoceptor alpha 1d
droxidopa,parkinson disease,adrenoceptor alpha 1b
droxidopa,parkinson disease,adrenoceptor alpha 2a
droxidopa,parkinson disease,adrenoceptor alpha 1a
droxidopa,parkinson disease,adrenoceptor beta 1
droxidopa,parkinson disease,dopa decarboxylase
droxidopa,parkinson disease,adrenoceptor alpha 2c
carbidopa,parkinson disease,dopa decarboxylase
selegiline,parkinson disease,atp binding cassette subfamily b member 1
selegiline,parkinson disease,cytochrome p450 family 2 subfamily e member 1
selegiline,parkinson disease,cytochrome p450 family 2 subfamily d member 6
procyclidine,parkinson disease,cholinergic receptor muscarinic 2
procyclidine,parkinson disease,cholinergic receptor muscarinic 4
procyclidine,parkinson disease,cholinergic receptor muscarinic 1
ropinirole,parkinson disease,dopamine receptor d1
ropinirole,parkinson disease,cytochrome p450 family 2 subfamily d member 6
ropinirole,parkinson disease,dopamine receptor d4
ropinirole,parkinson disease,adrenoceptor alpha 2a
ropinirole,parkinson disease,5-hydroxytryptamine receptor 2a
ropinirole,parkinson disease,adrenoceptor alpha 2c
ropinirole,parkinson disease,5-hydroxytryptamine receptor 1a
ropinirole,parkinson disease,dopamine receptor d5
ropinirole,parkinson disease,adrenoceptor alpha 2b
ropinirole,parkinson disease,5-hydroxytryptamine receptor 7
biperiden,parkinson disease,atp binding cassette subfamily b member 1
biperiden,parkinson disease,cholinergic receptor muscarinic 2
biperiden,parkinson disease,cytochrome p450 family 2 subfamily d member 6
biperiden,parkinson disease,cholinergic receptor muscarinic 4
dabrafenib,metastatic melanoma,salt inducible kinase 1
dabrafenib,metastatic melanoma,"fyn proto-oncogene, src family tyrosine kinase"
dabrafenib,metastatic melanoma,cyclin dependent kinase 6
vincristine,rhabdomyosarcoma,tubulin beta 8 class viii
vincristine,rhabdomyosarcoma,tubulin beta 3 class iii
vincristine,rhabdomyosarcoma,tubulin beta 1 class vi
vincristine,rhabdomyosarcoma,tubulin beta 4a class iva
vincristine,rhabdomyosarcoma,tubulin beta 2a class iia
vincristine,rhabdomyosarcoma,tubulin beta 2b class iib
vincristine,rhabdomyosarcoma,tubulin beta 4b class ivb
vincristine,rhabdomyosarcoma,tubulin beta 6 class v
danazol,breast fibrocystic disease,androgen receptor
danazol,breast fibrocystic disease,progesterone receptor
danazol,breast fibrocystic disease,sex hormone binding globulin
danazol,breast fibrocystic disease,gonadotropin releasing hormone receptor
etoposide,non-small cell lung carcinoma,glutathione s-transferase pi 1
etoposide,non-small cell lung carcinoma,cytochrome p450 family 2 subfamily e member 1
etoposide,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
vinblastine,non-small cell lung carcinoma,tubulin beta 4a class iva
vinblastine,non-small cell lung carcinoma,tubulin beta 1 class vi
vinblastine,non-small cell lung carcinoma,tubulin beta 8 class viii
vinblastine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
vinblastine,non-small cell lung carcinoma,tubulin beta 2b class iib
vinblastine,non-small cell lung carcinoma,tubulin beta 4b class ivb
vinblastine,non-small cell lung carcinoma,tubulin beta class i
vinblastine,non-small cell lung carcinoma,tubulin beta 2a class iia
vinblastine,non-small cell lung carcinoma,tubulin beta 3 class iii
vinblastine,non-small cell lung carcinoma,tubulin beta 6 class v
carboplatin,non-small cell lung carcinoma,nad(p)h quinone dehydrogenase 1
carboplatin,non-small cell lung carcinoma,glutathione s-transferase pi 1
gemcitabine,non-small cell lung carcinoma,ribonucleotide reductase regulatory subunit m2
gemcitabine,non-small cell lung carcinoma,ribonucleotide reductase catalytic subunit m1
gemcitabine,non-small cell lung carcinoma,"dna polymerase epsilon, catalytic subunit"
gemcitabine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
gemcitabine,non-small cell lung carcinoma,"dna polymerase delta 1, catalytic subunit"
gemcitabine,non-small cell lung carcinoma,cytidine/uridine monophosphate kinase 1
gemcitabine,non-small cell lung carcinoma,"dna polymerase alpha 1, catalytic subunit"
gemcitabine,non-small cell lung carcinoma,thymidylate synthetase
ifosfamide,non-small cell lung carcinoma,cytochrome p450 family 2 subfamily a member 6
gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
gefitinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
gefitinib,non-small cell lung carcinoma,serine/threonine kinase 10
gefitinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
gefitinib,non-small cell lung carcinoma,ste20 like kinase
gefitinib,non-small cell lung carcinoma,nuak family kinase 2
gefitinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
gefitinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
gefitinib,non-small cell lung carcinoma,eph receptor b6
gefitinib,non-small cell lung carcinoma,cyclin g associated kinase
gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
gefitinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
gefitinib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
gefitinib,non-small cell lung carcinoma,erb-b2 receptor tyrosine kinase 2
docetaxel,non-small cell lung carcinoma,epidermal growth factor receptor
docetaxel,non-small cell lung carcinoma,tubulin beta 6 class v
docetaxel,non-small cell lung carcinoma,tubulin beta 2b class iib
docetaxel,non-small cell lung carcinoma,tubulin beta 2a class iia
docetaxel,non-small cell lung carcinoma,tubulin beta class i
docetaxel,non-small cell lung carcinoma,tubulin beta 3 class iii
docetaxel,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
docetaxel,non-small cell lung carcinoma,tubulin beta 4a class iva
docetaxel,non-small cell lung carcinoma,tubulin beta 4b class ivb
docetaxel,non-small cell lung carcinoma,tubulin beta 8 class viii
paclitaxel,non-small cell lung carcinoma,tubulin beta 2b class iib
paclitaxel,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
paclitaxel,non-small cell lung carcinoma,tubulin beta 6 class v
paclitaxel,non-small cell lung carcinoma,tubulin beta class i
paclitaxel,non-small cell lung carcinoma,tubulin beta 3 class iii
paclitaxel,non-small cell lung carcinoma,tubulin beta 8 class viii
paclitaxel,non-small cell lung carcinoma,tubulin beta 4a class iva
paclitaxel,non-small cell lung carcinoma,tubulin beta 2a class iia
paclitaxel,non-small cell lung carcinoma,tubulin beta 4b class ivb
pemetrexed,non-small cell lung carcinoma,solute carrier family 46 member 1
irinotecan,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
irinotecan,non-small cell lung carcinoma,dna topoisomerase i
ceritinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
ceritinib,non-small cell lung carcinoma,protein tyrosine kinase 2
ceritinib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
ceritinib,non-small cell lung carcinoma,cdc like kinase 1
ceritinib,non-small cell lung carcinoma,fer tyrosine kinase
ceritinib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
ceritinib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
ceritinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
vinorelbine,non-small cell lung carcinoma,tubulin beta 2b class iib
vinorelbine,non-small cell lung carcinoma,tubulin beta 6 class v
vinorelbine,non-small cell lung carcinoma,tubulin beta 1 class vi
vinorelbine,non-small cell lung carcinoma,tubulin beta 2a class iia
vinorelbine,non-small cell lung carcinoma,tubulin beta 4a class iva
vinorelbine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
vinorelbine,non-small cell lung carcinoma,tubulin beta class i
vinorelbine,non-small cell lung carcinoma,tubulin beta 4b class ivb
vinorelbine,non-small cell lung carcinoma,tubulin beta 8 class viii
vinorelbine,non-small cell lung carcinoma,tubulin beta 3 class iii
mitomycin c,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
sotorasib,non-small cell lung carcinoma,"kras proto-oncogene, gtpase"
nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
nintedanib,non-small cell lung carcinoma,alk receptor tyrosine kinase
nintedanib,non-small cell lung carcinoma,fibroblast growth factor receptor 3
nintedanib,non-small cell lung carcinoma,kinase insert domain receptor
nintedanib,non-small cell lung carcinoma,cdc like kinase 1
nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 3
nintedanib,non-small cell lung carcinoma,axl receptor tyrosine kinase
nintedanib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 1
nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 1
nintedanib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
nintedanib,non-small cell lung carcinoma,nuak family kinase 2
nintedanib,non-small cell lung carcinoma,insulin receptor related receptor
nintedanib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
nintedanib,non-small cell lung carcinoma,cyclin dependent kinase 16
nintedanib,non-small cell lung carcinoma,eph receptor b6
nintedanib,non-small cell lung carcinoma,serine/threonine kinase 16
nintedanib,non-small cell lung carcinoma,rio kinase 1
nintedanib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
nintedanib,non-small cell lung carcinoma,ste20 like kinase
nintedanib,non-small cell lung carcinoma,platelet derived growth factor receptor beta
nintedanib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
nintedanib,non-small cell lung carcinoma,maternal embryonic leucine zipper kinase
nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 2
nintedanib,non-small cell lung carcinoma,cdc like kinase 4
nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
nintedanib,non-small cell lung carcinoma,serine/threonine kinase 11
nintedanib,non-small cell lung carcinoma,srsf protein kinase 3
nintedanib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
nintedanib,non-small cell lung carcinoma,testis specific serine kinase 1b
nintedanib,non-small cell lung carcinoma,ttk protein kinase
nintedanib,non-small cell lung carcinoma,platelet derived growth factor receptor alpha
nintedanib,non-small cell lung carcinoma,serine/threonine kinase 4
nintedanib,non-small cell lung carcinoma,protein kinase cgmp-dependent 1
nintedanib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
nintedanib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
nintedanib,non-small cell lung carcinoma,bmp2 inducible kinase
nintedanib,non-small cell lung carcinoma,ret proto-oncogene
nintedanib,non-small cell lung carcinoma,pre-mrna processing factor kinase prp4k
nintedanib,non-small cell lung carcinoma,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
nintedanib,non-small cell lung carcinoma,protein tyrosine kinase 2
nintedanib,non-small cell lung carcinoma,serine/threonine kinase 10
nintedanib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
nintedanib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
nintedanib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 7
nintedanib,non-small cell lung carcinoma,fibroblast growth factor receptor 1
nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
nintedanib,non-small cell lung carcinoma,fer tyrosine kinase
nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
nintedanib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
nintedanib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
crizotinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
crizotinib,non-small cell lung carcinoma,serine/threonine kinase 4
crizotinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
crizotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
crizotinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
crizotinib,non-small cell lung carcinoma,ste20 like kinase
crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 1
crizotinib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
crizotinib,non-small cell lung carcinoma,serine/threonine kinase 10
crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
crizotinib,non-small cell lung carcinoma,insulin receptor related receptor
crizotinib,non-small cell lung carcinoma,bmp2 inducible kinase
crizotinib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
crizotinib,non-small cell lung carcinoma,fer tyrosine kinase
crizotinib,non-small cell lung carcinoma,nuak family kinase 2
crizotinib,non-small cell lung carcinoma,eph receptor b6
crizotinib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
crizotinib,non-small cell lung carcinoma,protein tyrosine kinase 2
crizotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
crizotinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
crizotinib,non-small cell lung carcinoma,srsf protein kinase 3
crizotinib,non-small cell lung carcinoma,ret proto-oncogene
crizotinib,non-small cell lung carcinoma,fibroblast growth factor receptor 3
crizotinib,non-small cell lung carcinoma,epidermal growth factor receptor
crizotinib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
crizotinib,non-small cell lung carcinoma,rio kinase 1
crizotinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 3
crizotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
crizotinib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
crizotinib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
crizotinib,non-small cell lung carcinoma,macrophage stimulating 1 receptor
crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 7
lorlatinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
lorlatinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
lorlatinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
alectinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
alectinib,non-small cell lung carcinoma,acyl-coa oxidase 1
alectinib,non-small cell lung carcinoma,cyclin g associated kinase
alectinib,non-small cell lung carcinoma,fer tyrosine kinase
alectinib,non-small cell lung carcinoma,cdc like kinase 1
erlotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
erlotinib,non-small cell lung carcinoma,serine/threonine kinase 10
erlotinib,non-small cell lung carcinoma,ste20 like kinase
erlotinib,non-small cell lung carcinoma,solute carrier organic anion transporter family member 2b1
erlotinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
erlotinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
erlotinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
erlotinib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
erlotinib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
erlotinib,non-small cell lung carcinoma,platelet derived growth factor receptor beta
erlotinib,non-small cell lung carcinoma,ttk protein kinase
erlotinib,non-small cell lung carcinoma,cyclin g associated kinase
erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
erlotinib,non-small cell lung carcinoma,erb-b2 receptor tyrosine kinase 2
erlotinib,non-small cell lung carcinoma,fibroblast growth factor receptor 2
erlotinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
erlotinib,non-small cell lung carcinoma,ret proto-oncogene
erlotinib,non-small cell lung carcinoma,eph receptor b6
erlotinib,non-small cell lung carcinoma,platelet derived growth factor receptor alpha
erlotinib,non-small cell lung carcinoma,bmp2 inducible kinase
erlotinib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
erlotinib,non-small cell lung carcinoma,srsf protein kinase 3
erlotinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
erlotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 4
erlotinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
erlotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
erlotinib,non-small cell lung carcinoma,kinase insert domain receptor
cefmetazole,pneumonia,albumin
minocycline,pneumonia,caspase 1
minocycline,pneumonia,interleukin 1 beta
cefalotin,pneumonia,albumin
tetracycline,pneumonia,albumin
ofloxacin,pneumonia,albumin
cefonicid,pneumonia,albumin
aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1d
aripiprazole,autism spectrum disorder,dopamine receptor d3
aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1a
aripiprazole,autism spectrum disorder,dopamine receptor d1
aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 3a
aripiprazole,autism spectrum disorder,cholinergic receptor muscarinic 4
aripiprazole,autism spectrum disorder,solute carrier family 6 member 4
aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1b
aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 2a
aripiprazole,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
aripiprazole,autism spectrum disorder,dopamine receptor d2
aripiprazole,autism spectrum disorder,adrenoceptor beta 2
aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 5a
risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1b
risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1d
risperidone,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
risperidone,autism spectrum disorder,dopamine receptor d1
risperidone,autism spectrum disorder,dopamine receptor d3
risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1a
risperidone,autism spectrum disorder,solute carrier family 6 member 4
risperidone,autism spectrum disorder,cholinergic receptor muscarinic 4
risperidone,autism spectrum disorder,neutrophil cytosolic factor 1
risperidone,autism spectrum disorder,adrenoceptor beta 2
paliperidone,autism spectrum disorder,dopamine receptor d2
paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1d
paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1a
paliperidone,autism spectrum disorder,dopamine receptor d3
paliperidone,autism spectrum disorder,dopamine receptor d1
paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 2a
paliperidone,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1b
paliperidone,autism spectrum disorder,adrenoceptor beta 2
triamcinolone,inflammatory bowel disease,prostaglandin-endoperoxide synthase 2
triamcinolone,inflammatory bowel disease,serpin family a member 6
betamethasone,inflammatory bowel disease,prostaglandin-endoperoxide synthase 2
betamethasone,inflammatory bowel disease,atp binding cassette subfamily b member 1
cortisol,inflammatory bowel disease,atp binding cassette subfamily b member 1
cortisol,inflammatory bowel disease,sex hormone binding globulin
cortisol,inflammatory bowel disease,serpin family a member 6
prednisone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
prednisone,inflammatory bowel disease,albumin
prednisone,inflammatory bowel disease,hydroxysteroid 11-beta dehydrogenase 1
prednisone,inflammatory bowel disease,atp binding cassette subfamily b member 1
methylprednisolone,inflammatory bowel disease,atp binding cassette subfamily b member 1
cromoglicic acid,inflammatory bowel disease,g protein-coupled receptor 35
prednisolone,inflammatory bowel disease,atp binding cassette subfamily b member 1
prednisolone,inflammatory bowel disease,serpin family a member 6
theophylline,lung disorder,adenosine a2a receptor
theophylline,lung disorder,adenosine a2b receptor
theophylline,lung disorder,phosphodiesterase 4a
theophylline,lung disorder,histone deacetylase 2
theophylline,lung disorder,phosphodiesterase 3a
theophylline,lung disorder,adenosine a1 receptor
theophylline,lung disorder,adenosine a3 receptor
phenazone,migraine disorder,prostaglandin-endoperoxide synthase 1
phenazone,migraine disorder,prostaglandin-endoperoxide synthase 2
butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha6
butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha2
butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha1
butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha4
butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit gamma2
butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha3
butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha5
naratriptan,migraine disorder,5-hydroxytryptamine receptor 1a
caffeine,migraine disorder,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"
caffeine,migraine disorder,phosphodiesterase 4b
caffeine,migraine disorder,adenosine a1 receptor
caffeine,migraine disorder,atm serine/threonine kinase
diphenhydramine,migraine disorder,prostaglandin-endoperoxide synthase 1
diphenhydramine,migraine disorder,solute carrier family 6 member 4
lisuride,migraine disorder,adrenoceptor alpha 2c
lisuride,migraine disorder,5-hydroxytryptamine receptor 1a
lisuride,migraine disorder,5-hydroxytryptamine receptor 2b
lisuride,migraine disorder,5-hydroxytryptamine receptor 2c
lisuride,migraine disorder,5-hydroxytryptamine receptor 1d
lisuride,migraine disorder,5-hydroxytryptamine receptor 2a
lisuride,migraine disorder,dopamine receptor d4
lisuride,migraine disorder,5-hydroxytryptamine receptor 1b
lisuride,migraine disorder,adrenoceptor alpha 1b
lisuride,migraine disorder,dopamine receptor d5
lisuride,migraine disorder,adrenoceptor alpha 2b
lisuride,migraine disorder,adrenoceptor alpha 2a
lisuride,migraine disorder,adrenoceptor alpha 1d
zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1a
paracetamol,migraine disorder,transient receptor potential cation channel subfamily v member 1
paracetamol,migraine disorder,cannabinoid receptor 1
rofecoxib,migraine disorder,prostaglandin-endoperoxide synthase 1
aspirin,migraine disorder,endothelin receptor type a
aspirin,migraine disorder,tumor protein p53
eletriptan,migraine disorder,5-hydroxytryptamine receptor 1e
eletriptan,migraine disorder,5-hydroxytryptamine receptor 2b
eletriptan,migraine disorder,5-hydroxytryptamine receptor 1f
eletriptan,migraine disorder,prostaglandin-endoperoxide synthase 1
eletriptan,migraine disorder,5-hydroxytryptamine receptor 7
ergotamine,migraine disorder,5-hydroxytryptamine receptor 2c
ergotamine,migraine disorder,5-hydroxytryptamine receptor 2a
ergotamine,migraine disorder,5-hydroxytryptamine receptor 2b
ergotamine,migraine disorder,5-hydroxytryptamine receptor 1e
ergotamine,migraine disorder,5-hydroxytryptamine receptor 1b
ergotamine,migraine disorder,5-hydroxytryptamine receptor 1f
ergotamine,migraine disorder,5-hydroxytryptamine receptor 1a
ergotamine,migraine disorder,5-hydroxytryptamine receptor 5a
rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1a
dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1a
dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 6
dihydroergotamine,migraine disorder,adrenoceptor alpha 2a
dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 2b
naproxen,migraine disorder,aldo-keto reductase family 1 member c3
olanzapine,migraine disorder,5-hydroxytryptamine receptor 3a
olanzapine,migraine disorder,adrenoceptor alpha 1b
olanzapine,migraine disorder,5-hydroxytryptamine receptor 6
olanzapine,migraine disorder,5-hydroxytryptamine receptor 7
olanzapine,migraine disorder,dopamine receptor d4
olanzapine,migraine disorder,5-hydroxytryptamine receptor 1b
olanzapine,migraine disorder,5-hydroxytryptamine receptor 1a
olanzapine,migraine disorder,5-hydroxytryptamine receptor 1e
olanzapine,migraine disorder,5-hydroxytryptamine receptor 2b
olanzapine,migraine disorder,adrenoceptor alpha 2b
olanzapine,migraine disorder,adrenoceptor alpha 2c
olanzapine,migraine disorder,5-hydroxytryptamine receptor 2a
olanzapine,migraine disorder,5-hydroxytryptamine receptor 5a
olanzapine,migraine disorder,5-hydroxytryptamine receptor 2c
olanzapine,migraine disorder,dopamine receptor d5
olanzapine,migraine disorder,adrenoceptor alpha 1a
olanzapine,migraine disorder,5-hydroxytryptamine receptor 1d
olanzapine,migraine disorder,adrenoceptor alpha 2a
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1f
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 3a
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1a
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 2c
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 2a
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 7
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1e
sumatriptan,migraine disorder,5-hydroxytryptamine receptor 6
prochlorperazine,migraine disorder,5-hydroxytryptamine receptor 2c
prochlorperazine,migraine disorder,adrenoceptor alpha 1a
prochlorperazine,migraine disorder,5-hydroxytryptamine receptor 1a
prochlorperazine,migraine disorder,adrenoceptor alpha 2a
prochlorperazine,migraine disorder,dopamine receptor d4
dabigatran etexilate,pulmonary embolism,"coagulation factor ii, thrombin"
rivaroxaban,pulmonary embolism,coagulation factor x
phentolamine,peripheral vascular disease,adrenoceptor alpha 2a
phentolamine,peripheral vascular disease,adrenoceptor alpha 2c
phentolamine,peripheral vascular disease,adrenoceptor alpha 2b
papaverine,peripheral vascular disease,phosphodiesterase 3b
papaverine,peripheral vascular disease,phosphodiesterase 3a
lidocaine,urethritis,sodium voltage-gated channel alpha subunit 2
lidocaine,urethritis,sodium voltage-gated channel alpha subunit 3
lidocaine,urethritis,sodium voltage-gated channel alpha subunit 4
ergocalciferol,osteoporosis,cytochrome p450 family 24 subfamily a member 1
ergocalciferol,osteoporosis,cytochrome p450 family 27 subfamily a member 1
ergocalciferol,osteoporosis,vitamin d receptor
benzocaine,osteoporosis,sodium voltage-gated channel alpha subunit 4
zoledronic acid,osteoporosis,carbonic anhydrase 2
dapagliflozin,chronic kidney disease,solute carrier family 5 member 4
dapagliflozin,chronic kidney disease,cytochrome p450 family 1 subfamily a member 1
dapagliflozin,chronic kidney disease,solute carrier family 5 member 11
dapagliflozin,chronic kidney disease,solute carrier family 5 member 2
dapagliflozin,chronic kidney disease,cytochrome p450 family 3 subfamily a member 4
dapagliflozin,chronic kidney disease,atp binding cassette subfamily b member 1
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 5
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 3
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 3
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 3
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 4
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 3
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 5
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 4
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 2
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily v member 2
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily b member 1
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 2
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 1
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 2
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 2
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 6
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 4
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 4
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 1
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 7
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 8
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 6
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 1
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 5
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 2
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily b member 2
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 4
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily f member 1
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 1
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily v member 1
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 10
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 3
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 1
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 3
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 7
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 1
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 2
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 3
fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 1
fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 2
prednisolone,multiple sclerosis,serpin family a member 6
triamcinolone,multiple sclerosis,butyrylcholinesterase
triamcinolone,multiple sclerosis,serpin family a member 6
prednisone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
prednisone,multiple sclerosis,albumin
betamethasone,multiple sclerosis,progesterone receptor
cortisol,multiple sclerosis,sex hormone binding globulin
cortisol,multiple sclerosis,serpin family a member 6
nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
nortriptyline,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
nortriptyline,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
nortriptyline,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
clonidine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
carbamazepine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
desipramine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
desipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
desipramine,"attention deficit hyperactivity disorder, inattentive type",sphingomyelin phosphodiesterase 1
desipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d1
desipramine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
amphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase b
amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
amphetamine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
atomoxetine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
atomoxetine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 1b
atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
imipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
imipramine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
imipramine,"attention deficit hyperactivity disorder, inattentive type",potassium voltage-gated channel subfamily d member 2
imipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d3
imipramine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
diclofenac,ankylosing spondylitis,c-x-c motif chemokine receptor 1
diclofenac,ankylosing spondylitis,c-x-c motif chemokine ligand 8
ketoprofen,ankylosing spondylitis,c-x-c motif chemokine ligand 8
ketoprofen,ankylosing spondylitis,c-x-c motif chemokine receptor 1
ketoprofen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
ketoprofen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
cortisol,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
cortisol,ankylosing spondylitis,sex hormone binding globulin
cortisol,ankylosing spondylitis,serpin family a member 6
meloxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
meloxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
prednisolone,ankylosing spondylitis,serpin family a member 6
nabumetone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
nabumetone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
celecoxib,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
etodolac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
etodolac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
triamcinolone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
triamcinolone,ankylosing spondylitis,serpin family a member 6
oxaprozin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
oxaprozin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
indomethacin,ankylosing spondylitis,c-x-c motif chemokine ligand 8
indomethacin,ankylosing spondylitis,aldo-keto reductase family 1 member c3
tolmetin,ankylosing spondylitis,c-x-c motif chemokine ligand 8
tolmetin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
tolmetin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
prednisone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
naproxen,ankylosing spondylitis,aldo-keto reductase family 1 member c3
meclofenamic acid,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
meclofenamic acid,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
meclofenamic acid,ankylosing spondylitis,aldo-keto reductase family 1 member c3
betamethasone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
betamethasone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
piroxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
piroxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
misoprostol (methyl ester),ankylosing spondylitis,prostaglandin e receptor 4
cladribine,relapsing-remitting multiple sclerosis,ribonucleotide reductase catalytic subunit m1
mitoxantrone,relapsing-remitting multiple sclerosis,solute carrier family 47 member 2
mitoxantrone,relapsing-remitting multiple sclerosis,solute carrier family 47 member 1
fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 3
fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 5
fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 1
fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 4
azelastine,seasonal allergic rhinitis,adrenoceptor alpha 1b
azelastine,seasonal allergic rhinitis,adrenoceptor alpha 1a
pseudoephedrine,seasonal allergic rhinitis,adrenoceptor alpha 2a
methylprednisolone,seasonal allergic rhinitis,nuclear receptor subfamily 3 group c member 1
promethazine,seasonal allergic rhinitis,adrenoceptor alpha 1a
phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 2a
triamcinolone,eye disorder,serpin family a member 6
cortisol,eye disorder,nuclear receptor subfamily 3 group c member 1
cortisol,eye disorder,sex hormone binding globulin
cortisol,eye disorder,serpin family a member 6
prednisolone,eye disorder,serpin family a member 6
bimatoprost,open-angle glaucoma,prostaglandin f receptor
pilocarpine,open-angle glaucoma,cholinergic receptor muscarinic 3
betaxolol,open-angle glaucoma,adrenoceptor beta 2
brinzolamide,open-angle glaucoma,carbonic anhydrase 12
brinzolamide,open-angle glaucoma,carbonic anhydrase 14
brinzolamide,open-angle glaucoma,carbonic anhydrase 7
brinzolamide,open-angle glaucoma,carbonic anhydrase 1
brinzolamide,open-angle glaucoma,carbonic anhydrase 4
brinzolamide,open-angle glaucoma,carbonic anhydrase 3
physostigmine,open-angle glaucoma,butyrylcholinesterase
diclofenamide,open-angle glaucoma,carbonic anhydrase 14
diclofenamide,open-angle glaucoma,carbonic anhydrase 3
brimonidine (uk14304),open-angle glaucoma,adrenoceptor alpha 1a
dipivefrine,open-angle glaucoma,adrenoceptor alpha 1a
dipivefrine,open-angle glaucoma,adrenoceptor alpha 2a
dipivefrine,open-angle glaucoma,adrenoceptor beta 2
dipivefrine,open-angle glaucoma,acetylcholinesterase (yt blood group)
dipivefrine,open-angle glaucoma,adrenoceptor alpha 2b
dipivefrine,open-angle glaucoma,butyrylcholinesterase
dipivefrine,open-angle glaucoma,adrenoceptor alpha 2c
dorzolamide,open-angle glaucoma,carbonic anhydrase 7
dorzolamide,open-angle glaucoma,carbonic anhydrase 12
dorzolamide,open-angle glaucoma,carbonic anhydrase 14
dorzolamide,open-angle glaucoma,carbonic anhydrase 4
dorzolamide,open-angle glaucoma,carbonic anhydrase 1
dorzolamide,open-angle glaucoma,carbonic anhydrase 3
apraclonidine,open-angle glaucoma,adrenoceptor alpha 2c
apraclonidine,open-angle glaucoma,adrenoceptor alpha 2b
apraclonidine,open-angle glaucoma,adrenoceptor alpha 1a
clonidine,open-angle glaucoma,adrenoceptor alpha 1d
clonidine,open-angle glaucoma,adrenoceptor alpha 1b
clonidine,open-angle glaucoma,adrenoceptor alpha 1a
paclitaxel,open-angle glaucoma,tubulin beta 2b class iib
paclitaxel,open-angle glaucoma,tubulin beta 1 class vi
paclitaxel,open-angle glaucoma,tubulin beta 6 class v
paclitaxel,open-angle glaucoma,tubulin beta class i
paclitaxel,open-angle glaucoma,tubulin beta 3 class iii
paclitaxel,open-angle glaucoma,tubulin beta 8 class viii
paclitaxel,open-angle glaucoma,cytochrome p450 family 1 subfamily b member 1
paclitaxel,open-angle glaucoma,tubulin beta 4a class iva
paclitaxel,open-angle glaucoma,tubulin beta 2a class iia
paclitaxel,open-angle glaucoma,tubulin beta 4b class ivb
timolol,open-angle glaucoma,adrenoceptor beta 1
timolol,open-angle glaucoma,adrenoceptor beta 2
(-)-adrenaline,open-angle glaucoma,adrenoceptor beta 1
(-)-adrenaline,open-angle glaucoma,adrenoceptor beta 2
(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 1a
(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 1b
(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 2b
(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 1d
(-)-adrenaline,open-angle glaucoma,adrenoceptor alpha 2c
acetazolamide,open-angle glaucoma,carbonic anhydrase 11
vismodegib,skin basal cell carcinoma,"smoothened, frizzled class receptor"
vismodegib,skin basal cell carcinoma,sonic hedgehog signaling molecule
sonidegib,skin basal cell carcinoma,"smoothened, frizzled class receptor"
fenofibrate,hypertriglyceridemia,peroxisome proliferator activated receptor alpha
simvastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
epa,hypertriglyceridemia,peroxisome proliferator activated receptor gamma
nicotinic acid,hypertriglyceridemia,hydroxycarboxylic acid receptor 2
nicotinic acid,hypertriglyceridemia,hydroxycarboxylic acid receptor 3
lovastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
budesonide,eosinophilic esophagitis,nuclear receptor subfamily 3 group c member 1
tadalafil,erectile dysfunction,phosphodiesterase 11a
vardenafil,erectile dysfunction,phosphodiesterase 11a
pge1,erectile dysfunction,prostaglandin e receptor 1
carbimazole,graves disease,thyroid peroxidase
clomiphene,male infertility,cytochrome p450 family 19 subfamily a member 1
clomiphene,male infertility,estrogen receptor 1
clomiphene,male infertility,cytochrome p450 family 1 subfamily a member 1
prednisolone,nephrotic syndrome,serpin family a member 6
triamcinolone,nephrotic syndrome,serpin family a member 6
cortisol,nephrotic syndrome,sex hormone binding globulin
cortisol,nephrotic syndrome,serpin family a member 6
prednisone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
prednisone,nephrotic syndrome,albumin
alendronate,bone paget disease,farnesyl diphosphate synthase
alendronate,bone paget disease,atpase h+ transporting v1 subunit a
chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
escitalopram,panic disorder,solute carrier family 6 member 4
escitalopram,panic disorder,solute carrier family 6 member 2
alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
venlafaxine,panic disorder,adrenoceptor alpha 2a
venlafaxine,panic disorder,5-hydroxytryptamine receptor 2a
paroxetine,panic disorder,5-hydroxytryptamine receptor 2a
paroxetine,panic disorder,solute carrier family 6 member 2
paroxetine,panic disorder,5-hydroxytryptamine receptor 1a
paroxetine,panic disorder,adrenoceptor alpha 2a
diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
desvenlafaxine,panic disorder,solute carrier family 6 member 2
desvenlafaxine,panic disorder,solute carrier family 6 member 4
clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
clomipramine,panic disorder,adrenoceptor alpha 2a
clomipramine,panic disorder,5-hydroxytryptamine receptor 2a
clomipramine,panic disorder,solute carrier family 6 member 2
clomipramine,panic disorder,solute carrier family 6 member 4
desipramine,panic disorder,5-hydroxytryptamine receptor 1a
desipramine,panic disorder,5-hydroxytryptamine receptor 2a
desipramine,panic disorder,solute carrier family 6 member 4
desipramine,panic disorder,solute carrier family 6 member 2
desipramine,panic disorder,adrenoceptor alpha 2a
citalopram,panic disorder,solute carrier family 6 member 2
citalopram,panic disorder,solute carrier family 6 member 4
sertraline,panic disorder,solute carrier family 6 member 2
sertraline,panic disorder,monoamine oxidase a
fluoxetine,panic disorder,5-hydroxytryptamine receptor 2a
fluoxetine,panic disorder,solute carrier family 6 member 2
fluoxetine,panic disorder,adrenoceptor alpha 2a
imipramine,panic disorder,5-hydroxytryptamine receptor 2a
imipramine,panic disorder,solute carrier family 6 member 2
imipramine,panic disorder,solute carrier family 6 member 4
imipramine,panic disorder,5-hydroxytryptamine receptor 1a
imipramine,panic disorder,5-hydroxytryptamine receptor 7
imipramine,panic disorder,adrenoceptor alpha 2a
oxcarbazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 5
phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 3
phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 1
phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 5
phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 2
phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 8
phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 4
phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 9
carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 4
carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 5
carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 9
primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
primidone,focal epilepsy,glutamate ionotropic receptor ampa type subunit 2
primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
ropinirole,restless legs syndrome,dopamine receptor d1
ropinirole,restless legs syndrome,dopamine receptor d4
ropinirole,restless legs syndrome,dopamine receptor d2
ropinirole,restless legs syndrome,dopamine receptor d3
ropinirole,restless legs syndrome,dopamine receptor d5
pramipexole,restless legs syndrome,dopamine receptor d5
pramipexole,restless legs syndrome,dopamine receptor d1
levodopa,restless legs syndrome,dopamine receptor d2
levodopa,restless legs syndrome,dopamine receptor d5
levodopa,restless legs syndrome,dopamine receptor d1
levodopa,restless legs syndrome,dopamine receptor d4
levodopa,restless legs syndrome,dopamine receptor d3
gabapentin,restless legs syndrome,calcium voltage-gated channel auxiliary subunit alpha2delta 2
indomethacin,gout,solute carrier family 22 member 11
indomethacin,gout,c-x-c motif chemokine ligand 8
indomethacin,gout,atp binding cassette subfamily c member 1 (abcc1 blood group)
indomethacin,gout,solute carrier family 22 member 6
indomethacin,gout,aldo-keto reductase family 1 member c3
indomethacin,gout,solute carrier family 22 member 8
phenylbutazone,gout,prostaglandin-endoperoxide synthase 2
phenylbutazone,gout,solute carrier family 22 member 8
phenylbutazone,gout,solute carrier family 22 member 6
phenylbutazone,gout,solute carrier family 22 member 11
phenylbutazone,gout,prostaglandin-endoperoxide synthase 1
triamcinolone,gout,prostaglandin-endoperoxide synthase 2
triamcinolone,gout,serpin family a member 6
sulindac,gout,solute carrier family 22 member 6
ketoprofen,gout,c-x-c motif chemokine ligand 8
ketoprofen,gout,solute carrier family 22 member 8
ketoprofen,gout,solute carrier family 22 member 6
ketoprofen,gout,solute carrier family 22 member 11
ketoprofen,gout,prostaglandin-endoperoxide synthase 2
ketoprofen,gout,prostaglandin-endoperoxide synthase 1
prednisone,gout,nuclear receptor subfamily 3 group c member 1
naproxen,gout,aldo-keto reductase family 1 member c3
naproxen,gout,solute carrier family 22 member 6
prednisolone,gout,serpin family a member 6
allopurinol,gout,solute carrier family 22 member 8
probenecid,gout,solute carrier family 2 member 9
probenecid,gout,solute carrier family 22 member 12
probenecid,gout,atp binding cassette subfamily c member 1 (abcc1 blood group)
cortisol,gout,atp binding cassette subfamily g member 2 (jr blood group)
cortisol,gout,nuclear receptor subfamily 3 group c member 1
cortisol,gout,sex hormone binding globulin
cortisol,gout,serpin family a member 6
betamethasone,gout,prostaglandin-endoperoxide synthase 2
betamethasone,gout,nuclear receptor subfamily 3 group c member 1
etodolac,gout,prostaglandin-endoperoxide synthase 1
etodolac,gout,solute carrier family 22 member 6
etodolac,gout,prostaglandin-endoperoxide synthase 2
colchicine,gout,atp binding cassette subfamily c member 1 (abcc1 blood group)
cimetidine,duodenal ulcer,solute carrier family 47 member 1
famotidine,duodenal ulcer,solute carrier family 47 member 1
esomeprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
rabeprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
pantoprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
pantoprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
lansoprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
gemcitabine,testicular cancer,atp binding cassette subfamily b member 1
vinblastine,testicular cancer,tubulin beta 4a class iva
vinblastine,testicular cancer,tubulin beta 1 class vi
vinblastine,testicular cancer,tubulin beta 8 class viii
vinblastine,testicular cancer,atp binding cassette subfamily b member 1
vinblastine,testicular cancer,tubulin beta 2b class iib
vinblastine,testicular cancer,tubulin beta 4b class ivb
vinblastine,testicular cancer,tubulin beta 2a class iia
vinblastine,testicular cancer,tubulin beta 3 class iii
vinblastine,testicular cancer,tubulin beta 6 class v
paclitaxel,testicular cancer,tubulin beta 2b class iib
paclitaxel,testicular cancer,atp binding cassette subfamily b member 1
paclitaxel,testicular cancer,tubulin beta 1 class vi
paclitaxel,testicular cancer,tubulin beta 6 class v
paclitaxel,testicular cancer,tubulin beta class i
paclitaxel,testicular cancer,tubulin beta 3 class iii
paclitaxel,testicular cancer,tubulin beta 8 class viii
paclitaxel,testicular cancer,tubulin beta 4a class iva
paclitaxel,testicular cancer,tubulin beta 2a class iia
paclitaxel,testicular cancer,tubulin beta 4b class ivb
etoposide,testicular cancer,atp binding cassette subfamily b member 1
amitriptyline,bulimia nervosa,solute carrier family 6 member 4
imipramine,bulimia nervosa,solute carrier family 6 member 4
desipramine,bulimia nervosa,solute carrier family 6 member 4
pentamidine,human african trypanosomiasis,amine oxidase copper containing 1
pentamidine,human african trypanosomiasis,s100 calcium binding protein b
suramin,human african trypanosomiasis,sirtuin 1
dopamine,hypotensive disorder,dopamine receptor d2
dopamine,hypotensive disorder,solute carrier family 6 member 2
dopamine,hypotensive disorder,monoamine oxidase b
dopamine,hypotensive disorder,dopamine receptor d1
dopamine,hypotensive disorder,monoamine oxidase a
dopamine,hypotensive disorder,adrenoceptor beta 1
dopamine,hypotensive disorder,adrenoceptor alpha 1a
phenylephrine,hypotensive disorder,adrenoceptor alpha 1a
phenylephrine,hypotensive disorder,monoamine oxidase a
phenylephrine,hypotensive disorder,adrenoceptor alpha 1b
phenylephrine,hypotensive disorder,adrenoceptor alpha 1d
phenylephrine,hypotensive disorder,adrenoceptor alpha 2a
(-)-adrenaline,hypotensive disorder,adrenoceptor alpha 1a
(-)-adrenaline,hypotensive disorder,adrenoceptor alpha 1b
(-)-adrenaline,hypotensive disorder,adrenoceptor alpha 2a
(-)-adrenaline,hypotensive disorder,adrenoceptor alpha 1d
(-)-adrenaline,hypotensive disorder,tumor necrosis factor
(-)-adrenaline,hypotensive disorder,dopamine receptor d2
(-)-adrenaline,hypotensive disorder,dopamine receptor d1
phentermine,hypotensive disorder,monoamine oxidase a
phentermine,hypotensive disorder,monoamine oxidase b
(-)-noradrenaline,hypotensive disorder,adrenoceptor alpha 2a
(-)-noradrenaline,hypotensive disorder,adrenoceptor beta 1
(-)-noradrenaline,hypotensive disorder,dopamine receptor d2
(-)-noradrenaline,hypotensive disorder,solute carrier family 6 member 2
(-)-noradrenaline,hypotensive disorder,dopamine receptor d1
methoxamine,hypotensive disorder,adrenoceptor alpha 1d
midodrine,orthostatic hypotension,adrenoceptor alpha 1a
droxidopa,orthostatic hypotension,adrenoceptor alpha 1a
magnesium sulfate,torsades de pointes,calcium voltage-gated channel subunit alpha1 c
fluocinolone acetonide,contact dermatitis,serpin family a member 6
clobetasol propionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
clobetasol propionate,contact dermatitis,cytochrome p450 family 1 subfamily a member 1
flumethasone pivalate,contact dermatitis,serpin family a member 6
mometasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
triamcinolone,contact dermatitis,serpin family a member 6
alclometasone dipropionate,contact dermatitis,serpin family a member 6
prednisolone,contact dermatitis,serpin family a member 6
cortisol,contact dermatitis,nuclear receptor subfamily 3 group c member 1
cortisol,contact dermatitis,sex hormone binding globulin
cortisol,contact dermatitis,serpin family a member 6
betamethasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
fluticasone,contact dermatitis,serpin family a member 6
methylprednisolone,contact dermatitis,glucose-6-phosphate dehydrogenase
prednisone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
acetophenazine,psychotic disorder,dopamine receptor d1
triflupromazine,psychotic disorder,atp binding cassette subfamily b member 1
promazine,psychotic disorder,dopamine receptor d4
promazine,psychotic disorder,5-hydroxytryptamine receptor 2a
promazine,psychotic disorder,dopamine receptor d2
promazine,psychotic disorder,cholinergic receptor muscarinic 1
promazine,psychotic disorder,dopamine receptor d1
promazine,psychotic disorder,cholinergic receptor muscarinic 2
fluphenazine,psychotic disorder,atp binding cassette subfamily b member 1
fluphenazine,psychotic disorder,dopamine receptor d1
fluphenazine,psychotic disorder,5-hydroxytryptamine receptor 2a
fluphenazine,psychotic disorder,cholinergic receptor muscarinic 2
fluphenazine,psychotic disorder,dopamine receptor d4
fluphenazine,psychotic disorder,dopamine receptor d5
paliperidone,psychotic disorder,dopamine receptor d2
paliperidone,psychotic disorder,dopamine receptor d1
paliperidone,psychotic disorder,5-hydroxytryptamine receptor 2a
paliperidone,psychotic disorder,dopamine receptor d4
paliperidone,psychotic disorder,5-hydroxytryptamine receptor 1b
paliperidone,psychotic disorder,cholinergic receptor muscarinic 2
chlorpromazine,psychotic disorder,dopamine receptor d5
chlorpromazine,psychotic disorder,5-hydroxytryptamine receptor 2a
chlorpromazine,psychotic disorder,cholinergic receptor muscarinic 1
chlorpromazine,psychotic disorder,dopamine receptor d4
chlorpromazine,psychotic disorder,dopamine receptor d1
chlorpromazine,psychotic disorder,atp binding cassette subfamily b member 1
chlorpromazine,psychotic disorder,5-hydroxytryptamine receptor 2b
chlorpromazine,psychotic disorder,cholinergic receptor muscarinic 2
chlorpromazine,psychotic disorder,potassium voltage-gated channel subfamily h member 2
reserpine,psychotic disorder,atp binding cassette subfamily b member 1
reserpine,psychotic disorder,solute carrier family 18 member a1
reserpine,psychotic disorder,dopamine receptor d2
reserpine,psychotic disorder,dopamine receptor d1
haloperidol,psychotic disorder,atp binding cassette subfamily b member 1
haloperidol,psychotic disorder,5-hydroxytryptamine receptor 2a
haloperidol,psychotic disorder,5-hydroxytryptamine receptor 1b
haloperidol,psychotic disorder,dopamine receptor d4
haloperidol,psychotic disorder,dopamine receptor d1
haloperidol,psychotic disorder,5-hydroxytryptamine receptor 2b
haloperidol,psychotic disorder,potassium voltage-gated channel subfamily h member 2
haloperidol,psychotic disorder,cholinergic receptor muscarinic 1
haloperidol,psychotic disorder,opioid receptor mu 1
haloperidol,psychotic disorder,transmembrane protein 97
haloperidol,psychotic disorder,dopamine receptor d5
paliperidone,schizoaffective disorder,dopamine receptor d2
paliperidone,schizoaffective disorder,5-hydroxytryptamine receptor 2a
paliperidone,schizoaffective disorder,5-hydroxytryptamine receptor 1b
cyproheptadine,urticaria,5-hydroxytryptamine receptor 2a
cyproheptadine,urticaria,dopamine receptor d2
promethazine,urticaria,dopamine receptor d2
promethazine,urticaria,5-hydroxytryptamine receptor 2a
clemastine,urticaria,transmembrane protein 97
loratadine,urticaria,histamine receptor h1
astemizole,urticaria,histamine receptor h1
astemizole,urticaria,transmembrane protein 97
hydroxyzine,urticaria,5-hydroxytryptamine receptor 2a
hydroxyzine,urticaria,dopamine receptor d2
promazine,urticaria,5-hydroxytryptamine receptor 2a
promazine,urticaria,dopamine receptor d2
promazine,urticaria,histamine receptor h1
cetirizine,urticaria,histamine receptor h1
calcifediol,rickets,vitamin d receptor
calcifediol,rickets,cytochrome p450 family 27 subfamily b member 1
calcifediol,rickets,cytochrome p450 family 24 subfamily a member 1
"1,25-dihydroxyvitamin d3",rickets,gc vitamin d binding protein
"1,25-dihydroxyvitamin d3",rickets,vitamin d receptor
"1,25-dihydroxyvitamin d3",rickets,cytochrome p450 family 24 subfamily a member 1
ergocalciferol,rickets,cytochrome p450 family 2 subfamily r member 1
ergocalciferol,rickets,cytochrome p450 family 24 subfamily a member 1
ergocalciferol,rickets,vitamin d receptor
ergocalciferol,rickets,cytochrome p450 family 27 subfamily b member 1
diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit beta3
diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha2
diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit gamma3
diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit gamma2
diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha3
diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha5
diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha1
diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit beta2
naloxone,opiate dependence,atp binding cassette subfamily b member 1
buprenorphine,opiate dependence,opioid related nociceptin receptor 1
buprenorphine,opiate dependence,opioid receptor delta 1
buprenorphine,opiate dependence,atp binding cassette subfamily b member 1
cortisol,proctitis,sex hormone binding globulin
cortisol,proctitis,serpin family a member 6
esmolol,acute coronary syndrome,adrenoceptor beta 1
heparin,acute coronary syndrome,serpin family c member 1
verapamil,acute coronary syndrome,calcium voltage-gated channel subunit alpha1 c
fondaparinux,acute coronary syndrome,serpin family c member 1
cortisol,brain edema,nuclear receptor subfamily 3 group c member 1
terbutaline,dry eye syndrome,adrenoceptor beta 2
terbutaline,dry eye syndrome,adrenoceptor beta 3
cyclosporin a,dry eye syndrome,protein phosphatase 3 catalytic subunit alpha
cyclosporin a,dry eye syndrome,fkbp prolyl isomerase 1b
cyclosporin a,dry eye syndrome,fkbp prolyl isomerase 4
cyclosporin a,dry eye syndrome,atp binding cassette subfamily b member 11
cyclosporin a,dry eye syndrome,solute carrier organic anion transporter family member 1b1
cyclosporin a,dry eye syndrome,peptidylprolyl isomerase d
cyclosporin a,dry eye syndrome,peptidylprolyl isomerase b
cyclosporin a,dry eye syndrome,solute carrier organic anion transporter family member 1b3
diclofenac,frozen shoulder,prostaglandin-endoperoxide synthase 2
dicumarol,intracranial embolism,g protein-coupled receptor 35
cortisol,iritis,sex hormone binding globulin
cortisol,iritis,serpin family a member 6
fluorometholone,iritis,nuclear receptor subfamily 3 group c member 1
fluorometholone,iritis,serpin family a member 6
prednisolone,iritis,serpin family a member 6
ceftriaxone,arthropathy,synuclein alpha
fluoxymesterone,klinefelter syndrome,sex hormone binding globulin
methyltestosterone,klinefelter syndrome,androgen receptor
methyltestosterone,klinefelter syndrome,sex hormone binding globulin
timolol,ocular hypertension,adrenoceptor beta 1
timolol,ocular hypertension,adrenoceptor beta 2
pilocarpine,ocular hypertension,cholinergic receptor muscarinic 3
clonidine,ocular hypertension,adrenoceptor alpha 2a
clonidine,ocular hypertension,adrenoceptor alpha 2b
clonidine,ocular hypertension,adrenoceptor alpha 2c
apraclonidine,ocular hypertension,adrenoceptor alpha 2c
apraclonidine,ocular hypertension,adrenoceptor alpha 2b
apraclonidine,ocular hypertension,adrenoceptor alpha 2a
paclitaxel,ocular hypertension,tubulin beta 2b class iib
paclitaxel,ocular hypertension,tubulin beta 1 class vi
paclitaxel,ocular hypertension,tubulin beta 6 class v
paclitaxel,ocular hypertension,tubulin beta class i
paclitaxel,ocular hypertension,tubulin beta 3 class iii
paclitaxel,ocular hypertension,tubulin beta 8 class viii
paclitaxel,ocular hypertension,tubulin beta 4a class iva
paclitaxel,ocular hypertension,tubulin beta 2a class iia
paclitaxel,ocular hypertension,tubulin beta 4b class ivb
betaxolol,ocular hypertension,adrenoceptor beta 2
bimatoprost,ocular hypertension,prostaglandin f receptor
esomeprazole,peptic esophagitis,atpase h+/k+ transporting subunit beta
famotidine,peptic esophagitis,solute carrier family 47 member 1
trimetaphan,pulmonary edema,cholinergic receptor nicotinic alpha 10 subunit
trimetaphan,pulmonary edema,cholinergic receptor nicotinic alpha 3 subunit
trimetaphan,pulmonary edema,cholinergic receptor nicotinic beta 4 subunit
norfloxacin,pyelonephritis,dna topoisomerase ii alpha
ofloxacin,pyelonephritis,dna topoisomerase ii alpha
dihydrotachysterol,renal osteodystrophy,vitamin d receptor
calcifediol,renal osteodystrophy,vitamin d receptor
calcifediol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
alfacalcidol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
alfacalcidol,renal osteodystrophy,gc vitamin d binding protein
alfacalcidol,renal osteodystrophy,vitamin d receptor
"1,25-dihydroxyvitamin d3",renal osteodystrophy,gc vitamin d binding protein
ergocalciferol,renal osteodystrophy,vitamin d receptor
ergocalciferol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
prednisolone,rheumatic heart disease,serpin family a member 6
cortisol,rheumatic heart disease,sex hormone binding globulin
cortisol,rheumatic heart disease,serpin family a member 6
betamethasone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
prednisone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
triamcinolone,rheumatic heart disease,serpin family a member 6
propylthiouracil,thyroid crisis,iodothyronine deiodinase 1
methimazole,thyroid crisis,thyroid peroxidase
gabapentin,alcohol dependence,adenosine a1 receptor
acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 1
acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 2a
acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit beta3
acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit gamma2
acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 2b
acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit alpha1
naltrexone,alcohol dependence,opioid receptor mu 1
naltrexone,alcohol dependence,opioid receptor kappa 1
naltrexone,alcohol dependence,opioid receptor delta 1
topiramate,alcohol dependence,carbonic anhydrase 2
topiramate,alcohol dependence,glutamate ionotropic receptor kainate type subunit 3
topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit alpha1
topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit beta2
topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit gamma2
topiramate,alcohol dependence,glutamate ionotropic receptor kainate type subunit 1
disulfiram,alcohol dependence,cytochrome p450 family 2 subfamily e member 1
disulfiram,alcohol dependence,dopamine beta-hydroxylase
disulfiram,alcohol dependence,aldehyde dehydrogenase 2 family member
betamethasone,autoimmune disease,prostaglandin-endoperoxide synthase 2
prednisone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
prednisone,autoimmune disease,albumin
cortisol,autoimmune disease,nuclear receptor subfamily 3 group c member 1
cortisol,autoimmune disease,serpin family a member 6
triamcinolone,autoimmune disease,prostaglandin-endoperoxide synthase 2
triamcinolone,autoimmune disease,serpin family a member 6
prednisolone,autoimmune disease,serpin family a member 6
lansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
famotidine,gastroesophageal reflux disease,solute carrier family 47 member 1
cisapride,gastroesophageal reflux disease,dopamine receptor d2
metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3a
metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3b
metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3c
metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3e
metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3d
pantoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
esomeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
cimetidine,gastroesophageal reflux disease,solute carrier family 47 member 1
rabeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
baclofen,gastroesophageal reflux disease,gamma-aminobutyric acid type b receptor subunit 2
vincristine,burkitt lymphoma,tubulin beta 8 class viii
vincristine,burkitt lymphoma,tubulin beta 3 class iii
vincristine,burkitt lymphoma,tubulin beta 1 class vi
vincristine,burkitt lymphoma,tubulin beta 4a class iva
vincristine,burkitt lymphoma,tubulin beta 2a class iia
vincristine,burkitt lymphoma,tubulin beta 2b class iib
vincristine,burkitt lymphoma,tubulin beta 4b class ivb
vincristine,burkitt lymphoma,tubulin beta 6 class v
etoposide,burkitt lymphoma,dna topoisomerase ii alpha
etoposide,burkitt lymphoma,cytochrome p450 family 2 subfamily e member 1
carboplatin,breast cancer,atp binding cassette subfamily g member 2 (jr blood group)
carboplatin,breast cancer,glutathione s-transferase theta 1
carboplatin,breast cancer,atpase copper transporting beta
carboplatin,breast cancer,xanthine dehydrogenase
carboplatin,breast cancer,nad(p)h quinone dehydrogenase 1
carboplatin,breast cancer,glutathione s-transferase pi 1
carboplatin,breast cancer,glutathione s-transferase mu 1
dromostanolone propionate,breast cancer,cytochrome p450 family 19 subfamily a member 1
dromostanolone propionate,breast cancer,sex hormone binding globulin
dromostanolone propionate,breast cancer,androgen receptor
cabozantinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
cabozantinib,hepatocellular carcinoma,aurora kinase a
cabozantinib,hepatocellular carcinoma,kinase insert domain receptor
cabozantinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
sorafenib,hepatocellular carcinoma,fibroblast growth factor receptor 1
sorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily b member 6
sorafenib,hepatocellular carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
sorafenib,hepatocellular carcinoma,epoxide hydrolase 2
sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 3
sorafenib,hepatocellular carcinoma,ret proto-oncogene
sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 1
sorafenib,hepatocellular carcinoma,cytochrome p450 family 1 subfamily a member 2
sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 4
sorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily c member 8
sorafenib,hepatocellular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
sorafenib,hepatocellular carcinoma,mitogen-activated protein kinase kinase kinase 20
sorafenib,hepatocellular carcinoma,atp binding cassette subfamily b member 1
sorafenib,hepatocellular carcinoma,kinase insert domain receptor
sorafenib,hepatocellular carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
sorafenib,hepatocellular carcinoma,homeodomain interacting protein kinase 4
sorafenib,hepatocellular carcinoma,platelet derived growth factor receptor alpha
sorafenib,hepatocellular carcinoma,platelet derived growth factor receptor beta
sorafenib,hepatocellular carcinoma,aurora kinase b
sorafenib,hepatocellular carcinoma,ttk protein kinase
sorafenib,hepatocellular carcinoma,axl receptor tyrosine kinase
sorafenib,hepatocellular carcinoma,transforming growth factor beta receptor 2
sorafenib,hepatocellular carcinoma,eph receptor a1
sorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
sorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
sorafenib,hepatocellular carcinoma,cyclin dependent kinase 14
sorafenib,hepatocellular carcinoma,tek receptor tyrosine kinase
regorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily c member 8
regorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 4
regorafenib,hepatocellular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
regorafenib,hepatocellular carcinoma,platelet derived growth factor receptor beta
regorafenib,hepatocellular carcinoma,epoxide hydrolase 2
regorafenib,hepatocellular carcinoma,ret proto-oncogene
regorafenib,hepatocellular carcinoma,atp binding cassette subfamily b member 1
regorafenib,hepatocellular carcinoma,tek receptor tyrosine kinase
regorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily b member 6
regorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
regorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
regorafenib,hepatocellular carcinoma,eph receptor a1
regorafenib,hepatocellular carcinoma,mitogen-activated protein kinase kinase kinase 20
regorafenib,hepatocellular carcinoma,ttk protein kinase
lenvatinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
lenvatinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
lenvatinib,hepatocellular carcinoma,kinase insert domain receptor
lenvatinib,hepatocellular carcinoma,ret proto-oncogene
lenvatinib,hepatocellular carcinoma,aurora kinase b
clomipramine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
clomipramine,obsessive-compulsive disorder,solute carrier family 6 member 2
clomipramine,obsessive-compulsive disorder,dopamine receptor d2
sertraline,obsessive-compulsive disorder,solute carrier family 6 member 2
citalopram,obsessive-compulsive disorder,solute carrier family 6 member 2
citalopram,obsessive-compulsive disorder,solute carrier family 6 member 4
fluvoxamine,obsessive-compulsive disorder,solute carrier family 6 member 2
escitalopram,obsessive-compulsive disorder,solute carrier family 6 member 4
escitalopram,obsessive-compulsive disorder,solute carrier family 6 member 2
fluoxetine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
fluoxetine,obsessive-compulsive disorder,solute carrier family 6 member 2
paroxetine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
paroxetine,obsessive-compulsive disorder,solute carrier family 6 member 2
ergocalciferol,postmenopausal osteoporosis,vitamin d receptor
norgestimate,postmenopausal osteoporosis,estrogen receptor 1
norgestimate,postmenopausal osteoporosis,progesterone receptor
alendronate,postmenopausal osteoporosis,farnesyl diphosphate synthase
alendronate,postmenopausal osteoporosis,atpase h+ transporting v1 subunit a
ethinylestradiol,postmenopausal osteoporosis,estrogen receptor 2
medroxyprogesterone,postmenopausal osteoporosis,progesterone receptor
medroxyprogesterone,postmenopausal osteoporosis,estrogen receptor 1
progesterone,postmenopausal osteoporosis,progesterone receptor
progesterone,postmenopausal osteoporosis,estrogen receptor 1
norethisterone,postmenopausal osteoporosis,progesterone receptor
levonorgestrel,postmenopausal osteoporosis,progesterone receptor
levonorgestrel,postmenopausal osteoporosis,estrogen receptor 1
cisplatin,ovarian cancer,atp binding cassette subfamily b member 1
cisplatin,ovarian cancer,superoxide dismutase 1
cisplatin,ovarian cancer,atpase copper transporting beta
docetaxel,ovarian cancer,epidermal growth factor receptor
docetaxel,ovarian cancer,tubulin beta 6 class v
docetaxel,ovarian cancer,tubulin beta 2b class iib
docetaxel,ovarian cancer,tubulin beta 2a class iia
docetaxel,ovarian cancer,tubulin beta class i
docetaxel,ovarian cancer,tubulin beta 3 class iii
docetaxel,ovarian cancer,tubulin beta 1 class vi
docetaxel,ovarian cancer,atp binding cassette subfamily b member 1
docetaxel,ovarian cancer,tubulin beta 4a class iva
docetaxel,ovarian cancer,tubulin beta 4b class ivb
docetaxel,ovarian cancer,tubulin beta 8 class viii
docetaxel,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
megestrol,ovarian cancer,atp binding cassette subfamily b member 1
megestrol,ovarian cancer,progesterone receptor
etoposide,ovarian cancer,dna topoisomerase ii alpha
etoposide,ovarian cancer,atp binding cassette subfamily b member 1
paclitaxel,ovarian cancer,tubulin beta 2b class iib
paclitaxel,ovarian cancer,atp binding cassette subfamily b member 1
paclitaxel,ovarian cancer,tubulin beta 6 class v
paclitaxel,ovarian cancer,tubulin beta class i
paclitaxel,ovarian cancer,tubulin beta 3 class iii
paclitaxel,ovarian cancer,tubulin beta 8 class viii
paclitaxel,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
paclitaxel,ovarian cancer,tubulin beta 4a class iva
paclitaxel,ovarian cancer,tubulin beta 2a class iia
paclitaxel,ovarian cancer,tubulin beta 4b class ivb
topotecan,ovarian cancer,atp binding cassette subfamily b member 1
topotecan,ovarian cancer,dna topoisomerase i mitochondrial
gemcitabine,ovarian cancer,ribonucleotide reductase regulatory subunit m2
gemcitabine,ovarian cancer,ribonucleotide reductase catalytic subunit m1
gemcitabine,ovarian cancer,"dna polymerase epsilon, catalytic subunit"
gemcitabine,ovarian cancer,atp binding cassette subfamily b member 1
gemcitabine,ovarian cancer,"dna polymerase delta 1, catalytic subunit"
gemcitabine,ovarian cancer,cytidine/uridine monophosphate kinase 1
gemcitabine,ovarian cancer,"dna polymerase alpha 1, catalytic subunit"
gemcitabine,ovarian cancer,thymidylate synthetase
carboplatin,ovarian cancer,atpase copper transporting beta
carboplatin,ovarian cancer,superoxide dismutase 1
olaparib,ovarian cancer,poly(adp-ribose) polymerase family member 4
olaparib,ovarian cancer,poly(adp-ribose) polymerase family member 10
capecitabine,ovarian cancer,thymidylate synthetase
cyclophosphamide,ovarian cancer,atp binding cassette subfamily b member 1
hydroxyurea,ovarian cancer,ribonucleotide reductase regulatory subunit m2
tamoxifen,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
tamoxifen,ovarian cancer,atp binding cassette subfamily b member 1
tamoxifen,ovarian cancer,estrogen receptor 1
niraparib,ovarian cancer,poly(adp-ribose) polymerase family member 10
niraparib,ovarian cancer,poly(adp-ribose) polymerase 2
niraparib,ovarian cancer,poly(adp-ribose) polymerase family member 4
niraparib,ovarian cancer,poly(adp-ribose) polymerase 1
hydroxocobalamin,pernicious anemia,cobalamin binding intrinsic factor
phentolamine,pheochromocytoma,adrenoceptor alpha 2a
phentolamine,pheochromocytoma,adrenoceptor alpha 2c
phentolamine,pheochromocytoma,adrenoceptor alpha 2b
promazine,acute intermittent porphyria,5-hydroxytryptamine receptor 2a
promazine,acute intermittent porphyria,dopamine receptor d2
promazine,acute intermittent porphyria,histamine receptor h1
chlorpromazine,acute intermittent porphyria,5-hydroxytryptamine receptor 2a
chlorpromazine,acute intermittent porphyria,histamine receptor h1
chlorpromazine,acute intermittent porphyria,atp binding cassette subfamily b member 1
carbetocin,prader-willi syndrome,oxytocin receptor
abiraterone acetate,prostate cancer,sulfotransferase family 2a member 1
docetaxel,prostate cancer,epidermal growth factor receptor
docetaxel,prostate cancer,tubulin beta 6 class v
docetaxel,prostate cancer,tubulin beta 2b class iib
docetaxel,prostate cancer,tubulin beta 2a class iia
docetaxel,prostate cancer,tubulin beta class i
docetaxel,prostate cancer,cytochrome p450 family 3 subfamily a member 4
docetaxel,prostate cancer,tubulin beta 3 class iii
docetaxel,prostate cancer,microtubule associated protein 2
docetaxel,prostate cancer,cytochrome p450 family 3 subfamily a member 5
docetaxel,prostate cancer,tubulin beta 4a class iva
docetaxel,prostate cancer,tubulin beta 4b class ivb
docetaxel,prostate cancer,tubulin beta 8 class viii
docetaxel,prostate cancer,cytochrome p450 family 1 subfamily b member 1
docetaxel,prostate cancer,paraoxonase 1
enzalutamide,prostate cancer,cytochrome p450 family 3 subfamily a member 5
enzalutamide,prostate cancer,cytochrome p450 family 2 subfamily c member 19
enzalutamide,prostate cancer,cytochrome p450 family 3 subfamily a member 4
enzalutamide,prostate cancer,cytochrome p450 family 2 subfamily c member 9
enzalutamide,prostate cancer,nuclear receptor subfamily 3 group c member 1
diflunisal,rheumatoid arthritis,transthyretin
diflunisal,rheumatoid arthritis,albumin
diflunisal,rheumatoid arthritis,dihydrofolate reductase
diflunisal,rheumatoid arthritis,high mobility group box 1
valdecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
valdecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
triamcinolone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
triamcinolone,rheumatoid arthritis,serpin family a member 6
meloxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
meloxicam,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
piroxicam,rheumatoid arthritis,albumin
naproxen,rheumatoid arthritis,albumin
naproxen,rheumatoid arthritis,aldo-keto reductase family 1 member c3
naproxen,rheumatoid arthritis,dihydrofolate reductase
penicillamine,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
leflunomide,rheumatoid arthritis,dihydroorotate dehydrogenase (quinone)
leflunomide,rheumatoid arthritis,aryl hydrocarbon receptor
leflunomide,rheumatoid arthritis,atp binding cassette subfamily g member 2 (jr blood group)
tolmetin,rheumatoid arthritis,c-x-c motif chemokine ligand 8
tolmetin,rheumatoid arthritis,myeloperoxidase
tolmetin,rheumatoid arthritis,albumin
rofecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
betamethasone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
betamethasone,rheumatoid arthritis,atp binding cassette subfamily b member 1
tofacitinib,rheumatoid arthritis,doublecortin like kinase 3
tofacitinib,rheumatoid arthritis,"lck proto-oncogene, src family tyrosine kinase"
tofacitinib,rheumatoid arthritis,ribosomal protein s6 kinase a1
tofacitinib,rheumatoid arthritis,mapk interacting serine/threonine kinase 2
tofacitinib,rheumatoid arthritis,tyrosine kinase 2
tofacitinib,rheumatoid arthritis,"abl proto-oncogene 1, non-receptor tyrosine kinase"
tofacitinib,rheumatoid arthritis,janus kinase 2
celecoxib,rheumatoid arthritis,albumin
celecoxib,rheumatoid arthritis,mitogen-activated protein kinase 14
celecoxib,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
celecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
chloroquine,rheumatoid arthritis,tumor necrosis factor
chloroquine,rheumatoid arthritis,toll like receptor 9
chloroquine,rheumatoid arthritis,atp binding cassette subfamily b member 1
chloroquine,rheumatoid arthritis,sigma non-opioid intracellular receptor 1
chloroquine,rheumatoid arthritis,transmembrane protein 97
salicylic acid,rheumatoid arthritis,albumin
salicylic acid,rheumatoid arthritis,atp binding cassette subfamily b member 1
salicylic acid,rheumatoid arthritis,high mobility group box 1
hydroxychloroquine,rheumatoid arthritis,toll like receptor 7
hydroxychloroquine,rheumatoid arthritis,toll like receptor 9
hydroxychloroquine,rheumatoid arthritis,sigma non-opioid intracellular receptor 1
hydroxychloroquine,rheumatoid arthritis,transmembrane protein 97
ketoprofen,rheumatoid arthritis,c-x-c motif chemokine ligand 8
ketoprofen,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
ketoprofen,rheumatoid arthritis,albumin
ketoprofen,rheumatoid arthritis,paraoxonase 1
aspirin,rheumatoid arthritis,albumin
aspirin,rheumatoid arthritis,atp binding cassette subfamily b member 1
aspirin,rheumatoid arthritis,tumor protein p53
aspirin,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
etodolac,rheumatoid arthritis,albumin
etodolac,rheumatoid arthritis,dihydrofolate reductase
ibuprofen,rheumatoid arthritis,c-x-c motif chemokine ligand 8
ibuprofen,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
ibuprofen,rheumatoid arthritis,atp binding cassette subfamily b member 1
ibuprofen,rheumatoid arthritis,albumin
ibuprofen,rheumatoid arthritis,dihydrofolate reductase
indomethacin,rheumatoid arthritis,atp binding cassette subfamily c member 3
indomethacin,rheumatoid arthritis,atp binding cassette subfamily c member 2
indomethacin,rheumatoid arthritis,c-x-c motif chemokine ligand 8
indomethacin,rheumatoid arthritis,albumin
indomethacin,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
indomethacin,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
indomethacin,rheumatoid arthritis,aldo-keto reductase family 1 member c3
indomethacin,rheumatoid arthritis,atp binding cassette subfamily b member 1
indomethacin,rheumatoid arthritis,solute carrier organic anion transporter family member 1b3
indomethacin,rheumatoid arthritis,paraoxonase 1
aceclofenac,rheumatoid arthritis,transthyretin
auranofin,rheumatoid arthritis,albumin
auranofin,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
flurbiprofen,rheumatoid arthritis,albumin
flurbiprofen,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
cortisol,rheumatoid arthritis,atp binding cassette subfamily g member 2 (jr blood group)
cortisol,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
cortisol,rheumatoid arthritis,atp binding cassette subfamily b member 1
cortisol,rheumatoid arthritis,sex hormone binding globulin
cortisol,rheumatoid arthritis,serpin family a member 6
baricitinib,rheumatoid arthritis,ap2 associated kinase 1
baricitinib,rheumatoid arthritis,septin 9
baricitinib,rheumatoid arthritis,cyclin g associated kinase
methylprednisolone,rheumatoid arthritis,atp binding cassette subfamily b member 1
cyclosporin a,rheumatoid arthritis,protein phosphatase 3 catalytic subunit alpha
cyclosporin a,rheumatoid arthritis,fkbp prolyl isomerase 1b
cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily b member 1
cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily g member 2 (jr blood group)
cyclosporin a,rheumatoid arthritis,fkbp prolyl isomerase 4
cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily c member 3
cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily c member 2
cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily b member 11
cyclosporin a,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase d
cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase b
cyclosporin a,rheumatoid arthritis,solute carrier organic anion transporter family member 1b3
meclofenamic acid,rheumatoid arthritis,arachidonate 5-lipoxygenase
meclofenamic acid,rheumatoid arthritis,aldo-keto reductase family 1 member c3
meclofenamic acid,rheumatoid arthritis,transthyretin
sulindac,rheumatoid arthritis,albumin
sulindac,rheumatoid arthritis,complement c5
diclofenac,rheumatoid arthritis,atp binding cassette subfamily b member 1
diclofenac,rheumatoid arthritis,c-x-c motif chemokine receptor 1
diclofenac,rheumatoid arthritis,atp binding cassette subfamily c member 4 (pel blood group)
diclofenac,rheumatoid arthritis,albumin
diclofenac,rheumatoid arthritis,arachidonate 5-lipoxygenase
diclofenac,rheumatoid arthritis,transthyretin
diclofenac,rheumatoid arthritis,c-x-c motif chemokine ligand 8
diclofenac,rheumatoid arthritis,dihydrofolate reductase
sulfasalazine,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
sulfasalazine,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
sulfasalazine,rheumatoid arthritis,arachidonate 5-lipoxygenase
sulfasalazine,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
sulfasalazine,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
sulfasalazine,rheumatoid arthritis,atp binding cassette subfamily c member 2
sulfasalazine,rheumatoid arthritis,solute carrier family 46 member 1
sulfasalazine,rheumatoid arthritis,atp binding cassette subfamily g member 2 (jr blood group)
minocycline,rheumatoid arthritis,caspase 1
minocycline,rheumatoid arthritis,interleukin 1 beta
minocycline,rheumatoid arthritis,matrix metallopeptidase 9
minocycline,rheumatoid arthritis,vascular endothelial growth factor a
minocycline,rheumatoid arthritis,arachidonate 5-lipoxygenase
prednisolone,rheumatoid arthritis,atp binding cassette subfamily b member 1
prednisolone,rheumatoid arthritis,serpin family a member 6
prednisone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
prednisone,rheumatoid arthritis,albumin
prednisone,rheumatoid arthritis,hydroxysteroid 11-beta dehydrogenase 1
prednisone,rheumatoid arthritis,atp binding cassette subfamily b member 1
nabumetone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
nabumetone,rheumatoid arthritis,myeloperoxidase
nabumetone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
oxaprozin,rheumatoid arthritis,complement c5
etoposide,small cell lung carcinoma,udp glucuronosyltransferase family 1 member a1
docetaxel,small cell lung carcinoma,epidermal growth factor receptor
topotecan,small cell lung carcinoma,dna topoisomerase i mitochondrial
irinotecan,small cell lung carcinoma,udp glucuronosyltransferase family 1 member a1
irinotecan,small cell lung carcinoma,dna topoisomerase i
irinotecan,small cell lung carcinoma,dna topoisomerase i mitochondrial
ifosfamide,small cell lung carcinoma,cytochrome p450 family 2 subfamily a member 6
metformin,polycystic ovary syndrome,nadh:ubiquinone oxidoreductase subunit a10
metformin,polycystic ovary syndrome,nadh:ubiquinone oxidoreductase complex assembly factor 2
metformin,polycystic ovary syndrome,nadh:ubiquinone oxidoreductase subunit a3
progesterone,polycystic ovary syndrome,progesterone receptor
progesterone,polycystic ovary syndrome,androgen receptor
progesterone,polycystic ovary syndrome,sex hormone binding globulin
progesterone,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
progesterone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
progesterone,polycystic ovary syndrome,estrogen receptor 1
progesterone,polycystic ovary syndrome,cytochrome p450 family 17 subfamily a member 1
estrone,polycystic ovary syndrome,estrogen receptor 1
estrone,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
estrone,polycystic ovary syndrome,sex hormone binding globulin
letrozole,polycystic ovary syndrome,cytochrome p450 family 19 subfamily a member 1
desogestrel,polycystic ovary syndrome,sex hormone binding globulin
desogestrel,polycystic ovary syndrome,progesterone receptor
desogestrel,polycystic ovary syndrome,estrogen receptor 1
estradiol valerate,polycystic ovary syndrome,estrogen receptor 1
estradiol valerate,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
estradiol valerate,polycystic ovary syndrome,sex hormone binding globulin
estradiol valerate,polycystic ovary syndrome,androgen receptor
norgestimate,polycystic ovary syndrome,estrogen receptor 1
norgestimate,polycystic ovary syndrome,progesterone receptor
medroxyprogesterone,polycystic ovary syndrome,aldo-keto reductase family 1 member c3
medroxyprogesterone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
medroxyprogesterone,polycystic ovary syndrome,sex hormone binding globulin
medroxyprogesterone,polycystic ovary syndrome,progesterone receptor
medroxyprogesterone,polycystic ovary syndrome,estrogen receptor 1
medroxyprogesterone,polycystic ovary syndrome,androgen receptor
medroxyprogesterone,polycystic ovary syndrome,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
ethynodiol diacetate,polycystic ovary syndrome,progesterone receptor
ethynodiol diacetate,polycystic ovary syndrome,estrogen receptor 1
levonorgestrel,polycystic ovary syndrome,steroid 5 alpha-reductase 1
levonorgestrel,polycystic ovary syndrome,cytochrome p450 family 19 subfamily a member 1
levonorgestrel,polycystic ovary syndrome,androgen receptor
levonorgestrel,polycystic ovary syndrome,progesterone receptor
levonorgestrel,polycystic ovary syndrome,sex hormone binding globulin
levonorgestrel,polycystic ovary syndrome,estrogen receptor 1
drospirenone,polycystic ovary syndrome,progesterone receptor
drospirenone,polycystic ovary syndrome,androgen receptor
ethinylestradiol,polycystic ovary syndrome,estrogen receptor 1
ethinylestradiol,polycystic ovary syndrome,sex hormone binding globulin
norethisterone,polycystic ovary syndrome,sex hormone binding globulin
norethisterone,polycystic ovary syndrome,progesterone receptor
spironolactone,polycystic ovary syndrome,progesterone receptor
spironolactone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
spironolactone,polycystic ovary syndrome,sex hormone binding globulin
spironolactone,polycystic ovary syndrome,androgen receptor
spironolactone,polycystic ovary syndrome,cytochrome p450 family 11 subfamily b member 1
prednisone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
prednisolone,temporal arteritis,serpin family a member 6
methylprednisolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
betamethasone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
triamcinolone,temporal arteritis,serpin family a member 6
pge1,tetralogy of fallot,prostaglandin e receptor 1
acenocoumarol,thrombophilia due to thrombin defect,vitamin k epoxide reductase complex subunit 1
bupropion,nicotine dependence,cytochrome p450 family 2 subfamily a member 6
bupropion,nicotine dependence,solute carrier family 6 member 2
nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 4 subunit
nicotine,nicotine dependence,cytochrome p450 family 2 subfamily a member 6
nicotine,nicotine dependence,cytochrome p450 family 1 subfamily a member 1
nicotine,nicotine dependence,cholinergic receptor nicotinic beta 2 subunit
nicotine,nicotine dependence,cholinergic receptor nicotinic beta 4 subunit
nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 5 subunit
nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 3 subunit
nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 7 subunit
nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 2 subunit
nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 10 subunit
nicotine,nicotine dependence,cholinergic receptor nicotinic beta 3 subunit
nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 6 subunit
nicotine,nicotine dependence,monoamine oxidase b
carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 4
carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 5
carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 9
paroxetine,fibromyalgia,solute carrier family 6 member 4
paroxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
paroxetine,fibromyalgia,solute carrier family 6 member 2
gabapentin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
gabapentin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
pregabalin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
duloxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
amitriptyline,fibromyalgia,solute carrier family 6 member 4
amitriptyline,fibromyalgia,5-hydroxytryptamine receptor 2a
amitriptyline,fibromyalgia,solute carrier family 6 member 2
tramadol,fibromyalgia,solute carrier family 6 member 2
tramadol,fibromyalgia,solute carrier family 6 member 4
fluoxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
fluoxetine,fibromyalgia,solute carrier family 6 member 4
fluoxetine,fibromyalgia,solute carrier family 6 member 2
cyclobenzaprine,fibromyalgia,5-hydroxytryptamine receptor 2a
pramipexole,fibromyalgia,5-hydroxytryptamine receptor 2a
cyclopentolate,cycloplegia,cholinergic receptor muscarinic 3
cyclopentolate,cycloplegia,cholinergic receptor muscarinic 1
morphine,neonatal abstinence syndrome,atp binding cassette subfamily b member 1
diflunisal,arthritic joint disease,prostaglandin-endoperoxide synthase 2
diflunisal,arthritic joint disease,albumin
diflunisal,arthritic joint disease,prostaglandin-endoperoxide synthase 1
diphenhydramine,anxiety disorder,solute carrier family 6 member 3
diphenhydramine,anxiety disorder,solute carrier family 6 member 4
haloperidol,anxiety disorder,5-hydroxytryptamine receptor 2a
haloperidol,anxiety disorder,dopamine receptor d2
haloperidol,anxiety disorder,sigma non-opioid intracellular receptor 1
haloperidol,anxiety disorder,5-hydroxytryptamine receptor 2c
haloperidol,anxiety disorder,5-hydroxytryptamine receptor 1a
haloperidol,anxiety disorder,solute carrier family 6 member 4
haloperidol,anxiety disorder,5-hydroxytryptamine receptor 7
5-fluorouracil,head and neck cancer,thymidylate synthetase
5-fluorouracil,head and neck cancer,dihydropyrimidine dehydrogenase
gemcitabine,head and neck cancer,thymidylate synthetase
docetaxel,head and neck cancer,epidermal growth factor receptor
docetaxel,head and neck cancer,bcl2 apoptosis regulator
paclitaxel,head and neck cancer,bcl2 apoptosis regulator
carboplatin,head and neck cancer,atpase copper transporting beta
carboplatin,head and neck cancer,glutathione s-transferase mu 1
promethazine,atopic conjunctivitis,dopamine receptor d2
promethazine,atopic conjunctivitis,adrenoceptor alpha 1a
promethazine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
diphenhydramine,atopic conjunctivitis,prostaglandin-endoperoxide synthase 1
diphenhydramine,atopic conjunctivitis,solute carrier family 6 member 2
azelastine,atopic conjunctivitis,adrenoceptor alpha 1b
azelastine,atopic conjunctivitis,adrenoceptor alpha 1a
pseudoephedrine,atopic conjunctivitis,adrenoceptor alpha 2a
pseudoephedrine,atopic conjunctivitis,solute carrier family 6 member 2
pseudoephedrine,atopic conjunctivitis,adrenoceptor beta 2
phenylephrine,atopic conjunctivitis,adrenoceptor alpha 2a
hydroxyzine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
hydroxyzine,atopic conjunctivitis,dopamine receptor d2
cyproheptadine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
cyproheptadine,atopic conjunctivitis,solute carrier family 6 member 2
cyproheptadine,atopic conjunctivitis,dopamine receptor d2
epinastine,atopic conjunctivitis,adrenoceptor alpha 1a
epinastine,atopic conjunctivitis,adrenoceptor alpha 2a
epinastine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
cromoglicic acid,atopic conjunctivitis,s100 calcium binding protein p
chlorpheniramine,atopic conjunctivitis,solute carrier family 6 member 2
ephedrine,atopic conjunctivitis,solute carrier family 6 member 2
ephedrine,atopic conjunctivitis,adrenoceptor beta 2
prednisolone,atopic conjunctivitis,serpin family a member 6
clemastine,atopic conjunctivitis,adrenoceptor alpha 2a
clemastine,atopic conjunctivitis,transmembrane protein 97
astemizole,atopic conjunctivitis,transmembrane protein 97
fluorometholone,atopic conjunctivitis,serpin family a member 6
cortisol,atopic conjunctivitis,sex hormone binding globulin
cortisol,atopic conjunctivitis,serpin family a member 6
promazine,atopic conjunctivitis,adrenoceptor alpha 1a
promazine,atopic conjunctivitis,adrenoceptor alpha 1b
promazine,atopic conjunctivitis,adrenoceptor alpha 2a
promazine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
promazine,atopic conjunctivitis,dopamine receptor d2
promazine,atopic conjunctivitis,adrenoceptor alpha 1d
promazine,atopic conjunctivitis,histamine receptor h1
podophyllotoxin,anogenital human papillomavirus infection,tubulin alpha 4a
bromodiphenhydramine,common cold,histamine receptor h1
pseudoephedrine,common cold,adrenoceptor alpha 2a
pseudoephedrine,common cold,solute carrier family 6 member 2
pseudoephedrine,common cold,adrenoceptor beta 1
hydromorphone,common cold,prostaglandin-endoperoxide synthase 1
hydromorphone,common cold,opioid receptor mu 1
phenylephrine,common cold,adrenoceptor alpha 2a
mepyramine,common cold,histamine receptor h1
dextromethorphan,common cold,opioid receptor mu 1
dextromethorphan,common cold,solute carrier family 6 member 2
codeine,common cold,opioid receptor mu 1
caffeine,common cold,adenosine a2b receptor
caffeine,common cold,phosphodiesterase 4b
caffeine,common cold,adenosine a1 receptor
caffeine,common cold,adenosine a2a receptor
caffeine,common cold,adenosine a3 receptor
chlorpheniramine,common cold,solute carrier family 6 member 2
chlorpheniramine,common cold,histamine receptor h1
doxylamine,common cold,cholinergic receptor muscarinic 1
ephedrine,common cold,solute carrier family 6 member 2
ephedrine,common cold,adrenoceptor beta 2
n-methyl scopolamine,common cold,cholinergic receptor muscarinic 1
n-methyl scopolamine,common cold,cholinergic receptor muscarinic 5
n-methyl scopolamine,common cold,cholinergic receptor muscarinic 2
n-methyl scopolamine,common cold,cholinergic receptor muscarinic 3
n-methyl scopolamine,common cold,cholinergic receptor muscarinic 4
chlophedianol,common cold,histamine receptor h1
hydrocodone,common cold,opioid receptor mu 1
paracetamol,common cold,transient receptor potential cation channel subfamily v member 1
paracetamol,common cold,cannabinoid receptor 1
prednisolone,eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
prednisolone,eosinophilic pneumonia,serpin family a member 6
acetazolamide,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 2
acetazolamide,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 4
phenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
phenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 3
phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 2
phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 8
phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 8
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 3
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 10
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 2
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 11
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 7
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 3
topiramate,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 2
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 4
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 5
topiramate,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
topiramate,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 3
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit beta2
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 1
topiramate,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 4
topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit gamma2
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 4
topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 1
carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
methylphenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
methylphenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit beta2
primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
primidone,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
primidone,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit gamma2
fluoxymesterone,eunuchism,androgen receptor
cabergoline,hyperprolactinemia,dopamine receptor d3
oseltamivir,influenza,solute carrier family 22 member 8
prednisolone,miliary tuberculosis,serpin family a member 6
triamcinolone,miliary tuberculosis,serpin family a member 6
miconazole,oral candidiasis,cytochrome p450 family 51 subfamily a member 1
miconazole,oral candidiasis,potassium calcium-activated channel subfamily n member 4
miconazole,oral candidiasis,cytochrome p450 family 17 subfamily a member 1
miconazole,oral candidiasis,cytochrome p450 family 11 subfamily b member 1
clotrimazole,oral candidiasis,cytochrome p450 family 11 subfamily b member 1
clotrimazole,oral candidiasis,cytochrome p450 family 17 subfamily a member 1
clotrimazole,oral candidiasis,cytochrome p450 family 51 subfamily a member 1
clotrimazole,oral candidiasis,potassium calcium-activated channel subfamily n member 4
miconazole,pityriasis versicolor,cytochrome p450 family 51 subfamily a member 1
miconazole,pityriasis versicolor,potassium calcium-activated channel subfamily n member 4
miconazole,pityriasis versicolor,cytochrome p450 family 17 subfamily a member 1
miconazole,pityriasis versicolor,cytochrome p450 family 11 subfamily b member 1
(-)-menthol,pityriasis versicolor,transient receptor potential cation channel subfamily m member 8
clotrimazole,pityriasis versicolor,cytochrome p450 family 11 subfamily b member 1
clotrimazole,pityriasis versicolor,cytochrome p450 family 17 subfamily a member 1
clotrimazole,pityriasis versicolor,cytochrome p450 family 51 subfamily a member 1
clotrimazole,pityriasis versicolor,potassium calcium-activated channel subfamily n member 4
proguanil,plasmodium falciparum malaria,dihydrofolate reductase
hydroxychloroquine,plasmodium falciparum malaria,toll like receptor 7
hydroxychloroquine,plasmodium falciparum malaria,toll like receptor 9
hydroxychloroquine,plasmodium falciparum malaria,transmembrane protein 97
chloroquine,plasmodium falciparum malaria,toll like receptor 9
chloroquine,plasmodium falciparum malaria,transmembrane protein 97
chloroquine,plasmodium vivax malaria,toll like receptor 9
chloroquine,plasmodium vivax malaria,transmembrane protein 97
hydroxychloroquine,plasmodium vivax malaria,toll like receptor 7
hydroxychloroquine,plasmodium vivax malaria,toll like receptor 9
hydroxychloroquine,plasmodium vivax malaria,transmembrane protein 97
fluoxetine,postpartum depression,solute carrier family 6 member 4
azatadine,familial dermatographia,histamine receptor h1
clemastine,familial dermatographia,histamine receptor h1
clemastine,familial dermatographia,transmembrane protein 97
brompheniramine,familial dermatographia,histamine receptor h1
antazoline,familial dermatographia,histamine receptor h1
diphenylpyraline,familial dermatographia,histamine receptor h1
hydroxyzine,familial dermatographia,histamine receptor h1
hydroxyzine,familial dermatographia,5-hydroxytryptamine receptor 2a
hydroxyzine,familial dermatographia,dopamine receptor d2
chlorpheniramine,familial dermatographia,histamine receptor h1
mepyramine,familial dermatographia,histamine receptor h1
carbinoxamine,familial dermatographia,histamine receptor h1
doxylamine,familial dermatographia,histamine receptor h1
promazine,familial dermatographia,5-hydroxytryptamine receptor 2a
promazine,familial dermatographia,dopamine receptor d2
promazine,familial dermatographia,histamine receptor h1
dexbrompheniramine,familial dermatographia,histamine receptor h1
cyproheptadine,familial dermatographia,5-hydroxytryptamine receptor 2a
cyproheptadine,familial dermatographia,dopamine receptor d2
cyproheptadine,familial dermatographia,histamine receptor h1
triprolidine,familial dermatographia,histamine receptor h1
methdilazine,familial dermatographia,histamine receptor h1
zonisamide,lewy body dementia,sodium voltage-gated channel alpha subunit 1
5-fluorouracil,esophageal cancer,cytochrome p450 family 2 subfamily a member 6
5-fluorouracil,esophageal cancer,thymidine phosphorylase
docetaxel,esophageal cancer,epidermal growth factor receptor
docetaxel,esophageal cancer,nuclear receptor subfamily 1 group i member 2
docetaxel,esophageal cancer,atp binding cassette subfamily c member 2
docetaxel,esophageal cancer,bcl2 apoptosis regulator
docetaxel,esophageal cancer,atp binding cassette subfamily b member 1
docetaxel,esophageal cancer,cytochrome p450 family 1 subfamily b member 1
clonidine,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
haloperidol,tourette syndrome,5-hydroxytryptamine receptor 2a
haloperidol,tourette syndrome,dopamine receptor d4
haloperidol,tourette syndrome,dopamine receptor d3
haloperidol,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
haloperidol,tourette syndrome,transmembrane protein 97
pimozide,tourette syndrome,5-hydroxytryptamine receptor 2a
pimozide,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
pimozide,tourette syndrome,dopamine receptor d4
fenofibrate,"hyperlipidemia, familial combined, lpl related",peroxisome proliferator activated receptor alpha
fenofibrate,"hyperlipidemia, familial combined, lpl related",fatty acid binding protein 2
nicotinic acid,"hyperlipidemia, familial combined, lpl related",hydroxycarboxylic acid receptor 2
nicotinic acid,"hyperlipidemia, familial combined, lpl related",hydroxycarboxylic acid receptor 3
lovastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
simvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
ezetimibe,"hyperlipidemia, familial combined, lpl related",atp binding cassette subfamily g member 8
diazoxide,islet cell adenomatosis,atp binding cassette subfamily c member 8
norethisterone,uterine corpus leiomyoma,sex hormone binding globulin
norethisterone,uterine corpus leiomyoma,progesterone receptor
ruxolitinib,vitiligo,ribosomal protein s6 kinase a2
ruxolitinib,vitiligo,serine/threonine kinase 25
ruxolitinib,vitiligo,homeodomain interacting protein kinase 1
ezetimibe,sitosterolemia,atp binding cassette subfamily g member 8
ezetimibe,sitosterolemia,atp binding cassette subfamily g member 5
fluoxymesterone,cryptorchidism,sex hormone binding globulin
methyltestosterone,cryptorchidism,androgen receptor
methyltestosterone,cryptorchidism,sex hormone binding globulin
methyltestosterone,cryptorchidism,cytochrome p450 family 19 subfamily a member 1
daunorubicin,acute monocytic leukemia,dna topoisomerase ii alpha
chloroquine,systemic lupus erythematosus,tumor necrosis factor
chloroquine,systemic lupus erythematosus,toll like receptor 9
chloroquine,systemic lupus erythematosus,transmembrane protein 97
hydroxychloroquine,systemic lupus erythematosus,toll like receptor 7
hydroxychloroquine,systemic lupus erythematosus,toll like receptor 9
hydroxychloroquine,systemic lupus erythematosus,transmembrane protein 97
prednisone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
prednisone,systemic lupus erythematosus,albumin
betamethasone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
cortisol,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
cortisol,systemic lupus erythematosus,sex hormone binding globulin
cortisol,systemic lupus erythematosus,serpin family a member 6
triamcinolone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
triamcinolone,systemic lupus erythematosus,serpin family a member 6
dapsone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
dapsone,systemic lupus erythematosus,n-acetyltransferase 2
prednisolone,systemic lupus erythematosus,serpin family a member 6
prednisolone,systemic lupus erythematosus,androgen receptor
biotin,propionic acidemia,propionyl-coa carboxylase subunit alpha
biotin,propionic acidemia,propionyl-coa carboxylase subunit beta
sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 33
sunitinib,gastrointestinal stromal tumor,myosin light chain kinase family member 4
sunitinib,gastrointestinal stromal tumor,"mer proto-oncogene, tyrosine kinase"
sunitinib,gastrointestinal stromal tumor,death associated protein kinase 3
sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 17a
sunitinib,gastrointestinal stromal tumor,cdc like kinase 4
sunitinib,gastrointestinal stromal tumor,p21 (rac1) activated kinase 3
sunitinib,gastrointestinal stromal tumor,cdc like kinase 2
sunitinib,gastrointestinal stromal tumor,ribosomal protein s6 kinase a2
sunitinib,gastrointestinal stromal tumor,cdc like kinase 1
sunitinib,gastrointestinal stromal tumor,homeodomain interacting protein kinase 2
sunitinib,gastrointestinal stromal tumor,ribosomal protein s6 kinase a5
sunitinib,gastrointestinal stromal tumor,mitogen-activated protein kinase kinase kinase 19
sunitinib,gastrointestinal stromal tumor,interleukin 1 receptor associated kinase 1
sunitinib,gastrointestinal stromal tumor,bmp2 inducible kinase
sunitinib,gastrointestinal stromal tumor,mitogen-activated protein kinase kinase kinase kinase 1
sunitinib,gastrointestinal stromal tumor,dual specificity tyrosine phosphorylation regulated kinase 2
sunitinib,gastrointestinal stromal tumor,checkpoint kinase 2
sunitinib,gastrointestinal stromal tumor,myosin light chain kinase
sunitinib,gastrointestinal stromal tumor,ret proto-oncogene
sunitinib,gastrointestinal stromal tumor,phosphorylase kinase catalytic subunit gamma 2
sunitinib,gastrointestinal stromal tumor,phosphorylase kinase catalytic subunit gamma 1
sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 4
sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 10
sunitinib,gastrointestinal stromal tumor,axl receptor tyrosine kinase
sunitinib,gastrointestinal stromal tumor,traf2 and nck interacting kinase
sunitinib,gastrointestinal stromal tumor,myosin light chain kinase 3
sunitinib,gastrointestinal stromal tumor,cyclin g associated kinase
sunitinib,gastrointestinal stromal tumor,unc-51 like autophagy activating kinase 1
sunitinib,gastrointestinal stromal tumor,casein kinase 1 delta
sunitinib,gastrointestinal stromal tumor,delta like non-canonical notch ligand 1
sunitinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
sunitinib,gastrointestinal stromal tumor,homeodomain interacting protein kinase 1
sunitinib,gastrointestinal stromal tumor,ap2 associated kinase 1
sunitinib,gastrointestinal stromal tumor,misshapen like kinase 1
sunitinib,gastrointestinal stromal tumor,"abl proto-oncogene 2, non-receptor tyrosine kinase"
sunitinib,gastrointestinal stromal tumor,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
sunitinib,gastrointestinal stromal tumor,unc-51 like autophagy activating kinase 2
sunitinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
sunitinib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
imatinib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
imatinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
imatinib,gastrointestinal stromal tumor,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
imatinib,gastrointestinal stromal tumor,colony stimulating factor 1 receptor
imatinib,gastrointestinal stromal tumor,solute carrier family 47 member 1
imatinib,gastrointestinal stromal tumor,"abl proto-oncogene 2, non-receptor tyrosine kinase"
imatinib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
imatinib,gastrointestinal stromal tumor,cdc like kinase 1
imatinib,gastrointestinal stromal tumor,serine/threonine kinase 17a
imatinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
imatinib,gastrointestinal stromal tumor,interleukin 1 receptor associated kinase 1
imatinib,gastrointestinal stromal tumor,"b-raf proto-oncogene, serine/threonine kinase"
imatinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 3
imatinib,gastrointestinal stromal tumor,cyclin g associated kinase
imatinib,gastrointestinal stromal tumor,dead-box helicase 3 x-linked
imatinib,gastrointestinal stromal tumor,cdc like kinase 4
regorafenib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 4
regorafenib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
regorafenib,gastrointestinal stromal tumor,epoxide hydrolase 2
regorafenib,gastrointestinal stromal tumor,"b-raf proto-oncogene, serine/threonine kinase"
regorafenib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
regorafenib,gastrointestinal stromal tumor,ret proto-oncogene
regorafenib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 1
regorafenib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
regorafenib,gastrointestinal stromal tumor,kinase insert domain receptor
regorafenib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
regorafenib,gastrointestinal stromal tumor,eph receptor a1
regorafenib,gastrointestinal stromal tumor,cdc like kinase 1
montelukast,allergic rhinitis,prostaglandin-endoperoxide synthase 1
azelastine,allergic rhinitis,adrenoceptor alpha 1b
azelastine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
azelastine,allergic rhinitis,adrenoceptor alpha 1a
promazine,allergic rhinitis,adrenoceptor alpha 1a
promazine,allergic rhinitis,adrenoceptor alpha 1b
promazine,allergic rhinitis,cholinergic receptor muscarinic 5
promazine,allergic rhinitis,adrenoceptor alpha 2a
promazine,allergic rhinitis,5-hydroxytryptamine receptor 2a
promazine,allergic rhinitis,dopamine receptor d2
promazine,allergic rhinitis,cholinergic receptor muscarinic 1
promazine,allergic rhinitis,adrenoceptor alpha 1d
promazine,allergic rhinitis,cholinergic receptor muscarinic 4
promazine,allergic rhinitis,histamine receptor h1
promazine,allergic rhinitis,cholinergic receptor muscarinic 3
promazine,allergic rhinitis,cholinergic receptor muscarinic 2
mepyramine,allergic rhinitis,solute carrier family 22 member 5
prednisone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
flunisolide,allergic rhinitis,serpin family a member 6
hydrocodone,allergic rhinitis,opioid receptor mu 1
fluticasone,allergic rhinitis,serpin family a member 6
pseudoephedrine,allergic rhinitis,adrenoceptor alpha 2a
pseudoephedrine,allergic rhinitis,solute carrier family 6 member 2
pseudoephedrine,allergic rhinitis,adrenoceptor beta 2
pseudoephedrine,allergic rhinitis,interleukin 2
phenylephrine,allergic rhinitis,adrenoceptor alpha 2a
cortisol,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
cortisol,allergic rhinitis,sex hormone binding globulin
cortisol,allergic rhinitis,serpin family a member 6
chlorpheniramine,allergic rhinitis,solute carrier family 6 member 2
caffeine,allergic rhinitis,adenosine a2b receptor
caffeine,allergic rhinitis,phosphodiesterase 4b
caffeine,allergic rhinitis,adenosine a1 receptor
caffeine,allergic rhinitis,adenosine a2a receptor
caffeine,allergic rhinitis,adenosine a3 receptor
clemastine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
clemastine,allergic rhinitis,adrenoceptor alpha 2a
clemastine,allergic rhinitis,cholinergic receptor muscarinic 4
clemastine,allergic rhinitis,transmembrane protein 97
clemastine,allergic rhinitis,cholinergic receptor muscarinic 3
clemastine,allergic rhinitis,cholinergic receptor muscarinic 5
clemastine,allergic rhinitis,cholinergic receptor muscarinic 1
clemastine,allergic rhinitis,cholinergic receptor muscarinic 2
brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 4
brompheniramine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 2
brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 5
brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 3
brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 1
mometasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
ephedrine,allergic rhinitis,solute carrier family 6 member 2
ephedrine,allergic rhinitis,adrenoceptor beta 2
hydroxyzine,allergic rhinitis,5-hydroxytryptamine receptor 2a
hydroxyzine,allergic rhinitis,dopamine receptor d2
fexofenadine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
dextromethorphan,allergic rhinitis,opioid receptor mu 1
dextromethorphan,allergic rhinitis,solute carrier family 6 member 2
beclometasone,allergic rhinitis,serpin family a member 6
beclometasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
paracetamol,allergic rhinitis,transient receptor potential cation channel subfamily v member 1
paracetamol,allergic rhinitis,sulfotransferase family 1a member 1
paracetamol,allergic rhinitis,cannabinoid receptor 1
cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 3
cyproheptadine,allergic rhinitis,5-hydroxytryptamine receptor 2a
cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 2
cyproheptadine,allergic rhinitis,solute carrier family 6 member 2
cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 1
cyproheptadine,allergic rhinitis,dopamine receptor d2
cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 5
cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 4
n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 1
n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 5
n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 2
n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 3
n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 4
dexbrompheniramine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
dexbrompheniramine,allergic rhinitis,histamine receptor h1
prednisolone,allergic rhinitis,serpin family a member 6
astemizole,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
astemizole,allergic rhinitis,"major histocompatibility complex, class i, a"
astemizole,allergic rhinitis,transmembrane protein 97
codeine,allergic rhinitis,opioid receptor mu 1
betamethasone,allergic rhinitis,prostaglandin-endoperoxide synthase 2
betamethasone,allergic rhinitis,phospholipase a2 group ib
doxylamine,allergic rhinitis,cholinergic receptor muscarinic 1
loratadine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
triamcinolone,allergic rhinitis,prostaglandin-endoperoxide synthase 2
triamcinolone,allergic rhinitis,serpin family a member 6
ibuprofen,patent ductus arteriosus,c-x-c motif chemokine ligand 8
ibuprofen,patent ductus arteriosus,albumin
indomethacin,patent ductus arteriosus,c-x-c motif chemokine ligand 8
indomethacin,patent ductus arteriosus,albumin
indomethacin,patent ductus arteriosus,aldo-keto reductase family 1 member c3
sulfasalazine,psoriatic arthritis,solute carrier family 46 member 1
sulfasalazine,psoriatic arthritis,acetyl-coa acetyltransferase 1
cortisol,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
cortisol,psoriatic arthritis,sex hormone binding globulin
cortisol,psoriatic arthritis,serpin family a member 6
prednisolone,psoriatic arthritis,serpin family a member 6
betamethasone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
triamcinolone,psoriatic arthritis,serpin family a member 6
tofacitinib,psoriatic arthritis,"fyn proto-oncogene, src family tyrosine kinase"
tofacitinib,psoriatic arthritis,janus kinase 3
tofacitinib,psoriatic arthritis,janus kinase 1
tofacitinib,psoriatic arthritis,janus kinase 2
leflunomide,psoriatic arthritis,dihydroorotate dehydrogenase (quinone)
prednisone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
imatinib,idiopathic hypereosinophilic syndrome,platelet derived growth factor receptor alpha
acebutolol,anxiety,adrenoceptor beta 2
acebutolol,anxiety,adrenoceptor beta 1
alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
alprazolam,anxiety,bromodomain containing 4
chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
doxepin,anxiety,5-hydroxytryptamine receptor 2a
doxepin,anxiety,solute carrier family 6 member 2
doxepin,anxiety,histamine receptor h1
doxepin,anxiety,dopamine receptor d2
doxepin,anxiety,solute carrier family 6 member 4
doxepin,anxiety,5-hydroxytryptamine receptor 1a
trifluoperazine,anxiety,sigma non-opioid intracellular receptor 1
trifluoperazine,anxiety,histamine receptor h1
trifluoperazine,anxiety,5-hydroxytryptamine receptor 1a
trifluoperazine,anxiety,5-hydroxytryptamine receptor 2a
imipramine,anxiety,histamine receptor h1
imipramine,anxiety,dopamine receptor d2
imipramine,anxiety,5-hydroxytryptamine receptor 2a
imipramine,anxiety,solute carrier family 6 member 2
imipramine,anxiety,solute carrier family 6 member 4
imipramine,anxiety,5-hydroxytryptamine receptor 1a
adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
methylphenobarbital,anxiety,glutamate ionotropic receptor kainate type subunit 2
methylphenobarbital,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
methylphenobarbital,anxiety,cholinergic receptor nicotinic alpha 4 subunit
clomipramine,anxiety,5-hydroxytryptamine receptor 2a
clomipramine,anxiety,solute carrier family 6 member 2
clomipramine,anxiety,solute carrier family 6 member 4
clomipramine,anxiety,dopamine receptor d2
clomipramine,anxiety,dopamine receptor d1
diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
desipramine,anxiety,adrenoceptor beta 2
desipramine,anxiety,5-hydroxytryptamine receptor 1a
desipramine,anxiety,adrenoceptor beta 1
desipramine,anxiety,5-hydroxytryptamine receptor 2a
desipramine,anxiety,dopamine receptor d2
desipramine,anxiety,solute carrier family 6 member 4
desipramine,anxiety,histamine receptor h1
desipramine,anxiety,solute carrier family 6 member 2
desipramine,anxiety,dopamine receptor d1
imatinib,dermatofibrosarcoma protuberans,"kit proto-oncogene, receptor tyrosine kinase"
imatinib,dermatofibrosarcoma protuberans,"abl proto-oncogene 1, non-receptor tyrosine kinase"
imatinib,dermatofibrosarcoma protuberans,discoidin domain receptor tyrosine kinase 1
imatinib,dermatofibrosarcoma protuberans,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
imatinib,dermatofibrosarcoma protuberans,solute carrier family 47 member 1
imatinib,dermatofibrosarcoma protuberans,"abl proto-oncogene 2, non-receptor tyrosine kinase"
imatinib,dermatofibrosarcoma protuberans,platelet derived growth factor receptor beta
imatinib,dermatofibrosarcoma protuberans,discoidin domain receptor tyrosine kinase 2
imatinib,dermatofibrosarcoma protuberans,dead-box helicase 3 x-linked
cephalotaxine,"chronic myelogenous leukemia, bcr-abl1 positive",ribosomal protein l3
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",discoidin domain receptor tyrosine kinase 1
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",platelet derived growth factor receptor alpha
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 2, non-receptor tyrosine kinase"
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",carbonic anhydrase 9
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 19
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","b-raf proto-oncogene, serine/threonine kinase"
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",mitogen-activated protein kinase 14
imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",platelet derived growth factor receptor alpha
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 2, non-receptor tyrosine kinase"
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",eph receptor a5
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",dead-box helicase 1
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 19
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",mitogen-activated protein kinase 14
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 8
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","b-raf proto-oncogene, serine/threonine kinase"
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",receptor interacting serine/threonine kinase 3
ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",discoidin domain receptor tyrosine kinase 1
hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",ribonucleotide reductase regulatory subunit m2
hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",carbonic anhydrase 9
pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit gamma2
pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha3
pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha5
pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha6
pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha1
pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha2
pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit beta2
pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha4
thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit gamma2
thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit beta2
biotin,biotinidase deficiency,holocarboxylase synthetase
biotin,holocarboxylase synthetase deficiency,holocarboxylase synthetase
methylprednisolone,mycosis fungoides,atp binding cassette subfamily b member 1
triamcinolone,mycosis fungoides,serpin family a member 6
prednisolone,mycosis fungoides,atp binding cassette subfamily b member 1
prednisolone,mycosis fungoides,serpin family a member 6
vincristine,mycosis fungoides,atp binding cassette subfamily b member 1
vincristine,mycosis fungoides,tubulin beta 8 class viii
vincristine,mycosis fungoides,tubulin beta 3 class iii
vincristine,mycosis fungoides,tubulin beta class i
vincristine,mycosis fungoides,tubulin beta 1 class vi
vincristine,mycosis fungoides,tubulin beta 4a class iva
vincristine,mycosis fungoides,tubulin beta 2a class iia
vincristine,mycosis fungoides,tubulin beta 2b class iib
vincristine,mycosis fungoides,tubulin beta 4b class ivb
vincristine,mycosis fungoides,tubulin beta 6 class v
cyclophosphamide,mycosis fungoides,atp binding cassette subfamily b member 1
prednisone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
prednisone,mycosis fungoides,atp binding cassette subfamily b member 1
betamethasone,mycosis fungoides,atp binding cassette subfamily b member 1
vinblastine,mycosis fungoides,tubulin beta 4a class iva
vinblastine,mycosis fungoides,tubulin beta 1 class vi
vinblastine,mycosis fungoides,tubulin beta 8 class viii
vinblastine,mycosis fungoides,atp binding cassette subfamily b member 1
vinblastine,mycosis fungoides,tubulin beta 2b class iib
vinblastine,mycosis fungoides,tubulin beta 4b class ivb
vinblastine,mycosis fungoides,tubulin beta 2a class iia
vinblastine,mycosis fungoides,tubulin beta 3 class iii
vinblastine,mycosis fungoides,tubulin beta 6 class v
cortisol,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
cortisol,mycosis fungoides,atp binding cassette subfamily b member 1
cortisol,mycosis fungoides,sex hormone binding globulin
cortisol,mycosis fungoides,serpin family a member 6
ruxolitinib,primary myelofibrosis,mitogen-activated protein kinase kinase kinase 19
ruxolitinib,primary myelofibrosis,death associated protein kinase 2
ruxolitinib,primary myelofibrosis,janus kinase 1
ruxolitinib,primary myelofibrosis,death associated protein kinase 3
ruxolitinib,primary myelofibrosis,bmp2 inducible kinase
ruxolitinib,primary myelofibrosis,doublecortin like kinase 3
ruxolitinib,primary myelofibrosis,janus kinase 2
ruxolitinib,primary myelofibrosis,serine/threonine kinase 16
ruxolitinib,primary myelofibrosis,cyclin g associated kinase
ruxolitinib,primary myelofibrosis,death associated protein kinase 1
betamethasone,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
betamethasone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
panobinostat,plasma cell myeloma,histone deacetylase 6
panobinostat,plasma cell myeloma,histone deacetylase 10
panobinostat,plasma cell myeloma,histone deacetylase 11
panobinostat,plasma cell myeloma,histone deacetylase 9
panobinostat,plasma cell myeloma,histone deacetylase 7
panobinostat,plasma cell myeloma,histone deacetylase 1
panobinostat,plasma cell myeloma,histone deacetylase 2
panobinostat,plasma cell myeloma,histone deacetylase 3
panobinostat,plasma cell myeloma,histone deacetylase 4
panobinostat,plasma cell myeloma,histone deacetylase 8
panobinostat,plasma cell myeloma,histone deacetylase 5
methylprednisolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
lenalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
lenalidomide,plasma cell myeloma,cereblon
triamcinolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
triamcinolone,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
etoposide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
etoposide,plasma cell myeloma,dna topoisomerase ii alpha
etoposide,plasma cell myeloma,atp binding cassette subfamily c member 1 (abcc1 blood group)
etoposide,plasma cell myeloma,glutathione s-transferase theta 1
vincristine,plasma cell myeloma,atp binding cassette subfamily c member 1 (abcc1 blood group)
prednisone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
pomalidomide,plasma cell myeloma,cereblon
prednisolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
bortezomib,plasma cell myeloma,proteasome 20s subunit alpha 1
bortezomib,plasma cell myeloma,cathepsin g
bortezomib,plasma cell myeloma,proteasome 20s subunit beta 2
bortezomib,plasma cell myeloma,proteasome 20s subunit beta 8
bortezomib,plasma cell myeloma,chymotrypsinogen b1
thalidomide,plasma cell myeloma,tumor necrosis factor
thalidomide,plasma cell myeloma,cereblon
thalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
prednisolone,sjogren syndrome,serpin family a member 6
cortisol,angioedema,sex hormone binding globulin
cortisol,angioedema,serpin family a member 6
prednisone,angioedema,nuclear receptor subfamily 3 group c member 1
prednisone,angioedema,albumin
prednisolone,angioedema,serpin family a member 6
betamethasone,angioedema,nuclear receptor subfamily 3 group c member 1
triamcinolone,angioedema,serpin family a member 6
promazine,angioedema,5-hydroxytryptamine receptor 2a
promazine,angioedema,dopamine receptor d2
promazine,angioedema,histamine receptor h1
vasopressin,hemophilia a,arginine vasopressin receptor 1b
vasopressin,hemophilia a,arginine vasopressin receptor 1a
vasopressin,hemophilia a,arginine vasopressin receptor 2
desmopressin,hemophilia a,arginine vasopressin receptor 1a
desmopressin,hemophilia a,arginine vasopressin receptor 1b
ergocalciferol,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 2 subfamily r member 1
ergocalciferol,x-linked dominant hypophosphatemic rickets,vitamin d receptor
ergocalciferol,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 27 subfamily b member 1
"1,25-dihydroxyvitamin d3",x-linked dominant hypophosphatemic rickets,vitamin d receptor
l-citrulline,ornithine carbamoyltransferase deficiency,ornithine transcarbamylase
finasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 2
finasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 1
tadalafil,benign prostatic hyperplasia,phosphodiesterase 5a
tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
prasugrel,cerebrovascular disorder,purinergic receptor p2y12
prasugrel,cerebrovascular disorder,albumin
caffeine,obesity disorder,cytochrome p450 family 1 subfamily b member 1
caffeine,obesity disorder,cytochrome p450 family 2 subfamily e member 1
caffeine,obesity disorder,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"
caffeine,obesity disorder,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"
caffeine,obesity disorder,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"
lorcaserin,obesity disorder,5-hydroxytryptamine receptor 2a
lorcaserin,obesity disorder,solute carrier family 6 member 4
sibutramine,obesity disorder,solute carrier family 6 member 3
sibutramine,obesity disorder,solute carrier family 6 member 4
sibutramine,obesity disorder,solute carrier family 6 member 2
fenfluramine,obesity disorder,5-hydroxytryptamine receptor 2c
fenfluramine,obesity disorder,5-hydroxytryptamine receptor 2a
methamphetamine,obesity disorder,solute carrier family 6 member 2
methamphetamine,obesity disorder,trace amine associated receptor 1
methamphetamine,obesity disorder,solute carrier family 22 member 3
methamphetamine,obesity disorder,solute carrier family 18 member a2
methamphetamine,obesity disorder,solute carrier family 6 member 3
methamphetamine,obesity disorder,solute carrier family 6 member 4
bupropion,obesity disorder,solute carrier family 6 member 2
bupropion,obesity disorder,solute carrier family 6 member 3
bupropion,obesity disorder,cytochrome p450 family 2 subfamily e member 1
bupropion,obesity disorder,adrenoceptor alpha 1a
bupropion,obesity disorder,solute carrier family 6 member 4
benzphetamine,obesity disorder,solute carrier family 18 member a2
benzphetamine,obesity disorder,solute carrier family 6 member 3
benzphetamine,obesity disorder,solute carrier family 6 member 2
phentermine,obesity disorder,solute carrier family 6 member 4
phentermine,obesity disorder,solute carrier family 6 member 3
rimonabant,obesity disorder,cannabinoid receptor 2
rimonabant,obesity disorder,cannabinoid receptor 1
naltrexone,obesity disorder,opioid receptor mu 1
naltrexone,obesity disorder,opioid receptor kappa 1
naltrexone,obesity disorder,opioid receptor delta 1
dexfenfluramine,obesity disorder,solute carrier family 6 member 4
dexfenfluramine,obesity disorder,5-hydroxytryptamine receptor 2c
dexfenfluramine,obesity disorder,cytochrome p450 family 2 subfamily e member 1
phenmetrazine,obesity disorder,solute carrier family 6 member 3
phenmetrazine,obesity disorder,solute carrier family 6 member 2
amphetamine,obesity disorder,solute carrier family 22 member 3
amphetamine,obesity disorder,solute carrier family 6 member 4
amphetamine,obesity disorder,solute carrier family 6 member 2
amphetamine,obesity disorder,dopamine receptor d2
amphetamine,obesity disorder,solute carrier family 6 member 3
secobarbital,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
zolpidem,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
zolpidem,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
choline,insomnia,adenosine a2a receptor
eszopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
zaleplon,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
triazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
triazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
melatonin,insomnia,calreticulin
nitrazepam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
nitrazepam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
midazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
midazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
pentobarbitone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
pentobarbitone,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
flurazepam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
flurazepam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
zopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
zopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
alprazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
alprazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
betamethasone,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
betamethasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
cetirizine,"dermatitis, atopic",histamine receptor h1
mometasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
doxepin,"dermatitis, atopic",histamine receptor h1
doxepin,"dermatitis, atopic",histamine receptor h2
clobetasol propionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
triamcinolone,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
prednisone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
cortisol,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
l-glutamine,sickle cell anemia,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
hydroxyurea,sickle cell anemia,ribonucleotide reductase regulatory subunit m2
prednisolone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
prednisolone,juvenile idiopathic arthritis,serpin family a member 6
etodolac,juvenile idiopathic arthritis,dihydrofolate reductase
methylprednisolone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
meloxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
salicylic acid,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
salicylic acid,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
salicylic acid,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
salicylic acid,juvenile idiopathic arthritis,high mobility group box 1
naproxen,juvenile idiopathic arthritis,aldo-keto reductase family 1 member c3
naproxen,juvenile idiopathic arthritis,dihydrofolate reductase
celecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
chloroquine,juvenile idiopathic arthritis,tumor necrosis factor
chloroquine,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
prednisone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
prednisone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
betamethasone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
betamethasone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
tolmetin,juvenile idiopathic arthritis,c-x-c motif chemokine ligand 8
triamcinolone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
triamcinolone,juvenile idiopathic arthritis,serpin family a member 6
nabumetone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
nabumetone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
sulfasalazine,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
sulfasalazine,juvenile idiopathic arthritis,arachidonate 5-lipoxygenase
sulfasalazine,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
sulfasalazine,juvenile idiopathic arthritis,solute carrier family 46 member 1
rofecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
ibuprofen,juvenile idiopathic arthritis,c-x-c motif chemokine ligand 8
ibuprofen,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
ibuprofen,juvenile idiopathic arthritis,dihydrofolate reductase
piroxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
piroxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
spironolactone,acne,progesterone receptor
spironolactone,acne,nuclear receptor subfamily 3 group c member 1
spironolactone,acne,sex hormone binding globulin
spironolactone,acne,androgen receptor
spironolactone,acne,cytochrome p450 family 11 subfamily b member 1
dapsone,acne,prostaglandin-endoperoxide synthase 2
dapsone,acne,prostaglandin-endoperoxide synthase 1
ethinylestradiol,acne,estrogen receptor 2
ethinylestradiol,acne,sex hormone binding globulin
estradiol valerate,acne,sex hormone binding globulin
estradiol valerate,acne,androgen receptor
azelaic acid,acne,tyrosinase
drospirenone,acne,progesterone receptor
drospirenone,acne,prostaglandin-endoperoxide synthase 2
drospirenone,acne,androgen receptor
tretinoin,acne,retinoid x receptor beta
cortisol,acne,cytochrome p450 family 11 subfamily b member 1
cortisol,acne,sex hormone binding globulin
norethisterone,acne,sex hormone binding globulin
norethisterone,acne,progesterone receptor
minocycline,acne,interleukin 1 beta
adapalene,acne,retinoid x receptor beta
adapalene,acne,retinoic acid receptor beta
adapalene,acne,retinoic acid receptor alpha
adapalene,acne,retinoic acid receptor gamma
levonorgestrel,acne,androgen receptor
levonorgestrel,acne,progesterone receptor
levonorgestrel,acne,sex hormone binding globulin
levonorgestrel,acne,estrogen receptor 1
norgestimate,acne,estrogen receptor 1
norgestimate,acne,progesterone receptor
estrone,acne,estrogen receptor 1
estrone,acne,estrogen receptor 2
estrone,acne,sex hormone binding globulin
tretinoin,acute promyelocytic leukemia,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
cytarabine,acute promyelocytic leukemia,"dna polymerase alpha 1, catalytic subunit"
cytarabine,acute promyelocytic leukemia,"dna polymerase delta 1, catalytic subunit"
cytarabine,acute promyelocytic leukemia,dna polymerase beta
cytarabine,acute promyelocytic leukemia,"dna polymerase epsilon, catalytic subunit"
tamibarotene,acute promyelocytic leukemia,retinoic acid receptor alpha
tamibarotene,acute promyelocytic leukemia,retinoic acid receptor beta
daunorubicin,acute promyelocytic leukemia,dna topoisomerase ii alpha
lovastatin,hypoalphalipoproteinemia,3-hydroxy-3-methylglutaryl-coa reductase
fenofibrate,hypoalphalipoproteinemia,peroxisome proliferator activated receptor alpha
simvastatin,hypoalphalipoproteinemia,3-hydroxy-3-methylglutaryl-coa reductase
gemfibrozil,hypoalphalipoproteinemia,peroxisome proliferator activated receptor alpha
prednisolone,hypersensitivity pneumonitis,serpin family a member 6
ceftriaxone,meningococcal meningitis,synuclein alpha
acth,west syndrome,melanocortin 3 receptor
vemurafenib,erdheim-chester disease,"b-raf proto-oncogene, serine/threonine kinase"
vandetanib,thyroid gland carcinoma,ret proto-oncogene
vandetanib,thyroid gland carcinoma,ste20 like kinase
sorafenib,thyroid gland carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
sorafenib,thyroid gland carcinoma,ret proto-oncogene
sorafenib,thyroid gland carcinoma,ste20 like kinase
triamcinolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
triamcinolone,chronic primary adrenal insufficiency,serpin family a member 6
prednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
prednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
prednisolone,chronic primary adrenal insufficiency,serpin family a member 6
prednisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
cortisol,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
cortisol,chronic primary adrenal insufficiency,sex hormone binding globulin
cortisol,chronic primary adrenal insufficiency,serpin family a member 6
cortisol,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
methylprednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
betamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
betamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
fludrocortisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
fludrocortisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
prednisolone,dermatitis herpetiformis,serpin family a member 6
triamcinolone,dermatitis herpetiformis,serpin family a member 6
prednisone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
dapsone,dermatitis herpetiformis,myeloperoxidase
cortisol,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
cortisol,dermatitis herpetiformis,sex hormone binding globulin
cortisol,dermatitis herpetiformis,serpin family a member 6
betamethasone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
imatinib,chronic eosinophilic leukemia,"kit proto-oncogene, receptor tyrosine kinase"
imatinib,chronic eosinophilic leukemia,"abl proto-oncogene 1, non-receptor tyrosine kinase"
imatinib,chronic eosinophilic leukemia,discoidin domain receptor tyrosine kinase 1
imatinib,chronic eosinophilic leukemia,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
imatinib,chronic eosinophilic leukemia,solute carrier family 47 member 1
imatinib,chronic eosinophilic leukemia,"abl proto-oncogene 2, non-receptor tyrosine kinase"
imatinib,chronic eosinophilic leukemia,platelet derived growth factor receptor beta
imatinib,chronic eosinophilic leukemia,discoidin domain receptor tyrosine kinase 2
imatinib,chronic eosinophilic leukemia,dead-box helicase 3 x-linked
imatinib,myeloid neoplasm associated with pdgfra rearrangement,platelet derived growth factor receptor alpha
cortisol,adrenogenital syndrome,cytochrome p450 family 11 subfamily b member 1
nitric oxide,pulmonary arterial hypertension,guanylate cyclase 1 soluble subunit alpha 2
pge1,pulmonary arterial hypertension,prostaglandin e receptor 1
pge1,pulmonary arterial hypertension,prostaglandin e receptor 2
pge1,pulmonary arterial hypertension,prostaglandin i2 receptor
iloprost,pulmonary arterial hypertension,prostaglandin i2 receptor
iloprost,pulmonary arterial hypertension,prostaglandin e receptor 1
iloprost,pulmonary arterial hypertension,prostaglandin e receptor 4
iloprost,pulmonary arterial hypertension,prostaglandin e receptor 2
tadalafil,pulmonary arterial hypertension,phosphodiesterase 5a
nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 2
nintedanib,interstitial lung disease,fibroblast growth factor receptor 3
nintedanib,interstitial lung disease,kinase insert domain receptor
nintedanib,interstitial lung disease,cdc like kinase 1
nintedanib,interstitial lung disease,axl receptor tyrosine kinase
nintedanib,interstitial lung disease,discoidin domain receptor tyrosine kinase 1
nintedanib,interstitial lung disease,nuak family kinase 2
nintedanib,interstitial lung disease,insulin receptor related receptor
nintedanib,interstitial lung disease,fms related receptor tyrosine kinase 1
nintedanib,interstitial lung disease,cyclin dependent kinase 16
nintedanib,interstitial lung disease,serine/threonine kinase 16
nintedanib,interstitial lung disease,rio kinase 1
nintedanib,interstitial lung disease,"mer proto-oncogene, tyrosine kinase"
nintedanib,interstitial lung disease,ste20 like kinase
nintedanib,interstitial lung disease,platelet derived growth factor receptor beta
nintedanib,interstitial lung disease,g protein-coupled receptor kinase 4
nintedanib,interstitial lung disease,maternal embryonic leucine zipper kinase
nintedanib,interstitial lung disease,cdc like kinase 4
nintedanib,interstitial lung disease,serine/threonine kinase 11
nintedanib,interstitial lung disease,srsf protein kinase 3
nintedanib,interstitial lung disease,ttk protein kinase
nintedanib,interstitial lung disease,platelet derived growth factor receptor alpha
nintedanib,interstitial lung disease,serine/threonine kinase 4
nintedanib,interstitial lung disease,protein kinase cgmp-dependent 1
nintedanib,interstitial lung disease,bmp2 inducible kinase
nintedanib,interstitial lung disease,pre-mrna processing factor kinase prp4k
nintedanib,interstitial lung disease,p21 (rac1) activated kinase 2
nintedanib,interstitial lung disease,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 7
nintedanib,interstitial lung disease,fibroblast growth factor receptor 1
nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 19
nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase 5
nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit gamma2
nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit alpha1
nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta2
nitrazepam,early myoclonic encephalopathy,sodium voltage-gated channel alpha subunit 1
nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta3
clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit alpha1
clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta2
clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit gamma2
mexiletine,myotonic syndrome,sodium voltage-gated channel alpha subunit 4
prednisolone,allergic bronchopulmonary aspergillosis,serpin family a member 6
triamcinolone,diamond-blackfan anemia,serpin family a member 6
cortisol,diamond-blackfan anemia,sex hormone binding globulin
cortisol,diamond-blackfan anemia,serpin family a member 6
prednisolone,diamond-blackfan anemia,serpin family a member 6
prednisolone,diamond-blackfan anemia,androgen receptor
prednisone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
triamcinolone,chronic beryllium disease,serpin family a member 6
cortisol,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
cortisol,chronic beryllium disease,sex hormone binding globulin
cortisol,chronic beryllium disease,serpin family a member 6
prednisone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
prednisolone,chronic beryllium disease,serpin family a member 6
vandetanib,medullary thyroid gland carcinoma,ret proto-oncogene
vandetanib,medullary thyroid gland carcinoma,kinase insert domain receptor
vandetanib,medullary thyroid gland carcinoma,tek receptor tyrosine kinase
vandetanib,medullary thyroid gland carcinoma,fms related receptor tyrosine kinase 3
vandetanib,medullary thyroid gland carcinoma,axl receptor tyrosine kinase
vandetanib,medullary thyroid gland carcinoma,"met proto-oncogene, receptor tyrosine kinase"
vandetanib,medullary thyroid gland carcinoma,discoidin domain receptor tyrosine kinase 1
vandetanib,medullary thyroid gland carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
cabozantinib,medullary thyroid gland carcinoma,discoidin domain receptor tyrosine kinase 1
lisuride,acromegaly,dopamine receptor d3
lisuride,acromegaly,5-hydroxytryptamine receptor 2b
lisuride,acromegaly,dopamine receptor d4
lisuride,acromegaly,dopamine receptor d5
bromocriptine,acromegaly,5-hydroxytryptamine receptor 6
bromocriptine,acromegaly,dopamine receptor d4
bromocriptine,acromegaly,5-hydroxytryptamine receptor 2b
bromocriptine,acromegaly,dopamine receptor d5
octreotide,acromegaly,somatostatin receptor 1
octreotide,acromegaly,somatostatin receptor 3
octreotide,acromegaly,somatostatin receptor 4
octreotide,acromegaly,somatostatin receptor 5
octreotide,acromegaly,somatostatin receptor 2
nicotine,pellagra,cholinergic receptor nicotinic alpha 4 subunit
nicotine,pellagra,cholinergic receptor nicotinic beta 2 subunit
nicotine,pellagra,cholinergic receptor nicotinic alpha 2 subunit
nicotine,pellagra,cholinergic receptor nicotinic beta 3 subunit
nicotine,pellagra,cholinergic receptor nicotinic alpha 6 subunit
ruxolitinib,myeloproliferative neoplasm,janus kinase 3
ruxolitinib,myeloproliferative neoplasm,"kit proto-oncogene, receptor tyrosine kinase"
ruxolitinib,myeloproliferative neoplasm,"abl proto-oncogene 1, non-receptor tyrosine kinase"
prednisolone,autoimmune hemolytic anemia,serpin family a member 6
cortisol,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
cortisol,autoimmune hemolytic anemia,sex hormone binding globulin
cortisol,autoimmune hemolytic anemia,serpin family a member 6
triamcinolone,autoimmune hemolytic anemia,serpin family a member 6
prednisone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
betamethasone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
prednisolone,uveitis,serpin family a member 6
fluorometholone,uveitis,serpin family a member 6
triamcinolone,uveitis,serpin family a member 6
cortisol,uveitis,sex hormone binding globulin
cortisol,uveitis,serpin family a member 6
cyclopentolate,uveitis,cholinergic receptor muscarinic 3
cyclopentolate,uveitis,cholinergic receptor muscarinic 1
azacitidine,chronic myelomonocytic leukemia,dna methyltransferase 3 alpha
azacitidine,chronic myelomonocytic leukemia,dna methyltransferase 1
azacitidine,chronic myelomonocytic leukemia,cytidine deaminase
midostaurin,aggressive systemic mastocytosis,microtubule affinity regulating kinase 3
midostaurin,aggressive systemic mastocytosis,protein kinase n1
midostaurin,aggressive systemic mastocytosis,tank binding kinase 1
midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 9
midostaurin,aggressive systemic mastocytosis,calcium/calmodulin dependent protein kinase ii alpha
midostaurin,aggressive systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
midostaurin,aggressive systemic mastocytosis,serine/threonine kinase 4
midostaurin,aggressive systemic mastocytosis,pre-mrna splicing tri-snrnp complex factor prpf4
midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 11
midostaurin,aggressive systemic mastocytosis,fms related receptor tyrosine kinase 3
midostaurin,aggressive systemic mastocytosis,protein kinase n2
midostaurin,aggressive systemic mastocytosis,tankyrase 2
midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 19
midostaurin,mast cell leukemia,microtubule affinity regulating kinase 3
midostaurin,mast cell leukemia,protein kinase n1
midostaurin,mast cell leukemia,tank binding kinase 1
midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 9
midostaurin,mast cell leukemia,calcium/calmodulin dependent protein kinase ii alpha
midostaurin,mast cell leukemia,serine/threonine kinase 4
midostaurin,mast cell leukemia,pre-mrna splicing tri-snrnp complex factor prpf4
midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 11
midostaurin,mast cell leukemia,protein kinase n2
midostaurin,mast cell leukemia,tankyrase 2
midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 19
carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 4
carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 5
carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 9
glibenclamide,neonatal diabetes mellitus,atp binding cassette subfamily c member 8
glibenclamide,neonatal diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 3
phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 2
phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 8
phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
felbamate,lennox-gastaut syndrome,glutamate ionotropic receptor nmda type subunit 2a
felbamate,lennox-gastaut syndrome,glutamate ionotropic receptor nmda type subunit 2b
lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 8
lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 3
lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 10
lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 2
phenobarbital,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
phenobarbital,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 3
topiramate,lennox-gastaut syndrome,carbonic anhydrase 2
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 4
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 5
topiramate,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
topiramate,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 3
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 1
topiramate,lennox-gastaut syndrome,carbonic anhydrase 4
topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 4
topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 1
carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
primidone,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
primidone,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
sapropterin,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,phenylalanine hydroxylase
nizatidine,systemic mastocytosis,histamine receptor h2
rabeprazole,systemic mastocytosis,atpase h+/k+ transporting subunit beta
cimetidine,systemic mastocytosis,solute carrier family 47 member 1
imatinib,systemic mastocytosis,"abl proto-oncogene 1, non-receptor tyrosine kinase"
imatinib,systemic mastocytosis,discoidin domain receptor tyrosine kinase 1
imatinib,systemic mastocytosis,n-ribosyldihydronicotinamide:quinone dehydrogenase 2
imatinib,systemic mastocytosis,solute carrier family 47 member 1
imatinib,systemic mastocytosis,"abl proto-oncogene 2, non-receptor tyrosine kinase"
imatinib,systemic mastocytosis,platelet derived growth factor receptor beta
imatinib,systemic mastocytosis,discoidin domain receptor tyrosine kinase 2
imatinib,systemic mastocytosis,dead-box helicase 3 x-linked
acth,stevens-johnson syndrome,melanocortin 3 receptor
prednisolone,stevens-johnson syndrome,serpin family a member 6
ezetimibe,homozygous familial hypercholesterolemia,atp binding cassette subfamily g member 8
ezetimibe,homozygous familial hypercholesterolemia,atp binding cassette subfamily g member 5
simvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
methylprednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
triamcinolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
triamcinolone,congenital adrenal hyperplasia,serpin family a member 6
prednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
prednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
prednisolone,congenital adrenal hyperplasia,serpin family a member 6
betamethasone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
betamethasone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
cortisol,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
cortisol,congenital adrenal hyperplasia,cytochrome p450 family 11 subfamily b member 1
cortisol,congenital adrenal hyperplasia,sex hormone binding globulin
cortisol,congenital adrenal hyperplasia,serpin family a member 6
cortisol,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
dantrolene,malignant hyperthermia of anesthesia,ryanodine receptor 1
dantrolene,malignant hyperthermia of anesthesia,ryanodine receptor 3
thalidomide,pyoderma gangrenosum,tumor necrosis factor
thalidomide,pyoderma gangrenosum,nuclear factor kappa b subunit 1
cytarabine,acute myeloid leukemia,"dna polymerase alpha 1, catalytic subunit"
cytarabine,acute myeloid leukemia,"dna polymerase delta 1, catalytic subunit"
cytarabine,acute myeloid leukemia,dna polymerase beta
cytarabine,acute myeloid leukemia,"dna polymerase epsilon, catalytic subunit"
daunorubicin,acute myeloid leukemia,dna topoisomerase ii beta
daunorubicin,acute myeloid leukemia,dna topoisomerase ii alpha
etoposide,acute myeloid leukemia,dna topoisomerase ii beta
etoposide,acute myeloid leukemia,dna topoisomerase ii alpha
fludarabine,acute myeloid leukemia,"dna polymerase alpha 1, catalytic subunit"
mercaptopurine,acute myeloid leukemia,hypoxanthine phosphoribosyltransferase 1
midostaurin,acute myeloid leukemia,microtubule affinity regulating kinase 3
midostaurin,acute myeloid leukemia,protein kinase n1
midostaurin,acute myeloid leukemia,tank binding kinase 1
midostaurin,acute myeloid leukemia,death associated protein kinase 1
midostaurin,acute myeloid leukemia,axl receptor tyrosine kinase
midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 9
midostaurin,acute myeloid leukemia,calcium/calmodulin dependent protein kinase ii alpha
midostaurin,acute myeloid leukemia,"mer proto-oncogene, tyrosine kinase"
midostaurin,acute myeloid leukemia,serine/threonine kinase 4
midostaurin,acute myeloid leukemia,"pim-2 proto-oncogene, serine/threonine kinase"
midostaurin,acute myeloid leukemia,pre-mrna splicing tri-snrnp complex factor prpf4
midostaurin,acute myeloid leukemia,unc-51 like kinase 3
midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 11
midostaurin,acute myeloid leukemia,polo like kinase 4
midostaurin,acute myeloid leukemia,protein kinase n2
midostaurin,acute myeloid leukemia,neurotrophic receptor tyrosine kinase 3
midostaurin,acute myeloid leukemia,cyclin g associated kinase
midostaurin,acute myeloid leukemia,interleukin 1 receptor associated kinase 3
midostaurin,acute myeloid leukemia,janus kinase 2
midostaurin,acute myeloid leukemia,tankyrase 2
midostaurin,acute myeloid leukemia,janus kinase 1
midostaurin,acute myeloid leukemia,"met proto-oncogene, receptor tyrosine kinase"
midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 19
midostaurin,acute myeloid leukemia,ap2 associated kinase 1
midostaurin,acute myeloid leukemia,colony stimulating factor 1 receptor
venetoclax,acute myeloid leukemia,bcl2 apoptosis regulator
venetoclax,acute myeloid leukemia,bcl2 like 2
venetoclax,acute myeloid leukemia,bcl2 like 1
mitoxantrone,acute myeloid leukemia,solute carrier family 47 member 2
mitoxantrone,acute myeloid leukemia,solute carrier family 47 member 1
quizartinib,acute myeloid leukemia,neurotrophic receptor tyrosine kinase 3
quizartinib,acute myeloid leukemia,"kit proto-oncogene, receptor tyrosine kinase"
quizartinib,acute myeloid leukemia,kinase insert domain receptor
quizartinib,acute myeloid leukemia,fms related receptor tyrosine kinase 3
quizartinib,acute myeloid leukemia,platelet derived growth factor receptor beta
quizartinib,acute myeloid leukemia,platelet derived growth factor receptor alpha
quizartinib,acute myeloid leukemia,myosin heavy chain 10
quizartinib,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 19
quizartinib,acute myeloid leukemia,colony stimulating factor 1 receptor
thioguanine,acute myeloid leukemia,hypoxanthine phosphoribosyltransferase 1
thioguanine,acute myeloid leukemia,inosine monophosphate dehydrogenase 2
thioguanine,acute myeloid leukemia,inosine monophosphate dehydrogenase 1
azacitidine,acute myeloid leukemia,dna methyltransferase 3 alpha
azacitidine,acute myeloid leukemia,dna methyltransferase 1
histamine,acute myeloid leukemia,histamine receptor h4
histamine,acute myeloid leukemia,histamine receptor h1
gilteritinib,acute myeloid leukemia,cyclin g associated kinase
gilteritinib,acute myeloid leukemia,"ran, member ras oncogene family"
gilteritinib,acute myeloid leukemia,solute carrier family 25 member 6
gilteritinib,acute myeloid leukemia,"tu translation elongation factor, mitochondrial"
gilteritinib,acute myeloid leukemia,24-dehydrocholesterol reductase
gilteritinib,acute myeloid leukemia,interleukin 1 receptor associated kinase 3
gilteritinib,acute myeloid leukemia,polo like kinase 4
gilteritinib,acute myeloid leukemia,solute carrier family 25 member 5
gilteritinib,acute myeloid leukemia,protein kinase c alpha
gilteritinib,acute myeloid leukemia,acyl-coa synthetase long chain family member 5
gilteritinib,acute myeloid leukemia,cytochrome c1
gilteritinib,acute myeloid leukemia,fms related receptor tyrosine kinase 3
gilteritinib,acute myeloid leukemia,unc-51 like kinase 3
gilteritinib,acute myeloid leukemia,ap2 associated kinase 1
gilteritinib,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 11
gilteritinib,acute myeloid leukemia,platelet derived growth factor receptor beta
vincristine,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
vincristine,diffuse large b-cell lymphoma,atp binding cassette subfamily g member 2 (jr blood group)
epirubicin,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
etoposide,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
etoposide,diffuse large b-cell lymphoma,atp binding cassette subfamily g member 2 (jr blood group)
etoposide,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
prednisone,diffuse large b-cell lymphoma,nuclear receptor subfamily 3 group c member 1
prednisone,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
lenalidomide,follicular lymphoma,cereblon
teniposide,follicular lymphoma,dna topoisomerase ii alpha
mitoxantrone,follicular lymphoma,dna topoisomerase ii alpha
prednisone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
cortisol,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
betamethasone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
prednisone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
ivermectin,onchocerciasis,glycine receptor alpha 3
thalidomide,poems syndrome,cereblon
ibrutinib,marginal zone lymphoma,erb-b2 receptor tyrosine kinase 2
cladribine,hairy cell leukemia,ribonucleotide reductase catalytic subunit m1
vinblastine,gestational trophoblastic neoplasm,tubulin beta 4a class iva
vinblastine,gestational trophoblastic neoplasm,tubulin beta 1 class vi
vinblastine,gestational trophoblastic neoplasm,tubulin beta 8 class viii
vinblastine,gestational trophoblastic neoplasm,atp binding cassette subfamily b member 1
vinblastine,gestational trophoblastic neoplasm,tubulin beta 2b class iib
vinblastine,gestational trophoblastic neoplasm,tubulin beta 4b class ivb
vinblastine,gestational trophoblastic neoplasm,tubulin beta class i
vinblastine,gestational trophoblastic neoplasm,tubulin beta 2a class iia
vinblastine,gestational trophoblastic neoplasm,tubulin beta 3 class iii
vinblastine,gestational trophoblastic neoplasm,tubulin beta 6 class v
methyltestosterone,noonan syndrome,androgen receptor
fluoxymesterone,noonan syndrome,androgen receptor
tafamidis,amyloidosis,transthyretin
prednisone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
methylprednisolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
triamcinolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
triamcinolone,idiopathic acute eosinophilic pneumonia,serpin family a member 6
prednisolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
prednisolone,idiopathic acute eosinophilic pneumonia,serpin family a member 6
cortisol,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
cortisol,idiopathic acute eosinophilic pneumonia,sex hormone binding globulin
cortisol,idiopathic acute eosinophilic pneumonia,serpin family a member 6
betamethasone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
prednisolone,sympathetic ophthalmia,serpin family a member 6
triamcinolone,sympathetic ophthalmia,serpin family a member 6
sapropterin,classic phenylketonuria,phenylalanine hydroxylase
triamcinolone,sarcoidosis,serpin family a member 6
cortisol,sarcoidosis,nuclear receptor subfamily 3 group c member 1
cortisol,sarcoidosis,sex hormone binding globulin
cortisol,sarcoidosis,serpin family a member 6
prednisone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
prednisolone,sarcoidosis,serpin family a member 6
bosentan,scleroderma,endothelin receptor type a
bosentan,scleroderma,endothelin receptor type b
tafamidis,attrv122i amyloidosis,transthyretin
prednisone,trichinellosis,nuclear receptor subfamily 3 group c member 1
triamcinolone,trichinellosis,serpin family a member 6
cortisol,trichinellosis,sex hormone binding globulin
cortisol,trichinellosis,serpin family a member 6
mometasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
chloroquine,discoid lupus erythematosus,toll like receptor 9
hydroxychloroquine,discoid lupus erythematosus,toll like receptor 7
hydroxychloroquine,discoid lupus erythematosus,toll like receptor 9
vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 1b
vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 1a
vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 2
desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 1a
desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 1b
desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 2
hydroxocobalamin,vitamin b12 deficiency,cubilin
hydroxocobalamin,vitamin b12 deficiency,cobalamin binding intrinsic factor
hydroxocobalamin,vitamin b12 deficiency,amnion associated transmembrane protein
ciprofloxacin,escherichia coli infection,atp binding cassette subfamily b member 1
oxaliplatin,malignant colon neoplasm,atp binding cassette subfamily g member 2 (jr blood group)
oxaliplatin,malignant colon neoplasm,glutathione s-transferase pi 1
oxaliplatin,malignant colon neoplasm,solute carrier family 22 member 1
oxaliplatin,malignant colon neoplasm,nad(p)h quinone dehydrogenase 1
oxaliplatin,malignant colon neoplasm,glutathione s-transferase mu 1
oxaliplatin,malignant colon neoplasm,atpase copper transporting alpha
trifluridine,malignant colon neoplasm,thymidylate synthetase
trifluridine,malignant colon neoplasm,thymidine phosphorylase
tipiracil,malignant colon neoplasm,thymidine phosphorylase
5-fluorouracil,malignant colon neoplasm,atp binding cassette subfamily g member 2 (jr blood group)
5-fluorouracil,malignant colon neoplasm,thymidine phosphorylase
5-fluorouracil,malignant colon neoplasm,thymidylate synthetase
5-fluorouracil,malignant colon neoplasm,methylenetetrahydrofolate reductase
5-fluorouracil,malignant colon neoplasm,dihydropyrimidine dehydrogenase
5-fluorouracil,malignant colon neoplasm,uridine monophosphate synthetase
biperiden,parkinsonian disorder,cholinergic receptor muscarinic 2
biperiden,parkinsonian disorder,cholinergic receptor muscarinic 4
carbidopa,parkinsonian disorder,dopa decarboxylase
procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 2
procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 4
procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 1
pergolide,parkinsonian disorder,dopamine receptor d1
pergolide,parkinsonian disorder,dopamine receptor d5
pergolide,parkinsonian disorder,dopamine receptor d3
pergolide,parkinsonian disorder,dopamine receptor d2
pergolide,parkinsonian disorder,dopamine receptor d4
methixene,parkinsonian disorder,cholinergic receptor muscarinic 4
methixene,parkinsonian disorder,cholinergic receptor muscarinic 2
methixene,parkinsonian disorder,cholinergic receptor muscarinic 1
amantadine,parkinsonian disorder,dopa decarboxylase
amantadine,parkinsonian disorder,monoamine oxidase b
amantadine,parkinsonian disorder,sigma non-opioid intracellular receptor 1
levodopa,parkinsonian disorder,dopa decarboxylase
benzatropine,parkinsonian disorder,cholinergic receptor muscarinic 2
orphenadrine,parkinsonian disorder,sodium voltage-gated channel alpha subunit 9
orphenadrine,parkinsonian disorder,sodium voltage-gated channel alpha subunit 1
orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 2
orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 4
orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 1
methylphenidate,narcolepsy,solute carrier family 6 member 3
methylphenidate,narcolepsy,solute carrier family 6 member 2
dexamfetamine,narcolepsy,trace amine associated receptor 1
amphetamine,narcolepsy,solute carrier family 6 member 2
amphetamine,narcolepsy,solute carrier family 6 member 3
imipramine,narcolepsy,5-hydroxytryptamine receptor 2a
imipramine,narcolepsy,solute carrier family 6 member 3
imipramine,narcolepsy,solute carrier family 6 member 2
clomiphene,female infertility,cytochrome p450 family 19 subfamily a member 1
clomiphene,female infertility,estrogen receptor 1
caffeine,headache disorder,phosphodiesterase 4b
haloperidol,headache disorder,histamine receptor h1
haloperidol,headache disorder,adrenoceptor alpha 1a
icosapent,hyperlipidemia,diacylglycerol o-acyltransferase 1
lovastatin,hyperlipidemia,3-hydroxy-3-methylglutaryl-coa reductase
nicotine,hyperlipidemia,cytochrome p450 family 19 subfamily a member 1
ezetimibe,hyperlipidemia,atp binding cassette subfamily g member 8
ezetimibe,hyperlipidemia,atp binding cassette subfamily g member 5
nicotinic acid,hyperlipidemia,hydroxycarboxylic acid receptor 3
bezafibrate,hyperlipidemia,3-hydroxy-3-methylglutaryl-coa reductase
fenofibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
estramustine,prostate neoplasm,cytochrome p450 family 3 subfamily a member 4
estramustine,prostate neoplasm,estrogen receptor 1
estramustine,prostate neoplasm,estrogen receptor 2
flutamide,prostate neoplasm,cytochrome p450 family 1 subfamily b member 1
flutamide,prostate neoplasm,cytochrome p450 family 1 subfamily a member 1
flutamide,prostate neoplasm,cytochrome p450 family 2 subfamily c member 19
flutamide,prostate neoplasm,cytochrome p450 family 3 subfamily a member 5
flutamide,prostate neoplasm,androgen receptor
flutamide,prostate neoplasm,aryl hydrocarbon receptor
flutamide,prostate neoplasm,cytochrome p450 family 3 subfamily a member 4
paclitaxel,neoplasm of esophagus,bcl2 apoptosis regulator
paclitaxel,neoplasm of esophagus,cytochrome p450 family 19 subfamily a member 1
paclitaxel,neoplasm of esophagus,atp binding cassette subfamily b member 1
paclitaxel,neoplasm of esophagus,nuclear receptor subfamily 1 group i member 2
clozapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
clozapine,manic bipolar affective disorder,dopamine receptor d1
aripiprazole,manic bipolar affective disorder,dopamine receptor d5
aripiprazole,manic bipolar affective disorder,dopamine receptor d1
aripiprazole,manic bipolar affective disorder,solute carrier family 6 member 4
aripiprazole,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
carbamazepine,manic bipolar affective disorder,solute carrier family 6 member 4
risperidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
risperidone,manic bipolar affective disorder,dopamine receptor d1
risperidone,manic bipolar affective disorder,tachykinin precursor 1
risperidone,manic bipolar affective disorder,dopamine receptor d5
risperidone,manic bipolar affective disorder,solute carrier family 6 member 4
asenapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
asenapine,manic bipolar affective disorder,dopamine receptor d1
asenapine,manic bipolar affective disorder,solute carrier family 6 member 4
asenapine,manic bipolar affective disorder,tachykinin precursor 1
paliperidone,manic bipolar affective disorder,dopamine receptor d1
paliperidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
paliperidone,manic bipolar affective disorder,tachykinin precursor 1
ziprasidone,manic bipolar affective disorder,dopamine receptor d1
ziprasidone,manic bipolar affective disorder,dopamine receptor d5
ziprasidone,manic bipolar affective disorder,solute carrier family 6 member 4
ziprasidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
ziprasidone,manic bipolar affective disorder,tachykinin precursor 1
olanzapine,manic bipolar affective disorder,dopamine receptor d1
olanzapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
olanzapine,manic bipolar affective disorder,dopamine receptor d5
promazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
promazine,manic bipolar affective disorder,dopamine receptor d1
quetiapine,manic bipolar affective disorder,dopamine receptor d5
quetiapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
quetiapine,manic bipolar affective disorder,dopamine receptor d1
quetiapine,manic bipolar affective disorder,tachykinin precursor 1
quetiapine,manic bipolar affective disorder,solute carrier family 6 member 4
cariprazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
cariprazine,manic bipolar affective disorder,dopamine receptor d5
cariprazine,manic bipolar affective disorder,dopamine receptor d1
chlorpromazine,manic bipolar affective disorder,dopamine receptor d5
chlorpromazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
chlorpromazine,manic bipolar affective disorder,dopamine receptor d1
chlorpromazine,manic bipolar affective disorder,solute carrier family 6 member 4
doxepin,bipolar depression,5-hydroxytryptamine receptor 2a
doxepin,bipolar depression,solute carrier family 6 member 4
doxepin,bipolar depression,5-hydroxytryptamine receptor 1a
primidone,bipolar depression,glutamate ionotropic receptor kainate type subunit 2
sertraline,bipolar depression,solute carrier family 6 member 4
sertraline,bipolar depression,monoamine oxidase a
paroxetine,bipolar depression,tachykinin receptor 1
paroxetine,bipolar depression,solute carrier family 6 member 4
paroxetine,bipolar depression,5-hydroxytryptamine receptor 2a
paroxetine,bipolar depression,5-hydroxytryptamine receptor 1a
quetiapine,bipolar depression,dopamine receptor d5
quetiapine,bipolar depression,5-hydroxytryptamine receptor 1a
quetiapine,bipolar depression,5-hydroxytryptamine receptor 2a
quetiapine,bipolar depression,dopamine receptor d1
quetiapine,bipolar depression,tachykinin precursor 1
quetiapine,bipolar depression,solute carrier family 6 member 4
lurasidone,bipolar depression,5-hydroxytryptamine receptor 1a
lurasidone,bipolar depression,5-hydroxytryptamine receptor 2a
carbamazepine,bipolar depression,solute carrier family 6 member 4
escitalopram,bipolar depression,solute carrier family 6 member 4
phenobarbital,bipolar depression,glutamate ionotropic receptor kainate type subunit 2
bupropion,bipolar depression,solute carrier family 6 member 4
nefazodone,bipolar depression,5-hydroxytryptamine receptor 1a
nefazodone,bipolar depression,5-hydroxytryptamine receptor 2a
nefazodone,bipolar depression,solute carrier family 6 member 4
citalopram,bipolar depression,solute carrier family 6 member 4
risperidone,bipolar depression,5-hydroxytryptamine receptor 2a
risperidone,bipolar depression,dopamine receptor d1
risperidone,bipolar depression,5-hydroxytryptamine receptor 1a
risperidone,bipolar depression,tachykinin precursor 1
risperidone,bipolar depression,dopamine receptor d5
risperidone,bipolar depression,solute carrier family 6 member 4
fluvoxamine,bipolar depression,solute carrier family 6 member 4
ziprasidone,bipolar depression,dopamine receptor d1
ziprasidone,bipolar depression,dopamine receptor d5
ziprasidone,bipolar depression,solute carrier family 6 member 4
ziprasidone,bipolar depression,5-hydroxytryptamine receptor 2a
ziprasidone,bipolar depression,5-hydroxytryptamine receptor 1a
ziprasidone,bipolar depression,tachykinin precursor 1
olanzapine,bipolar depression,5-hydroxytryptamine receptor 1a
olanzapine,bipolar depression,dopamine receptor d1
olanzapine,bipolar depression,5-hydroxytryptamine receptor 2a
olanzapine,bipolar depression,dopamine receptor d5
fluoxetine,bipolar depression,5-hydroxytryptamine receptor 2a
fluoxetine,bipolar depression,solute carrier family 6 member 4
paliperidone,bipolar depression,5-hydroxytryptamine receptor 1a
paliperidone,bipolar depression,dopamine receptor d1
paliperidone,bipolar depression,5-hydroxytryptamine receptor 2a
paliperidone,bipolar depression,tachykinin precursor 1
diazoxide,pancreatic insulinoma,atp binding cassette subfamily c member 8
cimetidine,zollinger-ellison syndrome,solute carrier family 47 member 1
rabeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
lansoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
nizatidine,zollinger-ellison syndrome,histamine receptor h2
pantoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
famotidine,zollinger-ellison syndrome,solute carrier family 47 member 1
esomeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
betamethasone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
prednisolone,polymyalgia rheumatica,serpin family a member 6
methylprednisolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
triamcinolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
triamcinolone,polymyalgia rheumatica,serpin family a member 6
prednisone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
ergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1b
dihydroergotamine,cluster headache syndrome,adrenoceptor alpha 2a
caffeine,cluster headache syndrome,phosphodiesterase 4b
prednisone,serum sickness,nuclear receptor subfamily 3 group c member 1
prednisone,serum sickness,albumin
cortisol,serum sickness,nuclear receptor subfamily 3 group c member 1
haloperidol,delirium,dopamine receptor d2
haloperidol,delirium,dopamine receptor d3
oxycodone,neuralgia,opioid receptor mu 1
phenytoin,neuralgia,sodium voltage-gated channel alpha subunit 5
phenytoin,neuralgia,sodium voltage-gated channel alpha subunit 9
gabapentin,neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
trimipramine,neuralgia,5-hydroxytryptamine receptor 2c
naltrexone,neuralgia,opioid receptor mu 1
desipramine,neuralgia,5-hydroxytryptamine receptor 2c
carbamazepine,neuralgia,sodium voltage-gated channel alpha subunit 5
carbamazepine,neuralgia,sodium voltage-gated channel alpha subunit 9
amitriptyline,neuralgia,5-hydroxytryptamine receptor 2c
amitriptyline,neuralgia,opioid receptor mu 1
amitriptyline,neuralgia,neurotrophic receptor tyrosine kinase 1
imipramine,neuralgia,5-hydroxytryptamine receptor 2c
venlafaxine,neuralgia,5-hydroxytryptamine receptor 2c
nortriptyline,neuralgia,5-hydroxytryptamine receptor 2c
morphine,neuralgia,opioid receptor mu 1
tramadol,neuralgia,opioid receptor mu 1
tramadol,neuralgia,5-hydroxytryptamine receptor 2c
lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 9
lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 5
lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 10
ritonavir,covid-19,solute carrier family 47 member 1
ibrutinib,waldenstrom macroglobulinemia,bmx non-receptor tyrosine kinase
ibrutinib,waldenstrom macroglobulinemia,tec protein tyrosine kinase
ibrutinib,waldenstrom macroglobulinemia,"blk proto-oncogene, src family tyrosine kinase"
ibrutinib,waldenstrom macroglobulinemia,txk tyrosine kinase
carmustine,malignant glioma,glutathione-disulfide reductase
phenobarbital,hyperbilirubinemia,atp binding cassette subfamily c member 2
phenobarbital,hyperbilirubinemia,atp binding cassette subfamily b member 11
riboflavin,vitamin deficiency disorder,riboflavin kinase
methylprednisolone,perennial allergic rhinitis,nuclear receptor subfamily 3 group c member 1
gabapentin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
pregabalin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
calcifediol,vitamin d deficiency,vitamin d receptor
"1,25-dihydroxyvitamin d3",vitamin d deficiency,vitamin d receptor
ergocalciferol,vitamin d deficiency,vitamin d receptor
nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 2
nintedanib,interstitial lung disease 2,dual specificity tyrosine phosphorylation regulated kinase 1b
nintedanib,interstitial lung disease 2,fibroblast growth factor receptor 3
nintedanib,interstitial lung disease 2,kinase insert domain receptor
nintedanib,interstitial lung disease 2,cdc like kinase 1
nintedanib,interstitial lung disease 2,doublecortin like kinase 1
nintedanib,interstitial lung disease 2,axl receptor tyrosine kinase
nintedanib,interstitial lung disease 2,txk tyrosine kinase
nintedanib,interstitial lung disease 2,discoidin domain receptor tyrosine kinase 1
nintedanib,interstitial lung disease 2,nuak family kinase 2
nintedanib,interstitial lung disease 2,insulin receptor related receptor
nintedanib,interstitial lung disease 2,fms related receptor tyrosine kinase 1
nintedanib,interstitial lung disease 2,cyclin dependent kinase 16
nintedanib,interstitial lung disease 2,serine/threonine kinase 16
nintedanib,interstitial lung disease 2,rio kinase 1
nintedanib,interstitial lung disease 2,"mer proto-oncogene, tyrosine kinase"
nintedanib,interstitial lung disease 2,platelet derived growth factor receptor beta
nintedanib,interstitial lung disease 2,g protein-coupled receptor kinase 4
nintedanib,interstitial lung disease 2,maternal embryonic leucine zipper kinase
nintedanib,interstitial lung disease 2,cdc like kinase 4
nintedanib,interstitial lung disease 2,serine/threonine kinase 11
nintedanib,interstitial lung disease 2,srsf protein kinase 3
nintedanib,interstitial lung disease 2,ribosomal protein s6 kinase a2
nintedanib,interstitial lung disease 2,ttk protein kinase
nintedanib,interstitial lung disease 2,platelet derived growth factor receptor alpha
nintedanib,interstitial lung disease 2,serine/threonine kinase 4
nintedanib,interstitial lung disease 2,protein kinase cgmp-dependent 1
nintedanib,interstitial lung disease 2,"hck proto-oncogene, src family tyrosine kinase"
nintedanib,interstitial lung disease 2,bmp2 inducible kinase
nintedanib,interstitial lung disease 2,ret proto-oncogene
nintedanib,interstitial lung disease 2,eph receptor a3
nintedanib,interstitial lung disease 2,pre-mrna processing factor kinase prp4k
nintedanib,interstitial lung disease 2,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
nintedanib,interstitial lung disease 2,unc-51 like autophagy activating kinase 1
nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 7
nintedanib,interstitial lung disease 2,"yes proto-oncogene 1, src family tyrosine kinase"
nintedanib,interstitial lung disease 2,fibroblast growth factor receptor 1
nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 19
nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase 5
nintedanib,interstitial lung disease 2,activin a receptor type 1
chlorpromazine,disruptive behavior disorder,dopamine receptor d4
promazine,disruptive behavior disorder,dopamine receptor d4
prednisone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
cortisol,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
methylprednisolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
betamethasone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
prednisone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
prednisolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
cortisol,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
clonazepam,absence epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
rivaroxaban,embolism,coagulation factor x
terbutaline,premature obstetric labor,adrenoceptor beta 2
imatinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
haloperidol,chronic schizophrenia,cytochrome p450 family 3 subfamily a member 4
haloperidol,chronic schizophrenia,cholinergic receptor muscarinic 1
mometasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
cortisol,pruritus ani,nuclear receptor subfamily 3 group c member 1
caffeine,vascular headaches,phosphodiesterase 4b
dihydroergotamine,vascular headaches,adrenoceptor alpha 2a
ergotamine,vascular headaches,5-hydroxytryptamine receptor 1b
trospium chloride,urge incontinence,cholinergic receptor muscarinic 2
trospium chloride,urge incontinence,cholinergic receptor muscarinic 1
trospium chloride,urge incontinence,cholinergic receptor muscarinic 3
darifenacin,urge incontinence,cholinergic receptor muscarinic 2
darifenacin,urge incontinence,cholinergic receptor muscarinic 1
tolterodine,urge incontinence,cholinergic receptor muscarinic 2
tolterodine,urge incontinence,cholinergic receptor muscarinic 1
drospirenone,premenstrual dysphoric disorder,nuclear receptor subfamily 3 group c member 2
ethinylestradiol,premenstrual dysphoric disorder,estrogen receptor 2
ivacaftor,pulmonary cystic fibrosis,cf transmembrane conductance regulator
tafamidis,"familial amyloid neuropathy, portuguese type",transthyretin
doxepin,severe major depression with psychotic features,5-hydroxytryptamine receptor 2a
pralidoxime,poisoning of animals with phosphate salts,butyrylcholinesterase
theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4c
theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4a
theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4d
theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4b